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INTRODUCTION 
The bound copy of The ~oaeedings appears in two volumes. The papers 
received for reproduction have been grouped into three major sections: 
Symposium Introduction, Detailed Test Objectives and Medical Experiments,
and Symposium Summary. The Detailed Test Objectives and Medical Experi­
ments have been further divided into five subsections: Detailed Test 
Objectives, Neurophysiology, and Musculoskeletal Changes comprise
Volume I; Biochemistry, Hematology and Cytology,Cardiovascular and 
Metabolic Function, and Symposium Summary comprise Volume II. The 
papers appear according to the order of presentation at the Symposium, 
but there are minor variances between contents of The ~oaeedings and 
the presentation due to the constraint of time imposed by the length 
of the program. Two papers included in The Proaeedings were "read by
title only" at the Symposium because of late submittal, i.e . .., Red Blood 
Metabolism and Determination of Cardiac Size from Chest Roentgenograms
Following Skylab Missions. Another paper, Immunity (Ml12), also "read 
by title onlyll has not, as yet, been submitted. 
A complete Table of Contents and Index of Authors/Panelists for both 
volumes are included:in each volume for ease of reference .. Every 
attempt has been made to minimize the size of The ~oaeedings and to 
facilitate reference of an author or his/her paper. 
Sylvia A. Rose 
November, 1974. 
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FOREWORD 
Good morning ladies and gentlemen; I would like to welcome you to the 

Skylab Life Sciences Symposium. For the next three days we will pre­

sent the results of an exhaustive series of medical studies conducted 

on missions of 28, 54 and 84 days. 

Before we move into the business at hand, I might take a few minutes to 
set the stage for our later presentations. 
In the history of man's first small steps toward ultimate flight to 
the planets and to distant stars, some notable milestones have been 
achieved. As we have moved along, step by step, the impact of our 
accomplishements has swung from one discipline to another. The success­
ful launch of Alan Shepard into suborbital flight in 1961 was a tre­
mendous boost for rocket specialists. It was, in fact, possible for 
U.S. rockets to launch a manned spacecraft. In the mid-1960s, the 
Gemini rendezvous and docking successes were particularly rewarding
for guidance engineers and those concerned with space mechanics. In 
Apollo, the materials brought back from the lunar surface had a special 
impact for the physical scientist. Now we come to Skylab, and the 
focus of attention moves to the life scientist. Skylab was, in many 
respects, our flight. The reams of data returned from these missions 
'provide 	our first real picture of how man lives in space. We already
knew, of course, that man could exist in space and that he could wopk 
in space. Well before Skylab we solved or understood the principal 
problems of life support, of food service, and of waste management.
But it was not until Skylab that we learned that man could truly Zive 
in space. 
I am happy to report that no major medical finding will be presented

which might curtail man's dreams of more extensive space exploration, 

rather we have found that man can adapt to the new and wonderous envi­

ronment of space. 

Many individuals have made a personal commitment to the success of 

Skylab and previous manned spaceflights, unfortunately all of these 

people will not be able to take part in these presentations. All of 
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us with NASA appreciate the outstanding contributions of these individ­
uals from other nations, the aerospace industry, universites, medical 
schools and other departments of government in making the space program 
one which we can all look to with pride. It is truely our honor to 
open this symposium and to have been a part of the Skylab medical team. 
Deputy Director of Life Sciences 
Lyndon B. Johnson Space Center 
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BIOCHEMICAL RESPONSES OF THE SKYLAB CREWMEN 

Prineipal Investigator: Carolyn S. Leaeh" Ph. D. * 
Principal Coordinating Scientist: Paul C. Rambaut" Se. D.* 
ABSTRACT 
The biochemical investigations of the Skylab crewmen were designed to 
study the physiological changes that were observed on flight crews 
returning from previous space flight missions as well as to study those 
changes expected to result from prolonged weightless exposure. These 
studies can be divided into two broad categories. One category in­
cluded routine blood studies similar to those used in clinical medical 
practice. The second included research-type endocrine analyses used 
to investigate more thoroughly the metabolic/endocrine responses to 
the space flight environment. The premission control values indicated 
that all Skylab crewmen were healthy and were free from biochemical 
abnormalities. The routine results during and after flight showed 
slight but significant changes in electrolytes, glucose, total protein, 
osmolality, uric acid, cholesterol, and creatinine. Plasma hormal 
changes included adrenocorticotrophic hormone, cortisol, angiotensin I, 
aldosterone, insulin, and thyroxine. The 24-hour urine analyses results 
revealed increased excretion of cortisol, catecho1amines, antidiuretic 
hormone, and aldosterone as well as excretion of significant electrolyte 
and uric acid during the Skylab flights. 
The measured changes are consistent with the hypotheses that a relative 
increase in thoracic blood volume upon transition to the zero-gravity 
environment is interpreted as a true intravascular volume expansion
resulting in a fluid and electrolyte loss. These losses, in association 
with other factors, ultimately results in a reduced intravascular volume 
leading to increased renin and secondary aldosteronism. Once these 
compensatory mechanisms are effective in reestablishing fluid balance, 
the crewmen are essenti ally adapted to the null-gravi ty envi ronment. 
Although the physiological cost of this adaptation is reflected by the 
electrolyte deficit and perhaps by other factors, it is assumed that 
the compensated state is adequate for the demands of the envi ronment; 
however, this new homeostatic set is not believed to be without 
physiological cost and, without proper precautions, could reduce the· 
functional reserves of the crewmembers. The general catabolic state 
found in returni ng spa·ce fl i ght crewmen has been documented wi th nega­
tive calcium, phosphorus, sodium, potassium, and nitrogen balances. 
Future research efforts will be directed toward the c13rification of 
*National Aeronautics and Space Administration - Lyndon B. Johnson 
Space Center, Houston, Texas 77058 
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the basis for these physiological changes and the procedures required 
to prevent or lessen these changes on extended space missions. 
INTRODUCTION 
The ability of man to adapt to new environments has intrigued the 
physiologist for many years. Underlying this basic adaptability, 
modern investigators have discerned the action of complex homeostatic 
control mechanisms. These mechanisms, both neural and hormonal mani­
fest themselves by a resistence to change in the internal milieu of 
the organism (1, 2). Provided that the imposed stresses are not 
overwhelming, only slight changes in this internal milieu can be 
expected.' Space flight incorporates unique environmental factors to 
which the organism has not previously been subjected in the course of 
its phylogenetic development. To measure the ability of the crew­
members to adjust to this environment, an extensive biochemical in­
vestigation was conducted on all three Skylab missions. 
METHODS 
Continuous metabolic monitoring of the Skylab crewmen began at least 
21 days prior to each flight and continued throughout each flight and 
for at least 17 days after return. Urine was collected on a void-by­
void basis before and after flight while the in-flight collections 
were performed with an automatic urine collection device. An aliquot 
of each day's in-flight urine was frozen in orbit, stored, and returned 
to our 1 aboratory for ana lys i s postfl tgh.t.. Table 1 snows the duration 
of metabolic monitoring for each mission. The nominal preflight 
control period of 21 days was extended on Skylab 2 and 4 due to the 
delays in launch dates. The nominal postflight period of 18 days was 
shortened by one day on Skylab 2. Following an overnight fast, blood 
samples were drawn at approximately 7 a.m. c.s.t./d.s.t. according to 
the schedule shown in table II. Sodium ethylenediaminetetraacetic 
acid (EDTA) was used as an anticoagulant. The more routine clinical 
biochemical tests were those generally used in laboratory medicine. 
Radi oassay, fl uorometri c and gas chromatographi c techni ques were used 
for most hormonal analyses. 
Radi onucl i de body compartment studi es were conducted 'prefl i ght and 
postflight. These included dilution studies of total body water 
(tritium), extracellular fluid (35sulghate), plasma volume (125I-protein)
and exchangeable potassium (42K and 43K). 
The data have been summarized for presentation. Statistical analyses 
included the covariant analysis and the paired t-Test. The 24-hour 
ur"j ne data have 'been grouped accordi ng to the di etary cycl es. 
428 
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TABLE I. EXPERIMENT SCHEDULE 

Skylab No. of No. of No. of 
Mission Preflight Flight Postflight 
)ti Days Days Days 
2 31 28 17 
~" 3 21 59 18 
4 27 84 18 
TABLE II. SKYLAB BLOOD SAMPLING SCHEDULE 
Sky lab Preflight Postflight 
Mission Oay In-Flight Oay Day 
2 31, 21, 14, 7, 1 4, 6, 13, 27 0,1,4,13 
3 21, 14. 7, 1 3, 6, 14, 20, 30, 38, 48, 58 0,1,3,14 
4 35, 21, 14, 3, 5, 21 , 38, 45, 59, 73, 82 0,1,3,14 
Table III lists all serum and plasma analyses accomplished on the 
Skylab crewmen. Analyses conducted on the in-flight samples by 
micronanalytical techniques are noted. Table IV lists the analyses 
accomplished on the 24 hour urine samples. 
RESULTS 
A comparison of each crewman1s premission values with values obtained • during and after the flight reveals a variety of changes. Tables V, 
Vf, VII and VIII show the results of the plasma and serum biochemical 
measurements. The in-flight and postflight values are compared with 
the mean of the preflight values. Those values statistically different 
from each crewman's own control values are indicated as (p < 0.05). 
Elevations in calcium-and phosphorus were present throughout the three 
missions and remained higher than control for several days following 
flight. Cortisol and Angiotensin I were generally elevated though not 
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TABLE III. PLASMA AND SERUM BIOCHEMICAL ANALYSES 

Substance/Property Quantitatively Determined 
Sodium* Uric acid 
PotassiUIR* Creatinine* 
Calei um* Total Protein 
Magnesium Alkaline phosphatase 
Chloride* Serum gluta.fc oxaloacetic transaminase (aspartate aminotransferase) 
Phosphorus* Creatine phosphokinase 
Osmolal i ty* Lactic dehydrogenase 
Carbon dioxide Glucose'*' 
Cholesterol Total bilirubin 
Triglycerides Growth hormone 
Adrenocorticotrophic hOrMOne* Thyroxine 
Cortisol* Thyroid stimulating hormone 
Angiotensin 1* Testosterone 
Aldosterone* Parathormone* 
Insul1 n* Calei ton1 n 
Blood urea nitrogen Y1ta""n 0 
*Determfned during flight 
TABLE IV. 24-HOUR URINE BIOCHEMICAL ANALYSES 
Substance/Property Quantitatively Determined 

Yolume Ant1diuretic hormone 

Sodillll Aldosterone 

Potas s illll Cortisol 

.. 
Cloride Epinephrine 

OSlIIDlal1ty Norepinephrine 

Calcillll Total l7-Hydroxycort1costerofds 

Phosphate-(PO.) Total l7-Ketosterofds 

MagnesiUIR Uric Acid 

Creatin1ne 
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TABLE V. SKYLAB SUMMARY, PLASMA BIOCHEMICAL RESULTS, (9 Crewmen) 
(Mean ± Standard Error) 
No. Sodium* Potassium Chloride Creatinine Glucose Osmolality Calcium Phosphate 
meq/1iter meq/liter meq/liter mg pet mg pet mOsmoles mg pet mg pet 
36 Prefl.fght 141±0.7 4.l2±0.O4 97.7±0.S 1.26±O.03 86.6±0.03 290±0.8 9.7±0.OS 3.4±0.l 
Mission Day 
9 3, 4 139±2 4.26±0.08 96.8±0.7 1.31±0.03 90.3±2.4 289±1 lO.4±0.l t 3.7±0.3 
8 S, 6 137±2t 4.30±0.14 96.9±0.8 1.27±0.03 86.7±1.8 287±lt 10.2±0.l t 3.6±0.3t 
6 13. 14 137±1 4.41±0.lS 94.7±1.1 t 1.28±0.03 86. 7±1.8 286±2 10.2±0.l t 3.9±0.3t 
6 20, 21 140±1 4.2S±0.11 9S.7±0.8 1.3S±0.03 87.0±1.8 289±2 10.l±0.2t 3.4±0.l t 
6 27, 30 138±0.8t 4.2S±0.lO 9S.2±0.8t 1.27±0.03 84.3±2.3 287±2t 10.4±0.1 t 3.9±0.3t 
..j:::a 
w 6 38 136±2t 4.0S±0.lSt 93.S±1.2 1.31±0.07 SO.1±2.St 2SO±4t 10.hO.2 3.1±0.St 
...... 
6 4S, 48 137±2t 4.30±0.13 94.S±0.7 1. 34±0.03 84.4:t1.4t 287±3 10.1±0.lt 3.8±0.l t 
6 S8. S9 137±2t 4.l9±D.13 94.0±1.S 1.38±0.12 81 ..8±2.2t 286±4 10.l±D.2t 3.8±0.2t 
3 73 139±2 3.7S±0.20 94.6±1.2 1.ShO.OS SO.9±2.2 284±2 10.1±0.3 3.9±0.2t 
3 82 137±0.6 4.19±0.06 9S.8±0.2 l.S4±0.03 81.0±1.2t 28S±2t lO.l±0.1 3.6±0.1 
Recovery (R) 
9 R+O 139±l 4.l8±0.OS 96.2±1.0t 1.28±0.OS 100.S±2.6t 289±l 1O.0±O.lt 3.9±O.2t 
9 R+1 l39±1 4.l0±O.O8 96.4±l.Ot l.3l±0.O6 92.3±2.8 289±l lO.l±O.lt 3.6±O.03t 
9 R+3, 4 l39±l 4.02±O.13 96.9±l.O 1. 26±0.06 9O.S±1.4t 294±2t 9.8±O.l 3.4±O.2 
6 R+14 l41±O.8 4.0S±0.OS 97.7±1.6 1. 33±O.09 8S.4±D.7 289±2 9.4±0.l t 2.8±O.2 
* Corrected for Na-EDTA 
t P ,::.O.OS 
TABLE VI. SKYLAB SUMMARY, PLASMA BIOCHEMICAL RESULTS (9 Crewmen) 

(Mean ± Standard Error) 
NO. CORTISOL ANGIOTENSIN I ALDOSTERONE ACTH INSULIN HGH PTH 
llg/IOO ml ng/ml per hour pg/IOO ml pg/m1 \.IU/m1 ng/m1 ng/m1 
39 Preflight 12.2±0.7 0.77±0.14 180±25 35.7± 3.3 17±0.6 1.3±0.2 17±1 
Mission Day 
9 3. 4 12.7±1.6 1.09±0.24 176±58 15.2± 4.9* 15±2 2.1±0.5* 17±2 
8 5. 6 14.8±1.0* 1. 75±0.42 163±75 26.5± 9.2 18±6 1.2tO.3 16±3 
6 13. 14 13.4±1.7 .91±0.28 252±65 33.0± 8 18±3 1.5±0.2 14±1 
6 20. 21 12.3±1.5 .52±0.12 163±90 11.9± 4* 8±1* 1.2±0.3 20±4 
6 27. 30 13.6±2.1 .45±0.16 204±88 32.0± 7 20±3 3.2±2.0 14±2 
.po 
w 6 38 13.7±1.0 •72±0.36 94±17 17.7±11.6 10±1* 1.1±0.3 15±2 
N 
6 45. 48 14.3±1.3 .37±0.10 118±7 12. h 5.3* 9±2* 1.5±0.5 18±4 
6 58. 59 13.5±0.7* 1.11±0.51* 148:1:31 32.3±18.7 9±2* 1.6±0.4 18±3 
3 73 14.5±3.4 .27±0.08 117±39 6.5± 6.6* 0.6±0.1 24±2 
3 82 16.1±0.6* .32±0. 04 142±17 8.7± 5.2 0.7±0.1 25±2 
Recovery (R) 
9 R+O 13.2±2.1 .71±0.23 215±74 23.8± 6.3 20±3 2.9±0 •.6* 17±2 
9 R+] 10.8±1.0 2.15±0.55* 478±77* 24.0± 7.5* 20±2 2.8±0.8* 19±3 
9 R+3. 4 13.7±3.0 •86±0.45 357±65* 23.3± 2.4* 18±2 2.6±0.8* 19±3 
9 R+13. 14 10.6±0.7 .14±0.05* 153±35 38.2±13.9 17±3 1.2±0.2 18±4 
* p ~ 0.05 Key: TV • Total volume 
ACTH • Adrenocorticotrophic hormone 
HGH.- Hu.tn growth hormone 
PTH • Parathormone 
.~ .. ;fO\ 
... 
TABLE VII. SKYLAB SUMMARY, PLASMA BIOCHEMICAL RESULTS, (9 Crewmen)
IlIA 
(Mean 1 Standard Error) 
No. QIOL£ST£AOl SOOT BUN URIC ACID ALI( PHOS MAGNESIUM BIll T CPI( 
1IIg pet mU/ml JIg pet 1IIg pet IU 1IIg pet IIIg pet IU 
36 Preflight 20517 1310.5 19tO.5 6.4±0.2 2411 2.110.02 0.6tO.02 66t7 
Recoyery (R) 
9 RiO 192:1:25* 121 I 1911 5.510.3* 21±1 2.010.03* 0.510.1 6818 
9 11+1 17Bt23* I3tO.3 19t1 6.0tO.3* 21t1 2.0:1;0.03*' 0.810.2 85111 
9 11+3. 4 188114* 1311 17tl* 6.0tO.3* 20tl 2.010.03 0.510.1 86112 
9 R+14 204t14 14tO.7 1711* 6.5tO.3 2512 2.1:t0.03 0.4tO.1 4717 
,. P ~ 0.05 
Key: 
SOOT· SerUIII glutalll1c oxaloacet1c transalllinase 

BUN • Blood urea nitrogen 

All( Phos - Alkal1ne phospllatase 

BIll T· Bflirubin (total) 

CPI( - Creatinine phosphokinase 

TABLE VIII. 	 SKYLAB SUMMARY, PLASMA BIOCHEMICAL RESULTS (9 Cre\'lTlen) 
Oteall t Standard Error) 
CARBON 
110. 	 lDH TRIGL Y DIOXIDE AlBUMIN PROTEIN T3 TEST TIIYROXINE TSH VITAMIN D 
mU/ml JIg pet IIIq/ltter !III pet !III pet pet UPTAKE ~g pet ~/lIIl n9/1111 
36 Preflight ZOOt6 8615 2210.7 4.410.07 6.8tO.05 32.910.4 7.0tO.3 4.5tO.6 43.3± 3.7 
9 RiO lBlt10 97115 2411* 4.510.1 7.210.1* 33.1±1.3 8.710.5* 8.412.3 39.6110.9 
9 R+l 16717 111t23 2510.5* 4.3tO.l 7.010.07* 29.413.3 9.0tl.O* 7.511.5 43.91 7.7 
9 R+3. 4 23h14* 95113 26tl* 4.1±0.2* 6.6tO.07 34.2tO.7 8.1t0.8 8.2tl.3* 42.1I± 6.6 
9 R+14 194112* 84t6 26tO.5 4. ltO.l* 6.4tO.07 33.410.5 6.~0.3 8. ltO.9* 44.6t 8.8 
• 	 *p ~ 0.05 
KEY: 
lDH - Lactic dehydrogenase 
TRIG!.Y - Tritycerides 
TSIf • Thyroi sthllltatfng lIol"llOlle
',,-- T3 • Trliodotllyrolline 
R+ • Recovery 
always significantly. Potassium and creatinine tended to increase 
in-flight and remain high in the sample obtained immediately after 
recovery. Plasma aldosterone levels varied in-flight but were signifi­
cantly increased postflight. Other parameters, not measured in the 
samples obtained in-flight, were found to be increased postflight.
These include total protein, carbon dioxide, thyroid stimulating 
hormone and thyroxine. 
Those plasma measurements which were less than preflight control in­
flight and postflight include sodium, chloride, osmolality, and ACTH. 
Glucose, insulin and aldosterone were decreased in-flight ~ut increased 
postflight. Other measurements showing decreases postflignt which 
were not measured in-flight included cholesterol, uric acid, magnesium,
lactic dehydrogenase, and total bilirubin. Blood urea nitrogen and 
albumin were not changed at recovery but were decreased the third and 
fourteenth day. 
Those constituents of the 24-hour urine sample which were elevated 
in-flight and postflight are shown in table IX. All of the electro­
lytes were increased in-flight along with aldosterone, cortisol and 
total l7-ketosteroids. Postflight increases were seen in epinephrine, 
norepinepherine, aldosterone, and cortisol. The data also show trends 
toward in-flight decreases in antidiuretic hormone (ADH), epinephrine,
norepinephrine and uric acid. Postflight significant decreases in 
sodium, potassium, chloride, osmolality, P04, magnesium, and uric acid, ADH and total 17 hydroxycorticosteroids were observed. 
DISCUSSION 
The environment of space flight with its combination of stresses offers 
unique challenge to biochemical control mechanisms. That homeostasis 
has been maintained despite these stresses cannot be taken as eVidence 
of the benign nature of the space environment. Men returning from 
previous space flights have undergone changes of sufficient magnitude
and complexity to warrant detailed study of most endocrinologic and 
metabolic changes during and after flight. In view of these considera­
tions, this experiment was designed to investigate particular homeo­
static response in the areas of (1) fluid and electrolyte balance, 
(2) regulation of calcium metabolism, (3) adrenal function, and (4) 
carbohydrate, fat and protein utilization. 
Fluid and Electrolyte Balance 
It has been consistently demonstrated that exposure to weightlessness 
produces changes in the distribution of total blood volume (3). It is 
thought that this redistribution simulates a relative volume expansion 
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TABLE IX. SKYLAB SUMMARY, URINE BIOCHEMICAL RESULTS (9 Crewmen) 
UNITS 
PREFLIGHT 
DAYS 
1-28 
(Mean ± Standard Error) 
1ft-FLIGHT DAYS 
29-59 60-85 1-6 
POSTFLIGHT DAYS 
7-13 14-18 
..J::> 
w 
U'1 
meq/TV 
meq/TV 
meq/TV 
mg/TV 
nCsmles 
meq/T¥ 
mg/TV 
mg/TV 
meq/TV 
Sodium 
Potassium 
Chloride 
Creatinine 
Osmlality 
Calcium 
Phosphates 
Uric Acid 
Magnesium 
160.0± 3.0 
74.0± -1.0 
148.0± 4.0 
1955.0±2O.0 
6SO.0±17 .0 
8.Ot 0.2 
1045.0±15.0 
969.0±15.0 
8.9± 0.1 
174.0± 3.0 
82.0± 2.0 
162.01 5.0 
2079.0±4O.0 
789.0±27.0 
14.4± 0.8 
1270.0±27.0 
899.0±22.0 
10.St 0.2 
190.0± 7.0 
8(1.0± 2.0 
177.0± 6.0 
2104.0±55.0 
791.0±19.0 
14.5±0.8 
1196.0±35.0 
934.0±38.0 
9.4:1 0.4 
199.0± 6.0 
81.0± 3.0 
180 .O:t 5.0 
2081. 0±31. 0 
717.0:!:24.0 
11.& 0.4 
1181.0±3O.0 
884.0±33.0 
8.7± 0.5 
121.0±11.0 
65.0± 4.0 
116.0:tll.0 
2005.0±95.0 
593.0t60.0 
11.2± 1.6 
934.0±55.0 
884.0:!:41.0 
7.7± 0.5 
170.0± 6.0 
76.0± 4.0 
160.0t 6.0 
2037.0:!:78.0 
549.0±49.0 
8.8± 1.0 
1029.0:!:55.0 
929.0±50.0 
9.1± 0.4 
173.0± 11.0 
82.01 5.0 
_164.0:t 11.0 
1969.0±109.0 
584.0± 66.0 
8.lt 1.0 
1031.0± SO.O 
942.0± 53.0 
9.1± 0.4 
JIg/TV 
Ilg/TV 
119/TV 
I191TV 
III\I/TV 
Cortisol 
Aldosterone 
Epinephrine 
Norepinephrine 
Antidiruretic hOnlOne 
54.3± 4.1 
11.3t 1.1 
27.2± 4.6 
69.4± 6.0. 
SO.ltl0.0 
94.4± 4.8 
32.8± 2.2 
24.lt 1.4 
59.9± 2.0 
41.9t 4.3 
83.6± 4.0 
22.4± 1. 7 
21.lt 1.7 
66.7± 4.0 
24.1± 2.4 
90.2± 5.3 
3O.0± 3.1 
38.1:1: 3.3 
65.2± 6.4 
20.lt 2.5 
69.5± 5.8 
18.6± 4.3 
37.2± 3.1 
99.4± 6.2 
46.5±10.0 
63.3± 6.0 
11.8± 3.0 
33.7± 3.4 
88.8± 6.4 
25.6± 8.0 
76.6± 
11.4± 
37.5± 
89.6± 
31.0± 
8.0 
3.3 
7.2 
6.6 
8.2 
mg/TV Total 17 Hydro­
~corticosteroids 6.h 0.4 6.2± 0.4 6.5± 0.3 6.2± 1.0 5.2± 0.5 5. h 0.4 5.2± 0.8 
1liii/TV Total 17 Ketosteroids 7.0± 0.5 10.3± 0.4 10.8± 0.5 13.5± 1.3 7.0± 0.7 7.4± 0.5 7.6± 0.6 
and necessitates compensatory changes in water balance with a net loss 
of water and electrolytes. A negative water balance is evidenced by
nearly universal body weight loss in the returning crews and a rapid 
regain of body weight on the first postmission day. Some of the weight 
loss is attributable to a loss of adipose tissue resulting from in­
sufficient caloric intake; however, protein, mineral and electrolyte 
loss are believed to occur at a proportionately higher rate than can 
be accounted for on the basis of a hypocaloric regimen (4). 
Change in body fluid volume is a sensitive index of homeostatic response. 
During the first six days in-flight all nine crewmen excreted less 
urine (average 400 milliliters) than preflight and there was an 
accompanying decrease of water intake of approximately 700 milliliters. 
These data support a net loss of water during this period. Sweat and 
insensible losses are not included but would be expected to be higher 
at the environmental pressures of the spacecraft (5). It is apparent,
however, that a water diuresis did not occur since the osmolality of 
the urine formed was higher than that of plasma. The urine osmolality 
(for the first 6-day period in-flight) averaged 300 mOsmoles higher
than an equal stable preflight period in spite of decreased electrolyte 
intake during the first period. These data when totally considered 
suggest that an increased solute excretion did occur during the initial 
exposure to weightlessness. 
Twenty-four hour urine volume results (fig. 1) indicate that, except
for the first period in-flight, the crewmen generally excreted volumes 
similar to the preflight control values for each man. 
A similar pattern to that observed for urine volume is exhibited by 
urinary antidiuretic hormone (fig. 2). Significant increases in 
urinary antidiuretic hormone occurred early in-flight in all men. Due 
to inability to refigerate the urine sample obtained on the first day 
in-flight, it could not be analyzed for this hormone. Tables X and XI 
show decreases of about 1.7 percent in total body water, and about 
1.9 percent in extracellular fluid volume following recovery; however, 
when the weight losses are taken into consideration, there is actually
a proportional increase in body water on a volume. per unit weight basis. 
These data, along with fluid volumes and osmolality results, indicate 
that except for Skylab 2 (urine antidiuretic hormone) was minimally 
stimulated. 
Plasma sodium was generally decreased throughout the flight and 
potassium demonstrated trends toward becoming slightly though not 
significantly elevated. In-flight, the quantity of urinary sodium 
excreted each twenty-four hours was elevated above the mean of the 
24-hour periods preflight for all nine crewmen (fig. 3). Urinary 
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Figure 1. Urine volume excretion. 
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Figure 2. Urinary antidiuretic hormone excretion. 
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Figure 3. Urinary sodium excretion. 
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potassium was more variable but, in general, was also elevated (fig. 4). 
Postflight, both of these electrolytes were significantly decreased 
in all of the crewmen. The intakes of these two electrolytes were 
comparable during the three phases of each flight. The loss in 
potassium was also measured by the decrease in total body exchangeable 
potassium shown in table XII. 
TABLE X. SKYLAB SUMMARY TOTAL BODY WATER 
Volume Change (%) 
MissiQn Commander Sci enti st Pil ot Pilot Mean 
2 -2.4 -0.8 -4.4 -2.5 
3 -1.4 +l.3 -3.2 -1. 1 
4 -2.0 -1.1 -1.2 -1.4 
. 

TABLE XI. SKYLAB SUMMARY EXTRACELLULAR FLUID 
Volume Change (%) 
Mission Commander Scientist Pilot Pilot Mean 
2 -1.9 -l.9 +1.3 -0.8 
3 -5.6 -10.2 -O.S -S.4 
4 +7.2 -4.S -l.6 +0.4 
TABLE XI!. EXCHANGEABLE POTASSIUM 
Percent Change
(meq) 
Skylab 2 Skyl ab 3 Skylab 4 
Commander -8.3 -S.6 -3.7 
Scientist Pilot -6.1 -1.1 -8.8 
Pilot -8.8 -3.S -12.3 
Mission Mean -7.7 -3.4 -8.2 
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Figure 4. Urinary potassium excretion. 
A postflight decrease of as much as 20 percent in total body potassium
had previously been shown by measurement of the total body potassium-40
after early Apollo flights. Total body exchangeable potassium, utilizing
potassium-42, was measured on the Apollo 15, 16, and 17 crewmen. It 
was found to be generally decreased postflight even though adequate 
potassium had been ingested throughout these missions (6). The crewmen 
of the Gemini 7 mission demonstrated positive potassium balance before 
and after the flight with a negative balance during the mission. 
The Gemini 7 results were accompanied by increased urinary aldosterone 
excretion (7). During the in-flight phase of the Skylab missions, 
aldosterone output was increased in all nine crewmen (fig. 5). The 
aldosterone concentration reached in this period of time could certain­
ly account for the urinary losses of potassium. However, this mechanism 
is not consistent with the observation that a loss of sodium also 
occurred. Results of the in-flight metabolic experiment on the 
thirteen day Apollo 17 mission suggested similar responses by that 
crew (8). These changes may be explained by functional alterations 
in the renal tubule proximal to the site of aldosterone action in the 
distal tubule involving either humoral or physical factors (9, 10). 
The results of plasma aldosterone measurements on all three missions 
are shown in relation to preflight baseline values in table XIII. 
These data, together with changes in plasma renin activity (table XIV)
indicate that there was an absolute increase in production of aldoster­
one. This was probably triggered by increased renin-angiotensin 
secretion. This elevation could be produced in response to a decrease 
in effective renal blood flow or in pressure changes in carotid 
arteries or right heart (11). Increased aldosterone secretion is the 
probable cause of the potassium loss. 
TABLE XIII. PLASMA ALDOSTERONE 
Mean Percent Change 
Skylab 2 +68 +127 -57 
Sky1ab 3 +28 -11 +138 +53 
Skylab 4 -62 -44 -2 + 44 -32 
~ 
Days 
In-flight 1-28 29-56 57-82 
Postflight 0-4 14 
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Figure 5. Urinary aldosterone. 
TABLE XIV. ANGIOTENSIN I (RENIN ACTIVITY) 
Mean Percent Change 
Sky1ab 2 +7 -18 -72 
Sky1ab 3 +144 +103 +203 
-80 
Sky1ab 4 +203 +30 +25 +56 -61 
Days 
In-flight 1-28 29-56 57-82 
Postflight 0-4 14 
The decreased blood urea nitrogen values generally found postflight 
are thought to be indicative of hemodilution and rehydration. The 
resulting elevations in the rate of urine flow produce a passive in­
crease in urea excretion. The first days I postflight water intake 
exceeded water intake during equal periods before or during flight. 
Similar results have been reported from the Soviet space flight of 
18 to 24 days duiing which actual increases in blood urea nitrogen 
were measured (12). The interpretation of these findings agree with 
our assumption that the levels of urea nitrogen in blood are a re­
flection of hydration and renal handling of urea. In Sky1ab, slight
increases were observed in plasma creatinine which are presumably
indicative of slight decreases in creatinine clearance. These findings 
support minor alterations in renal function in-flight, a supposition 
also advanced by Soviet investigators (12). 
The excretion of uric acid was decreased throughout the missions in 
most of the crewmen. Postflight there were significantly decreased 
levels of plasma uric acid. These findings confirm earlier Apollo
results (13) and are distinctly different from clinical findings where 
low serum uric acid levels are infrequently observed. In almost all 
instances such findings are attributed to a failure in the renal 
mechanism responsible for the return of the metabolite to the systemic 
circulation. 
Regulation of Calcium Metabolism 
The threat of bone mineral losses during prolonged weightless exposure 
has been a constant concern (14). A complete metabolic balance was 
conducted to ascertain the extent and time course of these losses. 
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To extend the input/output studies, measurement of plasma levels of 
25-hydroxycholecalciferol and hormones implicated in the regulation of 
calcium were conducted together with plasma calcium and phosphorus. 
Calcium and phorphorus levels were significantly elevated in the plasma 
as in the urine throughout the in-flight and early postflight phases. 
Parathormone levels were more variable in-flight but some were slightly
increased with no changes postflight. On the Skylab 4 crewmen, 
25-hydroxycholecalciferol was slightly decreased postflight and un­
changed in the Skylab 2 and Skylab 3 crewmen. Since calcitonin was 
below the level of detection for the assay used, it is apparent that 
no clinically significant increases occurred. In addition to its 
presence in food, Vitamin D was supplied in supplemental form with a 
resultant net intake of 400-500 IU/day. These results support the 
observations of other investigators that the rate of demineralization 
was slow and is probably attributable to an enhanced resorption
possibly mediated by parathyroid hormone. 
Adrenal Regulation 
The levels of adrenal medullary and adrenal cortical hormones were 
of particular interest because of changes found in the urinary 
specimens from the Mercury, Gemini and Apollo flight crews (6, 15). 
Following these earlier missions, the catecholamines, epinephrine and 
norepinephrine have been generally increased in the first 24 hours. 
In addition epinephrine changed to a greater extent than norepinephrine 
following the entry phase of the missions (16). 
In Skylab urinary epinephrine (fig. 6) was generally normal to decreased 
in-flight and elevated postflight. Norepinephrine (fig. 7) was more 
variable but did show periods of increase during the flight and 
significant increases postflight. Adrenal medullary activity is in­
creased by a variety of physical and psychological stimuli. It is well 
established that epinephrine is most often associated with anxiety 
responses whereas norepinephrine is more closely related to physical 
stress (17). Since a primary role of the autonomic nervous system 
is to maintain adquate blood pressure and flow under conditions of 
altered gravitational stresses, modification in adrenal medullary 
activity might be anticipated. The in-flight norepinephrine levels 
are probably the reflection of the high levels of physical exercise 
undertaken by each crewman during the flight. Collaborative data from 
this laboratory suggests that exercise in bedrest is effective in 
preventing decreases in norepinephrine excretion observed in non­
exercised subjects (18). 
After the Apollo flights, the plasma cortisol values were below pre­
flight values. However, the pooled urine sample collected during the 
first 24 hours after recovery did show the anticipated increase in 
cortisol exretion (6). The cortisol levels were not accompanied by 
445 
100 
50 
0 
-50 
-100 
400 ~ S~lab 3 
300 
200 
PERCENT 

CHANGE 100
t 
0'1 
0 
-50 
160 
80 
0 
COlllTlander 0 
Scientist Pilot. 
Pilot. 
~ 

-120--~--~~--------~--~--~--~--~--~--~~ 
DAYS 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 +1 +2 +3 
IN-FLIGHT POSTFLIGHT 
PERIOD PERIOD 
Figure 6. Urinary epinephrine. 
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Figure 7. Urinary n'orepinephrine. 
significant decreases in plasma ACTH although there was a slight trend 
toward such a decrease. It is recognized that the extremely short 
plasma half-life of adrenocorticotrophic hormone may have obliterated 
momentary increases dur"ing the recovery operations. In Gemini 7 
there were decreases in total 17-hydroxycorticosteroid in the in-flight
urine samples (7). Balakhovskiy and Natochin also reported decreased 
total l7-hydroxycorticosteroids in urine collected in space flight. 
These authors suggested that sample deterioration might account for the 
decreases observed (12). Our tests, in preparation for the Skylab 
flights, indicated that the freezing of urine was sufficient to 
prevent change in steroid concentrations (19). A decrease in 17-hydroxy­
corticosteroids was also seen in the one in-flight sample obtained in 
Apollo 16. 'In these samples the crewmen exhibited either in "an 
increase" or "no change" in free cortisol excretion. Elevated in-
flight urine cortisol levels and depressed plasma cortisol recovery 
levels are not a manifestation of alterations in circadian rhythmicity 
relative to the sampling time during the recovery phase (20). 
In Skylab. plasma adrenocorticotrophic hormone values were decreased 
during the flight and plasma cortisols were elevated. Postflight
adrenocorticotrophic hormone remained decreased and cortisol, although 
more variable, was generally increased. Twenty-four hour urinary 
cortisol levels were increased significantly through the missions on 
all crewmen (fig. 8), This was generally accompanied by either no 
change or slight decreases in daily total l7-hydroxycorticosteroids, 
even though the summary results indicate no real difference from 
preflight control values. Decreases in pregnanetriol and tetrahydro­
cortisone and slight increases in tetrahydrocortisol accounted for the 
total 17-hydroxycorticosteroid values. There was an increase in total 
17-ketosteroids parti'cularly demonstrated by increases in pregnanediol 
androsterone and etiocholanolone. 
The metabolism or excretion or both of these steroids appears to have 
been altered. Whether such changes occurred within the adrenal, at 
the site of liver conjugation or in the kidney is the subject of con­
tinuing investigations. 
Carbohydrate, Fat and Protein Utilization 
Data from the Gemini and Apollo programs show significant loss of lean 
body mass during the mis.sions.This loss of tissue was ,evidenced by 
elevations in nitrogen excretion (7, 21). Whether such losses are due 
to weightlessness, the hypobaric atmosphere or are merely a result of 
the psychological stress of the mission is unknown although results of 
th~ Skylab Medical Experiment Altitude Test would tend to implicate 
welghtlessness as the primary causative factor in these losses (22). 
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Similar loss of nitrogen had been observed throughout the Skylab
flights and has been accompanied by losses in potassium and water. 
Moreover, it has been shown that diminution in volume and strength
accompanied loss of these components of lean body mass. Urinary amino 
acids levels were elevated in-flight and postflight. Analysis shows 
an increase in the ratio-essential :nonessential urinary amino acids 
during flight. Further attempts to elucidate primary source of protein 
loss shows evidence of collagen breakdown in-flight as reflected mainly
by the increased excretion of total hydroxylysine (fig. 9). Caloric 
intake has generally been below body requirements so that the weight 
loss could have been partly caused by an inadequate food intake, in most 
crewmembers. 
In man both hypoglycemia and fasting stimulate growth hormone secretion, 
the former quickly and the latter more slowly. Growth hormone, an in­
sulin antagonist, raises blood glucose and plasma free fatty acids 
while lowering plasma amino acids,. Growth hormone measurements were 
made together with measurements of insulin and glucose. Plasma 
growth hormone levels were quite variable, however, significant eleva­
tion occurred during the first days in-flight and the first days
after recovery. Insulin and glucose were significantly decreased 
during the flight and increased after recovery. There was an increase 
in plasma cholesterol on recovery day. The constancy of the diets pre­
flight, in-flight, and postflight would tend to preclude diet as a 
significant factor in these changes immediately after flight. Although
losses in body fat stores throughout the long missions may account for 
the mobilization of triglycerides after recovery. 
The significant increases in thyroxine and the trend toward higher
thyroid stimulating hormone levels correlate well with the decreases 
in cholesterol for two weeks following recovery. These data confirm 
earlier Apollo findings that there is increased circulating free 
thyroxine after space flight (23). Similar findings were reported by
the Soviets. They were able to correlate weight loss to cholesterol 
decreases and suggested without supportive data that the thyroid gland 
might be implicated (12). 
It appears that at recovery blood glucose is raised by the action of 
catecholamines, cortisol, and growth hormone while the insulin is 
increased as a response to the elevated blood sugar. The in-flight 
decreases observed in both glucose and insulin have also been observed 
in bedrest, although it did not become significant until 56 days in 
bedrest (24), while the decrease became significant at 38 days in 
space. The impaired tolerance to a glucose load which has been reported
following exposure to bedrest was not measured in this study (25). 
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Figure 9. Urinary excretion of hydroxylysine and its glycosides (Skylab 4). 
Total plasma protein increased on recovery day as did albumin. Albumin 
decreased on the third day and fourteenth day after recovery, but not 
as much as total protein. This is inferential evidence that the 
glycoproteins were increased immediately postflight. The cholesterol 
increase seen at recovery may also indicate an elevation in lipoproteins,
particularly in high density lipoproteins. Plasma volume increases 
were recorded during this period due to water and electrolyte retention 
as the vascular system responded to the effects of gravity. Thus, the 
decrease in albumin may have been dilutional rather than absolute. 
Unlike the Apollo results, triglycerides were elevated after flight .~ 
until the 14th postflight day. 
SUMMARY 
This experiment, concerened with the biochemical reactions of the body 
to the stress of space flight, includes both endocrine and metabolic 
measurements. It is the first comprehensive and integrated study of 
endocrinology and metabolism during prolonged space flight. Significant
biochemical changes were observed. They varied in magnitude and 
direction but all disappeared shortly after return to Earth. 
These changes are for the most part indicative of a successful adapta­
tion by the body to the combined stresses of weightlessness. The 
transient nature of some of these changes, particularly in fluid and 
electrolyte metabolism, tend to support the conclusion that a new and 
stable condition of homeostasis condition has been achieved. In other 
areas, particularly in those concerned with the metabolism of bone 
mineral, protein and carbohydrates unstable states appear to persist 
and it is unclear at this time in which form the ultimate sequelae of 
these changes will manifest themselves after flight has continued for 
much longer periods of time. 
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CYTOGENETIC STUDIES OF BLOOD (EXPERIMENT Mlll) 
Lillian H. Lockhart, M.D. 
The miversity of Texas MedicaZ Branch, GaZveston, Texas 
ABSTRACT 
The Skylab Mlll experiment is a continuation of the preflight and post.
flight chromosomal analyses of the flight crews that have been performed 
since the Gemini III mission. The. experiment is designed to determine 
whether some space flight parameter produces cytogenetic effects in 
human cells and to provide biological radiation dosimetric capability
in the event of significant radiation exposure to a flight crew. 
On each of the Skylab flights, blood lymphocytes for analysis of chromo­
somes for structural defects were obtained from each of the prime crew­
members and from a ground-based control group before and after flight.
The cultures were successful except for occasional specimens obtained 
on recovery day on board the recovery ship. These specimens had to be 
handled differently than the others. All specimens were in culture 
for 60 to 70 hours and then were processed by treatemnt with colcemid, 
a hypotonic solution, followed by fixation and flame-dry slide prepara­
tion. On each of the studies, two examiners each counted and analyzed
100 to 150 cells at random for structural defects of the chromosomes. 
Two types of defects were recorded. The minor defects included the 
following aberrations: chromatid fragments, chromosome fragments, and 
deletions. Structural rearrangements such as dicentrics, exchanges, 
ring chromosomes, and translocations were photographed, and the cells 
were karyotyped to delineate, when possible, the chromosome or chromo­
somes involved in the rearrangement. 
Except for one study of a control subject, no individual study demon­
strated greater than eight percent minor chromosomal structure defects. 
In considering the more involved structural rearrangements found in 
individuals, it is apparent that both the astronauts and the controls 
had one or more such defects on several occasions. These were found 
both before and after flight, but they were found more consistently 
in both groups after flight. This result seems to indicate that the 
flight itself was not a major contributing factor. The influence of 
repeated isotope injections given to astronauts and to controls 
must also be considered. 
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INTRODUCTION 

It has been appreciated for some time that increased frequency of 
chromosomal aberration occurs in man following exposure to ionizing
radiation. Information has been obtained by study of persons receiving 
an external body source, such as therapeutic dosage or of those acci­
dently exposed. Others receiving radiation exposure from an internal 
source, such as the decay of radiOisotopes administered for diagnosis 
or treatment, have also been analyzed. It is obvious that interpreta­
tion of such data may be fraught with many problems. The radiation 
exposure may be acute or chronic, partial or total body, repeated or 
a single event. The tissue studied and the time elapsed following 
exposure have also been quite variable. 
Structural chromosomal aberrations are also known to occur following
exposure to other environmental factors such as viruses (both DNA and 
RNA) acquired either through immunization or infection, to various 
chemicals such as benzene, and to numerous drugs. 
Concern over the possible harm of low levels of radiation exposure 
centers mostly around its association with hereditary damage or malig­
nancy. Essentially no information is available concerning radiation 
effects on the chromosomes of gonadal or meiotic cells of man and 
estimates of hereditary damage are based in large part on theoretical 
views. It should be remembered that we cannot extrapolate findings in 
somatic cells (in the case under discussion circulating lymphocytes)
to gametic chromosomal patterns. On the other hand, concern regarding 
the cancer hazard in irradiated hUman populations has been suggested by
well founded studies (1). A classic example is that of patients 
treated with x-rays for ankylosing spondylitis who have on the average 
a ten~fold increase in mortality from leukemia (2). These patients 
were reported by Buckton, et aZ. (3) in 1962 to have structural chromo­
somal damage of cultured peripheral leukocytes some years after the 
treatment. The fact that many agents which produce tumors in man and 
animals can also produce chromosomal aberrations in their cells is 
clearly established. This information coupled with the fact that in 
several rare human disorders (Bloom's syndrome, Fanconi's anemia and 
ataxia telangiectasia) there is a constitutional predilection for in­
creased chromosomal aberrations as well as an increased incidence of 
leukemia and lymphoma has suggested that an increase in structural 
chromosome aberrations cannot be ignored. 
These chromosomal aberrations are structural in nature, that is, they
arise through breakage of the strands of chromatin. These breaks may 
occur either in one or in both chromatids of a single chromosome or 
multiple breaks may occur in several chromosomes within an individual 
cell. Following such accidents, the strands mayor may not recombine 
within themselves or the broken ends of several chromosomes may 
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combine with each other. Two general types of aberrations occur 
depending on the stage of the cell cycle in which the break cccurs. If 
the cell is in the pre-DNA synthesis period, chromosome strands are 
single (chromatids) and if the accident occurs after synthesis, the 
chromosome consists of two chromatids. Chromosomes are technically
examined in the metaphase stage of division because that is when they 
can be separated as individuals, so replication mayor may not have 
occurred when we examine the chromosomes of peripheral lymphocytes, 
depending in part on the time in culture. In general, these two types
of aberrations may be morphologically separated, however, in several 
instances it is impossible to tell whether the break occurred in the 
pre-DNA synthesis, and was replicated, or whether both strands were 
affected after replication. A break will produce a fragment that is 
generally lost in the next cell division. 
Separation of the aberrations into chromatid or chromosome in nature 
is useful since the type of structural defect occurring in humans as 
a response to a specific exposure, has varied with the agent to which 
the person is exposed. 
It is with these considerations in mind that the NASA program has wisely
considered cytogenetic studies important in past years and has especially
concentrated on such aspects in the Skylab program with extended 
missions and possible increase in radiation exposure. 
MATERIALS AND METHODS 
This discussion centers on experiments designed for Skylab 2 since 
results for the other missions are not yet complete. Blood lymphocyte
studies were obtained on eleven occasions preflight and eight instances 
postflight from the three members of the crew, from three controls 
and from the backup crew until it was apparent that they would not 
replace the crew. The control group consisted of three persons in the 
NASA program who would have an environment somewhat similar to the 
crew over the experimental period except for the flight. A total of 
90 cultures were processed and 79 have been analyzed, the remainder 
being specimens of the backup crew. Venous heparinized blood was drawn 
either at the Johnson Space Center or the Kennedy Space Center in one 
to two milliliters aliquots and was obtained at the time of drawing for 
other medical procedures. The cultures were instituted at the Univer­
sity of Texas Medical Branch on all occasions except for the first two 
postflight studies which were obtained aboard the recovery ship. Each 
sample was allowed to settle and five to seven drops of the buffy coat 
were placed in Chromosome Medium lA. Four such cultures were initiated 
on each person from each blood drawing. The cultures were then incu­
bated for a period of 60 to 70 hours at 37 0 C and processed by a 
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modified method of Moorehead (4). Co1cemid was added to a concentration 
of O.l~g/ml for two hours. The cell suspension was then treated with 
a hypotonic solution followed by numerous washings with fixative 
(3 methano1:1 acetic acid), Slides were prepared on the same day by
flame drying and the cells stained with Wright's stain. 
The slides were coded and each of two examiners studied from 100 to 
150 cells on each specimen. Cells were selected on low magnification
if they appeared to be analyzable and then examined under high magnifi­
cation; each cell was counted and a search made for any type of 
structural defect. When a structural defect was found the cell was 
photographed for further analysis by karyotyping in an attempt to 
delineate whenever possible the chromosome and/or chromosomes involved 
in the aberrations. 
The cells were scored for the following structural arrangements: 
chromatid and chromosome constrictions and gaps (not to be considered 
in this paper); chromatid and chromosome breaks, fragments, and deletions 
(to be referred to as minor defects); and dicentrics, rings, inversions, 
translocations, and exchanges (to be referred to as structural re­
arrangements). 
RESULTS AND DISCUSSION 
The results of the cyogenetic analysis of lymphocytes of the Sky1ab 2 
astronauts are shown in table I. There were four studies that were 
unsuccessful. These involved the recovery day specimens of the crew 
and of one control. These cultures were instituted aboard ship and 
transported by portable incubator. Several of these specimens had a 
dark brown appearance upon arrival at the laboratory. 
There were no individual studies from this mission that demonstrated 
greater than 8.0 percent minor structural defects except for one on 
specimen L, a control. The blood had been drawn aboard ship on the 
day before recovery. In only 16 studies did such aberrations appear in 
from 5.0 to 7.9 percent of the cells examined. In our laboratory under 
similar technical conditions where 13 000 cells a year are counteq and 
analyzed, it is expected that three to four percent of the cells 
analyzed will show one or more breaks, deletions or fragments. In other 
laboratories with varying preparation of cells for study, this aberra­
tion incidence may even be slightly greater. These defects are known 
to increase in peripheral leukocyte cultures of persons following a 
viral illness such as measles or adenovirus, after administration of 
viral vaccines, after certain diagnostic x-ray studies, and after exposure
to certain chemicals. This increase in response to such exposures is 
in general only temporary, and little can be suggested as to harmful 
effects. 
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TABLE I 
Skylab 2 
No. Cells % Minor 
Examined Defects 
4-2-73 F-53 KSC 
C (26) 268 3.35 
K (43) 239 3.34 1 Exchan~e 
W (34) 250 2.80 
A (80) 259 3.86 
H (55) 260 1. 15 1 Inversion 
L (14) 271 2.95 
Md84) 223 0.44 
M (65) 238 1.68 
S (72) 231 1.73 
4-24-73 F-31 KSC 
277 1. 44;- f:!~ 244 2.45 
4-25-73 F-30 KSC 
A (28) 256 3.90 1 Exehanlle 
H (85) 234 1.28 
L (38) 217 4.60 
4-26-73 F-29 KSC 
C 
K 
W 
(22) 
(I2) 
(59) 
273 
263 
241 
1. 83 
7.2Z 
1.66 
1 Dicentric 
A 
H 
(7) 
(89) 
255 
234 
6.27 
2.13 1 Dicentrie 
4-27-73 F-28 KSC 
C (31) 241 1. 24 
K (10) 257 4.66 I Translocation 
W (69) 244 4.09 
JSC 
242 0.83 
247 4.05 2 Translocations 
5-2-73 F-23 JSC 
eC (64) 260 5.39 2 RinJ! s. 1 ExchanR 
K (91) 257 3.89 
W (81) 250 5.20 
A (50) 244 6.56 
Crew: Conrad (C), Kerwin (K), Weitz (W) 
Controls: Alexander (A), Hordinsky (H), La Pinta (L) 
Backup Crew: McCandless (Me), Musgrave (M), Schweickert (S) 
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TABtE I (Continued) 
No. Cells % Minor 
Examined Defects 
5-7-73 F-18 JSC 
C (4) 247 3.64 
K {95} 230 3.48 I RinlZ 
W 
A 
fl31 
(2<1) 
243 
238 
2.06 
5.04 I Dicentric 
I ExchanlZe 
5-8-73 F-17 	 JSC 
257 O. 78 
267 3.74~ ~~:l 
5-14-73 F-ll JSC 
C (661 273 4.03 I Exchange 
K 
W 
(35) 
(511 
246 
243 
4.47 
5.34 
I Dicentric 
1 Exchange 
A 
H 
(25) 
(5) 
244 
245 
7.37 
2.85 
I Exchange 
L (17) 277 1. 80 I Dicentric 
5-24-13 F-I KSC 
C 
K 
W 
(41) 
(77) 
(99) 
269 
231 
239 
1. 86 
4.76 
5.43 
A (53) 238 3.78 I Exchange 
H 
L 
(83) 
(98) 
Z41 
259 
2.90 
3.41 
Flight: 5-25-13 
6-21-73 
A (92) 
H (67) 
L (97) 
R-l Ship 
258 I 
Unsuccessful 
139 I 
1.75 
11.51 
1 Dicentric 
6-22-73 R+O Ship 
C (15) Unsuccessful 
K (90) Unsuccessful 
W (56) Unsuccessful 
-
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TABLE I (Concluded) 
No. Cells 0/0 Minor 
Examined Defects 
6-23-73 R+l Ship 
C (23) 257 3.50 
K (32) 234 4.70 1 Chromatid ExchanJ!;e 
W (45) 255 1. 57 
A (93) 274 5. 11 
H (76) 266 2.25 
L (86) 249 4.01 
6-26-73 R+4 JSC 
C (19) 261 4.21 1 Tricentric 
1 ExchanlZe 
K j63) 264 2.65 1 RinlZ 
W (57) 290 3. 10 I Dicentric, I Ring 
A 194) 256 2.73 
H (11) 234 2.99 2 Dicentrics 
L (82) 250 2.00 
6-29-73 R+7 JSC 
C (27) 245 1. 22 
K (44) 260 6. 15 1 Dicentric 
W (70) 248 2.02 1 Dicentric 
A (87) 239 6.28 2 Exchanges 
1 Dicentric 
H (3) 232 0.43 
L (52) 248 2.82 1 Dicentric 
I Exchange 
7-5-73 R+13 JSC 
C(88) 
K (60) 
223 
260 
6.72 
4.62 
1 ExchanRe 
W (54) 
A (37) 
244 
273 
4.91 
6.23 I Dicentric 
3 ExchanlZes 
7-9-73 R+17 JSC 
K (30) I 276 2.90 
7-10-73 R+18 JSC 
C (68) 256 7.03 I Tricentric 
-
W 
A 
(73) 
(49) 
246 
262 
4.07 
3.81 
1 Dicentric 
1 Ring 
H (33) 255 0.78 
L (42) 238 Z.10 
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Table II lists the radioisotope injections administered to crew and 
controls alike in the present study. You will note that only one blood 
culture was instituted prior to such administration (4-2-74), and no 
one in the crew, backup crew, or control group had greater than 3.86 per­
cent aberrations on the first study. This may well be chance because 
at various other occasions throughout the experiment, each person 
demonstrated such low values. It is quite possible that control L had a 
viremia at the time in which the 11.51 percent aberrations were found, 
and throughout the remainder of the study his values returned to ex­
pected levels. ~ 
TABLE II. ISOTOPE INJECTIONS 
1973 
4/2 4/24 
1251 125 1251 12511 
51 Cr 51 Cr 51 Cr 51 Cr 
35S 35 35S S 
3H 
Speculation as to the significance of structural rearrangements is more 
difficult. It is noteworthy that in the first culture there was one 
crewmember and one control with evidence of breakage and recombination. 
This is not characteristic of the general population. It has been re­
ported that such aberrations as dicentrics, rings, inversions, and 
exhanges occur very rarely, (fig. 1). Bloom, et aZ. (5) found only one 
dicentric and no rings in 7188 cells examined. Bender, et aZ. (6) 
reported 3 dicentrics and no ring chromosomes in 1642 cells from normal, 
unirradiated individuals. In our experience, it is less common. We 
would be the first to admit, however, that neither the crew nor the 
control group under discussion today are members of the general popula­
tion. As to the crew, we might speculate for a moment what possible
exposures occurred prior to chromosome culture. Obviously in such a 
professional lifetime there are many, varied experiences in comparison 
to the general population. Perhaps they came to Skylab and even to 
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Figure 1. Skylab abnormalities. 
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NASA with these findings. Gooch and Berry (7) reporting on the chromo­
some aberrations of the Gemini astronauts also noted an occasional 
dicentric or ring chromosome. 
In reviewing the medical log of this mission, one wonders about such 
potential problems as exposure to various gases, too high temperatures, 
to the atmospheric conditions in flight, and in fact, to weightlessness. 
Prince, et at. (8) reported observations on man in an oxygen-helium
environment and included chromosome study. They noted up to 4 percent 
chromatid-type lesions in the subjects. There is otherwise no infor­
mation relating such variables to chromosome aberration. There is very
good documentation regarding illness and drug ingestion in the astro­
nauts of Skylab 2 and comparison of this data with the chromosomal 
pattern does not suggest a cause and effect relationship. 
The appearance of one or more structural rearrangements in 250 cells is 
unusual, however, in this study there is no difference in the crew and 
in the control group in regard to such aberrations as they occur 
sporadically throughout. However, there is one factor common to both 
groups that cannot be ruled out and this is the administration of 
radioisotopes for various medical studies. Some subjects from both 
groups have had such a series on repeated occasions even prior to this 
mission. . 
It is indeed impossible to say that the appearance of such aberrations 
increased in the crew following the mission, and frustrating to admit 
that what might have been the most important specimens from the crew 
were unsuccessful. Initially it was thought culture failure may have 
been the result of transporting the specimens and of difficult culture 
conditions. In personal communication with Dr. S. E. Ritzman (experi­
ment Ml12), however, it was realized that the problem may be related 
to defective lymphocyte transformation and/or DNA synthesis on the day
of recovery. 
There are several obvious problems in this experiment. Primarily there 
is no normal control group, that is persons from the general population 
not receiving isotopes and without previous high altitude or orbital 
flight experience, analyzed simultaneously .. Secondly, we did not have 
occasion to study the crew over a long period prior to introducing 
other variables. Arrangements have been made, however, to continue to 
study them intermittently to determine whether these findings are only 
temporary. Thirdly, in planning the culture time, a shorter period 
would have allowed for study of more cells after only one division 
in culture, and perhaps finding an even greater number of aberrations. 
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SlIr~MARY 
In summary, I would like to reiterate that the appearance of structural 
rearrangement in 250 cells examined from one specimen is unusual, that 
it may only be a temporary finding, and that the data does not seem 
to suggest that the external sources of radiation to which the crew 
were exposed in orbit resulted in an aberration increase. 
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ABSTRACT 
The hardware, Woodlawn Wanderer 9, used to perform the S015 experiment, 
was fully automated and designed to achieve four major objectives. 
o 	 To maintain living cell cultures by supplying them with proper 
nutrients at a constant temperature of 360 C. 
o 	 To produce two phase-contrast time-lapse motion pictures of 
living cells for 28 days, 
o 	 To fix a group of the cultures at predetermined intervals, 
o 	 To return some of the cultures of living cells intact for 
subsequent subculture and preservation. 
These living cell cultures were maintained at a temperature of approxi­
mately 22° C after the first 12 days of the Skylab 3 mission. 
The purpose of the S015 experiment was to extend observations of the 
effects of zero gravity to i ntl ude the study of some of these effects 
on living human cells during and after the 59-day Skylab 3 mission. A 
strain of diploid human embryonic lung cells, WI-38, was chosen for 
this purpose, The WI-38 cells were obtained from the laboratory of 
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School, Dallas, Texas. 

~Department of Medical Microbiology, Stanford UniverSity, Palo Alto, 
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Dr. Leonard Hayflick, Department of Medical Microbiology, Stanford 
University. The studies reported here were concerned with observations 
designed to detect the effects of zero gravity on cell growth rates and 
on cell structure using light microscopy, studies of cell function and 
cell cycle were performed using time-lapse motion picture photography, 
whereas studies for cell deoxyribonucleic acid content were performed 
using Feulgen staining and microspectrophotometry. Subsequent study of 
the returned living cells included karyotyping, G- and C-banding, and 
analyses of the culture media used. Some of the returned living cells 
were banked by deep-freeze techniques for possible future experiments. 
The presentation of the experiment results will include a discussion of 
all these data in addition to the showing of a time-lapse motion picture 
of living human cells in the zero-gravity environment. 
INTRODUCTION 
The advent of satellites has awakened and renewed interest in the 
effects of gravity on living material. Prior to this time the major 
interest had been centered on the effects of increased gravity on 
living material as simulated by acceleration in various types of 
centrifuges. These studies began as early as 1806 when Knight used 
water driven centrifuges to demonstrate that it was the direction of 
the gravitational vector which oriented the growth of plants (1). In 
1883, E. Pfluger performed the classic experiment of maintaining a 
developing frog's egg in an inverted position and demonstrated that 
this led to abnormalities of development (2). In 1930, Harvey and 
Loomis workin~ at Princeton, designed and constructed a centrifuge 
microscope (3). This instrument or modifications of it has been used 
to study the effects of acceleration on sea urchin eggs and amoebae 
(4,5,6,7). Because of the buoyant effect of the media in which most 
specimens have been immersed during the period of acceleration, other 
investigators such as Matthews and Wunder have used a variety of 
terrestrial forms of life in their studies (8,9). In general, as might
be expected, it takes much larger increases in the gravitational field 
to produce detectable effects in bacteria (10) than it does to produce 
detectable effects in amoeba (11), and in the case of the more complex
and heavier organisms from the size of rats to man, relatively small 
increments of gravity may produce measurable and/or lethal effects. 
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OBJECTIVES 
The purpose of the S015 experiment was to extend our observations of 
the effects of zero-gravity to living human cells during and subsequent 
to a 59-day flight on Skylab 3. A strain of diploid human embryonic 
lung cells, WI-38, was chosen for this purpose 1 • The studies reported 
in this paper were concerned with observations designed to detect the 
effects of zero-gravity on cell growth rates and on cell structure as 
observed by light microscopy, transmission and scanning electron 
microscopy and histochemistry. Studies of the effects of zero-gravity 
on the cell functi on and the ce11 cycl e were performed by ti me 1 apse 
motion picture photography and microspectrophotometry. Subsequent
study of the returned living cells included karotyp"ing, G- and C-banding, 
and analyses of the culture media used. Some of the living cells 
returned were banked by deep freeze techniques for possible future 
experiments. 
Fl; ght Hardware 
The hardware, Woodlawn Wanderer 9, used to carry out the S015 experiment, 
was fully automated and designed to achieve four major objectives. 
o 	 To maintain living cell cultures by supplying them with proper 
nutrients and temperature, 36 0 C. 
o 	 To produce two phase-contrast time-lapse motion pictures of 
living cells for 28 days. 
o 	 To fix a group of the cultures at predetermined intervals. 
o 	 To return intact some of the cultures of living cells for 
subsequent subculture and preservation. These cultures were 
maintained at approximately 220 C after the first 12 days of 
the mission. 
As with most equipment developed for space flight, the hardware design 
was restricted by limitations of size, weight, and power while high 
reliability and safety standards were achieved. In this case, biologi­
cal compatability of materials and the necessity to sterilize some of 
the components at high temperatures were major constraints not usually 
encountered in flight hardware deSign. 
lWI-38 cells were obtained from the Laboratory of Dr. Leonard Hayflick, 
Department of Me'dical Microbiology, Stanford University. 
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The hardware consisted of a single self-contained package installed in 
the spacecraft Command Module which supplied the power required to 
maintain an ambient temperature of between 10° and 35° C. The unit 
was hermeti ca11 y sealed to provi de an i nterna 1 press ure of one atmos­
phere. Figure 1 is a photograph of the exterior of the unit. The 
fully loaded package weighed 10 kilograms and measured 
40 x 19 x 17 centimeters. 
Internally, the package was separated into a camera-microscope section 
and a separately sealed growth curve experiment section. Figure 2 
illustrates the interior arrangement with the camera-microscope section 
on top, the growth curve experiment section below, and the electronic 
circuitry required to fully automate the experiments located between 
the two. 
In the camera-microscope section there were two independent camera­
microscope systems. One system photographed living cells through a 
20 power phase-contrast microscope, the other photographed living cells 
through a 40 power phase-contrast microscope. Each microscope and lamp 
was miniaturized and measured 7 x 4 x 2.5 centimeters. The phase­
contrast image produced by the microscope was projected through an 
optical system onto the 16 millimeter film. The film was supplied by a 
film pack which contained two rolls of 16 millimeter film, each 
100 meters long. The camera which recorded through the 40 power micro­
scope was operated for a 40 minute period once every 12 hours at the 
rate of five frames per minute. The 20 power microscope camera 
operated continuously and exposed one frame every 3.2 minutes. 
Each camera-microscope system recorded the images of living WI-38 cells 
grown on glass in a 0.05 cubic centimeter chamber. The chamber was 
formed by a gasket sandwiched between two glass discs. Tubes were 
attached to the gasket for the injection of fresh nutrient and for the 
removal of the waste medium. The entire chamber was held in a heated 
block thermostatically controlled to maintain a temperature of 36° C. 
In order to fill the chambers, culture medium containing 7000 cells/
milliliter was injected into the chamber through a syringe. After a 
few hours, the cells settled and became attached to the lower glass 
disc. The chamber was then installed in the microscope stage and the 
microscope was locked in a focused position. 
Fresh medium was supplied by a cylindrical reservoir containing a piston 
threaded on a screw extending the length of the cylinder. After the 
screw was automatically rotated 4.5 revolutions every 12 hours, fresh 
medium was forced into the specimen chamber and waste medium was pulled
into the vacuum created on the back side of the moving piston. 
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Figure 1. External configuration of Woodlawn Wanderer 9. 
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Figure 2. Interior configuration of Woodlawn Wanderer 9. 
471 
The growth curve experiment was carried out in a module that was easily
removed from the rest of the package for biological servicing. The 
module was separated into two identical independent assemblies to pro­
vide some degree of duplication and control (fig. 3). Each assembly 
ELECTRICAL 
CONNECTOR 
MEDIA PUMP 
TAPE PROGRAMMER 
FIXATIVE PUMP 
FIX PUMP MOTOR 
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Figure 3. Interior of Woodlawn Wanderer 9. 
provided nine miniaturized Rose-type cell culture chambers installed in 
a temperature-controlled holder. In each assembly the cells were fed 
automatically by a single nutrient medium pump-reservoir similar in 
design concept to those used in the camera-microscope systems. In this 
case, however, the medium passed through a reservoir to be heated before 
it was injected into the culture chambers in order to avoid temperature 
shock to the cells in the growth curve module. The culture chambers 
were connected by tubing in series such that the medium of the first 
chamber emptied into the second which emptied into the third and so on 
down the line. At each feeding enough medium was supplied to provide 
the last chamber in the series with fresh medium. 
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At programed intervals during the experiment one chamber at a time was 
removed from the nutrient supply circuit and connected to a fixative 
supply by a device called the fixing valve. The fixative employed was 
5 percent glutaraldehyde in Earle's Balanced Salt Solution. The fixing
of cells was accomplished by a motor which, upon signal command by a 
mechanism using a programed punched tape, rotated the fixing valve 
22.5 degrees and then advanced the fixative pump sufficiently to fill 
one chamber with fixative. Similar commands signaled by the program 
tape then effected fixation of the other chambers. Each time a culture 
was fixed it no longer required feeding and, accordingly, the tape­
program signaled reduction of the amount of nutrient medium provided by
the pump to, the remaining culture chambers. 
The program tape and nutrient supply pump were driven by the same motor. 
The tape was programed by two rows of punched holes. Microswitch actua­
tors then rode on the tape and dropped into the holes to activate the 
motor. One row of holes controlled the release of the correct amount 
of each nutrient feeding while the other row initiated the cycles which 
injected the fixative solution into each chamber. 
Four of the nine chambers of each assembly were not fixed in-flight and 
after mission day 12 were maintained at approximately 22° C with 
reduced feedings throughout the rest of the mission. These cells were 
returned live for subsequent subculturing. 
METHODS 
Subcultivation and Cell Counting Procedures 
Stock cultures of mycoplasma free WI-38 cells, passage number 13, 
were trypsinized with 0.125 percent trypsin in phosphate buffered 
saline with 0.02 percent Versene. The cells were thoroughly agitated
and suspended in Earle's BME2 buffered with 28 millimolar HEPES3 
and supplemented with 10 percent fetal calf serum and 100 units/ 
milliliter each of penicillin and streptomycin. The cells in this 
suspension were counted in a hemocytometer and then diluted to 
provide a final concentration of 1000 cells per square centimeter. 
This concentration of cells was then injected into the chambers 
and allowed to attach to the glass coverslips. After attachment 
of the cells, the cell population of each chamber was determ"ined 
by counting the cells with the aid of phase-contrast microscopy. For 
2BME = Eagle's basal medium Earle's. 
3HEPES = N-2-hydroxyethylpiperazine-N2-ethanesulfonic acid. 
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this purpose a one millimeter grid reticle was placed in the lOX eye­
piece of the microscope and only those cells were counted which had 
their nucleus inside or on the top and left edge of the grid square. 
A total of 16 such areas were counted by moving the chamber in a 
4 by 4 pattern. After counting 16 areas, the average cell number per 
area and the 20 standard error were calculated. Areas outside of the 
20 limits were rejected and a new average was calculated. This average 
was multiplied by a factor of 210 to give the number of cells per square 
centimeter in each chamber. Since there were no chambers fixed on 
day one, the average cell count of the five chambers was used as the 
point on the growth curve for day one. 
When the hardware was returned to the laboratory after the flight, the 
cell population of each fixed chamber was again determined in the same 
manner as the initial cell count with one exception. When a population 
of 10 000 cells per square centimeter was attained, counting was per­
formed at a higher magnification by using the same grid reticle in a 
15X eyepiece instead of the lOX eyepiece. This procedure was necessary 
to help el"iminate the error in counting cells of high density popula­
tion. The average number of cells per area was then multiplied by a 
factor of 400 to give the number of cells per square centimeter. 
The final number of cells per square centimeter for each chamber was 
then plotted on 3-cycle semi-logrithmic paper corresponding to the day 
on which each particular chamber was fixed. For example, 
chamber 9-(GCM-l) plotted for day 3, chamber 9-(GCM-2) plotted for 
day 4, chamber 8-(GCM-l) plotted for day 5, et cetera. 
Film Analysis Procedures 
The time lapse films were analyzed with a projector which permitted 
projection at 1-8, 16 and 24 frames/second in forward, reverse and 
still and was equipped with a fram~ counter. Since the intervals 
between frames were known, it was possible to calculate the exact 
time of exposure of each frame. 
Cell s were counted on the projected "image every three hours of recorded 
20X film. When the cells reached confluency, counting became difficult 
because cells in close contact were not clearly distinguishable from 
each other. Consequently, further cell multiplication was determined 
by adding up the number of observed mitoses. For this purpose the time 
and location of every mitosis in the field were recorded. 
~1itotic activity was calculated from the average cell density and the 
number of observed mitoses during a given time interval. 
474 

The length of individual cell cycles was determined by projection of 
the film in reverse. Individual cells undergoing mitosis were followed 
to their previous mitosis or until they migrated out of the field or 
until they could not be clearly distinguished because they were in 
close contact with other cells. The observation in reverse was time­
saving since only one cell needed to be followed instead of two as in 
the forward mode. This method also inherently excluded observation of 
cells which migrated out of the field in forward mode. The length of a 
cycle was arbitrarily chosen to be the time elapsed between the last 
frame of metaphase of one mitosis and the last frame of metaphase of 
the following mitosis. 
The rate of cell migration was studied by covering the projection 
screen with paper and tracing the location of the nucleus of individual 
cells every hour. The displacements were then measured and tabulated. 
From these data average rates of migration were calculated for indi­
vidual cells as well as for a given time interval. 
Transmission Electron Microscopy 
The whole coverslips with attached cell monolayers in 4 percent 
glutaraldehyde in a cacodylate buffer4 were received in the electron 
microscopy laboratory. The coverslips were scored with a diamond 
pencil and broken into four quarters. Three of the quarters were 
stored in 4 percent glutaraldehyde and used subsequently for scanning 
electron microscopy, phase microscopy, and microspectrophotometry. The 
remaining quarter was prepared for transmission electron microscopy. 
The coverslips portions (quarters) for transmission electron microscopy 
were arranged in a specially designed Teflon rack and placed in an 
accompanying tank. The cells were rinsed for five minutes in distilled 
water and then postfixed in Palade1s osmium tetroxide fixative (12) for 
20 minutes. After a 5-minute distilled water rinse they were stained 
secondarily with 2 percent uranyl acetate in 70 percent ethyl alcohol 
for 20 minutes. Following staining with uranyl acetate the coverslips 
were dehydrated in graded alcohol solutions followed by two propylene 
oxide baths for five minutes each. The cells were then placed in a 
1:1 mixture of propylene oxide and Maraglas for 30 minutes followed by
straight Maraglas solution overnight, in the refrigerator. The 
following day the cells were allowed to come to room temperature. Beem 
plastic capsules were filled to .within one-eighth inch of the top with 
Maraglas and the capsules as well as the coverslips were placed in a 
4Cacodylate buffer is made as follows: glutaraldehyde 8 percent, EM 
grade, 100 cc; 0.2 Msodium cacodylate, 84 milliliters; and lOX con­
centrated Earle1s Balanced Salt Solution without sodium bicarbonate, 
16 milliliters; to make a total volume of 200 milliliters. 
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bell jar which was evacuated to release any air bubbles which might be 
present in the Maraglas. After the vacuum treatment, the coverslips 
were drained and laid cell side up on a thin piece of aluminum foil. 
The Beem capsules were inverted over the coverslips and the coverslips 
were then placed in a 60° C oven. After 16 to 17 hours and partial 
polymerization, the capsules were removed one at a time from the oven 
and, using a pair of tongs, the lower half of the coverslips was 
immersed in an acetone dry ice bath at -80° C for about 60 seconds. 
The coverslip was immediately popped off using the thumb on part of 
the overlapping coverslip as leverage. This procedure \'Ias successful 
on ly if the capsul es vJere taken from the oven one at a time since any 
cooling of the capsule resulted in failure of the coverslip to be 
removed. When the coverslip was removed, it left the monolayer of 
cells embedded in the Maraglas. The capsules were returned to the 
60° C oven for 48 hours to complete polymerization. The Beem plastic
capsule was cut and removed from the plastic block. The surface of 
the block containing the cell monolayer was then scored with a small 
radial saw producing one millimeter squares. The scored cell surface 
was examined under a dissecting microscope and an area selected for 
sectioning. The remaining squares were sawed off with a jeweler's 
blade and stored for future use. Sections were cut with a microtome 
and a diamond knife. Silver colored sections were used. Copper 
grids of 300 mesh with and without Formvar films were used to hold 
the sections. Sections were stained with uranyl acetate and lead 
citrate (13) and examined with a transmission electron microscope. 
Scanni ng El ectron ~1i croscopy 
Selected coverslip portions (quarters) with attached cell monolayers 
were prepared for scanning electron microscopy. The cells were fixed 
in glutaraldehyde and Palade's solution identical to the procedures 
outlined for transmission electron microscopy. They were dehydrated 
in graded alcohols and, after the absolute alcohol, they were trans­
ferred to a mixture of absolute ethanol and amyl acetate. This was 
followed by two changes of amyl acetate and subsequent critical-point 
drying, utilizing liquid carbon dioxide and a critical-point drying 
apparatus (14). After critical-point drying, the coverslips were 
removed from the drying chamber and coated with gold and palladium
in an evaporator. The dried and coated specimens were examined with 
a scanning electron microscope. 
Phase Microscopy 
For phase microscopy the cells were fixed with glutaraldehyde and 
osmic acid as for electron microscopy. After osmic acid fixation the 
cells were rinsed in distilled water and mounted in a gelatin phenol
mixture (15). The mixture of gelatin and phenol has a refractive index 
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of approximately 1.041 and is an ideal embedding medium for examination 
of fixed cells with phase microscopy. The cells were examined with a 
regular phase and anoptral phase microscope utilizing a W-58 green 
filter. In addition, the preparations were studied with an inter­
ference phase microscope utilizing the W-58 green Wratten filter. 
Chromosome Analysis 
Chromosome analyses were performed on preflight and flight backup con­
trol cultures and on subcultured flight cultures. The cultures were 
incubated overnight with fresh growth medium, then harvested by stan­
dard colchimid arrest and hypotonic treatment procedures. Air dried 
slides were made for banding analysis. If the cultures were confluent 
when received they were lightly subcultured and harvested the following 
day. Cultures were saved and subsequently frozen for storage from all 
lots of cells received. Air dried slides obtained from the cultures 
were treated with either urea (16) or trypsin (17) to obtain G-banding 
pa tterns. C-band patterns VJere obtai ned by the a 1 ka 1 i ne-SSC denatura­
tion-renaturation procedure (18). All slides were coded before analysis 
and banding pattern data recorded by number to reduce bias. At least 
50 cells were counted from each culture lot to determine the 2n count. 
Five cells from each control culture were analyzed for G-band pattern
and 10 cells were analyzed for C-band pattern. At least 10 cells of 
the "flightll culture were analyzed for G-band pattern and 20 cells 
were analyzed for C-band pattern. 
Microspectrophotometry 
Scanning microspectrophotometry was used to compare semiquantitative 
data from Feulgen-stained nuclei of human tissue culture cells grown 
during space flight (Skylab 3) in zero-gravity with matched ground
controls (19,20,21,22,23). In-flight and control specimens obtained 
on mission days 3,6,7, 10 and 11 were used for this study. 
Scanning microspectrophotometry was performed on selected areas of 
the nuclei using a scanning microscope photometer having a l-micron 
measuring spot at 1 micron intervals at 540 nanometers. For each 
nucleus scanned, three traverses through the center, or near the 
center, were made. The edited data provided a raw data matrix of 
5 x 3 (15 adjacent optical density values 1 micron apart) from within 
the nucleus. The data was stored on LINC tape using aPDP-12 computer. 
Selected area scans of approximately 50 nuclei were obtained for each 
population of cells. Various computer programs were used for addi­
tional editing, raw data print-out matrices, and statistical analysis 
of the data. 
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Tissue culture cells stained with Schiff1s reagent using a modified 
Feu1gen procedure were used for this study. To identify deoxyribo­
nucleic acid (DNA) Schiff-positive sites in glutaraldehyde-fixed cells, 
it was necessary to modify the standard Feu1gen reaction by addition 
of a prestaining oxidation with acidified hydrogen peroxide (H202), a 
modification of procedure described by Pool (24). 
Materials. Schiff1s Reagent: Dissolve one gram of basic fuschin 
(Cert. PF-3, C.I. H2500) in 200 milliliters boiling distilled water. 
After cool i ng to 50° C, fil ter and add 20 mi 11 il iters of 1 N hydro­
chloric acid (HC1) to the filtrate. Cool this solution to 25° C, add 
1 gram of sodium metabisu1fite and place the solution in the dark for 
24 hours. Decolorize with 2 grams of activated charcoal, and filter. 
Oxidizing solution (HPSA): Prepare a 10 percent acidified hydrogen 
peroxide solution by adding 45 milliliters of 30 percent HZ02 to 
90 milliliters of distilled water. Adjust the pH to 3.2 wlth 0.1 N 
sulfuric acid. 
Procedure for processing tissue culture cells for DNA Schiff positive 
sites. 
l. Oxidize with HPSA for 20 minutes. 
2. Rinse briefly in distilled water. 
3. Place in 1 N HCl at 60° C for three minutes. 
4. Rinse briefly in distilled water. 
5. Transfer to Schiff1s reagent for 30 minutes. 
6. Rinse in distilled water. 
7. Dehydrate in alcohol. 
8. Clear in xylene and mount in Permount. 
~1edi a Ana 1ys is 
When the flight hardware and the backup units were returned to the 
laboratory, samples of the used media were analyzed in the SMA-12 auto­
analyzer at the clinical laboratories of Parkland Hospital in Dallas, 
Texas by Dr. Robert Putnam. Amino acid analyses were performed by 
Dr. Kenneth Wiggans, biochemist at the University of Texas Health Science 
Center in Dallas. These results were compared with similar analyses of 
freshly prepared media. 
RESULTS 
Growth Curve Analysis 
Figure 4 delineates the data for the growth curves of the cells in the 
flight unit and for the cells in the second backup unit. Inspection of 
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the two curves show them to be identical S-shaped growth curves. All 
of the ground based control studies performed yielded identical curves . 
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Figure 4. Growth curve data for flight and ground control units. 
Film Analysis 
Table I is a table of the length of individual cell cycles, in hours, 
from cells in the flight units and from cells in the backup units. The 
data indicate that exposure to zero-gravity did not influence the 
duration of the cell cycle nor the results of mitosis. 
TABLE I. LENGTH OF INDIVIDUAL CELL CYCLES, IN HOURS 
FLIGHT CONTROL 
28.2 32.4 
27.4 22.2 
23.7 20.8 
22.8 20.7 
22.5 19.6 
21. 3 19.6 
21.0 18.8 
20.7 17.7 
19.9 17 .2 
19.4 14.5 
18.5 
AVERAGE 22.3 ~ 3.1 20.4 ~ 4.8 
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Figure 5 is a graph indicating the number of mitoses in the flight
units and in the backup units. As can be seen there are no significant
differences between the flight units and the control or backup units. 
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Figure 5. Mitotic Index for flight and ground control cultures. 
Table II compares the migration rates of cells in the flight unit with 
the migration of cells in the backup unit. In each case the migration 
rates are comparable. 
TABLE II. RATES OF CELL MIGRATION IN THE FLIGHT AND GROUND 
CONTROL CULTURES 
FLI GHT CONTROL 
TOTAL NUMBER OF HOURLY DISPLACEMENTS MEASURED 332 480 
AVERAGE RATE OF MIGRATION (microns/h) 37.25 34.7 
STANDARD DEVIATION (microns/h) :!:.20.8 :!:.22.5 
LOWEST OBSERVED RATE (microns/h) 3 0 
HIGHEST OBSERVED RATE (microns/h) 95 114 
The flight and control films were independently reviewed by several 
scientists. No differences between the flight films and the backup
control films were observed for such cellular parameters as vacuole 
formation, mitosis, cell movement, cell size, nuclear size and location; 
480 
.. 
• • 
, 

nucleolar size, shape, location, and number; presence and location of 
cytoplasmic organelles, sol-gel state of the cytoplasm and cellular 
behavior on contact as confluence in each culture was reached. 
Chromosome Banding Pattern Analysis 
The normal G-band and C-bad patterns were found in all cultures, 
including the flight material, examined. No abnormalities of banding 
patterns were observed. The normal G-band pattern is presented in 
figure 6 and the normal C-band pattern is seen in figure 7. Both 
figures are from the "flight" culture. 
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Figure 6. 	 Chromosome G-banding Figure 7. Chromosome C-banding 
of WI-38 flight cells. of WI-38 flight cells. 
The preflight control culture received from Dr. Montgomery, the control 
and backup cultures GCM-2053, GCM-2147, GCM-2l38, GCM-1808, and the 
"flight" culture GCM-2052 received from the Hayflick Laboratory all 
grew well and all were normal diploid lines. 
C-banding patterns (constitutive heterochromatin) are khown to vary 
• 	 greatly in human populations (25) while G-band patterns are extremely 
stable. The G-band pattern of man may even be recognized as changed 
little from those in other higher primates (26, 27). Therefore, we 
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expected that rearrangements in flight material, if found, would be of 
the C-band type. However, no C-band changes were noted in any of the 
cultures. 
The results obtained from this study are in keeping with data 
accumulated by this laboratory from a number of experiments with both 
human and nonhuman cell cultures. It has been established that 
diploid cultures, properly maintained, seldom show rearrangements of 
the chromosomes or changes in banding patterns (28). Cells subjected 
to radiation (29), chemical stress (30) or other stress factors (31) 
may develop chromosomal abberations. 
Microspectrophotometry 
The average optical density value for the 15 determinations from each 
nucleus was obtained. This value was then used to obtain a mean and 
±l standard deviation 
in Table III. 
(SD) for each population. The results are shown 
TABLE III. AVERAGE OPTICAL DENSITY OF NUCLEI 
AND CONTROL (C) CELLS 
OF FLIGHT (F) 
3-DAY 6-DAY 7-DAY 10-DAY 11 D~ 
• 

C F C F C F C F C F 

Mean 40 44 39 48 41 40 46 45 45 40 
+1 SD 14 15 12 12 13 12 12 11 11 7
-
aC ContTol 
F = Flight 
The mean for in-flight specimens is within ±l SD of the corresponding 
control. The decrease in the standard deviation with increase in age
of the cells is attributed to cell culture growth characteristics. The 
three-day specimens were characterized by a low population density and 
the cells were in an asynchronous growth state with all stages of the 
cell cycle represented. 
48L 
Figure 8 is a histogram of the frequency of occurrence of the average 
nuclear optical density value for 3-day, 6-day, 7-day, lO-day, and ll-day 
control and in-flight nuclei. The distribution of the values shows 
nuclei in Gl, Sand G2 phases.
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Figure 8. 	 Histogram showing average optical density of flight
and control cells. 
The ll-day nuclei exhibit a much narrower range in distribution and were 
also characterized by the lowest standard deviation. This is attributed 
to the cells having reached a stationary phase since the optical density 
values indicated a rather uniform population of nuclei in the Gl phase. 
When the histograms of the populations are compared, the trend from a 
growth phase (3- and 6-day) to a stationary phase (10- and ll-day) is 
readily observed. 
Whenever possible, mitotic nuclei were scanned in the 3-, 6- and 7-day 
specimens. On the basis of optical density values, it was determined 
that all mitotic nuclei contained the 2C complement of nucleoprotein. 
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None of the scanned yielded data suggesting aneuploidy at the 4C or 8C 
level. Mitotic nuclei in the lO-day and ll-day specimens were rarely 
seen and when found, they were usually not in a position to obtain 
accurate data. 
Medium Analysis 
Table IV is the result of the SMA-12 analysis of the freshly prepared 
medium, the used flight medium and the used medium from the backup 
control unit. The freshly prepared medium differs from the two used 
medium samples mainly in a higher glucose concentration. There is an 
unexplained difference in glucose concentration in the used control 
culture medium (75 mg%) and the flight culture medium (93 mg%). Other­
wise, there is no significant difference between the used flight
medium and the used control medium. 
TABLE IV. SMA-12 ANALYSIS OF FRESH, USED FLIGHT, AND USED GROUND 

CONTROL CULTURE MEDIUM 

FRESH MEDIA FLIGHT UNIT CONTROL 
GCMl GCM2 GCMl GCM2 
Na+ (meq/l) 130.0 131.0 132.0 131.0 130.0 
K+ (meq/l) 5.98 6.22 6.24 6.24 6.20 
CO2 (meq/l) 3.2 0.9 1.2 1.0 1.0 
T.P. (g%) 0.7 0.3 0.35 0.3 0.3 
Alb. (g%) 0.22 0.06 0.01 0.08 0.08 
Ca++ (mg%) 7.3 7.35 7.35 7.32 7.35 
Glu. (mg%) 124.0 94.0 91.0 71.0 79.0 
BUN (mg%) 2.0 1.0 1.0 1.0 1.0 
Creat. (mg%) 0.55 0.39 0.42 0.4 0.4 
Alk. Phos. (mU/ml) 32.0 9.0 29.0 28.0 28.0 
SOOT (ntl/ml) 14.0 6.0 7.0 6.0 6.0 
Table V gives the results of the amino acid ana lyses for the freshly 
prepared medium, the used flight medium and the used backup control 
unit medium. There appear to be no significant differences between 
the two samples of used medium. 
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TABLE V. AMINO 	 ACID ANALYSIS OF FRESH, USED FLIGHT, AND USED 
GROUND CONTROL CULTURE MEDIA 
FRESH MEDIA FLIGHT UNIT CONTROL 
GCM 1 GCM 2 GCM 1 GCM 2 
LYSINE 0.0405 0.0527 0.0502 0.0471 0.0391 
IIISTIDINE .0092 .009 .00~8 .0085 Trace 
ARGININE .0113 Trace Trace Trace 
ASPARTIC ACID .0057 .0049 .0033 .0062 .0060 
TIlREONINE .0318 .0318 .0326 .0251 .0280 
SERINE .2825 .280 .277 .222 .266 
GLUTAMIC ACID .0537 .0447 .0442 .0493 .0527 
GLYCINE .0122 .0150 .0197 .0135 .0137 
ALANINE .0160 .0288 .0376 .0283 .0315 
CYSTINE (HALF) .0034 
VALINE .0379 .0360 .0344 .0298 .033 
METHIONINE .0328 .0153 .0106 .0121 .0085 
ISOLEOCINE .0501 .0282 .0301 .0260 .0280 
LUECINE .104 .0305 .0326 .0283 .0328 
TYROSINE .0137 .0154 .0134 .0124 
PIIENYLALANINE .0151 .0171 .0146 .007 
Phase, Electron, and Scanning Microscopy of Fixed Cells 
A zero-gravity environment produced no observable differences in the 
flight cells as compared with the ground controls. Both flight and 
control cells showed identical morphologic changes during the period 
of the experiment, which we have attributed to age and population
density of the cultures. These changes are similar to aging changes 
in WI-38 cells described by Lipetz and Cristofalo (32). Microvilli 
are relatively sparse as compared with those present in other cell 
lines such as Chang liver and Hela cells. As the culture ages and a 
complete monolayer is formed, the cells become spindle shape and are 
aligned in a longitudinal direction with other cells to form unidirec­
tional bundles. As these bundles of cells grow and increase in size, 
they intersect other bundles at varying angles. At the point of junction the two bundles of cells not only interlace but may c,ross 
each other at different levels forming a multiple cell layer, rather 
than a monolayer of cells. 
Young cultures at 3 to 6 days of age are rich in ribosomes, filamentous 
mitochondria, and endoplasmic retiCUlum, especially in the central 
portions of the cytoplasm corresponding to the endoplasm. The outer 
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ectoplasm is rich in microtubules and microfibrils (fiq. g) micro­
fibrils are especially dense adjacent to the plasma membrane where 
they form distinct bundles which may be demonstrated as light or dark 
bands with phase microscopy. These bands run in a longitudinal direc­
tion just beneath the plasma membrane of the cell (fig. 10) . 
. 

As the cultures age, a variety of cytoplasmic vacuoles are formed. 
Transmission electron microscopy shows the vacuoles maybe dilated 
mitochondria, lysosomes, and autophagosomes and fat vacuoles 
(Fig· 10). 
In the 11 to 12 day old cultures filamentous mitochondria and lysosomes
are decreased. Endoplasmic reticulum may be decreased and there 
appears to be a piling up of ribosomes around slightly dilated endo­
plasmic reticulum tubules. There is a marked increase in the number 
of microtubules and microfibrils (fig. 11). 
Scanning electron microscopy confirms the phase microscopy and trans­
mission electron microscopy observations that these cells have a 
generally smooth surface and relatively few microvilli. Movies reveal 
rapid membranous movement of the distal cell surfaces in a beating 
fashion. This activity was demonstrated in static fashion with the 
scanning electron microscope (figs. 12 and 13). 
CONCLUSION 
Twenty separate cultures of WI-38 human embryonic lung cells have 
been exposed to a zero-gravity environment on a space satellite for 
peri ods of ti me va ryi ng from one to 59 days. Dup 1 i ca te CIJ 1 tlJres were 
run concurrently as ground controls. Ten cultures were fixed during 
the first 12 days of flight. Growth curves, DNA microspectrophometry,
phase microscopy, and ultrastructural studies of the fixed cells 
revealed no effects of a zero-gravity environment on the ten cultures. 
Two cultures were photographed by means of phase time-lapse cinematog­
raphy during the first 27 days of the flight. Analysis of the films 
revealed no differences in mitotic index, cell cycle, and migration 
between the flight and control cells. 
Eight cultures were not fixed but returned to earth in a viable state 
after being incubated at 36° C during the first 12 days of the flight 
and at 22° C for the remainder of the flight. At the present time only 
karotyping and chromosome banding have been performed in these cells. 
There are no differences between the flight and control cell cultures. 
Minor unexplained differences have been found in biochemical constituents 
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Figure 9. 	 Transmission electron photomicropraph of 6-day old culture at 
junction of central organelle rich zone of cytoplasm and ecto­
plasm. Vacuoles in central zone represent swollen mitochon­
dria (M), lysosomes, microtubules (MT), autophagosomes (A) and 
lipid droplets (L). Endoplasmic reticulum (R). Flight and 
control cultures are identical. Magnification 50 OOOX. 
Figure 10. Phase photomicrograph of 8-day old WI-38 cell culture. Note
• overgrowth 	of one cell over another producing a multilayered 
colony (0). Numerous clear vacuoles are present (V). A few 
filamentous mitochondria (M) are present. Glutaraldehyde and 
osmium tetroxide fixation. Gelatin-phenol mount. Magnifica­
tion 2000X. 
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Figure 11. 	 Transmission electron photomicrograph of peripheral cytoplasm 
showing free ribosomes (R), microtubules (MT) and bundles of 
microfibrils (MF) beneath plasma membrane. Magnification 
100 OOOX. 
Figure 12. Scanning electron 
photomicrograph of 
WI-38 cell near end 
of telophase. Some 
cytoplasmic bubbling 
(B) is present. Tri­
angular shaped mem­
branous cytoplasm is 
beginning to form (T). 
Figure 13. High magnification of 
triangular shaped mem­
branous cytoplasm in 
previous picture. Note 
folded cytoplasm (F), 
static view of the 
membranous beating of 
peripheral cytoplasm 
typical of cells in 
tissue culture. Mic­
rovilli are sparse in 
the WI-38 cell. 
Magnification 20 OOOX. 
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of the used flight and control media. Our present opinion is that 
these changes are of no significance. 
Within the limits of the experimental' design, it was found that a zero­
gravity environment produced no detectable effects on Wistar-38 human 
embryonic lung cells in tissue culture. 
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BLOOD VOLUME CHANGES 
Phitip C. Johnson~ M.D'*3 Theda B. Driscott* 
and Adrian D. LeBtance3 Ph.D.* 
ABSTRACT 
Analysis of radionuclide volume determinations made for the crewmembers 
of selected Gemini and Apollo missions showed that orbital spaceflight 
has an effect on red cell mass. Because the methods and the protocol 
developed for earlier flights were used for the crews of the three 
Skylab missions, direct comparisons are possible. After each Skylab 
mission, decreases were found in crewmembers ' red cell masses. The 
mean red cell mass decrease of 11 percent or 232 milliliters was 
approximately equal to the 10 percent mean red cell mass decrease of 
the Apollo 14 to 17 crewmembers. 
The red cell mass drop was greatest and the postrecovery reticulocyte 
response least for crewmembers of the 28-day Skylab 2 mission. Analy­
ses of data from the red cell mass determinations indicate that the red 
cell mass drops occurred in the first 30 days of flight and that a 
gradual recovery of the red cell mass deficits began approximately 
60 days after launch. The beginning of red cell mass regeneration 
during the Skylab 4 flight may explain the higher postmission 
reticulocyte counts. 
INTRODUCTION 
Decreased red cell mass has been found regularly among astronauts who 
return from space flight. This was first documented in the crew of 
the 8-day Gemini 5 mission and confirmed in the crewmembers of the 
14-day Gemini 7 mission. Simultaneously estimated 51Cr red blood cell 
halftimes were shortened suggesting hemolysis combined with a bone 
marrow unresponsive to the decrease were the major causes of the 
observed decrease in red cell mass (1). Similar studies after four 
Apollo moon landing missions showed that the red cell mass decreases 
were not associated with decreased 51Cr red blood cell survivals 
suggesting that marrow inhibition rather than hemolysis may have 
been the cause of the 10 percent mean red cell mass loss. The crews of 
both the Apollo and Gemini missions were exposed to at least four 
hours of 100 percent oxygen at 760 torr (1.0132 X 105 N/m2) prior to 
*Baylor College of Medicine, Houston, Texas 
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1 aunch and duri ng fl i ght to a hypobari c;..hypet.pgi c atmosphere [100 per­

cent oxygen, 258 torr (0.3440 X 105 N/m2 )J. It has been tempting to 

explain the decrease in red cell mass as que to the effects of hyper­

oxia since hyperoxia is known to both inhibit erythropoiesis and 

cause hemolysis (2,3). 

The Skylab missions differ from the Apollo missions by not having 

hyperoxic environment except for two hours of 100 percent oxygen at 

.760 torr .( 1.·OJ32X ~ 05N/m2 ) prior to launch and. for a few hours dUring 
the firstAay when the atmosphere' was similar to that of Apollo. Tile 
Skylab, missions' have afforded an opportunity to rule out the hyper:-oxic 
hypothesis of the. red, cell mass decreiise while at the same time 
testing whether changes in red cell'mass are progressive .witll longer
periods in Weightlessness. . . . 
METHODS 
. " 
R.ed ce11 mas·s me.a,~urements were made accordi ng to the foll owi ng 

sch~dule.· Skylab 2, a 2S:".day missJon:29 days prior. to laimch, 

recovery :day and 13, 42 and 67 daysla,ter; Skylab 3, a 5.9-day. mission: 

20 days befor.e 1 aunch, recovery day and 14 and 45 days later;. and 

Skylab 4, an 84:"day mission: 21 and 1 day before launch" reCOVery, 

day and 14.an<t 31.days later. All specimens were drawn; n ;tne morni.ng 

after anovern; ghtrest with the creWnian fpst; ng ,except for the 

recovery day samples which were drawn within two hours of the time wnen 

the spacecraft landed in the ocean. The 12.5 milliliters of blood dr~wn 

for the red cell mass was mixed with 2.5 milliliters of special ACO 

solution and 25 )lCi 51Cr. Sixty milliliters of blood to satisfy the 

blood requirements of other experiments was drawn prior to the rein­

fusion of the ]0 milliliters of the 5ler tagged red cells. The cells 

were incubated for Jour minutes at room temperature and subsequently .. 

14 milligrams of ascorbic acid was added prior to'reinfusion. The'red 

celT ,mass determination was obtained by averaging the red cell '.: 

radioactivity of a 30- and 31-mtrtute sample. F6r each specimen, 

2.5 milliliters of 'blood was drawn. Plasma radioactivity was separated 
to remove the effect' ofuntaggedthromi um~' The methods used to assure 
accurateihjection and stati,sticall,y Significant counting' drthe radio­
activ;-ty are described elsewhere ;(4). ,,' " . ... 
, ,,' ., , , 1 
Thirty ,days' prior: 'to launch, 50 lJti 14C-glycine was injected intra-'· 
· vehouslY for a red cell 1ife span study'; the 14C radioactiVity was 
followed for a total of 125 days on the first mission, 13'ldays on 
the second mission, and 141 days on the third mission. Bloodwas 
generally drawn weekly throughout this period including the time in 
space. Radioactivity was determined: by extracting' h'eme,_i'gniting 
the dried extract and determining )lCi of 14C per milligram heme. At 
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recovery, 2 ~Ci of 59Fe citrate was injected for calculation of iron 
turnover using the 30-, 3l-minute samples and a blood sample drawn 2 
to 3 hours later. Iron reappearance was obtained from b10q{J samples 
drawn 1, 3, 7, and l4 days after recovery. Ret; cu 1 ocyte counts were 
obtained weekly preflight and postmission. Activity of 51Cr red cells 
was measured to estimate red cen chromium halftime. The total blood 
drawn for each crewmember is shown in table I . 
TABLE I. BLOOD DRAWN FOR SKYLAB CREW MEMBERS AND CONTROL SOBJECTS 
Mission During Mean 
Duration Preflight Fl ight Postflight Total* .' ml/day 
(Days) ml/days m1/days ml/days ml/days ml 
28 385/30 44/28 365/18 794/76 ~ 10 
59 344/21 88/59 373/20 805/100. 8 
84 378/35 88/84 423/21 889/140 6 
*Total milliliters blood/days between first and last blood draw. 
No single blood specimen exceeded 100 milliliters in any 24-hour 
period. 
To insure that the amount of blood drawn did not influence these re-. 
sults, similar amounts of blood were drawn from healthy control sub­jects. These control subjects were approximately the same age as the 
crewmembers. Since the control subjects accompanied the medical team 
to the recovery carriers and Cape Kennedy, their blood results were a 
confirmation that the remote facilities and delayed final preparation
did not affect the results. . 
RESULTS 
Table II shows the red cell mass volume values obtained from the nine 
crewmembers'and the nine control subjects. These are presented as 
total red cell mass (milliliters) and on a milliliters per kilogram 
body weight basis. . . 
The mean value of the premission red cell mass of the crewmembers was 
2075 milliliters which is not different from the mea.n values of the 
control s ,2053 milliliterS'.. The mean values of the red cell mass/ki 10­
grams body wei ght was 28.9 mi 11 il iters/ ki logram for the crew and 
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TABLE I I. RED CELL MASS AND RED CELL MASS/KILOGRAM BODY WEIGHT OF 
SKYLAB CREWMEMBERS AND CONTROL SUBJECTS 
Crewmember 	 Controls (milliliters/milliliters per kilogram) (milliliters/milliliters per kilogram) 
Scientist 
Mission Day Commander Pilot Pilot 1 2 3 
28-Day 	 F-29 2097/33.5 2088/26.6 2394/29.3 1918/25.6 2213/27.6 1798/23.0
R+O 1778/29.5 1763/23.7 2104/27.7 1949/26.0 2299/28.9 1718/21.9 
R+13 1729/28.4 1745/23.3 2088/27.0 1911/26.0 
R+42 1927/30.0 2340/28.7
R+67 2033/31.1 2120/27.3 2441/29.8 
.;::. 
1.0 59-Day 	 F-20 1841/26.9 1780/28.9 2608/30.0 2237/28.0 2250/30.0 1932/29.5 
co 	 R+O 1728/26.7 1427/24.3 2332/27.2 2154/27.3 2259/30.2 1899/28.2 
R+14 1792/27.2 1534/25.1 2454/27.6 2122/26.6 1883/28.3 
R+45 1898/27.2 1810/28.9 2690/30.4 
84-Day 	 F-21 1920/28.4 2030/28.5 1904/28.0 2119/27.4 2197/29.7 1817/24.2 
F-1 1891/27.8 2000/28.0 1962/29.2 2119/27.4 2258/30.5 1766/23.3 
R+O 1813/26.6 1851/26.4 1790/27.0 2096/27.8 2187/29.4 1845/24.2 
R+14 1829/26.6 1941/27.1 1826/27.0 2070/26.7 2175/29.6 1752/23.1 
R+31 1995/28.8 2066/27.8 2010/28.8 
F is days before launch. 

R is days following recovery from flight . 

.". .. 
... 
27.2 milliliters/kilogram for the controls. These mean values are not 
different statistically. The recovery mean value of the crew, 
1843 milliliters, was different from their preflight mean value and 
different from the control postflight mean of 2046 milliliters 
(p = <0.05). The crewmernbers showed a mean value decrease of 232 milli­
liters and the controls showed a decrease of 8 milliliters. Calculated 
on a milliliters/kilogram body weight basis, the crewts postmission 
mean value was 26.6 milliliters/kilogram body weight or 2.3 milliliters 
less than premission while the controls did not change from the pre­
mission value of 27 milliliters/kilogram body weight. 
Evidence against a hemolytic process is presented in table III where 
the 51Cr red cell T~ preflight and postmission values and the 
l4C-glycine red cell life span mean values are shown. There is no 
difference of statistical significance between the preflight and post­
flight crew mean values or the crew and control mean values either for 
the 51Cr T~ or the l4C-glycine red cell mean life span. 
Table IV shows the iron turnover results. The 0.32 milliliters/kilogram
body weight per day for the crew is similar to the 0.30 milliliters/
kilogram body weight per day for the control subjects. Statistical 
analysis indicates no difference between controls and crew in re­
appearance or turnover indicating that the rate of erythropoiesis was 
essentially the same for crewmembers and control subjects. 
Table V shows the reticulocyte counts arranged according to mission. 
These are shown as the number of reticulocytes per cubic milliliters 
of blood X 10-3. The reticuoctye counts were low when drawn at re­
covery following each mission. Postmission reticulocyte counts greater 
than premission means were found in only one crewmember of the 28-day 
mission at 2 weeks, the 3 crewmembers of the 59-day mission at 1 week, 
and 1 week or less for the 84-day mission1s crew. These results 
indicate that red cell mass regeneration did not occur until fourteen 
or more days after recovery from the shortest mission. The control 
subjects did not develop a change in the reticulocyte count at any
time indicating that reticulocyte changes found in the crewmembers were 
not caused by the blood drawing schedule. 
DISCUSSION 
The red cell mass results of the Skylab studies show that the crewmembers 
sustained a statistically significant decrease in circulating red cells. 
The decreases were not found among the ground-based control subjects
indicating that the blood drawn for the extensive metabolic studies 
did not cause the change. Additionally, the second red cell mass 
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TABLE I I 1. 
51 Cr RED CELL HALFTIMES 	 IN DAYS OF SKYLAB CREWMEMBERS 
.­AND CONTROL SUBJECTS 
Crewmembers 	 Controls 
Mission 
Duration Post- Post­
(Days) Prefl i ght Flight Change Pref1 i ght Flight Change 
28 31.2 24.2 -7.0 23.8 23.3 -0.5 
26.6 21.7 -4.9 24.7 23.0 -1. 7 

27.9 24.4 -3.5 23.1 21.0 -2.1 
59 24.4 22.8 -1.6 26.4 22.0 -4.4 
28.8 27.2 -1.6 21.5 22.0 +0.5 
25.6 23.6 -2.0 24.0 23.2 -0.8 
84 24.4 27.4 +3.0 29.0 26.7 -2.3 
22.7 24.5 +1.8 25.6 24.8 -0.8 
23.5 21.8 -1. 7 20.0 20.1 +0.1 
MEAN 26.1 	 24.2 -1.9 24.2 22.9 -1. 3 

±S. E. ±0.9 	 ±0.7 ±1.0 ±0.9 ±0.7 ±0.5 
14C-GLYCINE RED CELL MEAN LIFE SPAN IN DAYS 
Crewmembers 	 Controls 
28 	 130 

117 

116 

59 	 128 116 

122 122 

122 107 

84 	 125 130 

131 128 

'" 113 	 106 

MEAN 123 	 121 

±S.E. ±2 ±4 
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TABLE IV. IRON TURNOVER 

Mission Duration 
(Days) 
(m1/kg body weight per day)
Crewmembers Controls 
28 0.22 0.38 
0.35 0.33 
0.38 0.35 
59 0.39 0.29 
0.24 0.30 
0.21 0.29 
84 0.30 0.21 
0.38 0.23 
0.42 0.32 
MEAN 0.32 0.30 
±S.E. ±0.03 ±0.01 
obtained from the crew prior to the 84-day mission showed that no de­
crease in red cell mass occurred prior to launch indicating that pre­
mission preparations did not cause the change. Iron turnover immediately 
post recovery was normal. The depressed reticulocyte counts at re­
covery indicate inhibited reticulocyte release or accelerated loss of 
reticular material. The lowering of reticulocyte counts was greatest 
for the crew of the shortest mission and least for the crew of the 
longest mission. This suggests the 84-day crew may already have been 
in the recovery or replacement phase of red cell mass prior to their 
return from weightlessness. The red cell mass mean decrease found after 
the 28-day Skylab mission was greater than the mean results obtained 
from the Apollo crewmembers while the mean decrease found after the 
longest Sky1ab mission was less (5). 
The etiology of the red cell mass drop and lowered reticulocyte counts 
at recovery is unknown. The red cell mass is the most stable of the 
various blood constituents. Sudden drops in red cell mass are possible
due to hemorrhaging or hemolysis. Gradual decreases are produced by
inhibition of bOMe marrow activity, ineffective erythropoiesis or chronic 
hemorrhage. There was no clinical evidence of hemorrhage among the 
crews and haptog10bin levels have tended to be normal or elevated 
rather than suppressed indicating that intravascular hemolysis did not 
occur in Apollo or Skylab crews (6). Iron reappearance data gave no 
clinical evidence to suggest ineffective erythropoiesis. The low reticu­
locyte counts are additional evidence against ineffective erythropoiesis. 
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TABLE V. RETICULOCYTE COUNTS OF SKYLAB CREW MEMBERS 
(Reticu1ocytes X 10-3/mm3 Blood) 
Mission Duration 28 Days 59 Days 84 Days 
Crewmentlers Comnander 
Scientist 
Pilot Pilot Commander 
Scientist 
Pilot Pilot Commander 
Scientist 
Pi 1ot Pilot 
Premission Mean 
:!:SD 
37 
2 
37 
1 
27 
3 
32 
6 
33 
3 
43 
2 
48 
5 
43 
7 
44 
3 
(J"I 
0 
N 
Recovery Day (R) 
R+l Day 
17 
18 
19 
24 
8 
12 
25 21 29 41 
46 
38 
45 
40 
67* 
R+3 Days 24 30 14 29 24 41 38 48* 31 
R+l Week 29 30 22 42* 55* 102* 66* 55 72 
R+2 Weeks 28 38* 21 38 81 126 77 88 83 
R+3 Weeks 33 35 26 88 74 91 77 78 88 
*First value greater than premission mean. 
~ ;.. 'I 
An age dependent loss of red cells is a possibility and would not be 
seen in the survival curves obtained if red cells greater than 30 days
of age were sequestrated and destroyed selectively during the first 
few mission days. Loss of cells older than 30 days would not affect 
the results since the older cell did not contain the l4C-g1ycine. 
Premature loss of older cells without intravascular hemolysis suggests 
red cell surface and shape changes. This was actually found since all 
crewmembers showed an increase in abnormal red cell shapes including 
crenated erythrocytes in the scanning electron microscope evaluation 
of their blood samples taken at the end of the flight (7). Hyperoxia
through lipid peroxidation could cause the red cell shape changes. 
This may have been the cause of the red cell mass decreases found in 
Gemini and Apollo crewmembers. It could not explain the red cell 
mass decrease noted in the Skylab crewmembers. Therefore, other 
aspects of the environment must have caused this change. A possible 
but unproven explanation of this combination of abnormally shaped
red cells and decreased red cell mass among the Skylab astronauts 
would be a change in splenic function during the mission. Hyper­
splenism could start early during the mission when the blood volume 
was relatively too large perhaps associated with the increased portal 
pressure and/or decreased portal flow. This would be consistent with 
the two or three days of nausea and loss of appetite reported by sus­
ceptible crewmembers. 
The crewmembers' reticulocyte counts were low at recovery indicating 
increased splenic removal of reticulum or decreased bone marrow 
production rates. A vitamin E deficiency is one cause of early
reticulum loss, but inhibited bone marrow is more likely because the 
red cell mass stayed low. Bone marrow function would not increase to 
replace the lost red cells if oxygen delivery to the kidney was main­
tained. Either hyperoxia or hyperphosphatemia could cause this by
shift"ing the oxygen disassociation curve to the right. In this way 
net oxygen delivery to the tissues is increased making a lowered red 
cell mass adequate for tissue oxygen (8). This mechanism helps
account for the Skylab results since in-flight blood specimens showed 
higher phosphorus levels. The red cell mass decrease associated with 
space flight is not followed by a decrease in hemoglobin concentration 
since plasma volume decreases occur at the same time (5). The kidneys 
use both changes in hemoglobin concentration and oxygen delivery to 
modulate erythropoietin release. Thus, the decreased red cell masses 
of the Skylab crewmembers might not be followed by compensatory in­
creases in erythropoietin unt"il plasma volume increased. Without 
increased erythropoietin, bone marrow activity would not increase and 
should appear inhibited until a new equilibrium is reached. 
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Both hyperphosphatemia and the decreased plasma volume seem to explain 
the low reticulocyte counts found at recovery. At recovery iron 
turnover was normal indicating a possible rebound in bone marrow 
activity. The rapid expansion in plasma volume during that time 
could account for the normal iron turnover. 
SUMMARY 
Taken in its totality with previous flight data, the Skylab data 
confirm that a decrease in red cell mass is a constant occurrence 
in space flight. Except in the Gemini missions the decrease does not 
seem to be caused by intravascular hemolysis. Splenic trapping of 
red cells is a plausible explanation for the loss of red cells. After 
the initial loss, there is at least a 30-day delay before the red 
cell mass begins to reconstitute itself indicating an inhibited bone 
marrow. Bone marrow function is inhibited because the decrease in 
red cell mass is associated with a decrease in plasma volume and 
increased plasma phosphorus levels. This combination probably 
explains the observed decrease in reticulocyte counts. 
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RED CELL METABOLISM STUDIES ON SKYLAB 
Charles E. Mengel., Iv!. D. 
Lhiversity of~issouri., 
Columbia., Missouri 
ABSTRACT 
In previous laboratory experiments on animals exposed to levels of 
hyperoxia, it was demonstrated that several metabolic effects occurred in 
red cells during such exposure. The most dramatic of these effects was 
the occurrence of lipid peroxidation in red blood cells and subsequent 
hemolysis. Other metabolic alterations noted were some changes of 
glycolytic intermediates (including increases of adenosine triphosphate 
and decreases of 2, 3 diphosphoglyceric acid and inhibition of phospho­
fructokinase. On the basis of these background data, similar metabolic 
studies were performed on humans involved in space flight. These 
studies included the Skylab experiences. The primary purpose of the 
investigations was to study red cells for (l) evidences of lipid per­
oxidation or (2) changes at various points in the glycolytic pathway. 
The Skylab missions were an opportunity to study blood samples before, 
during, and after flight and to compare results with simultaneous 
controls. No direct evidence that lipid peroxidation had occurred in 
the red blood cells was apparent in the studies. 
Nevertheless, certain metabolic changes in red cells were noted. 
o 	 Skylab 2: Increases of hexokinase, glyceraldehyde 3-phosphate 

dehydrogenase, and pyruvate kinase during flight, and decreases 

of phosphofructokinase after flight. 

o 	 Skylab 3: Decreases of hexokinase, phosphoglyceric kinase, 

acetylcholinesterase, and increases of pyruvate kinase during 

flight; and decreases in glutathione, glyceraldehyde phos­

phate dehydrogenase, and phosphoglyceric kinase, and increased 

adenosine triphosphate, and pyruvate kinase after flight. 

o 	 Skylab 4: Decreases of glutathione, glucose-phosphate 

dehydrogenase, and phosphofructokinase, glyceraldehyde 

3-phosphate dehydrogenase during flight. 
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The most consistent changes (including laboratory high oxygen pressure 
studies, Skylab Medical Experiments Altitude Test, and Skylab) have 
included: 
o increased adenosine triphosphate 
o decreased phosphofructokinase 
o decreased phosphoglyceric kinase 
o increased pyruvate kinase 
o decreased acetylcholinesterase 
The data are consistent with the hypothesis that these conditions of 
space flight do not produce metabolic changes (lipid peroxidation)
that are known to result in hemolysis but do result in significant 
alterations of glycolytic intermediates and enzymes. 
INTRODUCT ION 
The untoward effects of high oxygen tension for many years had been 
largely of academic and in vitro interest only. Development of the 
use of oxygen under high pressure for medical purposes, and the use of 
a hyperoxic environment in the cabins of space vehicles for United 
States manned space flights increased the practical implications of the 
potential untoward effects. These situations also provided a special 
opportunity for study of varying aspects of red cell metabolism. It 
had been demonstrated that susceptible animals exposed to oxygen under 
high pressure developed hemolysis due to peroxidation of unsaturated 
fatty acids in red cell membrane (1). It was also demonstrated that a 
similar event could occur in humans (2). Subsequent studies under 
simulated and actual space flight conditions demonstrated variable 
decreases of the red cell mass. 
A major limiting factor in the interpretation of data obtained during 
the Gemini and Apollo series, however, was that blood samples were 
analyzed before and after flight. There was no information as to what, 
if any, changes occurred during space flight itself. The Skylab pro­
gram thus offered a unique opportunity for the study of the possible 
effects of that environment and flight on red cell metabolism. 
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The studies carried out included an analysis of red cell componets 
involved with 
o 	 peroxidation of red cell lipids, 
o 	 enzymes of red cell metabolism, 
o 	 levels of 2, 3-diphosphoglyceric acid and adenosine tri­

phosphate. 

MATERIALS AND METHODS 
The details and schedules of sampling appear elsewhere. 

Blood was kept frozen for transport of samples from the Johnson Space

Center to the investigator's laboratory. Samples there remained frozen 

at -700 F (-39 0 C) until the time of determination. In all procedures,

samples of blood drawn concomitantly from controls were run simultane­

ously with astronaut specimen~. 

Details of most analytic procedures used have been previously described 

(3 through 8). 

The procedures employed for 2, 3 diphosphoglyceric acid were basically

those described by Oski (9) and Krimsky (10). 

A hemoglobin determination as made on blood samples using the cyanmethemo­

globin method. The tinal readings were thus expressed as micromoles of 

red cell 2, 3 diphosphoglyceric acid per gram of hemoglobin. Simulta­

neous standards were performed with runs, and also checked against a 

prepared standard curve. The range used on the standard curve was 

between 0.1 and 0.4 micromoles (~M). 

Abbreviations used: 

GSH Reduced glutathione 

ATP Adenosine triphosphate 

2, 3-DPG 2, 3-diphosphoglyceric acid 

G6PD Glucose-6-phosphate dehydrogenase 

HK Hexokinase 

PFK Phosphofructokinase 
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G3PD Glyceraldehyde phosphate dehydrogenase 
PGK Phosphoglyceric kinase 
PK PyrlJvate kinase 
AChE Acetylcholinesterase 
RESULTS 
The data obtained from Skylab 2 are shown in table I. Preflight differ­
ences between astronauts and controls were not noted. 
With the in-flight samples, there were increases of hexokinase, pyruvate 
kinase, and glyceraldehyde phosphate dehydrogenase. The changes of 
adenosine triphosphate and 2, 3-diphosphoglyceric acid were not sig­
ni fi cant. 
Postflight there was a significant decrease of phosphofructokinase. 
The data obtained from Skylab 3 are summarized in tables II and III. 
Astronauts and controls were identical preflight. 
During flight there were significant decreases of hexokinase, phospho­
glyceric kinase, and acetylcholinesterase, and increases of pyruvate 
kinase. 
Postflight the changes noted on recovery day and days 1 and 14 varied. 
The results of Skylab 4 studies are shown in table IV through VI. 
They show that the only significant change occurred in phosphofructo­
kinase during the early stage of the in-flight samples. 
DISCUSSION 
The advent of the use of medical hyperoxia and the use of increased 
oxygen tensions in space capsules prompted the need for further study 
into changes induced by variable environments and the potential untoward 
effects on many tissues including red cells. Previous studies in our 
•laboratory had indicated that a mechanism, in fact the only mechanism, 
responsible for destruction of red cells by hyperoxia was peroxidation 
of the unsaturated fatty acids in red cell membranes. 
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TABLE 1. SKYLAB 2 
PREFLIGHT IN.FLIGHT* POSTFLIGHT 
Controls Astronauts Controls Astronauts Controls Astronauts 
Determination t Mean ± 1 SD Mean ± 1 SO Mean ± 1 SO Mean ± 1 SO Sill· Mean ± 1 SO Mean ± i SO 51!!. 
SSH (1119 ~) 195.0 ±30.0 183.0 ±56.0 162.0 ±23.0 169.0 ±24.0 130.0 ±. 9.0 148.0 ±19.0 
ATP (IIM/9 Hb) 5.7 ± 1.3 5.7 ± 0.8 3,7 ± 0.7 4.5 ± 1.7 3.6 ± 0.6 3.5 ± 0.5 
Lipid Peroxides 0 0 0 0 0 0 
2,3·0PG (IIM/g Hb) 9.6 ± 2.9 8.1±2.7 9.2 ± 2.7 7.8 ± 3.5 14.4 ± 3.0 14.7 :!: 4.6 
G6PO (Ill/g Hb) 7.0 ± 1.4 7.1±1.6 3.9 :!: 1.3 3.9 ± 1.1 4.9 ± 0.7 5.3 i 0.4 
01 
....... 
HK (Ell/g Hb) 0.50:!: 0.13 0.46± 0.13 0.65± 0.17 2.4 ± 1.6 P<0.005 0.18± 0.09 0.48± 0.4 
...... 
PFK (Ell/g Hb) 26.2 ± 7.5 22.7 ± 5.7 30.4 ± 8.5 28.8 ±11.3 37.0 ± 7.0 25.0 ± 6.0 P<0.025 
G3PO (EII/g Hb) 59.0 ±12.0 65.0 ± 8.0 44.0 ± 8.0 53.0 ± 9.0 P<0.05 56.0 ±11.0 53.0 ± 4.0 
PGK (E11/g Hb) 28.4 ± 4.0 26.7 ± 8.4 18.5 ± 7.0 20.4 ± 6.3 17.8 ± 3.6 19.5 ± 2.5 
PK (EII/g Hb) 12.6 ± 4.0 10.7 ± 5.2 4.0 ± 1.2 5.7 ± 1.4 P<O.Ol 8.6 ± 1.8 7.6 :!: 1.8 
AChE (Ell/g Hb) 62.0 ± 6.0 64.0 ± 8.0 53.0 ± 6.0 55.0 ± 6.0 60.0 :!: 6.0 65.0 ± 4.0 
*Data given includes all samples. No differences between controls and 
astronauts were observed at each individual sampling time. 
tSee pages 3 and 4 for translation of these abbreviations. 
Determination* 
GSH (mg %) 
ATP ().tM/g Hb) 
Lipid Peroxides 
2,3-DPG ().tM/g Hb) 
(J"I 
--' 
N 	 G6PD (ElJ/g Hb) 
HK (E).t/g Hb) 
PFK (E).t/g Hb) 
G3PD (E).t/g Hb) 
PGK (E).t/g Hb) 
PK (E).t/g Hb) 
AChE (E).t/g Hb) 
TABLE II. 
PREFLIGHT 
Controls 

Mean ± 1 SO 

167.0 ±20.0 
S.9 ± 0.9 
0 
6.1 ± 2.4 
9.1±1.0 
0.38± 0.11 
2S.0 ± 2.0 
62.0 ±14.0 
36.0 ± 7.0 
5.2 ± 1.6 
43.0 ± 4.0 
Astronauts 
Mean ± 1 SO 
163.0 ±21.0 
5.9 ± O.S 
0 
7.1 	 ± 1:3 
9.6 ± 1.9 
0.37±0.18 
27.0 ± 1.0 
61.0 ±14.0 
33.0 ± 2.0 
5.9 ± 1.0 
4S.0 ± 7.0 
SKYLAB 3 
Controls 
Mean ± 1 SO 
IN-FLIGHT 
Astronauts 
Mean ± 1 SO Sig 
119.0 ±74.0 
S.3 ± 0.9 
0 
6.1 	 ± 3.6 
4.7 ± 1.1 
O.Sl± 0.17 
28.1 ± 9.S 
39.0 ± 9.0 
24.6 ± 5.2 
S.1±1.6 
34.0 ±10.0 
121.0 ±SO.O 
S.9 ± 0.9 
0 
7.9 ± 4.3 
4.3 ± 1.3 
0.28± 0.13 P<O.OOS 
28.0 ± 3.7 
42.0 ± S.O 
20.1 ± 8.3 P<O.OS 
6.S ± 2.2 p<0.05 
27.0.± 7.0 P<O.OS 
*See pages 3 and 4 for translation of these abbreviations • 
... ~- ,\ 	 .... 
.... 
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TABLE III. SKYLA8 3 
POSTFLIGIfT (DAY) 
II + 0 R + 1 R + 14 R + O. II + 1. R + 14 
Detel'lllinatioll* C.,ntrols Astronauti Sig. COntrols Astronauts Si9· COntrols Astronauts Sig. ~ontrols Astronauts Slg. 
GSH (1119 1'.) 70.0 % 6.0 37.0 113.0 p<O.OI 104.0 1 3.0 64.0 %10.0 p<O.OI 181.0 156.0 183.0 112.0 118.0 ±56.0 94.0 ±64.0 
ATP (uM/g Hb) 4.3 %0.8 6.1 ± 0.4 P<0.01 4.3 ± 6.0 5.4 :I: 0.3 p<0.025 7.0 ± 0.7 9.8 :t 1.4 p<0.025 5.21± 1.5 6.6 ± 1.9 
Lipid Peroxides t) 0 0 0 0 0 0 0 
2.3-DPG (uM/g Hb) 5.6 t 1.9 6.5 ± 1.8 8.3 ± 4.0 9.1 ± 1.4 4.5 ± 2.0 4.3 ± 1.7 6.1 ± 3.1 6.8 ± 2.2 
G6PD (Ell/g Hb) 6.0 1 1.8 6.1 ± 0.6 5.3 ± 1.2 5.5 ± 1.5 5.8 ± 0.5 7.8 1 0.2 1'<0.01 5.7 1 1.2 6.5 1 1.3 
HK (Eu/g Hb) 0.49± 0.13 0.67 ± 0.31 0.481 0.11 0.50± 0.08 0.38± 0.09 0.39± 0.03 0.45± 0.12 0.52± 0.22 
(J'1 
PFK (Eu/g Hb l 35.0 ±13.0 29.0 ± 4.0 27.0 ± 7.0 27.0 ± 6.0 28.0 ± 2.0 32.01 4.0 30.0 ±10.0 29.0 ± 5.0 
--' 
W' G3PD (EllI9 Hb) 63.0 1 4.0 52.0 ± 6.0 1'<0.05 69.0 ±20.0 54.0 1 6.0 45.0 1 1.0 43.0 ± 5.0 59.0 116.0 50.0. % 7.0 
PGK (Eu/g Hb) 27.0 %1.0 19.0 ± 4.0 1'<0.01 28.0 ± 3.0 28.0 1 5.0 21.0 ± 3.0 27.0 ± 2.0 p<0.025 25.0 ± 4.0 24.0 ± 6.0 
PK (Eu/g Hb) 6.1 ± 0.8 7.812.0 5.5 ± 0.7 7.8 ± 1.2 1'<0.025 17.0 ± 2.0 18.0 ± 5.0 9.6 ± 5.0 11.4 ± 6.0 
AChE (Eu/g Hb) 33.0 ± 2.0 29.0 1 4.0 29.0 ± 3.0 35.0 ± 8.0 29.0 ± 3.0 26.0 ± 3.0 30.0 ± 3.0 30.0 ± 6.0 
*See pages 3 and 4 for translation of these abbreviations. 
TABLE IV. SKYLAB 4 
PREFLIGHT 
~ 
Controls Astronauts J 
Oetermi na t; on * Mean 1 SO Mean 1 SO S;g. 
Met Hgb (%) 0.90± 1.08 4.22± 3.67 P<0.005 
• 
GSH (mg %) 139. 55±28. 19 128.37±27.90 
ATP (llr~/9 Hb) 7.11 ± 0.54 8.29± 1.80 
Li pi d Peroxides 0 0 
2,3-0PG (llM/g Hb) 9.24± 3.09 9.18± 4.99 
G6PO (Ell/g Hb) 7.29± 1.12 6.84± 1.32 
HK (Ell/ 9 Hb) 0.72± 0.10 0.73±0.11 
PFK (Ell/g Hb) 36.04± 9.36 33.80± 9.56 
G3PO (Ell/g Hb) 54.57± 8.64 56.45±10.79 
PGK (Ell.! 9 Hb) 29.74± 6.17 27.76± 3.76 
PK (Ell/g Hb) 10.25± 4.24 10.06± 2.57 
AChE (Ell/g Hb) 54.68±10.89 60.40±10.04 
ATPase 11 . 17 ± 1.36 10.35± 0.79 
*See pages 3 and 4 for translation of theses abbreviations. 
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TABLE 	 V. SKYLAB 4 
(INF 1...4) IN...FLIGHT (INF 5-8)
Controls Astronauts Controls Astronauts 
Detenninatton * Mean ± 1 SO Mean ± 1 SO Si!h Mean ± 1 SO Mean ± 1 SD S1g. 
Met Hgb (~) 28.45± 5.92 27.07± 6.13 20.54± 8.20 28.71± 3.16 p<0.OO5 
GSH (mg %) 107.77±38.99 88. 33±28.08 110.09±38.92 l00.86±25.60 
ATP (l1M!g Hb-) 8.34± 1.83 7.64± 1.48 6.69± 2.13 6.52± 2.39 
lipid Peroxides 0 0 0 0 
2,3-0PG (~M!g Hb) 3.47± 1.68 3.35± 0.89 4.15± 1.21 4.22± 1.66 
G6PO (E~!g Hb) 6.42± 1.62 4.80± 1.29 p<0.025 4.92± 1.12 4.77± 0.870'1 
....... 

0'1 	 HK (Eil!g Hb) 0.22± 0.10 0.20± 0.09 0.39± 0.09 0.38± 0.07 
PFK (E~!g Hb) 35.03± 7.75 25.89± 6.68 p<O.Ol 26.30± 9.73 24.92± 4.58 
G3PO (El1!g Hb) 55.25± 9.31 49.85± 7.02 63.79±17.86 58.32±17.15 
PGK (El1!g Hb) 14.90± 4.10 15.47± 5.52 18.87± 5.58 18.22± 7.79 
PK (E~!g Hb) 8.92± 3.63 7.76± 2.67 5.08± 1.20 4.87± 1.00 
AChE (E~!g Hb) 55.62± 8.67 51.06± 9.45 50.48± 7.37 43.73± 7.86 
*See 	pages 3 and 4 for translation of these abbreviations. 
TABLE VI. SKYLAB 4 
POST FLIGHT (DAY) 
R + 0 R + 1 R + 14 R + 0, R + 1, R + 14 
Determlnation* Controls Astronauts Slg. Controls Astronauts SiS· Controls Astronauts Si!!. Control§ A!tronluu SI!!. 
Met Hgb (S) 2.96± 2.58 9.33± 5.62 7.0S± 4.61 8.04± 4.68 11 .351 3.93 13.39± 3.74 7.1215.11 10.25± 5.26 
GSH (mg S) 75.33117 .20 7l.42± 6.87. 70.16±11.44 56.51±10.12 78.58±12.11 90.96± 2.02 74.69± 14.25 72.96115.82 
ATP (~M/g Hb) 6.60± 0.36 7.681 1.00 S.2S± 0.22 5.30± 0.14 4.47± 0.00 5.53± 0.37 5.53± 0.81 6.17± 1.23 
lipid PerOxides 0 0 0 0 0 0 0 0 
2 ,3-0PG (~H/g Hb) 5.171 1.00 8.861 2.49 3.14± 0.10 4.27± 1.45 2.31± 0.32 2.57± 0.46 3.S4± 1.35 S.23± 3.14 
G6PO (B'~/g Hb) 7.46:1:. 1.60 8.85± 1.89 3.SS± OAO 4.8J± 1.40 4.21± 0.60 4.27± 0.97 5.18± 1.90 5.97± 2.51 
HK (B'~/g Hb) 0.6l± 0.20 0.49± 0.00 0.2l± 0.00 0.19± 0.00 0.19± 0.00 0.27± 0.00 0.34± 0.22 0.321 0.10 
PFK (E~/"9 Hb) 38.26± 1.41 35.6417.05 19.38± 5.10 16.40± 8.55 19.31±10.01 18.26± 4.38 2S.65±11.11 23.43±11.07 
(J"I 
-oJ G3PD (Evl 9 Hb) 79.14± 9.64 82.43:t 4.68 39.27:t 5.49 39.94± 7.13 46.04± 4.52 42.19:1:. 5.78 54 .81± 18.74 54.85120.40 
m PGK (B'~/g Hb) 25.21± 7.63 24.5617.37 9.80± 1.12 n.13± 2.91 9.23± 0.83 11. 76± 2.36 14.75± 8.65 15.8117.81 
PK (E~/g Hb) 12.8J± 3.10 14.01± 0.55 4.54± 1.46 4.66± 1.48 3.8h 0.30 6.14:!: 1.13 P<0.05 7.08i 4.52 8.27:1: 4.25 
AChE (B'~/g Hb) 72.22± 8.48 60.5O± 5.41 28.931 1.01 29.5S± 3.83 32.03± 2.65 35.64± 3.16 44.39:1:.20.38 41.93±14.08 
*See pages 3 and 4 for translation of these abbreviations. 
l. '- \ , ... ... 
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In addition to these changes, other studies also demonstrated altera­
tions of glycolytic intermediates and enzymes which, however, could 
not be linked to concrete evidence of cell damage. 
Previous space flight studies were limited by the fact that samples
could only be obtained before and after flight, and frequently inappro­
priate controls existed. The major contribution allowed by the Skylab 
series of studies was the availability of simultaneous control samples 
as well as in-flight samples from astronauts. It should be noted, 
however, that there were progressive gas composition changes as the 
varied series of Gemini, Apollo, and Skylab flights occurred. 
In our present studies, there was no evidence of lipid peroxidation
in any of the samples. This may be taken as evidence that the likeli­
hood of overt red cell damage would be slim. There were, however, cer­
tain changes observed in glycolytic intermediates and enzymes. For 
perspective, these may be summarized in Table VII. Included in this 
table are summary data from the Skylab t~edical Experiments Altitude 
Test (SMEAT) and our own laboratory (OHP) studies using oxygen under 
pressure. It is apparent that the most consistent change noted, a 
decrease of phosphofructokinase, had been verified a number of times. 
It is this enzyme step which is thought to be at the center of the so­
called Pasteur effect, and which is susceptible to the effects of oxygen. 
Other changes have been less consistent and the significance of all of 
these changes is not understood. 
SUMMARY 
In summary therefore, it is possible to conclude that there are no 
evidences of lipid peroxidation, that biochemical effect known to be 
associated with irreversible red cell damage, and the changes observed 
in glycolytic intermediates and enzymes cannot be directly implicated 
as indicating evidence of red cell, damage. 
TABLE VI J. SIMWIY OF RBC METABOLISM CHANGES 
DETERIIIIlATlOIS· 0Ht' STUDIES SMEAT SKYLAB 2 SKYLAB 3 SKYLAB 4 
6SH 
ATP 
lI,ld PeroxIdes 
2.3-DPG 
66PD 
HI( 
PfK 
G3PD 
PGK 
PK 
AChE 
·See pages 3 and 4 for translatIon of these abbreylatlons, 
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EXPERIMENT Ml15 - SPECIAL HEMATOLOGIC EFFECTS: 
DYNAMIC CHANGES IN RED CELL SHAPE 
IN RESPONSE TO THE SPACE-FLIGHT ENVIRONMENT 
Stephen L. Kimzey~ Ph.D.*; Linda C. Burns~ M.S.t; 

and 

Craig L. Fischer~ M.D.~ 

ABSTRACT 
Deviations from the normal biconcave discoid shape of red blood cells 
may be permanent and result from a metabolic or functional disorder of 
the cell, or may be reversible and result from the influence of plasma­
borne factors. The transient alterations are predictable and form the 
basis for a classification of red cell configurations that may be used 
as an indicator of body response to unfavorable conditions which have 
altered the constancy of the plasma milieu. Scanning electron 
microscopy techniques, with improved spatial resolution and greater 
depth of focus, have enabled major refinements in the critical inter­
pretation of red cell shape changes. 
Blood samples collected during the preflight, in-flight. and postflight 
phases of each Skylab mission were examined using the scanning electron 
microscope and the populations of red cells classified according to 
their surface morphology. Blood samples collected simultaneously from 
ground-based control subjects were analyzed for comparison. Significant 
changes in the distribution of red cell shapes did occur in the crew 
samples collected during the in-flight phase of each mtsston~ Some 
individual variations among crewmembers were seen but other types of 
changes observed were generally consistent. The primary changes ob­
served in all samples were increases in the number of echinocytes
(crenated cells), stomatocytes, and knizocytes. The Skylab 4 flight 
crew experienced a substantial elevation in the number of leptocytes 
(thin, flattened cells); 50 percent of one crewmember's cells were of 
this type by mission day 82. The magnitude of the major shift in the 
red cell population classification (discocyte to echinocyte) appears 
to be correlated to the mission duration; the greatest change occured 
*National Aeronautics and Space Administration - Lyndon B. Johnson 
Space Center, Houston, Texas 
tNorthrop Services, Incorporated, Houston, Texas 
tEisenhower Memorial Hospital, Palm Desert, California 
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in the later in-flight samples from the Skylab 3 and Skylab 4 missions. 
Most of the changes observed were reversible, and the postflight 
samples returned to preflight conditions quickly. 
This rapid return to preflight values suggests that the alterations 
in the red cell shape profiles were due to modifications in the plasma 
environment as opposed to more permanent alterations of red cell meta­
bolic or structural characteristics. The significance of these red 
cell transformations must be considered with respect to: splenic 
removal of abnormal cell types that might contribute to the observed 
red cell mass loss, oxygen-carrying capacity of the cells, changes in 
the plasmi composition during flight, and implications relative to 
crew selection criteria for future missions. 
INTRODUCTI ON 
The famil i ar bi concave di scoi d shape of the mature erythrocyte repre­
sents a unique structural configuration among cell types. This 
peculiar shape is so consistent and characteristic of normal erythro­
cytes that deviations from the discoid form have provided the basis 
for the detection and diagnosis of a variety of congenital and acquired 
hematologic disorders (Bessis et aZ., 1973; Brecher and Bessis, 1972; 
Bull and Kuhn, 1970; Cooper, 1969; Cooper and Jandl, 1968; Kayden and 
Bessis, 1970). The mechanisms involved in the maintenance of this 
biconcave shape have been of considerable interest to physiologists, 
chemists and mathematicians for a nurnber of years. Several theories 
have been proposed to explain the physical and chemical bases of this 
configuration (Adams, 1972, 1973; Bull, 1973; Bull and Brailsford, 
1973; Evans and Leblond, 1973), but as yet no single explanation is 
acceptable to all investigators. 
Regardless of the exact mechanism by which the red cell maintains its 
IInormalll discoid shape and regardless of the advantages or disadvantages 
of this shape relative to the red cell functions (i.e., optimum gas 
exchange, deformability, survival), it is quite evident that a delicate 
balance exists between the chemical and physical forces and the meta­
bolic energy and ultrastructual organization of molecules - all inter­
acting to exert a complex array of vectorial forces on the red cell _I 
membrane. It is probable that alterations in this balance of forces 
are responsible for the red cell IS exhibiting a variety of different 
morphological states ranging from a discocyte to a spherocyte with many
intermediate shapes. This imbalance may be the result of an intrinsic ~ 
metabolic or structural defect of the cell usually associated with a 
hemolytic anemia. 
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A second class of factors causing alteration in the red cell shape are 
extrinsic properties of the plasma milieu. This second type of shape 
change is usually of a less severe nature and, provided the cell is 
not destroyed by selective removal in the reticuloendothelial system 
or hemolyzed due to an imbalance of ion and water regulation, these 
changes are reversible if the causative agent is neutralized or removed 
from the plasma. The most common and most widely investigated type of 
red cell shape change due to extrinsic factors is the conversion of the 
normal discocyte to a spiculed cell, the discocyte-echinocyte trans­
formation. Thus, the evaluation of this type of reversible change in 
red cell shape may provide an indicator not only of alterations in red 
cell functional capacity, but may also be used to detect and identify 
subtle changes in plasma constituents, especially those known to have 
effects on red cell shape. 
As one aspect of the protocol for Skylab Experiment Ml15, Special 
Hematologic Effects, samples of blood collected from the crewmen pre­
flight,. in-flight, and postflight were critically examined by light 
and scanning electron microscopy for alterations in the shape of the 
red blood cells. This study was designed specifically to investigate, 
detect, and characterize alterations in red cell shape either during or 
following extended exposure to the space environment. The following 
report will describe previously unpublished results on the alterations 
in red cell shape observed during the extended Skylab space flights 
and the rapid reversal of these changes upon entry into a normal gravita­
tional environment. Possible causes for these modifications in red cell 
shape will be discussed, as will the significance of these changes to 
man's functional capacity in space and to other observed hematologic 
changes. 
MATERIALS AND METHODS 
Red blood cells from astronaut crews were processed for scanning 
electron microscopy using the following procedures. 
Fixation 
Blood samples from preflight and postflight medical examinations were 
collected in heparin; in-flight samples were collected in ethylene­
diaminetetracetic acid (EOTA). Approximately 0.1 milliliter (ml) of 
whole blood per sample was added to 1.0 ml 0.5 percent glutaraldehyde, 
pH 7.4, 320 mOsmoles, prepared in a standard incubation medium!. 
IThe standard incubation medium used in these procedures consisted of 

10 millimolar (mM) potassium chloride, 141 mM sodium chloride, 1.0 mM 

magnesium chloride, 1.3 mM calcium chloride, 0.8 mM sodium biphosphate

and 5 mM disodium phosphate. 
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Time in the fixative varied from 1 hour for preflight and postflight 
samples to 1,2, 24, 57, and 81 days for in-flight samples. No effect 
was found on cell morphology as a result of the varying lengths of 
ti me the red ce11 s spent in gl utara 1 dehyde. The fi xed ce11 samples 
were washed twice in a standard incubation medium, pH 7.3, 300 mOsmoles, 
and then twice in deionized water prior to critical point drying. 
Dehydration and Critical Point Drying 
Each red cell sample was allowed to sediment for 5 minutes from water 
onto a clean 9 x 22 millimeter glass cover slip without air-drying. 
The sample was dehydrated to 100 percent ethyl alcohol by gently adding 
graded ethyl alcohol solutions dropwise to the water on the cover slip. 
Three rinses were made with each solution; the third rinse was allowed 
to remain on the cell sample for 5 minutes prior to replacement with 
the next solution. A stepwise series of 20%, 50%, 75%, 90%, and 100%. 
ethyl alcohol solutions were used. The ethyl alcohol was then replaced 
with 50% amyl acetate/50% ethyl alcohol and finally 100% amyl acetate. 
The samples were critical-point dried from liquid carbon dioxide using 
a Denton critical point drying apparatus. 
Coating 
The glass cover slips with the red cell samples were mounted on aluminum 
stubs using double-edge conductive tape and silver conducting paint. 
the samples were then coated with approximately 300 angstrom (A) gold/
palladium (60%/40%) in an Edwards evaporator equipped with a rotary/tilt 
stage. 
Scanning Electron Microscope 
The red cell samples were examined in an ETEC Autoscan at 20 kilovolt 
with 2000X magnification. Resolution of the microscope under these 
conditions is on the order of 200 A. Magnification and other instru­
ment parameters were held constant for all red cell classification. 
Classification 
A quantitative, differential classification scheme for red cell shapes 
was utilized by the Cellular Analytical Laboratory at the Johnson Space
Center in ground-based studies [Skylab Medical Experiments Altitude 
Test (SMEAT) and ground control subjects] and in support of the Apollo 17 
mission prior to its implementation in the Skylab Program. The criteria 
for differentiation of cell shapes and the terminology used are out­
lined in table I and are consistent with those recently discussed at 
a~workshop on red cell shape at the Institute of Cell Pathology,
Hopital de Bicetre, Paris, France (Bessis, et al., 1973). 
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TABLE l. RED CELL SHAPE CLASSIFICATION 
DES! GNATION CHARACTERISTIC COt+lENTS SCANNING ELECTRON MICROSCOPIC CRITERIA 
Discocyte Disc Normal Biconcave Erythrocyte Shallow but visible round depression
in central portion of cell. 
Leptocyte Thin, F1 at Fl attened Cell No viSible depression and no evidence 
of cell sphering (cell diameter normal 
or larger than normal). 
Codocyte Bell Bell-shape erythrocyte 
(appearance depends upon
side of cell uppermost) 
Single concavity with extruded opposite 
side or flattened ring around elevated 
central portion of cell. 
Stomatocyte Single Concavity Various stages of cup shapes Swollen cell periphery with smaller 
concavity or concavity flattened on 
one side, indicating the beginnings of 
sphering. 
Knizocyte Pinch Triconcave Erythrocyte Triconcave depression or cell with 
pinched area in center. 
Echinocyte Spiny Various stages of crenation Deformed and angular cell periphery
with spicule formation. 
This classification of red cell morphology by shape rather than by 
disease or origin appears to be desirable from the standpoint that 
similar or identical shapes may arise from more than one type of dis­
order or condition. The terminology proposed by Bessis will be used 
throughout the following discussion. 
In each red cell sample, from 500 to 1000 red cells were examined and 
classified into one of four distinct groups of cells. For the third 
manned Skylab mission, this classification scheme was enlarged to in­
clude two additional categories. Examples of the types of red cell 
shapes observed in the Skylab samples are illustrated in figures 1 
through 11. 
Light Microscopy 
Red blood cell smears were prepared for routine examination using 
standard hematological procedures with Wright's stain. 
RESULTS 
Routine hematologic red cell smears prepared from blood s~mples collect­
ed immediately postflight (within two hours of splashdown) and examined 
by light microscopy (oil-immersion, 1000X magnification) were by all 
standard criteria essentially normal. There were no obvious variations 
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Figure 1. Distribution of normal red cells (Discocytes) 
Magnification: 3040X. 
Figure 2. 	 Field containing abnormal red cell types 
Magnification: 3l20X. 
524 
Figure 3. Platelet with normal erythrocyte (Discocyte) 
Magnification: 7840X. 
Figure 4. 	 Leptocyte and Stomatocyte 
Magnification: 5600X. 
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Figure 5. 	 Knizocyte 
Magnification: 11 920X. 
Figure 6. 	 Stomatocyte 
Magnification: 11 920X. 
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Figure 7. Codocyte 

Magnification: 12 560X . 

Figure 8. 	 Cooocytes as viewed from inverted position 
(Target Cells) Magnification : 5280X. 
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Figure 9. Echinocyte, Stage I 

Magnification: 11 840X. 

Figure 10. 	 Echinocyte, Stage II 

Magnification: 15 840X. 
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Figure 11. 	 Echinocyte, Stage III, with Discocyte 
and Platelet 
Magnification: l1900X 
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in the size or shape of the cells as compared to preflight samples. 
Cell edges were smooth, and the cells were essentially normochromic 
with no evidence of cytoplasmic inclusions. Quantitative microspectro­
photometric examination of single cells indicated no change in the 
hemoglobin content, and the calculated mean corpuscular hemoglobin and 
mean corpuscular hemoglobin concentration were also normal. No slides 
were prepared from the blood samples collected during the in-flight 
phase of the missions for comparison. 
However, a quantitative classification of the red cell population, 
based on variations in cell shape as determined by scanning electron 
microscopy, indicates a significant variation in the distribution of 
cell types during the in-flight portions of each mission (figures 
12 through 14). During the preflight phase 80 to 90 percent of the 
circulating red cells were classified as discocytes (mean = 83.4 ± 10.3), 
but there was considerable variation among individual crewmembers 
(range, 60.9-92.9 percent). The percentage of discocytes in the blood 
samples collected immediately postflight {mean = 82.7 ± 7.9) was not 
significantly different from preflight levels. The remaining 15 to 20 
percent of the nondiscoid cells present during the preflight control 
phase of each mission consisted primarily of leptocytes, stomatocytes 
and knizocytes (figs. 4 through 6) with the frequency of echinocytes 
(fig. 9) present being less than one percent. These data are summarized 
in figures 12 through 14. 
However, during exposure of the crews to the space flight environment, 
the frequency of echinocytes increased significantly, and this increase 
appeared to be related to the duration of each mission (fig. 15). 
Again, considerable individual variation was evident (figs. 16 through 
18) but the increase in the numbers of echinocytes, expressed as an 
average of each crew, was statistically significant after the first 
sampling period of 'each mission. The majority of the echinocytes 
present in these samples were, of the stage I type (fig. 9), witli few 
progressing to stages II or III (fiQs. 10, 11). The first sample
collected postflight [Recovery + 0 day, (R+O) was prepared within 
two hours of entry of the spacecraft. The number of echinocytes observed 
in this sample represented less than one percent of the red cell popula­
tion, and was therefore comparable to the preflight value. This rapid 
reversal of the discocyte-ech-inocyte transformation is significant 
and will be discussed in detail. 
The pattern of change observed with respect to increases in the numbers 
of stomatocytes and knizocytes was different from that recorded for 
transformation to echinocytic shapes. If the data from all three 
manned missions are considered as a composite there appears to be 
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Changes in red cell shape/Skylab 2 
Echinocytes KEY: 
CDR=Coomander,3 SPT=Scientist Pilot, 
PLT=Pilot2 F=Prefl i ght 
MD=Mission Day
1 R=Recovery 
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Stomatocytes + knizocytes 
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Sampling F-1 
period (DAYS) 
One red cell sample from eac~ crewmember (prepared as described in the Materials and Methods 
Section) was classified by scanning electron microscopy into five categories of cell types.
Mission days 4 and 27 represent blood samples taken during the mission by the crew 4 days and 
27 days after launch. F-l and RtO represent blood samples taken from the crew during the 
medical examinations on day 1 preceding launch, and on recovery. 
Figure 12. Distribution of red cell shapes during the first manned 
Skylab mission (Skylab 2). 
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Changes in red cell shape/Skylab 3 
Ech inocytes 
Stomatocytes + knizocytes 
Leptocytes 
Discocytes 
CDR SPT PLT 
MD3 
CDR SPT PLT 
MD58 
KEY: 
CDR=COII1IIander 
SPT=Scientist Pilot 
PLT=Pilot 
F=Prefl ight 
MD=Mission Day
R=Recovery 
CDR SPT PLT 
R+O 
One red cell sample from each crewmember (prepared as described in the r1aterials and Methods 
Section was classified by scanning electron microscopy into five categories of cell types.
11ission days 4 and 58 represent blood samples taken during the mission by the crew 3 and 58 days
after launch. F-l and R+O represent blood samples taken from the crew durinq medical examina­
tions on day 1 preced,ing launch, and on recovery. 
Figure 13. Distribution of red cell shapes during the second manned 
Skylab mission (Skylab 3). 
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KEY; 
CDR=COII1lIander 
SPT=Scientist Pilot 
PLT=Pilot 
F=Prefl ight
MD=Miss ion Day
R=Recovery 
[1:.:.;-:  •• ~••••• 
CDR SPTPLT 
R+O 
One red cell sample from each crewmember (prepared as described in the Materials and r1ethods 
Section) was classified by scanning electron microscooy into five categories of cell types.
Mission days 4 and 82 represent blood samples taken during the mission by the crew 4 days and 
82 days after launch. F-l and R+O represent blood samples taken from the crew during the 
medical examinations on day 1 preceding launch, and on recovery. 
Figure 14. Distribution of, red cell shapes during the third manned 
Skylab Mission (Sky1ab 4). 
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Each point represents the average value of the crew for the mission and sampling day indicated. 
The dotted lines represent the range of values for the three crewmembers from the mission 
measured at that period. 
Figure 15. Percent of echinocytes in crew red cell samples during the 
Skylab Missions. 
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The points for each crewmember are plotted as a function of time after launCh. Sampling periods
indicated are F-l. MD4. MD27. and R+O. 
Figure 16. Percent of echinocytes in crew red cell samples during the 
first manned Skylab mission (Skylab 2). 
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Figure 17. Percent of echinocytes in crew red cell samples during the 
second manned Skylab mission (Skylab 3), 
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Figure 18. Percent of echinocytes in crew red cell samples during the 
third manned Skylab mission (Skylab 4). 
535 
Pl.T 
SPT 
maximum increase prior to mission day 27 and a gradual reduction with 
continued time in flight (fig. 19). The percentage of stomatocytes 
and knizocytes present on mission day 82 is not significantly different 
from that on recovery day (R+O). It is possible that these altered 
cells underwent a further transformation to a~ echinocytic type later 
in the mission. All Skylab crewmen and particularly those individuals 
exhibiting the greatest change in the number of echinocytes (Pilot-3, 
Commander-4, and Pilot-4) did not show a further reduction in their 
discocyte frequency after the first in-flight sample. (The response
of the Pilot-4 is an exception and will be discussed in more detail.) 
The mean discocyte frequency in 8 of the 9 crewmen was 82.6% ± 10.3 
on mission day 3(4) as compared to 81.0% ± 6.8 on the second sampling 
day (mission day 27, mission day 58, or mission day 82, respectively. 
However, these values may be somewhat misleading because of the 
individual variation and relatively small sample size. 
The kinetics of the transformation from discocyte to leptocyte demon­
strated even a third pattern, with only two of the three crewmen of 
the 84-day mission (Skylab 4) showing a significant elevation in the 
frequency of this cell type (fig. 20). Even among the Skylab 4 crew 
the increased average frequency is due primarily to the response of the 
Pilot-4 (fig. 21) with the other two crewmen showing only a slight 
elevation earlier in the mission. It should also be noted that the 
Pilot-4 had a high percentage (15.5) of leptocytes present during the 
preflight phase and the lowest percentage (60.9) of discocytes of the 
nine crewmen examined (figs. 12 through 14). 
Attempts to compare the degree of change in red cell shape with alter­
ations in several plasma and cellular constituents (sodium, potassium, 
calcium, magnesium, chloride, osmolality, adenosine triphosphate, and 
2,3-diphosphoglyceric acid) failed to demonstrate a significant linear 
correlation. This finding was not surprising when one considers the 
sparsity of data values and the inherent characteristics of the 
mathematical determination of linear correlation coefficients. Data 
relative to other plasma echinocytogenic factors (especially lecithin 
and lysolecithin, cholesterol, and free fatty acids) and their cellular 
concentrations were not available for comparison. 
Similar studies were done in support of Apollo 17 and the SMEAT at 
Johnson Space Center. There were no significant changes in red cell 
shape distributions during the 56-day SMEAT study in the three-man 
crew (discocyte mean for entire study = 85.0% ± 3.9) or ground-based 
control group (mean - 78.9% ± 4.4) either during or immediately follow­
ing the exposure period (Kimzey, 1973). On Apollo 17 the postflight 
percentage of discocytes (84.0 ± 6.5) was not significantly different 
from preflight crew values (90.4% ± 3.6) or those of the control 
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Each point represents the average value of the crew fO.r the mission and sampling day indicated. 
The dotted lines represent the range of values for the three cre~embers from the mission 
measured at that period. The soli·d line preceding the graph represents the mean and standard 
deviation of all crew samples for all missions from the medical exams taken day 1 prior to launch. 
Figure 19. 	 Percent of stomatocytes plus knizocytes in crew red cell 
samples during the Skylab missions. 
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The dotted lines represent the range of values for the three crewmembers from the mission 
measured at that period. 
Figure 20. 	 Percentage of leptocytes in crew red cell samples during 
the Skylab missions. 
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Figure 21. Percent 1eptocytes in crew red cell samples during 
the third manned Sky1ab mission (Skylab 4), 
group (preflight mean - 87.3% ± 11, postflight mean - 90.5% ± 3.3). 
The Skylab ground control group had no changes during the in-flight
phase when fixed red cells were maintained exactly as those prepared 
by the astronauts. 
DISCUSSION 
The results of this study suggest that during extended exposure to 
the space flight environment significant alterations occur in the 
distribution of red cell shapes in the peripheral circulation. The 
most consistent change observed was the discocyte-echinocyte transfor­
mation which was readily reversed following completion of the mission. 
The kinetics and causes for this type of red cell shape change have 
been extensively studied in both in vitro and in vivo systems (Bessis 
and Lessin, 1970; Brecher and Bessis, 1972; Bull and Kuhn, 1970; 
Cooper, 1969; Cooper and Jandl, 1968; Deuticke, 1968; Feo, 1973; Kayden 
and Bessis, 1970; LaCelle, et aZ., 1973; Leblond, 1973; Shohet and 
Haley, 1973; Weed and Chailley, 1973). The concept of echinocytogenic 
plasma, plasma capable of crenating normal red cells, has been well 
documented by these investigators. Various echinocytogenic factors 
identified this far are summarized in table II. A detailed discussion 
of all of the extrinsic, echinocytogenic agents identified in the 
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Table II. Reversible, Echinocytogenic Factors Affecting 
Red Cell Shape 
Fatty aci ds: Sedatives: 
oleate barbiturates 
caprylate Diuretics: 
Detergents: ethacrynic acid 
a"1 kyl sul fonates Coronary vasodilators: 
Bil e aci ds dipyridamole 
Lysolecithin Food preservatives; 
Hypertoni ci ty substituted benzoates 
Increased pH Metabolic drugs: 
Alcohols: 2, 4-dinitrophenol 
ethanol Anti-inflammatory drugs: 
butanol i ndomethaci n 
phenylbutazone 
phenopyrazone 
Plant glucosides, glycosides and 
deri vat; ves: 
phloridzin 
phloratin 
tanni c aci d 
.. saponins 
Modified from Bessis, et at., 1973 2nd Deuticke, 1968. 
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plasma is outside the scope of this presentation. However, the follow­
ing points should be emphasized relative to the results of this study
and the body of knowledge existing relative to echinocyte formation. 
The characteristics of the echinocyte formation observed during the 
Skylab flights are comparable to those of the discocyte-echinocyte 
transformation induced by elevations of plasma lecithin, lysolecithin, 
and/or free fatty acids. Most of the eChinocytes observed in the 
Skylab study were of the state I type (fig. 9) suggesting that the 
changes in the plasma echinocytogenic factors were moderate. It has 
been demonstrated by Shohet and Haley (1973) that only a small 
elevation in the lysolecithin content of the red cell membrane is 
sufficient to initiate this shape change. The discocyte-echinocyte
transformation can occur in seconds when echinocytogenic plasma is 
added to normal red cells (Bessis, 1973). All of the red cell shape 
changes, regardless of the cell type or duration of the mission, had 
almost completely reverted to the preflight levels by the first post­
flight sampling period (R+O). Thus the modifications in cell shape, 
which in some cases had occurred over a two to three month period, 
were neutralized within two to three hours of entry into the Earth's 
normal gravitational environment. 
Most changes in red cell shape induced by intrinsic factors and those 
related to aged red cells are not readily reversible. This observation 
would support the concept of a change in one or more of the plasma
constituents and its uptake by the cell membrane as being the primary 
cause of the shape changes. 
The magnitude of the red cell shape change was not linearly correlated 
with any plasma constituent measured in the Skylab studies. However, 
lecithin, lysolecithin, free fatty acids, and albumin (significant to 
the clearance of free fatty acids) were not measured in either the 
in-flight plasma or red cell samples. It has been shown that it is 
the accumulation of the plasma echinocytogenic agent by the cell 
membrane which causes the shape change, not merely the addition of the 
agent to the plasma. This being the case, and because the transfor­
mations were all early stages of change, it is possible that extensive 
chemical analyses of these compounds in the plasma would not provide
sufficient information relative to< the shape changes. 
The significance of the observed red cell shape transformations during 
Skylab is not readily apparent. Based upon the crews' in-flight
exercise performance capacity and based upon their in-flight cardio­
vascular response to the stress of lower body negative pressure, it 
seems apparent that these changes in red cell shape do not represent 
a significant compromise to the body systems' ability to function 
normally with respect to adequate blood flow and tissue oxygen demand. 
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However, the impact of alterations in red cell shape with respect to 
the reduction in circulating red cell mass {Johnson, 1974} might be 
more significant. Severe deformation of circulating red cells can 
result in their premature sequestration by the reticuloendothelial 
system, primarily the hepatic and splenic systems (Rifkind, 1966). 
The alteration in red cell shape during space flight might provide a 
sufficient stimulus to the reticuloendothelial system to initiate 
trapping and eventual removal of these cells from the circulating red 
cell mass. 
Maintenance of normal red cell shape and normal deformability are 
essential to survival of the cell in vivo. A major function of the 
reticuloendothelial system is to remove from circulation those cells 
whose structure is abnormal or the membrane too rigid. Since the cells 
that were examined in this study came from peripheral blood samples, 
they apparently satisfied the criteria of the reticuloendothelial 
system for nondestruction. However, the abnormal cells remaining in 
the circulation may be indicative of a greater degree of shape alter­
ation in other cells which were then removed from circulation. 
Sufficient data are not available to answer this question with cer­
tainty. As stated earlier, all of the echinocytes observed were of 
the stage I type. Studies on the deformability characteristics of 
echinocytes produced by extrinsic plasma echinocytogenic factors 
have shown that there are no significant differences in the deforma­
bility of these cells compared to discocytes (Leblond, 1973). It is 
only when the crenation progresses to a point where change in the 
membrane results in loss of effective surface area, that the con­
sequences are different, and the cells have a reduction in their 
deformability. The absence of stage II or stage III echinocytes
would seem to indicate that the changes observed were not progressing 
to further, more extensive shape alterations. 
The magnitude of the echinocyte formation appears to be related to 
the duration of the flight with no apparent plateau in the curve 
depicting the response evident after 82 days. The curve describing 
the combined stomatocyte and knizocyte formation has a peak value 
between 20 and 30 days after launch, and by 82 days the percent of 
these types of cells is comparable to the preflight value. This second 
type of pattern is consistent with that characteristic of the red cell 
mass loss during these missions. The loss of circulating red cells 
was also maximal at 20 to 40 days and decreased after that time. 
However, the recovery of red cell mass was independent of weightless­
ness or normal gravity after the initial insult (Johnson, 1974). 
Thus, it is not possible to substantiate a direct relationship between 
the red cell shape alterations during the Skylab missions to the 
concomitant loss in red cell mass. However, it is an area that merits 
further investigation. 
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CONCLUSIONS 

The significance of the transformations in red cell shape observed 
during the Skylab study must be considered relative to the limitation 
of man's participation in extended space flight missions. The results 
of this one study are not conclusive with respect to this question.
Based on these examinations of red cells in normal, healthy men and 
based on other Skylab experiment data relative to the functional 
capacity of the red cells in vitro and the performance capacity of 
man as an integrated system, the changes observed in this study would 
not appear to be the limiting factor in deter-mining man's stay in 
space. However, the results of this experiment and the documented 
red cell mass loss during space flight raise serious questions at this 
time relative to the selection criteria utilized for passengers and 
crews of future space flights. Serious consideration should be given 
to testing the effectiveness and reserve capacity of the erythropoetic 
system in those individuals, and until the questions relative to the 
specific cause and impact of the red cell shape change on cell survival 
in vivo can be resolved, individuals with diagnosed hematologic 
abnormalities should not be considered as prime candidates for missions, 
especially those of longer duration. 
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CARDIOVASCULAR AND METABOLIC FUNCTION 
LOWER BODY NEGATIVE PRESSURE: THIRD MANNED SKYLAB MISSION 

R. L. Johnson J M. D.*; G. W. Hoffler, M. D.*; A. E. Niaogossian, M. D.*; 
S. A. Bergman, M. D.*; and M. M. Jaakson, M. S.* 
ABSTRACT 
The crew of the Skylab 4 Mission exhibited physiological changes during 
their 84-day mission that resembled but in several important areas 
did not reach the magnitude of changes exhibited in crewmen of the 
two earlier Skylab flights. For example, calf girth diminished rapidly 
at first and continued throughout the flight, but at a slower rate than 
in the first two crews. At rest all three crewmen showed, in compari­
son to preflight levels, elevated mean systolic and pulse pressures 
and decreased mean diastolic and mean arterial pressures. Similar 
changes were seen in most Skylab 2 and Skylab 3 crewmen. While mean 
resting heart rates of both the Skylab 3 and Skylab 4 crews were 
elevated, those of the Skylab 2 crew were, however, lower than during 
preflight tests. Stressed heart rates followed previous patterns in 
being consistently elevated over preflight values. Again, increases 
of calf volume during lower body negative pressure greatly exceeded 
preflight increases .. Postflight changes in cardiovascular parameters 
for the most part resembled those seen in previous crewmen of space 
missions. Their recovery to preflight limits occurred rapidly. 
In-flight data and subjective impressions of the crewmen confirmed, a$ 
in previous Skylab flights, that lower body negative pressure in 
weigh~lessness imposed a greater stress upon the cardiovascular system 
than in Earth's gravity. Changed relationships in the anatomical 
distribution of blood volume and extravascular fluids, altered patterns
of blood flow, and reduced total circulating blood volume induced by
the weightless environment are offered as partial explanations for the 
changes in cardiovascular responses to lower body negative pressure. 
The exaggerated in-flight responses to lower body negative pressure 
generally appeared to decline after the first 30 to 50 days of flight. 
In-flight data served as a fairly accurate prediction of the post­
flight status of orthostatic tolerance. 
*National Aeronautics and Space Administration - Lyndon B. Johnston 
Space Center, Houston, Texas. 
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INTRODUCTION 

Medical evaluations after Gemini and Apollo flights demonstrated re­
duced orthostatic tolerance in virtually all crewmen specifically
tested (1,2). This diminished ability of the cardiovascular system 
to function effectively against gravitational stress following exposure 
to weightlessness, while usually mild and never operationally signifi­
cant, sometimes resulted in pronounced increases in heart rate and 
decreases in pulse pressure during orthostatic testing. However, 
forty-eight hours or less nearly always sufficed for orthostatic 
responses to regain their preflight status. The magnitude of this 
postflight loss of orthostatic tolerance showed no clear correlation 
with flight durations ranging between four and fourteen days. This 
enigma was compounded by the Russian reports of severe orthostatic 
intolerance in the Soyuz 9 crewmen after their eighteen-day flight (3). 
Against this background, concern for postflight orthostatic-intoler­
ance in the crewmen of the planned twenty-eight-day flight of the first 
manned Skylab Mission, Skylab 2, reached greater dimensions. 
The objective of the Skylab lower body negative pressure experiment 
designated M092, was to determine the extent and the time course of 
changes in orthostatic tolerance during the weightlessness of space 
flight and to determine whether in-flight data from the experiment 
would be useful in predicting the postflight status of orthostatic 
tolerance. 
Compared to preflight results, lower body negative pressure produced
exaggerated blood pressure and heart rate responses during the first 
in-flight test of the Skylab 2 crewmen and showed no clear-cut trend 
toward preflight levels during the twenty-eight-day flight (4). Heart 
rate responses to the last in-flight test, however, compared quite
closely to those of the first postflight test. Postflight orthostatic 
intolerance was not more severe than that seen after some Apollo flights
and differed chiefly in requiring longer periods of time to return to 
preflight levels. 
During the second manned mission, Skylab 3, similar exaggeration of 
blood pressure and heart rate responses occurred during the first 
in-flight test (5). Again no definite trend toward preflight values 
could be seen during the first twenty-eight days but cardiovascular 
responses to lower body negative pressure appeared to become more 
stable by the sixth to eighth v/eek of flight. In ~eneral, the test 
results in-flight served to predict quite well the orthostatic toler­
ance of the individual crewmen in the immediate postflight period. 
The Skylab 3 crew responded surprisingly well to postflight lower 
body negative pressure tests. Moreover, the return of orthostatic 
responses to preflight values occurred more rapidly than after the 
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twenty-eight-day flight. During both flights the results of lower 
body negative pressure assumed an important role in assessing the 
in-flight status of crew health. The experience of the first two 
missions with the lower body negative pressure and other biomedical 
experiments greatly reduced apprehension toward extension of the third 
manned mission, Skylab 4, beyond the 59 days flown by the Skylab 3 
crew. 
METHODS AND MATERIALS 
Preflight baseline data were acquired from the Skylab 4 crewmen over a 
four and one-half month period from four tests conducted at approximate­
ly monthly intervals and three during the last six weeks prior to 
launch. All tests were carried out in the Orbital Workshop one-g 
Trainer or the Skylab Mobile Laboratories using flight-type hardware. 
Training in the techniques of the test and operation of the equipment 
took place prior to the acquisition of baseline data, most of which 
was obtained from tests conducted by the astronauts acting both as 
subjects and observers as they would later do in flight. In-flight 
tests were conducted usually at three- or four-day intervals while 
postflight tests were carri~d out daily at first and then at increasing
intervals of tinie over a period of approximately two months. Table I 
shows the number of tests on each Skylab 4 crewman during each period 
of the mission as well as those for the first two manned missions. 
Scheduling was such that, insofar as possible, each crewman1s test was 
carried out at the same time of day and at least one, but if possible, 
two hours after meals or vigorous exercise. 
TABLE I. LOWER· BODr NEGATIY[ PRESSURE DURING PREFLIGHT. 
IN-FLIGHT AND POSTFLIGIIT PERIOOS OF THE THREE SKYLAD MISSIOKS 
AlII TOTAL TESTS FOR EACH PtlASE AND EACH MISSION. 
Skylab 
Mission Pref11ght In-flight Post flight Total 
2 ComnInder 6 7 8 21 
Scientist Pilot 6 7 8 21 
pnot 6 
18 
8 
~ 
8 
24 
22 
64 
3 	 ConnInder 6 16 8 30 
Sclentist P110t S 17 8 30 
Pilot S 16 8 29 
W- 49 24 -ur 
4 	 C_neler 6 22 9 37 
Scientist pnot 22 9 38 
pnot 7 23 9 39 
~ bI "IT lT4 
Total: 3 Mlsstons S4 138 7S 267 
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The 10l'fer body negati ve pressure devi ce, constructed of anodi zed 
aluminum, was tubular in shape and could be separated at its center 
to allow access to the subject's legs (figs. 1 and 2). Movable 
sup'erior and lateral iris-like templates around the circular opening 
could be adjusted to fit snugly around the subject's waist. A waist 
seal of fire-resistant material encircled the end of the device and 
was fitted closely to the waist by means of a zippered opening and 
Velcro overlap, and a belt which encircled the waist just outside 
the metal opening. A padded post, which served as a saddle, could 
be adjusted footward or headward so that the iliac crests of the 
subject were at the level of the metal templates. Decreased pressure 
within the device was provided by a vacuum plenum, or during flight, 
the vacuum of space. In addition to a valve in this system, a second 
valve and a pressure gage mounted on the lower body negative pressure 
device permitted fine adjustment of the pressure within the device 
to any level beb/een zero and 55 mm Hg belo\'1 ambient pressure. Safety 
features included a quick-release valve, easily accessible to subject 
and observer, and an automatic mechanism to prevent negative pressure 
from exceeding 55 mm Hg. Sensors mounted inside and external to the 
device provided internal and.ambient temperature records. 
Basic measurements during all tests included blood pressure at 30­
second intervals from an automatic system which detected and analyzed 
Korotkoff sounds, heart rate continuously from one component of a 
Frank lead vectorcardiogram and percentage change in calf volume 
continuously from capacitance plethysmographic bands encircling the 
legs (fig. 3). Prior to positioning these bands, a manual measurement 
was made of circumference of the largest portion of the calves, which 
also corresponded to the position where the left band was to be placed. 
Since the right band served solely to measure capacitance changes due 
to alterations of temperature and humidity within the negative pres­
sure device, it was therefore placed around a rigid metal band which 
encircled the right leg at the lower level of the calf muscle. 
Additional measurements carried out during preflight and postflight 
tests included respiratory excursions from a mercury strain gage 
across the lower thorax, systolic time intervals from a phonocardio­
gram and carotid pulse transducer, and, in Skylab 4, echocardiograms. 
These along with vectorcardiographic findings and preflight and post­
flight chest x-rays for cardiac size are discussed elsewhere (6-9). 
Prior to the lower body negative tests, as in Apollo 16 and 17 flight 
crew evaluations, lower limb volume was estimated from a series of 
girth measurements taken at three centimeter intervals between ankles 
and upper thighs. For the first time the latter measurement was also 
made several times during the Skylab4 flight (10). 
An Experiment Support System provided power and appropriate con­
trols, including those necessary for calibration, to the hardlf.!are 
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Figure 1. 	 Photograph of the Lower Body Negative Pressure (LBNP) 
device, showing waist seal with zipper. Movable 
templates are hidden from view by the seal. 
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Figure 2. 	 Photograph showing side view of Lower Body Negative
Pressure device. The ESS and its displays are in 
the background. 
550 
Figure 3. 	 Photograph of capacitive plethysmographs and plug-in 
locking connectors. 
551 

units already mentioned. The Experimental Support System (ESS) also 
contained displays for heart rate, which was updated every five beats, 
systolic and diastolic pressures, percentage changes in calf volume, 
and temperature within and exterior to the Lower Body Negative Pres­
sure Device. 
The lower body negative pressure protocol was identical to that adopt­
ed for Apollo studies. The first and last 5 minutes of the 25-minute 
test were at ambient atmospheric pressure to provide data from resting 
control and recovery periods, respectively. The 15-minute stress 
period consisted of five distinct levels of negative pressure applied 
sequentially: 8 and 16 mm Hg negative pressure for one minute each, 
30 mm Hg for three minutes, and 40 and 50 mm Hg negative pressure for 
5 minutes each (fig. 4). 
Prior to entry, ,each crewman donned a garment which covered the lower 
body (see Skylab Medical Program Overview, fig. 6). Garment pressure 
against the skin was provided by lateral inflatable bJadders and 
capstans. When inflated to gage pressure of 170 to 180 mm Hg, the 
capstans produced 85 to 90mm Hg pressure at the ankles and a decreas­
ing gradient of pressure headward which declined to 10 mm Hg at the 
waist. These garments remained pressurized, except durina times when 
the crewmen could be recumbent, until beqinning of the first post~ 
flight lower body negative pressure test. 
Blood pressure and heart rate data in this paper, unless otherwise 
specified, refer to mean values during the lower body negative pressure 
phase, usually the 5-minute periods during resting control and ex­
posure to -50 mm Hg pressure. Mean values from preflight tests 
established fiducial limits at the P < 0.05 significance level for 
evaluating in-flight and postflight data. The subject of the Results, 
which follows, applies only to Skylab 4 crewmen except when otherwise 
specified. 
RESULTS 
In-flight 
Heart Rate 
During their first in-flight tests on mission days 5 and 6, resting 
heart rates of the Commander and the Scientist Pilot showed elevations 
of resting heart rates above fiducial limits established from pre­
flight tests. The Pilot, on the other hand, on mission day 5 
exhibited a resting heart rate that was relatively slow and well within 
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Figure 4. 	 Levels of lower body negative pressure and time of 
individual phases of the lower body negative pressure 
protocol. 
preflight limits. Typical preflight and the first in-flight tests of 
each crewman are shown in figures 5 through 10. After mission day 5 
resting heart rates were elevated above preflight limits in nearly 
every test, although a probable trend toward lower rates appeared
during the last third of the mission. This was more apparent in the 
Commander whose resting heart rates fell within preflight limits in 
three of nine tests after mission day 51 (fig. 11). 
During the -50 mm Hg phase of lower body negative pressure heart rates 
became significantly elevated in all three crewmen in the first and 
in nearly every subsequent test throughout the flight. The degree of 
elevation fluctuated rather markedly from test to test. The Commander 
showed the least fluctuation and, after mission day 39, had no further 
tests in which stressed (-50 mm Hg) mean heart rates exceeded 81 beats 
per minute. In the majority of tests after mission day 51, his 
stressed heart rates remained within preflight limits. Fluctuations 
of mean stressed heart rates of the Scientist Pilot continued through­
out the mission but remained significantly elevated above preflight 
limits. A slight downward trend may have been present after mission 
day 34 (fig. 12). Certainly after this time, tests with excessively 
high heart rate responses occurred less frequently. Stressed heart 
rate fluctuations of the Pilot becal11e sll1aller after mission day 29 and 
a slowly declining heart rate response to lower body negative pressure 
may have been present after this time (fig. 13). 
Blood Pressure 
Mean values of systolic blood pressure (SBP) of the Commander during
the resting control period of in-flight lower body negative pressure 
tests were usually within preflight limits. Significant elevations 
o:curred infrequent~y ~nd sporadically bu~ were more common durin~ the 
flrst half of the mlSSlon. Conversely, dlastolic blood pressure (DBP) 
at rest was usually significantly lower than preflight values. Resting
pulse pressure therefore usually exceeded preflight limits. Calculated 
mean a~terial pressure (SBP + SBP3- OBP) ranged.bel~w preflight limits in 
approxlmate1y one-half of the tests, occurrlng ln four successive tests 
between mission day 11 and mission day 21 and in five of six tests 
between mission day 47 and mission day 66. The magnitude by which 
in-flight blood pressure and heart rate means of the Sky1ab 4 crewmen 
differed from preflight values appear in table II. 
Diastolic pressure of .the Commander during lower body negative pressure 
rose over resting values by significantly greater increments during 
in-flight tests than in preflight tests (fig. 14). Despite the greater 
in-flight rise, mean stressed diastolic pressure, while lower than 
preflight values, was not so to a significant degree. Higher resting 
levels and smaller falls of systolic pressure characterized in-f1iQht 
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Cardiovascular responses during first in-flight test 
of Skylab 4 Commander on mission day 5. Moderate 
depression of diastolic pressure, elevation of systolic
pressure during the resting control phase, and increased 
heart rate and calf volume change during lower body
negative pressure are apparent. 
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Figure 8. 	 Cardiovascular responses during first in-flight test 
...of the Skylab 4 Scientist Pilot on mission day 6. 
Changes from preflight values resemble those of the 
Commander in figure 6 but are more pronounced. The 
slightly early termination of negative pressure was 
not due to 	symptoms. 
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Figure 11. Mean heart rate of the Commander during resting and -50 mm Hg
phases of lower body negative pressure. 
Note the contracted time scale during the preflight period in this figure and similar 
figures that follow. Highest heart rate responses occurred on mission days 21 and 39 
and post flight on recovery plus one day. A presyncopal episode on mission day 16 
probably prevented higher mean heart rate on that day since the test was terminated 
after a little more than two minutes exposure to -50 mm Hg lower body negative pressure. 
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Figure 12. Mean heart rate of the Scientist Pilot during resting and 
-50 mm Hg phases of lower body negative pressure. 
Presyncopa1 episodes on mission days 14 and 61 may have prevented higher stressed heart 
rates during these tests although such an effect was not apparent on mission days 34 
and 71 when presyncopal symptoms also caused the tests to be terminated. Periodic high 
stressed heart rates climbed to a peak at,mission day 34. Thereafter, these declined 
in magnitude and also in frequency • 
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Figure 13. Mean heart rate of the Pilot during resting and -50 mm Hg
phases of lower body negative pressure. 
The high heart rates that appeared periodically declined in magnitude after the first 
month in-flight. A slight downward trend in stressed heart rates was apparent during 
the latter period. A presyncopal episode on mission day 10 may have been associated 
with the lower mean stressed heart rate on that day. 
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TABLE II 
DIFFERENCES BETWEEN MEAN IN-FLIGHT VALUES FOR HEART RATE AND BLOOD 
PRESSURE OF THE SKYLAB 4 CREWMEN DURING REST AND -50 mm Hg PHASE 
OF LOWER BODY NEGATIVE PRESSURE FROM CORRESPONDING MEAN VALUES 
DURING PREFLIGHT TESTS. 
Scientist 
Commander Pilot Pilot
"'" 
• 	 Resting Control 
Heart Rate (bpm) +7.8* +13.3* +11 .3* 
Systolic Blood Pressure (mm Hg) +1.8 + 2.5 + 1.0 
Diastolic Blood Pressure (mm Hg) -5.6* - 2.0 - 2.5 
Pulse Pressure (mm Hg) +7.4* + 4.5'" + 3.4 
Mean Arterial Pressure (mm Hg) _3.2 t - 0.5 - 1.3 
Stressed -50 ml,Tl Hg 
Heart Rate +12.2t +36.7* +26.7* 
Systolic Blood Pressure +6.2* -10.9* - 1.6 
Diastolic Blood Pressure -1.0 - 4.8 + 1.3 
Pulse Pressure +7.1* - 6.1 - 2.8 
Mean Arterial Pressure +1.5 - 6.8* + 0.3 
* Significant to 0.001 level by paired t-test 
l' Significant to 0.01 level by paired t-test 
.. '" Significant to 0.05 level by paired t-test 
... 
• 
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Figure 14. Mean diastolic blood pressure of the Sky1ab 4 Commander 
during resting control and -50 mm Hg pressure phases 
.. " 
of lower body negative pressure. The marked elevation on 
mission day 21 was associated with the highest stressed 
heart rate seen in the Commander's in-flight tests. The 
elevated diastolic pressure on mission day 39, on the 
other hand, occurred in association with a heart rate 
that was only modestly elevated. 
.. f 
.. r 
lower body negative pressure tests of the Commander as compared to 
preflight. This combination led to the unusual finding of a signifi­
cantly higher in-flight mean value of pulse pressure during -50 mm Hg 
than preflight. Stressed pulse pressure in-flight exceeded preflight
stressed pulse pressure in only two other Skylab crewmen, the Commander 
of Skylab 3 and the Pilot of Skylab 2. In-flight mean values for mean 
arterial pressure of the Commander during the -50 mm Hg phase of lower 
body negative pressure differed only slightly from preflight values. 
Evidence for any trend of change in blood pressure parameters during 
flight were lacking. 
While blood pressure of the Commander showed less variance from test 
to test in the preflight period than any of the other eight Skylab 
astronauts, both the Scientist Pilot and the Pilot showed considerable 
lability of blood pressure during their preflight tests. As a con­
sequence, in-flight changes from preflight values did not achieve 
statistical significance unless the~1 were of large magnitude. 
Even though resting systolic blood pressure of the Scientist Pilot 
during in-flight tests exceeded preflight limits rather frequently
during the first half of the mission, its mean value for all in-flight 
tests did not depart significantly from preflight values. Diastolic 
pressure at rest showed little change from mean preflight values. The 
mean of in-flight values for resting pulse pressure of the Scientist 
Pilot exceeded preflight means by a significant margin. In addition, 
most individual tests during the first half of the mission revealed 
resting pulse pressures significantly higher than preflight fiducial 
limits. Figure 15 shows mean values of systolic and diastolic pressure 
of the Scientist Pilot during rest and the -50 mm Hg phase of lower body
negative pressure in all tests. 
Stressed systolic blood pressure of the Scientist Pilot fell below 
preflight limits in nearly every in-flight test. Decreases of diastolic 
pressure below preflight limits during lower body negative pressure 
occurred less frequently. Stressed pulse pressure and mean arterial 
pressure frequently declined below preflight limits, and the mean 
value of mean arterial pressure during in-flight tests were significant­
ly lower than the mean of preflight values. Over the in-flight period 
there appeared to be a slight downward trend in resting systolic and 
diastolic pressures and a questionable downward trend in their values 
during stress. 
k Resting and stressed systolic and diastolic blood pressures of the 
Pilot were within the rather wide preflight limits for these values in 
nearly all in-flight tests. The resting pulse pressure exceeded pre­
flight limits occasionally and sporadically in in-flight tests since 
systolic blood pressure tended to be higher and diastolic pressure 
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Figure 15. Mean systolic and diastolic blood pressures of the 
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~50 mm Hg lower body negative pressure phases of individual 
tests. The magnitude of falls in systolic pressure during 
stress tended to decline during the course of the mission . 
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lower than preflight levels. While pulse pressure showed no definite 
trend or change during the flight, systolic, diastolic and mean arte­
rial pressures, both at rest and during lower body negative pressure 
stress, showed definite declining trends (figs. 16, 17). 
Calf Volume Increase Induced by Lower Body Negative Pressure 
As had been observed in the first two Skylab Missions, calf volume 
increases during lower body negative pressure greatly exceeded those 
which had occurred in preflight tests. As illustrated in figures 
18 and 19, the rate and magnitude of increase were especially pronounced 
• 	 at the lower levels of negative pressure, -8, -16, and -30 mm Hg. In 
some tests, calf volume increased so rapidly that the leveling off 
usually seen before the end of each minute of exposure to -8 and 
-16 mm Hg pressure did not occur until after the -30 mm Hg level had 
been reached. This pronounced change in calf volume appeared in the 
first test and continued, although varying considerably between tests, 
throughout the mission. 
Calf volume increases of the Commander in preflight tests were rela­
tively small in contrast to those of the Scientist Pilot and Pilot, 
which were larger than usually seen. This same pattern of difference 
continued throughout the flight. Even when using the least sensitive 
band available, calf volume of the Scientist Pilot and Pilot rather 
frequently reached off-scale values after increasing to about 8.5 per­
cent. On 	 mission day 54, following instructions from the ground. 
the crew made adjustments to reduce sensitivity of the band used by 
these two 	 crewmen by about 30 percent. Thereafter, the off-scale 
condition 	was not reached, even though calf volume increases 
sometimes 	exceeded 11 percent. Whereas preflight calf volume increases 
at the end of the -50 mm Hg phase averaged between 3 and 4 percent, 
during in-flight tests they reached values usually between 8 and 11 per­
cent in the Scientist Pilot and Pilot. In the Commander, calf volume 
increases averaged 2.4 percent preflight but usually reached levels 
ranging between 5 and 7 percent in-flight. 
During preflight tests, calf volume decreases indicating venous 
drainage usually were seen during the five minutes of rest preceding 
negative pressure. Calf volume during this five-minute period in­
flight tests usually shifted upward, indicating an increase in venous 
inflow. Frequently during the -8 mm Hg and -16 mm Hg phase in pre­
flight tests, evidence of active venous contraction occurred after the 
initial filling period. This phenomenon was seen more often in the 
Commander than in either the Scientist Pilot or Pilot. During in-flight 
• 	 tests such indication of venous contraction occurred only infrequently 
and sporadically. 
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Figure 16. 
Mean diastolic pressure 
of the Skylab 4 Pilot 
during resting and 
-50 mm Hg phases of 
individual lower body 
negative pressure tests. 
In most tests, especially through the first two-thirds of the mission, elevations in 
diastolic pressure during stress were of large magnitude. 
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Figure 17. 
Mean arterial pressure
during resting and 
-50 mm Hg phases of 
individual tests of the 
Skylab 4 Pilot. 
A trend toward lower values is extended throughout the in-flight period. 
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The values shown indicate percent volume increase at the ends of the one- minute 
-16 mm Hg and the three-minute -30 mm Hg phases of lower body negative pressure. 
Resting calf volumes are shown as zero, but actually declined during the course of 
the flight. 
564 
.. 
.. 
<.n 
C"I 
<.n 
~ If • f 
PERCENT 
PREFLIGHT 
(6 TESTS)
10 i i 
8t­
I 
6 
4 r 
2 
.. ... 
.. 
IN-FLIGHT POSTFLIGHT 
I· • -16 mm Hg
•.H._I. -30 mm Hg 
I 
" 
•...:." ....... ,~ 
':;w:­ ...... I 
60 80 +15 +35 
10 50 70 R+5 
MISSION DAY 
Figure 19. Percentage increase in calf volume of the Skylab 4 
Commander at the end of -16 and the -30 mm Hg phases 
+25 
of individual tests of the Commander. Absolute values 
during both preflight and in-flight periods were lower 
than those of the Scientist Pilot and Pilot (shown in 
preceding figure). Proportionate increases of in-flight 
over preflight values were similar. 
Following cessation of negative pressure, calf volume returned usually 
to within 0.5 percent above or below the resting value in preflight 
tests. Conversely, during in-flight tests, calf volume at the end of 
the five minute recovery period usually measured close to two percent
above baseline values. In the case of the Commander, there appeared 
to be an upward trend in this residual volume during the first five 
weeks of the mission (fig. 20). 
Other Measurements and Observations 
Resting calf circumference measurements were made by the Skylab 4 crew 
on mission day 2, three days before the first lower body negative
pressure experiment. At this time, both th~ Commander and the Pilot 
showed declines of approximately one centimeter from the last prefliqht 
measurement. The calf circumference of the Scientist Pilot showed a 
slight increase, a finding which cannot be adequately explained. 
These early measurements differed 1 ittle, if any, from the subsequent 
measurements on mission day 5 and mission day 6, which showed re­
ductions ranging from 0.8 to 2.0 percent'from the last preflight 
values. This represented a smaller reduction than had occurred in 
the Skylab 2 and Skylab 3 crewmen whose decreases after comoarable 
times in weightlessness had ranged between 3.5 and 5.0 percent 
(table III). Subsequent measurements throughout the Skylab 4 flight
showed further rapid decreases during the first three weeks and 
thereafter a slow but steady decline which was apparently continuing 
at the end of the 84-day mission (fig. 21). The rate of decline 
was considerably slower than in Skylab 2 and Skylab 3 crewmen, reach­
ing approximately the same level after 84 days that had occurred after 
25 to 27 days in crewmen of the first two Skylab flights. 
TABLE III 
PERCENT DECREASE FROM LAST PREFLIGHT VALUES IN MEAl! CALF CIRCUMFERENCES (R '2 l) 

OF THE TUllE SKYLAB CRElfIEN AT DESIGNATED MISSION DAYS IN-FLIGHT AND AT THE TIME OF THEIR 

FIRST FIVE POSTFLIGHT EXAMINATIONS. 

Percent Decrease 
SI;y1 ab 2 SI;y1ab 3 SI;y111b 4 
Scientist Scientist Scientist 
c-nder Pilot Pilot Connander P11 ot Pi 1 ot COIIIIIIInder Pilot Pilot 
IN-FLIGHT 
Mis5iOll Oay 
2 2.0 -0.8 2.5 
4 4.3 
5 3.7 5.0 3.S 2.0 2.5 
6 4.5 4.1 0.8 

25-27 6.6 6.8 10.1 6.2 7.6 6.4 2.9 3.1 4.8 

57-59 8.4 9.9 8.9 5.8 4.5 6.5 

82-83 6.7 5. ' 7.0 

POSTFLIGHT AI 
Recovery 

+0 6.0 6.8 8.3 9.1 10.3 7.3 7.2 5.7 7.7 

+1 4.8 5.8 5.6 8.1 8.1 8.6 4.1 4.9 6.1 

+2 4.6 5.0 7.5 8.3 8.1 1.5 3.2 3.9 4.9 

+4 5.4 4.7 5.6 5.6 7.0 2.1 2.9 1.5 3.5 

+5 

+8-11 4.6 2.4 4.5 5.1 3.8 2.1 1.9 0.1 1.0 
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Absolute increases expressed in milliliters, over resting
control values of leg volume at the end of the -30 mm Hg
and the end of the 5-minute recovery phases of individual 
tests of lower body negative pressure of the Sky1ab 4 
Commander. The latter measurement, representing residual 
volume increase, ranged slightly below the volume at 
-16 mm Hg in in-flight tests but fell below resting volumes 
preflight. 
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Figure 21. Calf girth of the three Skylab 4 crewmen measured just
prior to each lower body negative pressure test. The 
mean .t.;-l of the ri ght and 1eft ca1 f is shown. An 
eighth measurement, the last of those taken preflight, 
was made independently 6 days before flight and not in 
association with a lower body negative pressure test. 
This last measurement was used as a reference value, 
roo· percent, from whi ch percentage difference of all 
other. measurements were calculated. 
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Measurements of lower limbs to estimate volume were also made early, 
for the first time, in-flight. On mission day 3, estimates of lower 
limb volume indicated losses of 13.4 and 12.3 percent in the Commander 
and Scientist Pilot, respectively, compared with the mean of five pre­
flight measurements. The decrease in the Pilot amounted to 9.2 percent 
on mission day 5. Subsequently, volume of the lower limbs appeared 
to decrease further as shown in table IV. 
TABLE IV 
PERCENT DECREASE FROM PREFLIGHT VALUES IN VOLUME OF THE LOWER LIMBS 
AT THE TIME OF IN-FLIGHT MEASUREMENT, SKYLAB 4 
Volume of Lower Limbs 
Percent Decrease from Preflight Mean Values 
In-Flight Commander Scientist Pilot Pilot 
Mission Day 3 
5 
13.4 
12.2* 
12.3 
9.7* 9.2* 
8 13.4 13.5 13.1 
31 15.8 12.3 
37 15.3* 
57-59 17.5 12.4* 13.2 
81 12.2* 13.4* 
* based on measurement of left lower limb only 
Crewmen of the two previous missions had observed that lower body 
negative pressure in weightlessness forced them further into the Lower 
Body Negative Pressure Device. To compensate for this and to retain 
proper positioning of the iliac crests at the level of the iris-like 
templates, the saddle had usually been adjusted headward one and one­
half inches from the position used preflight. This adjustment also 
became necessary for the Skylab 4 crew. Additionally, like previous 
crews they experienced abdominal discomfort from contact with the 
templates and seal that had not occurred on preflight tests. They also 
reported that the lower body negative pressure test remained subjective­
ly very stressful throughout the flight. 
The first test in which it became necessary to terminate the test early 
because of presyncopal symptoms occurred on mission day 10 during the 
second in-flight test of the Pilot (fig. 22). After nearly four 
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Figure 22. 	 Cardiovascular responses of Skylab 4 Pilot during lower 
body negative pressure test on mission day 10. Presyncopal 
symptoms led to termination of the test after nearly four 
minutes' exposure to the -50 mm Hg phase (Skylab 4). 
minutes of exposure to -50 mm Hg pressure he experienced a sensation 
of dizziness. Associated with this was a further marked fall in 
systolic and diastolic pressure and narrowing of pulse pressure. Heart 
rate had reached approximately 100 beats per minute and was f~lling 
prior to restoring lower body negative pressure to ambient. In his 
first in-flight test on mission day 5 (fig. 10), although no presyncopal 
symptoms had occurred, blood pressure and heart rate were falling just
prior to completing the -50 mm Hg phase. In the recovery period 
following that test, marked sinus arrhythmia, bradycardia and atrio­
ventricular dissociation had occurred suggesting a high rebound vagal 
tone and that a vasovagal reaction had been imminent. Heart rate had 
reached about the same level as during the second test although the 
increase in calf volume had been lower, 6.1 percent, at the end of the 
-50 mm Hg phase as compared vii th 9 percent in the test in whi ch symptoms
occurred. This test was carried out late in the afternoon following 
a very busy day in which the Pilot had missed lunch, and a time when 
he was feeling quite fatigued. Although higher mean heart rates and 
greater increases in calf volume during lower body negative pressure 
occurred on many subsequent tests of the Pilot, especially during the 
first month, symptoms requiring early termination did not recur. 
As indicated earlier the blood pressure, heart rate and leg volume of 
the Scientist Pilot periodically responded quite markedly to lower 
body negative pressure throughout the mission. On mission day 14 
during his third in-flight test, calf volume reached an off-scale 
condition at slightly over 7 percent increase early in the -30 mm Hg
phase. Heart rate climbed rapidly and pulse pressure narrowed gradu­
ally during the ensuing minutes (fig. 23). After about two minutes 
of exposure to -50 mm Hg, systolic pressure fell more rapidly and 
diastolic pressure also began to fall. Heart rate reached nearly 
120 beats per minute and then began to fall. Concurrently, 1ight­
headedness and tingling of the arms occurred and ambient pressure was 
restored after about 4 minutes of exposure to -50 mm Hg. 
Symptoms such as tingling of the arms and shoulders and mild dizziness 
were commonly experienced by the Scientist Pilot but did not require 
another early termination of the test until mission day 34. This test 
terminated about two minutes early when the heart rate was falling
from a peak of 140 beats per minute (fig. 24). Presyncopal manifesta­
tions including mild faintness and sudden pallor, occurred about 
5 seconds before the -50 mm Hg phase was due to end on mission day 61 
when ambient temperature in the orbital workshop had climbed from the 
usual 23.3° C (74° F) to 26.5° C (79.6° F). Again on mission day 71 
symptoms led to ter~ination of the test about 30 seconds early. Each 
of these four episodes were associated with the fatigue of a very busy 
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exposure to this level of negative pressure. The leg
volume increase reached the upper limits of transducer 
output a few seconds after the onset of 30 mm Hg negative 
pressure. 
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Figure 24. Cardiovascular responses of the Sky1ab 4 Scientist Pilot 
during the lower body negative pressure test on mission 
day 34. Presyncopal symptoms occurred soon after expos­
ure to -50 mm Hg pressure phase which was terminated 
after approximately 2-1/3 minutes. 
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day, inadequate sleep during the previous night, and omission of his 
usual attempts to maintain a high fluid intake. 
The only instance in which the Commander experienced presyncopal 
symptoms was on mission day 16 when mild dizziness and a rapid falling 
blood pressure after about 2 minutes of the -50 mm Hg phase caused 
the test to be stopped early (fig. 25). Flight planning difficulties 
had led to scheduling this test in the afternoon rather than during 
the usual morning hours. On his next test performed on the morning 
of mission day 21 he again experienced symptoms including dizziness 
and the crset of cold sweating of the face but was able to complete 
the test. This latter test, which was preceded by ingestion of a 
large amount of water and some toe-rise exercises on the "treadmill", 
was associated with abdominal and saddle discomfort and also a higher 
heart rate than in any other of his tests (fig. 26). 
Postflight 
Heart Rate 
Resting and stressed heart rates of the Skylab 4 crewmen followed a 
somewhat similar pattern of change postflight during their first 
postflight tests on the day of recovery, all had resting heart rates 
which were quite slow and within preflight limits. Resting heart rates 
of the Commander and Scientist Pilot were elevated about 15 and 20 per­
cent, respectively, on the following day over those on recovery. 
On the second day after splashdown, the Commander's resting heart 
rate had declined to near recovery day value whereas t~e Scientist 
Pilot's rate reached its highest postflight value, 39 percent above 
the recovery day value. Resting heart rate of the Pilot continued 
to be low in all postflight tests (fig. 27, 28, 29). 
Mean heart rates of the Skylab 4 crew during -50 mm Hg lower body 
negative pressure at their recovery day examinations were fairly 
close to their respective values during their last in-flight tests 
(table V). Stressed heart rates of the Commander followed the same 
pattern as his resting heart rates with the greatest increase occurring 
during the day after the recovery day test. Heart rate responses to 
lower body negative pressure during subsequent tests returned to and 
remained within preflight limits. 
The Scientist Pilot exhibited his highest heart rate response to 
lovJer body negative pressure during the recovery day test conducted 
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Figure 25. Cardiovascular responses of the Sky1ab 4 Commander 
during the lower body negative pressure test on 
mission day 16. Presyncopa1 symptoms developed soon 
after onset of the -50 mm Hg phase and negative 
pressure was discontinued after a little over 
2 minutes at this level. 
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Figure 26. Cardiovascular responses of the Skylab 4 Commander 
during the lower body negative pressure test on 
mission day 21. During this test he exhibited a 
higher heart rate than in any other test. Symptoms
did not require the test to be terminated early. 
The -50 mm Hg phase was continued for a full 5 min­
utes but the -8, -16, and -30 mm Hg pressure phases 
were inadvertently shortened. 
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Figure 27. Mean heart rates of the Skylab 4 Commander during the 
resting control and the -50 mm Hg pressure phases of 
individual lower body negative pressure tests in the 
last part of the mission and in the postflight period. 
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Figure 28. Mean heart rates of the Skylab 4 Scientist Pilot during 
the resting control and the -50 mm Hg pressure phases of 
individual lower body negative pressure tests in the 
last part of the mission and in the postflight period. 
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Figure 29. Mean heart rates of the Skylab 4 Pilot during the 
resting control and the -50 mm Hg pressure phases of 
individual lower body negative pressure tests in the 
last part of the mission and in the postflight period. 
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six hours after splashdown. Heart rate during tests on the following 
day and the second day were elevated over preflight limits by a 
smaller magnitude, and on sub~equent tests returned to and remained 
within ~hese limits. 
Stressed heart rate of the Pilot was slightly elevated above preflight
limits on recovery day, climbed to a slightly higher level on the day 
after recovery, dropped to the recovery day va 1ue on the second day 
after recovery and were within preflight limits on the fourth day post­
mission, the heart rate response was again elevated slightly but was 
within preflight limits on subsequent tests. 
TABLE V 
MEAN HEART RATES OF THE SKYLAB 4 CREWMEN AT REST AND DURING THE -50 mm Hg PHASE OF 
LOWER BODY NEGATIVE PRESSURE RESULTS DURING PREFLIGHT AND IN-FLIGHT TESTS, DURING THE LAST 
IN-FLIGHT TEST, AND DURING EACH OF THE FIRST SIX POSTFLIGHT TESTS. 
Mean Heart Rate ~bPm)
Resting and Stressed -50 mm Hg) 
Commander Scientist Pilot Pilot 
Resting Stressed Resting Stressed Resting Stressed 
Preflight Mean 58.9 66.3 51.1 64.9 48.0 61.1 
In-flight Mean 66.7 78.5 64.4 101.6 59.9 87.8 
Last In-fl1 ght 66.3 80.2 67.2 108.3 57.4 79.2 
Postflight (Days) 
Recovery +0 60.6 68.1 53.0 113.0 51.6 71.2 
+1 70.6 82.7 60.9 88.8 51.9 78.7 
+2 64.8 68.5 73.8 86.3 53.5 71.6 
+4 60.9 62.9 60.4 63.7 46.5 67.8 
+5 64.5 65.8 52.0 63.0 51.2 73.4 
+11 60.7 61.3 49.7 63.5 46.2 69.1 
• 
, 
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Blood Pressure 
During the first few postflight days, the three Skylab 4 astronauts 
exhibited marked blood pressure changes both at rest and during lower 
body negative pressure stress. Although the time course of the post­
flight pattern differed among the three crewmen, all exhibited pro­
nounced elevation of diastolic and mean arterial pressures both at 
rest and during lower body negative pressure stress on one or more of 
the first three post flight tests. Systolic and pulse pressure during 
rest were also elevated at some time during this period. 
On the Commander's first postflight test, begun four hours after 
splashdown, resting systolic, diastolic and mean arterial pressure 
were markedly elevated over preflight limits during both resting
control and -50 mm Hg pressure phases. Mean arterial pressure both at 
rest and during -50 mm Hg pressure remained above preflight limits 
during each test through the fifth post recovery day (fig. 30). Pulse 
pressure during stress also slightly exceeded preflight limits. Rest­
ing and stressed systolic blood pressure and pulse pressure climbed 
to higher values on the first day after recovery. Thereafter all 
values declined on successive tests and were within preflight limits 
by either the fifth or eleventh day postflight. 
The Scientist Pilot, during his recovery day test 6 hours after splash­
down exhibited resting systolic, diastolic, pulse and mean arterial 
pressures that fell within preflight limits and quite close to those 
seen on the last test in-flight. During lower body negative pressure, 
however, diastolic pressure rose quite markedly above these values and 
pulse pressure narrowed proportionately (fig. 31). Systolic pressure 
both at rest and during lower body negative pressure reached its 
highest post flight value on the second day post flight while diastolic 
pressure showed little change at rest but during the -50 mm Hg 
pressure fell from its initially high level on recovery day to pro­
gressively lower levels during each of the four following tests. 
Resting systolic blood pressure and pulse pressure of the Pilot follow­
ed patterns similar to those of the Scientist Pilot in climbing to 
their highest value on the second day after recovery. Diastolic 
pressure at rest resembled that of the Commander in exhibiting its 
highest value during the first test eight hours after splashdown. 
Mean arterial pressure at rest remained elevated during the first four 
tests but during lower body negative pressure stress fell markedly 
during the recovery day test and reached successively higher levels 
during the following two tests. Stressed systolic, diastolic and pulse 
pressures showed the same pattern, reaching maximal levels on the 
second day after recovery (fig. 32). 
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Figure 30. 
Mean arterial pressure
of the Skylab 4 Commander 
during the resting con­
trol and the -50 mm Hg
pressure phases of indi­
vidual lower body negative
pressure tests in the last 
part of the mission and 
in the postf1i ght peri od. 
Figure 31. 
Mean pulse pressure of the 
Skylab 4 Scientist Pilot 
during theresti ng control 
and the -50 mm Hgpressure 
phases of individual low­
er body negative pressure 
tests in the 1 ast part of 
the mission and in the 
postflight period. 
Figure 32. 
Mean arterial pressure 
of the Sky1ab 4 Pilot 
during the resting 
control and the -50 mm Hg
pressure phases of indi­
vidual lower body negative 
pressure test in the 1 ast 
part of the mission and 
in the postflight peri od. 
Calf Volume Increase Induced by Lower Body Negative Pressure 
Calf volume increases at all levels of lower body negative pressure 
on recovery day dropped abruptly from the hi gh values that occurred 
in-flight to approximately preflight values. During the next test 
on the day after recovery, calf volume increase climbed higher than 
the recovery day values. While calf volume increase reached their 
highest postflight value on the day after recovery in the cases of 
the Commander and Pilot, it climbed slightly higher on the second 
postmission day in the Scientist Pilot. Thereafter, increase in calf 
vollJme induced by lower body negative pressure subsided but remained 
slightly elevated above preflight mean values. 
In contrast to in-flight patterns of increase in calf volume in which 
over one-half of the total increase had already occurred at the end 
of the -30 mm Hg phase, the greatest part of the postflight total 
increase took place usually during the -40 and -50 mm Hg phases.
Evidence interpreted as venous drainage during the resting control 
phase did not appear until tests made several days after splashdown
except in the Commander, where calf volume pattern indicated venous 
drainage in the recovery day test. Volume declines during the lower 
levels of lower body negative pressure thought to represent active 
venous contraction was similarly slow to appear. The preflight pattern
of nearly complete return of calf volume to resting control values 
during the five minute recovery period after cessation of negative 
pressure was first apparent in the Commander. Calf volume during 
recovery returned nearly to resting levels during the recovery period 
of the first and most subsequent postflight tests. Similar patterns 
in the Scientist Pilot and Pilot were considerably delayed. 
Other Measurements and Observations 
r4easured calf circumference after recovery, performed four, six, and 
eight hours after splashdown in the Commander, Scientist, and Pilot, 
respectively, was from 0.15 to 0.25 centimeters smaller than when 
determined during the last in-flight measurements on mission days 82 
and 83 (fig. 21). All showed successively larger calf circumferences 
through the 11 days after recovery with the exception of the Scientist 
Pilot who showed a slight decrease on the fifth day compared to the 
fourth day postflight measurment. The Commander and Pilot showed 
their greatest increment of increase between recovery day and the day 
after while the increase in the Scientist Pilot was more gradual during 
the first 48 hours and greatest between the second and fourth day post 
recovery measurement. All had regained calf girth from six or more 
percent to approximately two percent below preflight values by the 
fifth day or in the case of the Scientist Pilot by the fourth day after 
recovery. 
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Volume of the lower limbs. calculated as percent change from preflight 
means, was moderately increased at the time of the first postflight 
measurement over the last volume measured in-flight a little over 
48 hours earlier in the Scientist Pilot and Pilot and 28 days earlier 
in the Commander (fig. 33). All three postflight volume decreases on 
recovery day measured approximately the same as that of the Commander 
of Skylab 2 and slightly less than that of the Scientist Pilot of 
Skylab 3 at their first postflight measurment three and four hours, 
respectively, after splashdown. 
The postflight pattern of return of lower limb volumes toward preflight 
values followed a somewhat different pattern than the qain in calf 
girth. Postflight lower limb volume increased progressively until the 
second day. leveled off or decreased on the third day and thereafter 
increased at a generally slower rate. By the second day. or a little 
over 48 hours after splashdown, a large part of the loss of limb 
volume had been regained. 
During the first postflight test, the Commander exhibited higher 
systolic and diastolic pressures. narrower pulse pressure and slightly 
lower heart rates throu~hout the test than during his last in-flight 
test on mission day 83 (figs. 34. 35). The recovery day test of the 
Scientist Pilot produced heart rates quite similar to his last in­
flight test on mission day 82 but a higher diastolic pressure and 
narrower pulse pressure (figs. 36, 37). In the first postflight test of 
the Pilot. systolic and diastolic pressures remained higher than in his 
last in-flight test on mission day 83 until the -40 mm Hg phase was 
reached. At that time. systolic pressure began to fall and pulse 
pressure to narrow (figs. 38. 39). After the onset of -50 mm Hg. 
lower body negative pressure systolic and diastolic pressure fell and 
shortly afterwards mild presyncopal symptoms appeared. The test was 
terminated after approximately one minute of exposure to the -50 mm Hg 
level. Of possible significance to the outcome of this test is the 
fact that the Pilot. because of scheduling difficulties. had performed 
low levels of supine and upright bicycle ergometry approximately two 
hours earlier. 
The tests after recovery day were all completed without difficulty. 
Judging by heart rate responses only. preflight limits were attained 
by the fourth or fifth day after recovery. Blood pressure responses 
attained these limits by fifth or eleventh day postflight. The strik­
ing elevation of systolic pressure and widening of pulse pressure. 
characteristically greatest on the first day after recovery following 
Apollo flights and on the first and second day after recovery following 
Skylab flights, are illustrated in figure 40. 
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Cardiovascular responses of the Skylab 4 Commander during 
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Figure 35. Cardiovascular responses of the Skylab 4 Commander during
his first postflight test four hours after recovery_ 
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Cardiovascular responses of the Skylab 4 Scientist Pilot 
during his last in-fl.ight test on mission day 82. 
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Cardiovascular responses of the Skylab 4 Scientist Pilot 
during his first postflight test six hours after recovery. 
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DISCUSSION 
An explanation of the changes in cardiovascular responses to lm'ler body 
negative pressure in a weightless environment requires understanding of 
the manner in which the systems of the body and their functions adjust 
to the weightlessness of space flight. A more comprehensive under­
standing of these adjustments will, in turn, require the correlation 
of massive volumes of data from all of the Skylab experiments, a task 
of monumental proportions which has barely been started. 
Measurements of calf circumference of Skylab crewmen on the fourth to 
sixth day of flight revealed decreases of such magnitude that they 
could only result from loss of fluid. These rapid reductions of calf 
girth amounted to a mean of 1.1 centimeters or 3.0 percent below pre­
flight values. If volume losses from the measured portion of the 
lower limbs had declined in proportion to decrease in calf volume a 
mean estimated loss of more than one liter would have occurred. Volumes 
of the lower limbs as actually measured in-flight by the Skylab 4 
crewmen indicated somewhat greater losses, ranging between 1400 and 
2000 mi 11 il iters "/ithi n the fi rs t few days of fl i ght. Both types of 
measurement support a very early loss from the lower limbs of a relative­
ly large volume of fluid. In-flight observations of a full feeling of 
the head, nasal and ocular congestion, and distention of head and neck 
veins suggest that this process of headward fluid migration out of the 
lower extremities must begin simultaneously with achievement of 
\t~eightlessness. 
Increased outflow from veins of the legs tends to reduce local venous 
pressure and in turn pressure on the venous side of the local capillary 
bed, a condition which promotes the transfer of interstitial fluid into 
the capillaries. Capillary exchange of fluids is a highly dynamic 
process capable of moving large volumes of fluid very rapidly in 
either direction between capillaries and surrounding tissue. Such 
transfer of fluid would continue to replenish venous channels as their 
contents shifted upward until local tissue pressure declined to the 
level of venous pressure. The flow of lymph toward the central circu­
lation would also be expected to increase. Thus, interstitial fluid, 
lymph and blood can participate in the rapid outflow of fluid and 
consequent reduction of lower limb volume . 
Veins in regions above the heart are not normally subjected to venous 
pressure increases of more than small magnitudes and, except during 
recumbency, are not fill ed. Photographs and descri pti ons by the 
astronauts indicate, however, that cervical and cranial veins became 
distended early in flight and remained distended throughout flight. 
These superficial veins and presumably others in the upper part of the 
body appear then to accommodate a significant portion of the fluids 
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shi fted up\vard from the lower body. Edema of the eyl ids and peri orbita1 
tissues, also apparent from in-flight photographs, indicate that 
venous and intracapillary pressure in these regions are at least trans­
iently increased and that interstitial spaces in the upper body also 
participate in storing fluid displaced to that region. 
!~hether and to what extent the pulmonary vessels also accommodate blood 
beyond their normal storage capacity of 700 to 800 milliliters of blood 
are unanswered and important questions. Modest reductions in vital 
capacity during flight (11) suggest that they do. In the acute expan~ 
sion of blood volume by infusion, the lungs appear to be spared and the 
expanded blood volume is accommodated largely by systemic veins while 
in chronic circulatory congestion with normal hearts, the lungs seem 
to share in accommodating the expanded blood volume (12). Whatever 
the total blood volume in weightlessness, the pulmonary circulation 
must, at some time during adaptation to weightlessness, react as if 
total blood volume was increased. 
At some time early in the process of these regional shifts of fluid 
volume, atrial return and cardiac output must transiently increase. 
Whether atrial distention initiated neurohormonal stimulation of 
diuresis seems uncertain from available Skylab data at this time. 
Hemoglobin increases in blood samples taken in-flight suggest that 
hemoconcentration occurred relatively early in flight (13). ~hether 
plasma volume is reduced chiefly by diuresis or through other mechanisms, 
is not clear. The low humidity of the Skylab atmosphere and, in the 
Skylab 2 flight, high environmental temperature, \vould be expected to 
lead to large fluid decreases through insensi ~e losses and sweating. 
High pressure baroceptors, especially those of the carotid arteries, 
should initially sense the absence of hydrostatic forces as 
an elevated arterial pressure and initiate reflexes to reduce pressure 
and heart rate. Such an event was not observed in Skylab cardio­
vasculal' examinations but it would probably have occurred too early 
and transiently for detection. 
Much of the more dynamic changes of the type discussed must have 
already taken place before the earliest lower body negative pressure 
tests could be performed. The results of these tests suggest, however, 
that profound changes in circulatory dynamics continued to occur 
throughout much of the flight. Vigorous daily activities must also 
have impacted temporarily any equil i bri urn that had been reached. 
One can postulate with reasonable certainty, however, that by the time 
of the first in-flight lower body negative pressure tests, total 
circulating blood volume had been reduced, some hemoconcentration had 
occurred, and at least a significant fraction of fluids previously 
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located in the legs was now accommodated by veins and interstitial 
tissues of the upper part of the body. Whether these fluids were avail­
able to supplement circulating blood volume during lower body negative 
pressure is an unanswered question of great importance to understanding 
the lower body negative pressure results. 
Lower body negative pressure stresses the cardiovascular system by 
reducing effective circulating blood volume as blood is segregated in 
the veins of the lower half of the body. Reduced return of blood to 
the right heart results in reduced cardiac output comparable to that 
which occurs during orthostasis in a gravity field (13). The volume 
of blood thus diverted must be a determining factor in the degree of 
stress produced. 
The measurement of calf volume increases during lower body negative 
pressure should furnish an index to at least estimate the magnitude 
of this pooled volume. Calf volume increased by considerably greater 
percentages during in-flight lower body negative pressure than in pre­
flight tests. This change was apparent during the earliest in-flight 
tests, persisted throughout flight, and diminished again in postflight 
tests. Moreover, a large fraction of the total volume change in-flight
occurred during the first two minutes of lower body negative pressure 
when negative pressures were least. The most plausible explanation for 
the latter changes seems to lie in a relatively empty venous system
in the legs at the beginning of the tests. 
Veins require only low transmural pressures to retain their circular 
configuration. If lower pressures prevail, they tend to become 
elliptical or flat (15). In this state, relatively large volumes of 
blood could be accommodated before any change in venous pressure
occurred. This so-called zone of free distensibility, which does not 
involve stretching of venous wall muscle, probably accounts for the 
large volume increases in the calf at the slight negative pressure 
levels as discussed above. The volume of this zone of free distensibil­
ity, even during the alterations taking place due to weightlessness, 
may be expected to vary from time to time under the influence of daily 
activities. Physical activity in weightlessness requires minimal 
participation of lower extremity muscles. Such activity might be 
expected to result in a net loss of venous volume in the lolt!er 
extremities \</ith venous outflo\'! exceeding arterial inflow. Conversely, 
due to higher resting venous pressures in the upper body, periods of 
inactivity such as sleep may allow some filling of leg veins, thus 
reducing the zone of free distensibility. After periods of inactivity 
such as sleep, a smaller volume of blood would then be initially dis­
placed by lower body negative pressure than in the former situation. 
Pertinent to these considerations is the observation that none of the 
13 instances of early termination of tests due to presyncopa1 symptoms
occurred during tests conducted in the morning hours or within seven 
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hours of arlslng from sleep, although approximately one-third of all 
in-flight tests were conducted within that period. These 13 tests 
were associated with larger than usual calf volume increases during 
the lowest negative pressure phases of the tests. This suggests that 
the pooling of large volumes of blood during the first few minutes of 
the test may so alter the effectiveness of compensatory cardiovascular 
mechanisms as to render them incapable of adequate responsiveness to 
the greater stress later in the test. 
The higher incidence of presyncopal symptoms in test conducted seven 
or more hours after arising may be related to the hypothesis mentioned 
earlier, namely that fluids tend to migrate back to the lower extremi­
ties during the inactivity of sleep and that mild activity after 
sleep tends to empty them again. That this may occur is suggested by 
the observation of the astronauts that the symptoms of fullness of the 
head were usually absent on awakening but returned after arising.
Similarly, vigorous prolonged exercise on the bicycle ergometer, which 
should divert a much larger fraction of cardiac output to the muscles 
of the lower extremities, temporarily relieved these symptoms. If 
this reasoning ;s correct, in addition to long-term alterations in 
fluid volume distributions, fluid volumes in the capacitance vessels 
and tissues of the lower limbs may be greater in the early hours after 
arising than later in the day after activity has tended to displace 
these fluid volumes headward. 
Relatively larger proportions of fluid in the lower body early in the 
day would tend to limit the volume of fluid drawn into the legs and 
out of the effective circulating blood volume by lower body negative 
pressure. Other factors being equal, tolerance to lower body negative 
pressure would then be greater in tests done early than in those 
conducted late in the day. Among the three astronauts, the Commander 
of Skylab 2, the Pilot of Skylab 3, and the Commander of Skylab 4, 
whose in-flight tests were nominally performed in the morning, only one 
presyncopal episode occurred and this was in the Commander during a 
test performed in the afternoon over nine hours after arising. In 
addition, in these three astronauts the heart rate increases induced 
by -50 mm Hg negative pressure during their 45 in-flight tests, averaged
10.7 beats per minute higher than during preflight tests. The other 
six astronauts whose tests were nominally scheduled in the afternoons 
exhibited mean increases of 16.5 beats per minute over preflight
stressed values during their 93 in-flight tests. The former difference 
does not reach statistical significance while the difference between 
in-flight and preflight stressed heart rates of the six latter astro­
nauts was highly significant (P<O.OOl). While cardiovascular character­
istics of individual astronauts may account for these differences they, 
along with the presyncopal episodes, may also support the hypothesis 
that headward shifts of fluids occur during the course of daytime 
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activities, leading to decreasing orthostatic tolerance during the 
day, and that fluids tend to reaccumulate in the lower body during 
the inactivity of sleep in a weightless environment. 
Although the greatly expanded calf volume changes during the brief 
-8 and -16 mm Hg phases of in-flight tests were most striking, larger 
volume changes during the -30, -40, and -50 mm Hg phases also occurred 
during in-flight tests. At these levels, transmural pressures across 
venous walls must result in stretching of venous musculature. In­
creased capacitance of the veins, reduced tone of supporting muscle in 
proximity to the veins, and diminished tissue pressure must participate 
to varying degrees in the greater calf volume changes in weightlessness. 
The relative change in anyone of these factors could not be determined, 
but our current understanding of the effects of weightlessness suggests 
that all three should be affected. The larger residual volume at the 
end of the recovery period that occurred in-flight may reflect a 
greater outflow during lower body negative pressure of fluid from 
capillaries into tissues. It may also simply indicate that further 
venous contraction cannot occur, because the zone of free distensibility
has, been reached. While variations in calf volume increases and 
residual volume varied from test to test, a definite trend of change
during the flight was not seen in the Skylab 4 crew. In this crew the 
leg volume increase during lower body negative pressure reached higher 
levels, particularly in the Scientist Pilot and Pilot, than observed 
in crewmen of the first two flights. Whether the increased exercise, 
the slower decreases in calf circumference, and the smaller weight 
losses in the Skylab 4 crewmen were in some way related is not known. 
The volume of blood pooled in the lower extremities during in-flight 
tests did not seem to correlate from test to test with the magnitude 
of heart rate or blood pressure change during lower body negative pres­
sure. In general, however, those of the nine Skylab astronauts with the 
greatest increases in calf volume during the in-flight tests also show­
ed the greatest increases in heart rate and changes in blood pressure. 
In addition, although correlation of heart rate increases with leg 
volume increases was not evident in preflight tests, the crewmen 
whose calf volume increases were greatest in preflight tests usually 
also showed the largest increases during the in-flight tests. 
In-flight resting heart rates of the three Skylab 4 crewmen, like those 
of Skylab 3, were elevated significantly over preflight resting rates. 
Elevation of resting systolic blood pressure and pulse pressure along 
with decreases in diastolic pressure and mean arterial pressure,
changes seen in the majority of the Skylab 2 and Skylab 3 crewmen, 
occurred in all three Skylab 4 crewmen, though not always to a statis­
tically significant degree. Such changes are compatible with increased 
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stroke volume and lowered peripheral resistance due to increased cross 
section of the resistance vessels (16), If stroke volume was increased, 
a significant increase in cardiac output was present at rest. There 
would appear to be no need for increased cardiac output in terms of 
higher oxygen requirements under these conditions. A plausible and 
entirely hypothetical explanation of this apparent paradox postulates 
an alteration in the distribution of cardiac output secondary to 
weightlessness and the changed distribution of blood volume. If blood 
flow to the upper body is increased beyond the requirement for oxygen 
or thermal regulation, opening up and dilatation of normally closed 
..arteriovenous channels in the upper body would lead to a blood pres­
sure pattern of the type observed in the arms and conceivably shunt 
blood to venous channels in quantities sufficient to elevate cardiac 
output. Such a condition would be most apt to obtain during rest. 
The in-flight mean increase in heart rate during -50 mm Hg lower body
negative pressure over resting rates for all nine Skylab crewmen 
averaged 20.4 beats per minute, a highly significant difference. The 
increase in heart rate during orthostatic stress has generally proven 
to be the best single index in the assessment of orthostatic tolerance. 
According to reports of the Skylab 4 crewmen, -30 mm Hg lower body
negative pressure in-flight produced a stress subjectively similar to 
the -50 mm Hg level preflight. Comparison of mean heart rates for the 
three crewmen revealed that in-flight heart rates at -30 mm Hg slightly
exceeded those in preflight tests at -50 mm Hg, although the difference 
from resting values in-flight was slightly less than the difference 
preflight at these negative pressure levels. Greater reductions of 
mean in-flight stressed systolic pressure and pulse pressure also in­
dicated that -50 mm Hg negative pressure in-flight represented a 
considerably greater stress than the same level of lower body negative 
pressure preflight. 
The periodic major fluctuations of resting and stressed heart rates and 
blood pressures observed in previous flights occurred in the Skylab 4 
crewmen also. The pattern of these fluctuations varied for each 
crewman, but their magnitude and frequency were greater during the 
first part of the mission than later. Their nature and significance 
is unknown, but, in the case of the Skylab 4 crewmen, their prominence 
•and duration appeared to decrease as cardiovascular responses to 
in-flight lower body negative pressure stabilized. Adaptation of 
physiological systems to repetitive acute stress characteristically
involves a series of physiological oscillations between overcompensation 
and undercompensation which gradually declines in magnitude until an 
optimal accommodation is reached. Oscillating patterns of less pro­
nounced degree were also seen in the three astronauts receiving lower 
body negativE pressure at 3-day intervals in the 56-day Skylab Medical 
Experiments Altitude Test (SMEAT) (17). 
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In tests in which presyncopal symptoms required that the test be 
discontinued, recovery was prompt and complete. In each instance, 
the subject pushed the emergency relief valve although by then warning 
declines in heart rate and systolic pressure were usually apparent to 
the observer. Early forebodings concerning possible harm to the astro­
naut had assured provision for adequate monitoring displays and hard­
ware safety features. 
Postfligbt findings for Skylab 4 crewmen were remarkable for the 
relatively small loss of orthostatic tolerance and the rapid return 
of related cardiovascular parameters to preflight limits. Loss of 
calf girth was no greater than had been observed in the 59-day Skylab 
mission. Losses in volume of the lower limb as measured on Recovery 
day were slightly smaller than in crewmen of the 59-day Skylab 3 
mission. 
Blood pressure responses were similar to those seen postflight in 
previous missions with marked elevations of resting systolic and 
diastolic pressures and, during negative pressure stress, additional 
large increases in diastolic pressure. Calf volume increases during 
lower body negative pressure were small during the recovery day test, 
but thereafter usually somewhat above preflight levels during several 
successive tests. 
The heart rate and blood pressure responses during lovler body negative 
pressure postflight indicated intense sympathetic activity and an 
adequate cardiac and peripheral arteriolar response. The intensity 
of these responses paralleled those seen in the first weeks of flight 
despite evidence that the volume of blood displaced to the lower body 
was much smaller postflight than in weightlessness which seems probable 
that even brief periods of orthostasis initiates the process of shifting 
fluids footward. Relatively dehydrated tissues in the lower body 
undoubtedly accept large volumes of fluid when venous pressure in the 
lower extremities rises for even brief periods of time, creating the 
effect of a sudden hemorrhage in the face of an already contracted 
blood volume. Baroceptor mechanisms, particularly those involving 
the carotid sinus, long adjusted to the higher pressures than those 
experienced in weightlessness, may exhibit increased sensitivity for 
a time to the reduction in pressure associated with the reappearance 
of hydrostatic pressures in body fluids. Baroceptor responses may 
cause intense venoconstriction as well as arteriolar restriction and 
thus limit both inflow and capacity of the venous system. In addition, 
during in-flight tests, there was evidence that even though total 
blood volume was reduced, blood volume in the upper body may actually
be expanded and thus furnish a larger available reservoir from which to 
supply blood to the lower body during lower body negative pressure than 
in the early pristflight period. 
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The experience of Skylab indicates that protection against orthostatic 
forces during the first few hours postflight not only serves to 
prevent orthostatic hypotension but may play an important role in 
cushioning the cardiovascular effects of return to gravity by prevent­
ing sudden large shifts of intravascular fluids to lower extremity 
vessels and extravascular tissues. Recumbency and the use of external 
pressure to counteract hydrostatic forces while in the upright position 
retard these readaptive changes which, if allowed to take place 
rapidly, can only accentuate the adverse effects of an inadequate 
circulating blood volume. 
.• 
The Skyl ab ~1i ssi ons provi ded the fi rst Ameri can opportunity for 
detailed studies of the cardiovascular system during the course of 
prolonged exposure to weightlessness. Basic questions concerning the 
cardiovascular adaptations to this environment have been answered. 
For example, a better understanding of the lack of correlation between 
postflight decrements in orthostatic tolerance and flight exposures 
of from a few to Iq days was gained. Skylab studies have clearly 
shown that changes in fluid volume distribution during the first few 
hours of flight creates profound alterations in cardiovascular 
functions which in turn, impair orthostatic mechanisms to a marked 
degree as early as four or five days after entering the weightless 
environment. 
As anticipated, even though the understanding of cardiovascular 
responses to the conditions of space flight and to stresses resembling 
orthostasis has been significantly advanced, Skylab studies have 
raised other questions that have never before been asked; for example, 
those regarding altered vascular flow and pressure relationships and 
patterns. Space flight furnishes an environment for cardiovascular 
study which can be produced in no other way. It is difficult to 
imagine that increased understanding of cardiovascular function and 
control mechanisms, as they are altered in weightlessness, will not 
in the future become relevant to the cardiovascular problems that 
face us on earth. 
CONCLUS IONS 
f[ 
o The Skylab lower body negative pressure experiment demonstrated 

that loss of orthostatic tolerance had already developed by the 

time of the first tests after four to six days of flight. 

Cardiovascular responses to lower body negative pressure showed 

the greatest instability and orthostatic tolerance the greatest 

decrement during the first three weeks of flight. After approx­

imately five to seven weeks, cardiovascular responses became more 

stable and evidence of improving orthostic tolerance appeared. 
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o In-flight data from the lower body negative pressure experiment 
proved to be useful not only in predicting the early postflight 
status of orthostatic tolerance, but also in the in-flight
assessment of crew health status. 
o 	 The marked increases in calf volume induced by in-flight lower 
body negative pressure appeared to be secondary to large head­
ward shifts of fluid from the lower body as a result of weight­
.. 	 lessness. Judged by objective as well as subjective evidence, 

in-flight lower body negative pressure presented a much greater 

stress to the cardiovascular system than the same levels of 

negative pressure during preflight tests. 

o 	 ~1easurements of calf girth and, in Skylab 4, of the lower limbs 
confirmed an early, large reduction of lower limb volume. The 
beginning of this fluid shift appeared to correlate temporally
with the onset of signs and symptoms of congestion of the head 
and neck. 
o 	 At rest, in-flight mean resting heart rates, systolic blood pres­
sures and pulse pressures were typically increased while diastolic 
and mean arterial pressures decreased compared to preflight values 
in all three Skylab 4 crewmen and in the majority of the other 
Skylab crewmen. Differences in in-flight responses to lower body 
negative pressure stress from preflight responses included greater
heart rate and leg volume increases in all crewmen and, in most, 
higher diastolic pressures and mean arterial pressures and lower 
systolic blood pressures and pulse pressures. 
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ABSTRACT 
Vectorcardiograms were recorded via a modified Frank lead system from 
all crewmen of the three Skylab missions in conjuction with the Lower 
Body Negative Pressure - M092 Experiment. Data were analyzed by a 
specially developed computer program (VECTAN). Design of the test 
sequences allowed direct comparisons of supine resting, Earth based 
(reference) vectorcardiograms with those taken during lower body 
negative pressure stress and those obtained at rest in orbit, as well 
as combinations of these conditions. 
Results revealed several statistically significant space flight related 
changes; namely, increased resting and lower body negative pressure 
stressed heart rates, modestly increased PR interval and corrected 
QT interval, and greatly increased P and QRS loop maximal amplitudes. 
Incaddition, orientation changes in the QRS maximum vector and the 
J-vector at rest in space seem quite consistent among crewmen and 
different from those caused by the application of lower body negative 
pressure. No clinical abnormalities were observed. 
Etiology of these findings is conjectured to be, at least in part, 
related to fluid mass shifts occurring in weightlessness and attendant 
alterations in cardiovascular dynamics and myocardial autonomic control 
mechanisms. 
INTRODUCTION 
Electrocardiographic interval changes suggesting effects of increased 
vagal tone were observed early in some Gemini crewmembers (1). 
Preflight versus postflight amplitude differences appeard in electro­
cardiograms of several of the early Apollo crewmembers. In preflight 
and postflight crew evaluations of the last three Apollo fliqhts, 
quantitative postflight vectorcardiographic changes were for the 
first time determined in American space crews. Changes not considered 
related to heart rate were mainly those of increased P and QRS vector 
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magnitudes and orientation shifts. But since most of these post­
flight findings resembled those observed with the orthostatic stress 
of lower body negative pressure, it was inferred then that upon
their return from space, astronauts exhibited exaggerated responses 
to orthostasis in the vectorcardiogram as well as in measures of 
cardiovascular hemodynamics (2). No explicit information on in-flight
vectorcardiographic changes or on in-flight influence upon postflight 
findings existed before Skylab. To help resolve the question, vector­
cardiograms have been studied on all nine Skylab crewmen. 
The M093 investigators have studied and reported on the vectorcardio­
grams of exercising Skylab astronauts (3); this M092 report extends 
our data base with extensive vectorcardiographic recordings on all 
nine, supine resting astronauts periodically subjected to lower body
negative pressure stress. 
r>1ETHODS 
A specially designed Frank lead vectorcardiograph system (4) was used 
for all Skylab vectorcardiographic recordings (fig. 1). Safety and 
reliability features commensurate with other space hardware were 
added; the only other modification was the shifting of leg electrodes 
to the I:presacral" area to obtain greater stability of signals during 
the exercise experiments M093 and M17l. Body sites were permanently
marked to assure consistency in repeated application of electrodes 
(fig. 2). System controls provided individual electrode impedance 
checks and continual digital heart rate readout selectable from 
either of the three leads since no onboard display of analog signal 
was available in the Experiment Support System for crew monitoring.
Discrete gain settings for each lead allowed some degree of optimi­
zation for individual signal amplitude. All data were recorded 
primarily on digital magnetic tape with a sample frequency of 320 
samples per second per channel (limit of Skylab capability); in-flight 
data were telemetered from onboard recordings to ground tracking 
stations as they became accessible. Real-time ground monitoring of 
in-flight data, therefore, could be randomly available for only 
relatvely short periods. Data from complete experiment protocols were 
rarely seen in real time. .. 
Every test protocol consisted of 25 minutes of data recording, broken 
into five, 5-minute periods for vectorcardiographic analysis. This 
provided a resting supine control period, three graded levels of 
lower body negative pressure stress and a final period of recovery at 
ambient pressure (fig. 3). The first two minutes at lower levels of 
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Figure 2. Vectorcardiograph system in place on subject. 
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lower body negative pressure were included as part of the first major 
stress period for vectorcardiographic analysis. 
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Figure 3. 	 The lower body negative pressure protocol used for Skylab 
cardiovascular evaluations assessing orthostatic tolerance. 
Each astronaut trained both as subject and observer in a one-g flight
simulator of the Skylab Orbital Workshop beginning about six months 
before the launch of his flight. From each crewman, five to seven pre­
flight vectorcardiographic recordings during the lower body negative 
pressure protocol were obtained during this period to establish his 
normal vectorcardiogram and variance. Three of these recording 
sessions 	were scheduled in the month preceding, with the last approxi­
mately five days before, launch. ' 
The earliest in-flight lower body negative pressure tests (fig. 4) were 
performed on the fourth to sixth day of orbit for each crewman; there­
after in-flight tests were conducted approximately every third day. 
postflight 	tests were accomplished on recovery day aboard ship as 
soon as possible after splashdown and on the succeeding two days. 
Return to the Johnson Space Center usually occurred on the third day 
postflight. Subsequent postflight tests were done on fourth and 
.. 	
fifth day postflight and on at least three additional days, as late 
as one to two months after recovery. Flight related test dates were 
not necessarily the same for all crewmen. All postflight tests 
utilized Skylab hardware outfitted in a mobile laboratory (fig. 5). 
The separate systems of hardware were of identical design and departures 
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Figure 4. 	 Skylab 3 Scientist Pilot in Lower Body Negative Pressure 
device. Sensors in place for recording experimental data, 
including vectorcardiogram. 
• 	 Figure 5. Skylab Mobile Laboratory. Cardiovascular facility
for lower body negative pressure testing. 
603 

from equivalence lay only in necessary elements peculiar to one-g or 
zero-g environment operations, e.g.~ one-g upper torso support dolly 
for lower body negative pressure. 
All digital recordings were processed by a previously developed com­
puter program called VECTAN (5) which analyzed the three-dimensional 
spatial entity rather than planar projections in order to obviate 
perspective distortions. It has been verified with ground-based 
studies as well as by Apollo and Skylab Medical Experiments Altitude 
Test usage. The program basically reconstructs the mathematical 
elements of the spatial P-QRS-T vector loops (fig. 6) which include 
standard time intervals, vector magnitudes and orientations, calculated 
areas and circumferences and other quantitative parameters. These 
data are computed from the spatial vector for every complex analyzed
(one every five seconds) (fig. 7) and summarized statistically over 
discrete protocol pertods for every lower body negative pressure test 
and subsequently for every subject according to flight phase (preflight,
in-flight or postflight), test means and/or trends. Finally, group 
mean values for comparable flight phases have been calculated using 
the data from all nine crewmen. 
Standard statistical procedures have been used to establish in-flight
and postflight differences from preflight values for the h~st part 
two basic considerations are dealt with by selected vectorcardiographic 
parameters (table I): 
o 	 The effect of space flight itself. Answering this query has 

been attempted by calculating the in-flight (or postflight)

minus preflight difference in the resting phase only, since 

it has been assumed that the vectorcardiogram recorded on 

resting, supine subjects in Earth gravity is likely the 

closest approximation obtainable to the vectorcardiogram 

recorded on the same resting subject in space. Each subject 

was thereby his own control; the paired t-test was used to 

test for statistical significance. 

o 	 The effect of lower body negative pressure orthostati c stress. 
Since the test subject experienced no alterations in body
orientation, vectorcardiographic changes evidenced during 
application of lower body negative pressure should be fairly
discretely ascribable to fluidic, footward shifts of body mass, 
in space or on Earth. Hence differences between -50 mm Hg
of lower body negative pressure' and resting vectorcardio­
graphic measurements were also amenable to statistical analysis
by the paired t-test and were used for these comparisons. 
Various combinations of condition effects are readily evident 
in table I wnich is the comparison matrix used to test for 
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Figure 7. 
Vectorcardiogram P-QRS-T loops in space with three planar 
projections. . 
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QRS, and Troops. PR meon region is the computer null voltage reference. 

PB, QRS B, and TB are beginning; ,and PE, QRS E, and TE are ending; 

fiducial times for the respective loop components. 11, T2, Ml and M2 

are respective threshold and modal voltage values employed in the computer 

progrom. From these basic elements and the original orthogonal scalar data 

essentially all aspects of the P-QRS-T complex may be described mathemati­

cally in three dimensional space. 

Vectorcardiogram spatial vector length in scalar form for 
one complete P-QRS-T cycle. 
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vectorcardiographic changes observed after the experimental 

conditions of lower body negative pressure (LBNP) stress, 

the space environment itself and entry. 

TABLE I. M092 VECTORCARDIOGRAM COMPARISON MATRIX 
Percent Change After Designated Condition 

Reference Condition = LBNP Condition'" Flight 

Values (LBNP Stress Values) (Resting Values) 

PREFLIGHT IN-FLIGHT POSTFLIGHT IN-FLIGHT POSTFLIGHT 

LBNP LBNP LBNP Space Space 
Preflight (Alone) + + + 

Supine Space Space Entry 

Rest + 

Entry 
In-flight LBNP 

Rest (in space) Entry 

Postflight LBNP 

Rest (After Space) 

Throughout these data analyses, it has been assumed that all three 
Skylab crews, despite widely varying mission lengths and initally
high ambient temperatures for the Skylab,2 mission, experienced the 
same space stresses and that their physiologic responses should have 
been at least qualitatively similar. Using these premises, statistical 
comparisons have been made primarily on group (nine crewmen) mean 
values. In recognition of the differences in mission durations, how­
ever, and therefore of the possibility of trend changes, in-flight 
means as well as single test values early and late in each orbital 
period have been compared separately with preflight mean references. 
RESULTS 
Heart rate responses to lower body negative pressure (table II) are 
presented in this report also. It is sufficient to reiterate here 
that, compared to supine resting preflight values, resting heart rates 
were elevated in-flight (18%) for the Skylab 3 and Skylab 4 crewmen, 
and generally in the early postflight period (3%) for all nine 
Skylab astronauts. The Skylab 2 crewmen, however, differed somewhat 
in-flight by showing decreased resting heart rates. The average .. 
difference between in-flight and preflight resting heart rates of 
the Skylab 2 crewmen, all of whom showed decreases from preflight 
values, was significantly (p<O.OOl) different from the same average
difference for the .other six crewmen, who invariable exhibited higher 
resting heart rates in-flight than preflight. 
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During lower body negative pressure stress, heart rates were always 
elevated, 20 to 50% over their corresponding resting values, regard­
less of flight phase; however, a tendency tovJard greater than preflight 
stressed increases was evident in-flight and immediately postflight. 
The PR interval (table II) exhibited moderate, reciprocal changes with 
heart rate, decreasing significantly (4 to 10%) during lower body 
negative pressure stress for all but two crewmen (Skylab 2 Commander and 
Pilot). Though changes in the resting PR interval in-flight were 
individually sporadic and averaged some 2% less than preflight values 
for the earliest in-flight tests, mean in-flight values were signifi­
cantly greater (4%, P< 0.025) than preflight. There was, however, no 
clear time trend throughout the missions nor distinct relationship to 
duration of flight. 
For the QRS duration (table II), although in-flight resting values 
averaged slightly less than (2%) than the preflight counterpart, no 
consistent or significant .pattern of change with respect to flight 
phase was seen. A modest but significant(p< 0.02) decrease averaging 
about 5% in absolute value, however, occurred almost universally with 
the application of lower body negative pressure. 
The absolute QT interval (table II) was also uniformly decreased 
(6 to 15%) during lower body negative pressure stress and whenever the 
heart rate vias eleva ted, its res ponse fo 11 owi ng the expected rec i proca 1 
relationship to heart rate. Corrected resting QTc intervals by the Bazett equa'tion (6), however, showed an average increasing trend 
in-flight, which became significantly different in the late in-flight 
period from preflight mean values (3% increase, P< 0.05). Furthermore, 
QTc intervals during lower body negative pressure were elevated 
(2 to 7%, P< 0.05 to 0.001) over resting values at all phases of the 
mission. 
Effects on vectorcardiograph component amplitudes (table III) were 
greater than those on temporal measurements. The P-wave maximum vector 
magnitude (PmaxMAG) at rest significantly {p<0.025) increased in-flight.
averaging about 25%. This increase was greater early than late in 
flight, was still present on recovery, although already attenuated, 
but quickly returned to preflight values. Even more marked, however, 
was the increase in PmaxMAG during lower body negative pressure 
(ranging 28 to 55%), again the greater changes being seen in-flight 
and immediately postfli9ht . 
The group average QRS maximum vector magnitude (QRS~axMAG)(table II~) 
at rest also increased (12%) significantly (p<O.OOl) in-flight with 
an increasing in-flight trend, returning rather precipitously to pre­
flight levels about three days postflight. Preflight during lower 
body negative pressure the QRSmaxMAG decreased from resting 
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TABLE II. TEMPORAL MEASUREMENTS OF THE VECTORCARDIOGRAM 
Percentage changes from the nine crewmen group mean, 
preflight, supine resting values (as reference) of 
averages for heart rate, PR interval, QRS duration, and QT interval (basic and heart rate corrected, QTc)
during designated treatment condition. 
VECTORCARDIOGRAM 
MEASUREMENT 
PREFLIGHT 
REFERENCE 
VALUES 
SUPINE, RESTING 
MEAN ± SD 
CHANGE AFTER DESIGNATED CONDITION (%) 
CONDITION = LBNP CONDITION 
PREFLIGHT IN-FLIGHT POSTFLIGHT IN-FLIGHT 
R + 0 
= FLIGHT 
POST FLIGHT 
R + 0 
X p X * X * X p X p 
Heart rate (bpm) 56 t 6 +20 <0.001 +54 +57 +g NS +2 NS 
PR 	 interval (ms) 148 ± 16 -11 <0.01 - 6 - 5 +3 <0.025 . +2 NS 
QRS duration (ms) 98 ± 8 - 6 <0.001 - 6 - 4 -3 NS +2 NS 
QT 	 interval (ms) 419 ± 20 - 6 <0.001 -13 -14 -2 NS -1 NS 
QTC interval (ms) 402 ± 13 + 2 <0.001 + 7 + 7 +2 0.01 +0 NS 
NS 	 = not significant 
*p 	values were not computed for these comparisons because 

percentage changes are reckoned from prefli9ht resting

references, and compound treat~nt effects (i.e., LBNP. 

space and/or entry) are involved. Approximate Significance 

may be judged 1n relation to the P values for the relatively

"pure" treatments of preflight LBNP or fl1ght itself. 

TABLE III. 	 AMPLITUDE MEASUREMENTS OF THE VECTORCARDIOGRAM 
Percentage changes from the nine crewmen group mean, pre­
flight, supine resting values (as reference) of averages for 
P-wave maximum vector magnitude (Pm9xMAG), QRS complex
maximum vector magnitude (QRSmaxMAGJ, QRS spatial Eigenloop 
circumference (QRS-E CIRC), and ST-wave maximum vector magni­
tude (STmaxMAG) during designated treatment condition. 
CHANGE AFTER DESIGNATED CONDITION (%)
PREFLIGHT 
REFERENCE CONDITION = LBNP 	 CONDITION = FLIGHT 
VECTORCARDIOGRAM VALUES 
MEASUREMENT SUPINE, RESTING PREFLIGHT IN-FLIGHT POSTFLIGHT IN-FLIGHT POSTFLIGHT 
MEAN + SD R + 0 R + 0 
X P X X 1 P X P* * 
PmaxMAG (mV) 0.122 ± 0.0332 +27 <0.001 +78 +75 +24 <0.02 +16 NS 
QRSmaxMAG (mV) 1.70 ± 0.373 - 6 <0.02 +13 +12 +12 <0.001 +18 <0.001 
QRS-E ci rc (mY) 5.01 ± i .027 + 3 NS +24 +32 +19 <0.005 +21 <0.001 
STmaxMAG (mY) 0.646 ± 0.206 -15 <0.01 -32 -37 -10 NS - 6 NS 
NS not significant E 
*p va lues were not computed for these comparisons because percentage changes are 
reckoned from prefl1 ght resti ng references, and compound trea tment effects (i. e •• 
LBNP. space and/or entry) are involved. Approximate significance may be judged
in relation to the P values for the relatively "pure" treatments of preflight
lower body negative pressure or flight itself. 
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values (7%, P< 0.02) but showed no significant response to lower body 
negative pressure in-flight. This appears to be a differential response 
to lower body negative pressure preflinht versus in-flight. or perhaps 
an overriding dominance due to the effect of space flight alone. 
Perhaps a better indicator of change in the overall QRS depolarization 
complex. the total QRS Eigenloop* circumference (table III) reflected 
highly significant in-flight increases also (19%. P< 0.005), which 
generally progressed during the in-flight phase. In-flight increases 
and precipitous postflight return to preflight values caused this 
measurement to exhibit a "square wavel! phenomenon during the in-flight 
phase. Somewhat paradoxically, however, the QRS Eigenloop circumference 
also increased during lower body negative pressure, insignificantly
preflight, but to around 10% in-flight (P< 0.0025). 
The resting ST maximum vector magnitude (STmaxMAG) (table III) for the 
group underwent nonsignificant decrements in-flight (~10%). But 
here, as with the heart rate, a distinctly different pattern prevailed 
in the Skylab 2 crewmen compared to the other two crews such that the 
question of significantly different stressors may be considered a 
possible explanation. The effect of lower body negative pressure was 
always to increase STmaxMAG. 14% preflight (P< 0.01) up to 25% in-flight 
(P< 0.001) and 30% immediately postflight (P< 0.0001). 
Alterations in orientation of the PmaxMAG vector at rest in space were 
quite variable and nonuniform; lower body negative pressure produced a 
slightly greater and more consistent effect of a general shift of the 
PmaxMAG vector terminus inferiorly and rightward. 
In contrast to PmaxMAG orientation, the resting QRSmaxMAG vector 
terminus sho\'.Jed a rather consistent. though not large, shift toward 
more anterior orientation in-flight. with a nearly equivalent return 
on the day of recovery (fig. 8). Figures 8 and 9 depict the QRS 
maximum vector termini on a spherical surface (Aitoff equal area pro­jection) representing the body thorax with equatorial azimuth at heart 
level, 0° being the left axilla. and minus and plus 90°, anterior and 
posterior. respectively. Negative elevation angles represent headward. 
and positive. footward. declinations from the horizontal reference 
plane. A slight superior component is also seen in this orientation 
shift. Almost universally the QRSmaxMAG vector terminus shifted in the 
opposite direction (posteriorly and inferiorly) upon application of 
lower body negative pressure (fig. 9). The net effect of lower body 
negative pressure in-flight, therefore. was less than either effect alone. 
*The QRS Eigenloop is that unique spatial entity representing the 
net summation of all instantaneous vectors throughout the QRS 
depolarization cycle. It is normally fairly planar and is quanti­
fied and oriented within standard orthogonal reference axes. 
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Spherical grid is the same as for figure 8. 
Figure 9. Skylab M092 QRSmax orthogonal orientation. The effect of lower body negative pressure. 
The resting STmaxMAG vector orientation shifted slightly rightward
in-flight, but always remained in the left anterior inferior octant. 
Lower body negative pressure produced a similar and somewhat larger
shift, with an accompanying modest superior distortion. 
In table IV resting J-vector magnitude (the spatial distance between 
origin and end of the QRS loop) shows no significant in-flight changes i 
but a postflight increase of 18% was significant at P< 0.05. Much 
greater augmentation occurred during lower body negative pressure 
stress preflight (30%, P< 0.001) and in-flight (up to 41% in the early 
part of the 0rbital phase), 
TABLE IV. 	 DERIVED MEASUREMENTS OF THE VECTORCARDIOGRAM 
Percentage changes from the nine crewmen group mean, pre­
flight, supine resting values (as reference) of averages 
for J-VECTOR magnitude, ST slope, and QRS-T spatial angle. 
CHANGE AFTER DESIGNATED CONDITION (%)
PREFLIGHT 
REFERENCE CONDITION = LBNP CONDITION c FLIGHTVECTORCARDIOGRAM VALUES 

MEASUREMENT SUP INE. REST! NG PREFLIGHT IN-FLIGHT POSTFLIGHT IN-FLIGHT POSTFLIGHT

MEAN ± SO R + 0 R + 0 
y p y 
* 
y y p y p.
* 
J Vector (mV) 0.074 ± 0.024 +28 <0.001 +13 +26 + 6 NS +18 <0.05 
ST Slope (mV/s) 1.28 ± 0.528 
- 1 NS -21 -18 + 5 NS + 7 NS 
QRS-T angle (deg) 38 t 14 +61 <0.001 +13 +105 
-17 NS +12 NS 
NS 	 = not significant 
* 	 values were not computed for these comparisons because percentage

changes are reckoned from preflight resting references. and cam­

pound treatment effects i.e. lower body negative pressure, space 

and/or entry) are involved. Approximate significance may be 
judged in relation to the P values for the relatively "pure" 

treatments of preflight lower body negative pressure or flight

itsel.f . 
Orientation changes of the J-vector terminus were perhaps the most 
consistent and striking. At rest early in-flight seven of nine crew­
men (excepting the Commanders on Skylab 2 and 4) displayed considerable 
shift superiorly (figure 10). All n'ine crewmen by late in-flight 
produced a further leftward shift, while immediately on recovery day 
all resting J-vector orientations moved dramatically toward their 
respective preflight pOSitions. Preflight lower body negative pressure 
stress produced very minor J-vector shifts (fig. 11), mostly rightward, .. 
but in-flight and postflight reorientations during_lower body negative 
pressure were marked, especially in the superior direction; the terminus 
..of several moved to the left superior, anterior and posterior octants, 
well separated from their normal resting position in the left anterior 
inferior octant. This was most striking immediately postflight. 
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Resting values for the ST slope (table IV) averaged 1.3 and ranged 0.5 
to 2.1 millivolt/second. In-flight and postflight changes were rather 
variable and not statistically significant, though the group average 
was augmented in-flight above the preflight reference. Latest in­
flight tests were on mission day 25 for Skylab 2; average values for 
all nine crewmen taken on or near mission day 25 in their respective 
flights were elevated only 1% over the preflight reference, while a 
corresponding average 4% increase occurred on the Skylab 3 and Skylab 4 
six crewmen around mission day 58. The Skylab 4 crew did not show 
further increases later in orbit. but an average (nine crewmen) immed­
iate postflight elevation of 7% required up to several days t6 
disappear. 
The effect of lower body negative pressure on the ST slope was likewise 
variable. A preflight increase of 2% was not statistically significant. 
An average, but not significant, decrease of 21% early in-flight
augmented to a statistically significant 41% decrement (P< 0.01) late 
in-flight. On recovery day, however, this reduction in ST slope due 
to lower body negative pressure was already diminished to 15% with no 
statistical significance. 
The spatial angle between QRSmaxMAG and STmaxMAG vectors is a close 
approximation to the true QRS-I spatial angle. ,The average resting 
value of this QRS-T angle (table IV) decreased 17% in-flight (not
statistically significant). A distinct mission trend in reduction of 
the angle wa$ seen by an early in-flight decrease of only 3% progressing 
to an average 25% (P< 0.005) decrement in the late mission vectorcardio­
grams. Even so, on recovery day a complete reversal had already 
occurred with the group averaging a 12% increase over the preflight 
mean QRS-T angle. 
The effect of lower body negative pressure was large and highly variable, 
but almost always caused an increase in the QRS-T angle which was 
greater preflight and postflight (69%, P< 0.001 and 96%, P< 0.005, 
respectively) than in-flight. The average in-flight increase due to 
lower body negative pressure was only 47% (P< 0.02); a trend toward a 
lesser in-flight increase due to lower body negative pressure was evident 
with longer orbital stay. 
Concerning lower body negative pressure related arrhythmias, rare 
ectopic beats of both ventricular and supraventricular origin were 
noted at 5:ome time or other ina11 crewmen, but frequency appeared 
unrelated to mission phase. The only other notable occurrences were 
atrioventricular junctional rhythm seen primarily in all three Scientist 
Pilots and the Skylab 4 Pilot. These usually manifested themselves 
during higher levels of lower body negative pressure or immediately upon
release, but occasionally were present even at initial rest. They 
615 
were seen preflight, in-flight and postflight, perhaps slightly more 
often in the Skylab 4 Pilot, a representative scalar strip of whom is 
shown in figure 12. No arrhythmias of clinical concern were ever 
recorded during lower body negative pressure tests, although the Sky­
lab 3 Commander did exhibit a short episode of atrioventricular 
dissociation on mission day 21 at release of lower body negative 
pressure; this never recurred. Additionally, the Skylab 4 Pilot demon­
strated considerable distortion of his ST-T waveform occasionally 
during lower body negative pressure, both in-flight and postflight;
restoration was prompt after release of negative pressure. 
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Figure 12. Scalar XVZ vectorcardiogram leads of Skylab 4 Pilot show­
ing intermittent junctional arrhythmia shortly after re­
lease of lower body negative pressure on the day of entry. 
It should be further pOinted out that in no measurement described here 
did changes exceed the accepted clinical limits of the normal for that 
measurement. Changes are, therefore, not considereo in the pathological 
context, but as normal physiologic variants of the cardiac electrical 
phenomena affected by the stresses of the Skylab space environment or 
of lower body negative pressure. As such they may shed light on basic 
physiologic mechanisms. 
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DISCUSSION 

Since heart rate is perhaps the best measure of orthostatic stress and 
is also a pivotal element in considering vectorcardiographic findings, 
• the in-depth discussion of heart rate presented in another paper (7) is 
an essential to the understanding of the mechanisms involved. Uniformily 
lower body negative pressure stress produced heart rate elevations in 
one-g and in orbit. before and after flight. The normalized differen­
.. 	 tial. however. is greater in-flight and immediately postflight than 
prior to flight. Average percentage increases in heart rate during 
lower body negative pressure over resting heart rate are: Pre­
flight = 20%, early in-flight = 50%, around mission day 25 = 42%, 
around mission day 58 (six crewmen only) = 40%, late in-flight = 43%, 
and immediately postflight = 54%. Even though these differentials 
are significant in themselves, they are even further exaggerated by 
the fact that resting heart rates were generally elevated in-flight 
and postflight over preflight values. Of further importance is the 
high correlation of stressed heart rate with respective resting rates 
at any given test session. Therefore, whatever the conditions, stresses 
or events which affect an individual's resting heart rate must 
certainly reflect their effects in other physiologic and electrocardio­
graphic measurements. 
A modest reciprocal relationship between PR interval and heart rate is 
generally accepted (8). However, the data from Skylab indicate a more 
direct relationship; in-flight (especially late) resting heart rate 
elevations were usually accompanied by increases in the PR interval also. 
Conversely, the inverse response was observed during lower body negative 
pressure stress at all flight phases. This conceivably might indicate 
an in-flight alteration in cardiac autonomic control at rest which was 
overridden by the stress of lower body negative pressure. Altered 
autonomic control also might be related to the junctional rhythm 
observed not infrequently in several crewmen. 
Since the only significant changes in QRS duration were seen during 
lower body negative pressure stress, little difference across the 
flight phases occurred, and resting differences were insignificant, it 
is inferred that space flight produced no noteworthy effects on this 
measurement. 
Though the expected reciprocal relationship of QT interval and heart 
rate was evidenced throughout all flight phases, the trend tendency 
for the corrected QTc interval -to increase through the orbital phase 
favors a space related effect upon this measurement independent of 
heart rate. The effect was directionally the same as that due to 
lower body negative pressure, though of somewhat lesser magnitude. 
Since the QT interval represents total ventricular electrical systole 
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(depolarization and repolarization) and the QRS duration (depolarization) 
was essentially unchanged, this in-flight lengthening of the QTc 
interval must be chiefly due to prolongation of the repolarization 
process. This conceivably might be related to changes in autonomic 
balance, but could as likely involve basic cellular metabolic processes. 
A seeming paradox in PmaxMAG is difficult to explain. Lower body
negative pressure increases in this measurement have long been observed, 
sometimes attributed in part to more nearly synchronous depolarization 
of both atria with increased heart rate and relative adrenergic 
dominance. Experimental data on dogs by Nelson and co-workers (9) 
supports an increase in P-wave amplitude upon removal of blood. A 
space related increase in this measurement at rest, even for those 
crewmen of Skylab 2 who had decreased resting heart rates in-flight 
seems to address another mechanism. The fact that early in-flight 
vectorcardiograms exhibited the greater increases would point to a 
possible etiology related to fluid shifts which are felt to be operative 
early following orbital insertion. That fluid is shifted in the 
opposite direction during lower body negative pressure, when even 
greater PmaxMAG values are observed, compounds the paradox. Physiologic­
ally, positional changes in this vector do not appear relatively 
significant. 
Even more striking were the QRSmaxMAG and QRS Eigenloop circumference 
changes. These measures of increased ventricular depolarization voltage 
imply a definite space effect, since lower body negative pressure 
produced actual decreases in the former and nonsignificant increases in 
the latter preflight. End diastolic ventricular blood volume is con­
sidered by Nelson, et aZ. (9) to be a major factor affecting the QRS 
complex. Manoach, et aZ. (10), and others (11) have demonstrated in 
dogs a significant direct correlation of blood volume and QRS amplitude 
during controlled hemorrhage, volume replacement, vena caval occlusion 
and direct intracardial infusion overload. One might also consider 
the potential effect in space of relative hemodilution (12) which, 
according to Rosenthal, et aZ.(13), augments QRS magnitude by lowering 
intracavitary blood resistivity. 
In the hypothesized events occurring in space, a large fluid shift 
from the lower body centripetally would very likely produce initially a 
relatively increased intravascular and intracardiac volume. Subsequent
transfer of fluid from other compartments to the vascular tree could 
dilute the original hematacrit as well as increase total blood volume. 
This interactive complexity could also account for the modest vector 
orientation shifts observed, particularly as the two ventricular 
chambers may experience nonidentical alterations. Trying to relate 
these vectorcardiographic findings to hemodynamic events is enticing, 
but difficult (14). Our data and the study by Brody (15), who asserted 
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That intracavitary blood exerts a powerful effect upon surface lead 
electrical potentials of the heart by differentially decreasing 
tangential while augmenting radial dipoles seem to give our hypothesis
practical and theoretical support. Another perhaps less likely consid­
eration is that these increased surface potentials in-flight do in fact 
represent increased myocardial work, which might logically be considered 
due to increased stroke volume and/or elevated systemic pressure. 
Finally, since the J-vector and ST slope give important information on 
myocardial oxygenation, the absence of a significant space related 
alteration in these two measurements is encouraging. The increased 
J-vector magnitude and decreased ST slope during lower body negative 
pressure stress, however, need further investigation. 
CONCLUSIONS 
°Vectorcardiograms taken on all crewmen during the Lower Body Negative 
Pressure Experiment (M092) on the Skylab flights have shown several 
consistent changes apparently related to space flight. Principally
involved among these changes are temporal intervals, vector magnitudes 
and their orientations, and certain derived parameters, presumably 
as a consequence of altered autonomic neural imputs upon the myocardial 
conduction system and/or of major fluid shifts known to have occurred 
in flight. 
°Correlations of these electrocardiographic findings with other hemo­
dynamic and related changes appear reasonable and consistent, 
especially as regards the concept of headward fluid shifts in space. 
°All observed measurements have been well within accepted limits of 
normal and are considered to represent adaptative phenomena rather 
than pathological conditions. 
°These findings have, in a predictable fashion, opened new questions 
which will direct future ground-based and in flight researches - par­
ticularly in the area of cardiovascular electro-hemodynamic studies 
for the Shuttle era. 
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HEMODYNAMIC STUDIES OF THE LEGS UNDER WEIGHTLESSNESS 
Wittiam E. Thornton~ M.D.~ G. W. Hoffter~ M.D. 
Nationat Aeronautics and Space Administration 
Lyndon B. Johnson Space Center 
Houston~ Texas 
ABSTRACT 
Following exposure to weightlessness, alterations in the return of 
blood from the legs playa crucial role in orthostatic tolerance and 
may be an important factor in work tolerance. To investigate some of 
the hemodynamic mechanisms involved, an experiment was performed on 
the Skylab 3 and Skylab 4 missions to study arterial blood flow, venous 
compliance, and muscle pumping of blood. Skylab 4 results are pre­
sented. 
Venous compliance and arterial blood flow were determined by occluding 
venous flow with a pressure cuff above the knee and recording the 
resulting change in volume from a midcalf segment by means of a capaci­
tance volume transducer. For flow measurements. the cuff was inflated 
to 30 mm Hg pressure for three 10-second periods. This sequence was 
repeated at 50 mm Hg cuff pressure. Flow was calculated from the 
initial rate of volume change. Compliance curves at 30 mm Hg pressure 
were obtained by inflating the cuff to this pressure for 3 minutes and 
recording the volume change as olJtlined previously; two such determina­
tions were made at each recording. Compliance (differential volume/ 
differential pressure) was calculated from the known pressure point on 
the curve. 
Muscle pumping action was studied by placing the subject in lower body 
negative pressure at -30 mm Hg and recording volume change from a calf 
segment as before. After 3 minutes, the crewman made 10 maximum effort 
isometric contractions of the leg, waited one minute, and repeated the 
procedure. The amount of blood collected in the segment from the neg­
ative pressure and the amount remaining after pumping were determined. 
This entire sequence of studies was performed three times before flight, 
seven times during flight, and three times after flight. Blood flow 
showed a marked average increase in all crewmen througho~t the in­
flight phase; wide variations were seen but no clear trend. After 
flight, an immediate sharp reduction, virtually to prefli9ht values, 
occurred. Venous compliance demonstrated a slowly increasing 
compliance which reached a fivefold increase in two of the three crew­
men by mission day 15, a slowly decreasing trend in all three crewmen 
after mission day 40, and a precipitous drop to less than preflight 
values at recovery. The values for the Commander of Skylab 4 showed 
little change. After muscle pumping, the relative amount of blood 
remaining in leg veins was approximately the same during flight as 
before flight, but the absolute amount collected and remaining was 
increased several times. 
" 
It was concluded that the most likely cause of increased blood flow 
was an increase in cardiac output secondary to increased central venous 
pressure caused by blood redistribl.Ation. Changes in venous compliance 
are thought to be primarily changes in somatic musculature which is 
postulated to primarily determine venous compliance of the legs. This 
was also thought to be demonstrated by the changes in muscle pumping. 
It is thought that these compliance changes, when taken with the 
decreased blood volume; provide a basis for the changes seen in ortho­
static tolerance, work capacity and lower body negative pressure response. 
INTRODUCTION 
In the next two reports I shall describe experiments which were added 
to the original Skylab experiment protocol long after the schedule had 
been fixed. Only those of you familiar with space flight scheduling
and operations can appreciate the problems this causes. At the same 
time, the scheduling flexibility which was developed as the mission 
progressed produced far more valuable data than was originally hoped
for. These changes became a tribute to the flight crews and management 
team and again illustrated the outstanding characteristic of manned 
space flight, the flexibility to optimize returns from an experiment 
or from a mission; Scheduling under such situations was critical, and 
if there are recognized holes in the data or crucial data points missing, 
it was not due to the investigators oversight but to a matter of mission 
pri oriti es. 
Significant among the medical findings following prolonged space flight 
have been reduced orthostatic tolerance and ergometric work capacity. 
Changes in hemodynamics of the legs with increased blood pooling and 
reduction in cardiac output must be considered one of the most probable 
causes of these effects. Concern for the above plus the observed 
marked tissue changes occurring in the legs during flight prompted the 
addition of several procedures to evaluate hemodynamic changes in the 
leg; resting arterial blood flow, venous compliance and muscle pumping 
were investigated. 
• 
The Lower Body Negative Pressure experiment recorded leg volume changes 
and this inherently contains compliance information. However in measur­
ing such changes, stress is applied to a considerable portion of the 
body and affects many body systems capable of alterina the primary leg 
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volume response. In so far as possible, we looked at the initial 
reaction to pressure in the smallest possible vein segment. 
Impromptu studies were implemented during the latter. portion of the 
Skylab 3 mission. Results were of sufficient value to include more 
comprehensive studies on Skylab 4 which will be subsequently described 
fully; for convenience, each aspect of the experiment will be complete­
ly discussed in turn, except for conclusions. 
The entire series of procedures was actually performed three times 
preflight,seven times in-flight, and three times postflight. The 
minimal original in-flight schedule was further reduced by other 
scheduling requirements during periods critical to the experiment. 
Several trials were lost or severely compromised by artifacts which 
appeared to be electrical. Other than these problems, the data were 
collected without difficulty. 
PROCEDURE 
If an occlusive cuff placed around a limb segment is inflated some­
what above venous pressure, arterial flow will be little affected, 
but venous flow will be stopped until its pressure exceeds cuff pressure.
If volume change is also measured, its initial rate of change with time, 
before appreciable back pressure develops, approximates arterial inflow 
(fig. l). 
TO LEG SEGMENT 
VOLUME MEASURING 
ELECTRONICS AND 
RECORDER 
LEG VOLUME MEASURING 
SYSTEM BAND 
Figure l~ Arterial flow - measurement experimental arrangement. 
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There are several assumptions and sources of potential error in this 
measurement. 
By waiting until the volume reaches a plateau, i.e.~ until venous 
pressure equals cuff pressure and venous flow resumes, a single known 
value of compliance can be determined, figure 2. 
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Figure 2. Venous compliance record. 
Data for these two studies were obtained, as shown here, with an arm 

blood pressure cuff above the left knee and a capacitance limb volume 

measuring system band around the maximum girth of the calf. Volume 

changes actually measured are only those in the segment directly beneath 

the cuff. Volume changes of the entire leg or even calf cannot be 

inferred from this measurement. 

Blood flow was recorded by rapidly inflating the cuff to 30 mm Hg for 

20 seconds for three trials. This sequence was repeated at 50 mm Hg 

cuff pressure. Subjects are supine when measured under one-g. 

In-flight curves from such a series at 30 mm Hg are shown in figure 3. 

The first volume change probably caused a small sensor position artifact 

which in turn shifted the baseline slightly. .. 

2.0 2.5 3.0 
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Figure 3. Arterial flow record. 
Blood flow was calculated by manually drawing a tangent to the slope 
and measuring this slope in terms of changed volume/changed time. 
Usually there was an unexpected increase in volume change during cuff 
inflation which, in spite of the distance between plethysmograph 
segment and cuff, must be venous reflux. This initial slope and 
artifact were avoided during measurement. Another possible but un­
avoidable error was flow of blood from or into areas not typical of 
the segment under measurement, e.g., the foot. Blood and fluid flows 
were calculated in terms of 100 milliliters of tissue under the capaci­
tance band. 
Measurements were made at both 30 and 50 mm Hg pressure (figs. 4a and 4b) 
to indicate the effectiveness of occlusion of the leg vessels by an 
arm cuff ( a leg pressure cuff was not available in-flight) and which 
was used in all measurE'ments. The curves generally correspond 
well except for the last two postflight tests from the Scientist 
Pil ot. 
DISCUSSION OF DATA 
There is great variability in the in-flight data, some of which prob­
ably resulted from changes in temperature and in relationship of the 
time of measurement to ingestion of food and exercise. None of these 
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Figure 4a. Skylab 4 leg blood flow, 30 mm Hg pressure. 
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Figure 4b. Skylab 4 leg blood flow, 50 mm Hg pressure. 
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factors were controlled or adequately known to be properly accounted 
for. In spite of the variability, it seems safe to say that blood 
flow was elevated above preflight and postflight levels throughout the 
flight, and 	 probably remained slightly elevated in the Scientist Pilot 
postflight. 
Several possibilities should be considered for this increase in blood 
flow. Under one-g, an increase in muscle blood flow is seen in 
elevation of the legs while supine, or in other maneuvers which in­
• creased intrathoracic venous pressure, a mechanism which apparently_ 
releases sympathetic vasoconstrictor action. It will be shown in our 
next report (Anthropometric Changes and Fluid Shifts) that fluid and 
blood from the legs were shifted cephalad on exposure to weightlessness 
and this must have produced transient increase in venous pressures which 
may not have been completely restored to "normal" throughout the flight.
Decreases in transmural pressure could have allowed increase in vessel 
size and flow, but the changes required to do this in the legs are too 
large to be considered under the circustances. 
My own hypothesis is that cardiac output is increased secondary to an 
increase in the central venous pressure. While there is no hard 
supporting evidence for this hypothesis, several observations indicated 
that it may have happened. 
In-flight variation was too large to allow any statements about trends. 
Note, however, a marked difference between the Commander of Skylab 4 
and the other two crewmen. This difference was rather obvious in 
lower body negative pressure testing and it will be seen again in 
several experiments. Postflight there was an abrupt drop to just 
above preflight levels. This is consistent with any of the possible 
causes of increased blood flow which were mentioned. 
Compliance is the change in volume for a given change in pressure and, 
in this case, it is assumed to be a change in venous volume produced
by cuff pressure of 30 mm Hg or more simply stated, how much blood 
will be pooled in the veins at anyone pressure. Let me emphasize
that the compliance curve is alinear, and that this measurement is only 
one point on the curve from a vessel which was not completely empty 
at the start. Further, the exact starting pressure is not known. 
Compliance for the three Skylab 4 crewmen are plotted in figure 5 in 
terms of volume percent change (milliliters/lOO milliliters of tissue).
It is obvious that more points are needed on these curves, especially'. 	 in the 2 to 3 week period. It should be noted in all crewmen there was 
an increase in compliance that required to days or more to reach a 
maximum. It the,n appeared to decrease slowly, possibly cyclically in 
two crewmen, until recovery, when there was an i~lediate fall to or 
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Figure 5. Skylab 4 crew vascular compliance. 
even below preflight levels, with again a marked difference in 
Commander's response. 
Before attempting to expla in these results, 1et me give you my views 
of veins in the leg -­ veins which may differ and behave differently 
from those encountered elsewhere in the body. 
Figure 6 is an obviously exaggerated schematic of leg anatomy. The 
foot and skin of the leg are drained by unsupported veins with thick 
muscular walls, walls that will even go into spasm when irritated. 
The leg muscles are drained by much larger thin-walled conduits with 
little muscle or innervation; in some areas they are described as 
sinuses and are little more than a sac attached to the surrounding 
muscles. Response of such vessels should be more dependent upon the 
surrounding somatic muscles than upon its wall. These deep veins 
comprise the major venous volume - 85 percent is a commonly used 
value - the response that we see from the mid-calf is predominantly 
the response of these deep veins. There is no evidence for an increase 
in superficial venous volume in-flight. 
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Figure 6. 	 Distorted schematic of leg anatomy. Veins are 
in black. 
Referring back to the responses measured, my interpretation of the 
changes lie in the condition of the surroundinq muscles. There was a 
slow loss in volume of the calf segment during the first 20 days of 
weightlessness in contrast to the sudden loss of volume of the l~gs as 
a whole. A part of this loss was in the muscle itself. Further, with 
the unloading of external forces, there must have been some atrophy and 
a loss in muscle tone.* As the mission progressed, I suspect the body, 
as it always seems to do, tended to reestablish equilibrium, or "take up 
the slack" if you wi 11, such that effective tone was increased i n-f1; ght 
and very sharply increased on being resubjected to one-g. ~Jorking a 
muscle, as it was experienced on recovery, causes an increase in fluid 
volume which may have been effective here. 
Additional hemodynamic information was obtained by having the crewmen 
perform muscle pumping under negative pressure (fig. 7). After an 
experiment M092 test, the subject was left in the lower body negative
pressure device and -30 mm Hg pressure was applied for three minutes 
causing blood to pool, again assumed to be primarily in the deep veins. 
*It may be coincidence but work on the treadmill with heavy calf load"ing 
did not start until mission days 8 to 10. 
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At the end of this time, the subject made ten maximum effort isometric 
contractions of his legs. These contractions caused large pressure 
forces to develop against the blood in the deep veins which forced it 
into the central circulation through one-way vein valves. Time was 
allowed for an additional pooling to occur and the procedure was re­
peated. 
10 
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0 
-2 
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TIME, min 
Figure 7. Muscle pumping record. 
1 
The volumes of blood accumulated and the amount remaining are plotted 
in figure 8, for two subjects in-flight - the Scientist Pilot and 
Commander. The Pilot's responses, which are not shown, were generally
similar to those of the Scientist Pilot. The amount of blood pooled 
was generally comparable to that pooled by cuff occlusion at 30 mm Hg 
pressure (figs. 4a, 5), The one '\vild point" of the Scientist Pilot 
bothers me; try as I might, I cannot discredit it, so it remains. 
Again, the amount of blood pooled by the Scientist Pilot is roughly 
two times that of the Commander; however, after muscle pumping both 
have the same volume remaining. While this may be sheer coincidence, 
I suspect there is an anatomical difference in the Commander's deep 
venous structure. Postfliqht there was a marked and immerliate 
decrease in the amount of blood pooled while effective pumping action 
was still present. 
• 
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Figure 8. Skylab 4 crew leg volume changes from muscle pumping. 
Under one-g, a subject typically removes about 50 percent of pooled
volume from his calf, while thigh pumping is relatively less effective. 
About the same percentage is removed in-flight. The Commander's post­
flight pumping was less effective than his preflight average, and 
preflight and postflight efforts were relatively less effective than 
his in-flight pumping, which suggests that he has less deep venous 
volume capacity. This variance is further supported by blood volume 
studies and is discussed under anthropometry. 
How do these findings relate to crewmen in space flight? The Skylab 4 
crew confirmed the prompt postflight return to baseline seen in the 
measurements of this experiment by standing and walking easily for 
long periods on the day after recovery. The deficiencies were only 
detectable by the lower body negative pressure and ergometric tests 
and these also quickly returned to normal. 
It would appear that the general shape of the compliance curve for this 
flight (fig. 5) agreed with the experience of the crew and with the 
number of times the runs were prematurely ended. The crew felt that 
the test became increasingly stressful and then the stress declined. 
Abortion of lower body negative pressure tests also appeared to cluster 
within this one four-week period. The effects of a decreasing blood 
volume and red cell mass and increased compliance are probably the 
two fundamental parameters in lower body negative pressure response. 
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However, there are a host of factors, even and especially psychological 
factors, that can affect the compliance curve, to say nothing of final 
systemic responses. 
While it was gratifying to have the importance of venous changes and 
especially compliance so impressively recognized in the paper on 
lower body negative pressure, compliance and fluid volumes should not 
be over-emphasized at the expense of other mechanisms. Although I 
consider these fundamental, a great host of others remain to be explored. 
I would question the concept of significant changes in compliance being 
caused by empty and flattened veins. As I will show in the next re­
port on Anthropometry, leg veins were not empty, at least the super­
ficial leg veins were not. 
Secondly, I question the concept of compliance or potential volume 
spaces being changed by sleep in weightlessness which seems counter 
to common experience and to measurements done during Skylab, when 
muscular activity was shown to increase muscle volume. This activity 
would reduce potential venous volumes, especially of the deep veins 
enclosed with the muscles in fascial compartments. Muscle pumping is 
a very transient phenomena and removes only a portion of the blood. 
Thus I would look elsewhere for the short term variations in response 
to 10lAJer body negative pressure. 
CONCLUSION 
In summation: Changes in blood flow were demonstrated, which I think 
make the problem of obtaining cardiac output data in space even more 
imperative. 
Venous compliance changes were demonstrated which, with blood volume 
changes, should provide an initial and primary point of departure for 
investigation of the complete response to lower body negative pressure. 
Time course of the compliance changes should be considered by mission 
planners. Shuttle reentry, for example, v.Jill fall v.Jithin the zone of 
increased sensitivity to orthostatic stress. There was a demonstration 
of a marked difference in individual response on Skylab 4, which might 
also be considered in some flight operations. Since compliance of 
the leg vessels appears to be intimately related to leg muscle, this 
relationship should be properly investigated. Muscle condition may 
have played a major role in the slower return to normal of the crews of 
Skylab 2 and 3. In the future, proper cognizance should be given to 
such venous studies in bed rest, especially of the deep veins as both 
the medical community and NASA stand to benefit by such studies. 
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In conclusion, another portion of man's body has been demonstrated to 
be capable of making adaptations to weightlessness, which produces 
both stab"ility under weightlessness and rapid re-adaptation on return 
to one-g. This bodes well for future manned flights. 
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ANTHROPOMETRIC CHANGES AND FLUID SHIFTS 
William E. Thornton~ M.D.~ G. W. Hoff1er~ M.D. and J. A. Rummel~ Ph.D. 
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ABSTRACT 
Several observations of body size, shape, posture, and configuration 
were made to document changes resulting from direct effects of weight­
lessness during the Sky1ab 4 mission. These measurements constitute 
two broad, overlapping categories: anthropometric changes and fluid 
shifts. Direct anthropometric measurements of limbs and trunk were 
made from each crewman before, during, and after flight. At the same 
time, photographs were made of each crewman in the anatomic and relaxed 
position. Infrared augmented film, which emphasized superficial 
venous patterns, was used for these photographs. Center-of-gravity and 
center-of-mass determinations were also made. 
After the crewmen \'1ere placed in orbit, a number of ana tomi ca1 and 
anthropometric changes occurred including a straightening of the thoraco­
lumbar spine, a general decrease in truncal girth, and an increase in 
height. Relaxed posture resembles that of a quadruped. Some slight
trends toward preflight morphology were seen during the latter half of 
the mission with a prompt return to preflight configuration on recovery. 
The series of accurately located limb girth measurements allowed volume 
determinations of arm and leg segments. By the time of the earliest 
in-flight measurement on mission day 3, all crewmen had lost more than 
two liters of extravascular fluid from the calf and thigh. The puffy
facies. the "bird legs ll effect, the engorgement of upper body veins, 
and the reduced volume of lower body veins were all documented with 
photographs. Center-of-mass measurements confirmed a fluid shift 
cephalad. This shift remained throughout the mission until recovery, 
when a sharp reversal occurred; a major portion of the reversal was 
completed in a few hours. 
The anatomical changes are of considerable scientific interest and 
of import to the human factors design engineer, but the shifts of 
blood and extravascular fluid are of more consequence. It is hypo­
thesized that the driving force for the fluid shift is the intrinsic 
and unopposed lower limb elasticity that forces venous blood and then 
other fluid cephalad. This shift may be the driving force for a 
number of other phenomena, including blood volume loss and changes in 
leg hemodynamics, and should be considered in the vestibular area and 
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other problem areas. This phenomenon should also receive proper 
cognizance in bed-rest and other future simulation studies. 
INTRODUCTION 
Manis body, both as a species and as an individual, has been shaped 
by continuous exposure to gravity and a large portion of it is 
dedicated to more or less continuously opposing gravitational forces. 
One could confidently predict that placing the human body in weight­
lessness would produce changes in size, shape, and composition. Many
of these changes and their effects were described by astronauts from 
the earliest days of space flight. for example; puffy faces, stuffy 
noses, engorged head veins, low back discomfort, and the "bird legs" 
of space. 
The anthropometric studies in American space programs prior to Skylab 
were: 
°Preflight and postflight leg volume measurments on the later 

Apo 11 0 fl i ghts . 

°Stereophotogrammetry of the crew preflight and postflight on 

Apollo 16. 

On Skylab only leg volume measurements, and stereophotogrammetry preflight 
and postflight, and maximum calf girths in-flight were originally
scheduled. 
In an effort to obtain the most comprehensive and coherent picture of 
changes under weightlessness, we initiated a set of measurements on 
Skylab 2 and, at every opportunity, added additional studies. All 
pertinent information from ancillary sources, even news photographs 
was gleaned and collated. 
On Skylab 2, the initial anthropometric studies were scheduled in 
conjunction with the muscle study presented at the session this morning 
and consisted of direct limb girth measurements for limb volume and 
trunk girths. A single set of facial photographs was made in-flight.
Like measurements were continued on Skylab 3, with additional photo­
graphs and truncal and limb girth measurements in-flight. 
Prior to Skylab 4, a few of us felt there was considerable evidence for 
large and rapid fluid shifts, so a series of in-flight volume and center 
of mass measurements and infrared photographs were scheduled to be 
conducted as earJy as possible in the Skylab 4 mission. 
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A number of changes were properly documented for the first time, most 
important of which were the fluid shifts. The following description 
of Skylab anthropometrics \'Jill address work done on Skylab 4 primarily . 
PROCEDURE 
The series of direct anthropometric measurements shown in figure 1 
were made preflight and postflight on all missions, and in-flight on 
the Skylab 4 mission. Leg and arm girth measurements were made every 
three centimeters by means of a calibrated tape jig attached to the 
limb to insure accurate location. As part of their experimental
protocol, Drs. G. W. Hoffler and R. L. Johnson made such leg measure­
ments preflight and postflight on Apollo and Skylab and, to avoid 
repetition, data from these measurements vJere shared on Skylab. l~e 
extended their technique of measurement to include the arms on all Skylab
missions and preflight and postflight. The in-flight limb measure­
ments on Skylab 4 were made with an unattached singie tape and a 
calibrated longitudinal tape. 
CD NECK-CIRCUMFERENCE AT LARYNX 
(i)CHEST -CIRCU MFERENCE AT NIPPLE 
(INSP AND EXP) 
@ARM VOLUME (GIRTH EVERY 3 em) 
@ARM VOLUME (GIRTH EVERY 3 em) 
@ ABDOMINAL CIRCUMFERENCE 
AT UMBILICUS 
@HIP CIRCUMFERENCE AT 
GREATEST DIAMETER 
(l)LEG VOLUME (GIRTH EVERY 3 em) 
® LEG VOLUME (GIRTH EVERY 3 em) 
@HEIGHT 
Figure 1. Anthropometric measurements of Skylab crewmen. 
639 
For general documentation, a series of preflight, in-flight and 
~ostfli.aht front, side and back photoaraphs were made with the crp.wmen
1n stanaard anatomical position;' and to note postural changes, an in-
flight series of photographs were made with the crewman completely 
relaxed and free-floating. An infrared sensitive color film was used 
in an attempt to document the superficial venous blood distribution. 
The infrared film had poor resolution and at the last minute, 35 mm 
was substituted for 70 mm film further reducing resolution. Quality 
of the in-flight anatomical and postural photographs suffered. 
However, with diligence, a good deal of vascular detail could be 
determined that would not have been available on ordinary film. 
In an effort to devise a simple way to indicate fluid shifts, center 
of mass and center of gravity measurements were made (fig. 2). A 
teeter board was used for these measurements on Earth. 
In-flight it was possible to obtain center of mass directly by tying
a cord around the subject and then pulling the cord at right angles 
to the subject. If the cord was anywhere off the center of mass the 
subject would tilt. The crew claimed this scheme was accurate to a 
few mi 11 i meters. . 
Figure 2. 
1-------HEIGHT ------1 
ONE-G CENTER OF GRAVITY MEASUREMENT 
t------HEIGHT-------l 
-
ZERO-G CENTER OF MASS MEASUREMENT(in Weightlessness) 
Techniques used to measure center of gravity and center of 
mass at one-g and in weightlessness (Skylab 4). 
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Let's look first at the in-flight changes that occur. 
OBSERVATIONS AND DATA 
Figures 3 and 4 show a preflight and postfl1ght front vi.ew of a Skylab 4 
crewmen. Although these are third generation copies, one is able to 
see arm venous pattern clearly. 
The Commander of Skylab 3 is shown in-flight in figure 5. In one of 
the anatomical films, I thought that he had done a military brace in 
spite of his denials, for he isn't that trim and erect under one-g. 
Note the abdomen and ram rod spine. Also note, the jugular full to 
the angle of the jaw and other head veins. 
Figure 6 is an in-flight photograph of the subject free-floating and 
relaxed. Relaxed postural changes varied somewhat throughout the 
flight and from individual to individual; tracings, figure 7, from 
in-flight photographs of the Scientist Pilot of Skylab 4 are typical
of changes seen. 
The spinal column was flexed with loss of the thoracolumbar curve 
but with retention of the cervical curvature, such that the head is 
thrust forward. Both upper and lower limbs have moved toward a quad­
ruped position. Postflight, there was surprisingly little change from 
preflight posture. 
Figure 8 are plots showing what gravitational unloading does to truncal 
size. The Pilot of Skylab 4 had the largest changes with gain of 
some two inches in height and loss of four inches in abdominal girth. 
Chest girth was also initially reduced in both inspiration and expira­
tion, but trended toward IInormal" in-flight. Postflight, which is 
poorly shown in these figures, there was a more or less rapid trend 
toward preflight values. It seems that most of the increase in height 
was caused by expansion of the intervertebral discs which were unloaded. 
This stretched the torso and probably aided in reduction of abdominal 
girth. Abdominal viscera may be considered semiliquid, and when their 
vlei ght was removed the normal tone of abdomi na 1 muscles moved them in 
and upward. Changes in chest girth are not so easily explained, but 
if the spinal column moved upward without a similar anterior elevation 
of the sternum, then the rib (costovertebral) angles is increased, 
effectively reducing thoracic girth. Changes noted in the Commander 
were virtually the sam~ as those noted in the Scientist Pilot . 
There was considerable evidence of large and rapid shifts in fluid from 
the lower to upper body prior to Skylab 4. Indeed, no subject has 
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Figure 3. Preflight (color) anatomical photograph of • 
Skylab 4 crewmen with infrared augmented film 
to enhance superfical venous pattern. 
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Figure 4. 	 Postflight anatomical photograph, Skylab 4 
crewman. 
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Figure 5. 	 Photograph of the Skylab 3 Commander showing posture 
and full head and neck veins. 
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• Figure 6. In-flight astronaut free floating and relaxed. 
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IN-FLIGHT, RELAXEDPREFLIGHT, STANDING 
J 
PREFLIGHT IN-FLIGHT POSTFLIGHT 
Figure 7. Postural changes, Skylab 4 Scientist Pilot. 
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Figure 8. Plot showing in-flight and postflight anthropometric
changes, Skylab 4. 
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been discussed more in space physiology; nevertheless, virtually no 
one was willing to accept it. Such large and rapid shifts seemed to 
be contradicted by the relatively small gains in postflight leg 
volume which obviously contained tissue increases. Single midcalf 
girth measurements on Skylab 2 and 3, in-flight were also misleading 
for they indicated much smaller and slower changes consistent with a 
predominant component of muscle atrophy. 
There was obviously no way to prove the point without data and to do 
this during activation of an already overscheduled mission was the 
toughest job I tackled. Thanks to Messrs. Richard Johnston, Kenneth 
Kleinknecht and others, and above all, the crew, this data was 
gathered - not as much as desired, but to gather from the papers 
presented today, apparently enough to convince all concerned. Leg
and arm volumes were calculated by measuring the girth of each three­
centimeter segment and treating it as a tapered cylinder, then 
summing these volumes. 
Mission day 3 was the earliest possible that these measurements could 
be scheduled, although it is a measurement which should have started 
within hours of orbital insertion; even then, only two crewmen performed 
these measurements on mission day 3. Figure 9 shows that there is a 
rapid loss in leg volume; the curves on these plots are only estimates, 
and I suspect the shift was essentially over by the first day.
Remember these are changes in one leg only and on mission day 8 total 
change was approximately 2 liters and 13 percent of total leg volume 
for each crewman. 
Note that on recovery the majority of the increase in leg volume was 
complete by the time of first measurement on the day of recovery; or 
within a matter of hours after reexposure to one-g. 
I agree with Dr. Michael Whittle that the slower postflight trends 
show tissue replacement. Somewhat to my surprise, the arms showed no 
evidence of fluid shift and the changes seen were small and probably 
related to metabolism. 
Where did this fluid go? There was no weight loss in two of the three 
crewmen compatible with loss of this amount of fluid. 
Center of mass measurements were scheduled on this flight primarily to 
follow the time course of fluid shifts, since only minutes were 
required for the measurement. Unfortunately, schedules were changed 
such that the points of real interest were over before the first 
measurement could be made. Figure 10 is a plot of the center of mass, 
the upper curve shows the center of mass changes and the complication 
by the increase in height, shown in the lower curve. Center of mass 
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Figure 9. Change in left limb volumes, Skylab 4. 
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shifted cephalad more than could be accounted for by the height in­
crease which is another small confirmation of fluid shift. 
We have long had astronaut objective and subjective descriptions of 
puffy facies, head fullness and other symptoms of increased fluid in the 
head. 
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Figure 10. Center of gravity/center of mass, Skylab 4 Pilot. 
Finally, there are the photographs. While these do not allow quantita­
tion, they provided powerful evidence for increased fluid in the head 
and neck region. 
Figure 11, a photograph of the Pilot on Skylab 2, was the first 
taken for this purpose. Although it is. slightly distorted it still 
demonstrates the puffy facies - note the thickened eyelids. This 
in-flight photograph was made near the end of the mission and demon­
strates that this type of edema and venous congestion still remained. 
Next, figure 12, is a picture of the Commander of Skylab 3 with the 
preflight view on the right-hand side; again the in-flight photograph 
was made near the end of the mission. Although angle and lighting
differ, I believe the difference in facies are apparent. 
6-50 
Figure 11. 	 Skylab 2 Pilot showing the puffy facies still 
present toward the end of the mission. 
I n - F 1 i g h t Pref 1 i g h t 
Figure 12. Skylab 3 Commander comparing the puffy facies 
in-flight to the normal facies preflight. 
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Finally, we have the assessment of the infrared photographs. Original 
plans were to machine analyze the superficial venous pattern, but 
the quality was too variable, therefore, only a qualitative assessment 
was made. However, several features were obvious. From first through 
the last mission the following was observed in all in-flight photo­
graphs of the crewmen: 
o 	 Only superficial veins were visualized 
° 	 Foot and lower leg veins were not distend~d as they are when 

standing under one-g. 

o The'y were not completely empty for the dorsal arcade of the foot 
and digital branches were easily seen with the infrared film. 
o Calf veins were not distended but were still visible. 
o Several superior branches in the anterior thigh were moderate­
lyfull. 
o 	 Little difference could be seen between preflight and in-flight
patterns of the trunk and upper arms. Hand and forearm v~ins 
were well filled and distended in-flight. This surprised me 
since superficial arm veins, like those of the leg have increas­
ing amounts of wall muscle as they become more distal. 
° 	 Jugular veins were always completely full and distended as 

were veins of temple and forehead. 

o 	 Postfliaht, there was a prompt reversion to preflight pattern,
however, foot and lower leg filling appeared to be less in 
the early recovery period. 
Changes in mass have already been discussed and are obviously related 
to the changes seen here. 
It was not possible to document body composition changes with specific
gravity and other measurements. Observation of all crews, and 
especia11y those on Skylab 2 and 3, left the impression that loss of 
fat had occurred, except for the Commander of Skylab 4. Radioisotopic
studies by Drs. P. C. Johnson and C. S. Leach confirmed an increased 
loss of fat by all crewmen except the Commander of Skylab 4. 
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DISCUSSION 
What is the importance of the changes observed under weightlessness? 
The major changes are reviewed in table I. 
TABLE I. MAJOR ANTHROPOMETRIC CHANGES 
Truncal 
Cause 	 Effect 
Change in Height °Reducea load on s pi ne wi th °Pressure suit entry and fit 
Loss of thoracolumbar °Fit of other personally 
curvature fitted gear 
Expansion of inter­ °possibly changes thoracic cage 
vertebral discs 
Reduction in 
Waist Girth °Weightless abdominal °Probably alteration in 

con.tents are pushed "in" respiratory function and 

and "up" by unopposed capacity 

tone of abdominal 

°Change in internal structural 
muscles relations 
Reduction in °Possible increase of costal °Possible alteration in 
Chest Girth 	 angle from increase in respiratory function and 

spinal length capacity 

Change in height is as much a conversation piece as anything else. One 
crewman, for example, is shorter than his wife and was elated to find 
in flight that he was finally taller. Postflight there was an under­
shoot, and he cam~ home to her on the third day postflight shorter 
than ever. Such changes provide new data points for those studying 
the human skeleton and, hopefully, will add to the knowledge of it. 
In future flight, allowances may have to be made in custom fitted gear. 
For example, small height increases greatly increase the difficulty of 
donning pressure suits; these difficulties may show up in the time 
and motion studies on Skylab. 
Reduction in waist girth with cephalad shift of abdominal viscera prob­
ably alters maximum lung volumes but to no great extent. Vital capacity 
is reduced by lying down in one-g and the effects are somewhat analagous.
Apparently it did alter some internal relationships for at least one 
crewman felt that runnjng and jumping on the treadmill produced un­
pleasant jouncing of gastric contents. One could speculate on the 
effects that such shifts would have on pathological processes of the 
bowel - e.g.~ hiatus hernia or a perforation. It is hardly necessary 
to comment on the changes in chest girth which were small. 
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In-flight postural changes are listed in table II. These postural 
changes have two significant considerations. Human engineering should 
allow for the most efficient work positions in the future. For example,
a chair designed for use in one-g to support the weight of legs and 
torso, is not shaped to provide good passive support in weightlessness. 
The body has to be forced into such a position by use of a tight waist 
restraint. Secondly, these changes under weightlessness should be of 
interest to those making theoretical studies of postural mechanisms 
and the like and provide them with new data points. 
TABLE II. IN-FLIGHT POSTURAL CHANGES 
Relaxed 
Cause Effect 
Flexion of thoraco­ °Remova1 of anterior center °Pushes head anteriorlylumbar spine with of gravity with unopposed and inferiorly making
cervical curvature forces of vertebral new positionpreserved musculature 
Legs are semiflexed °Tilt of pelvis secondary to °Renders one-g seating
fleXion of spine - unbalan­ unsuitable for zero-g 
ced weightless legs with since body must work 
imbalance of resting muscle to maintain such 
forces positions 
Anns are elevated °Weightless arms with °This with flexion of back 
imbalance of ~esting puts anns and head in 
muscle forces unusual relationship for 
work or study 
Fluid shifts are of more importance. Although tissue fluid and blood 
shifts are so closely interrelated as to be difficult to separate, I 
feel something is ga"ined by treating them separately. Blood shifts 
occur rapidly; they begin seconds after change in forces but their long 
term effects may last months. 
Standing upright under one-g, veins and arteries below the heart have 
increasing hydrostatic pressure as the veins descend toward the feet 
where the force may be 80 to 100 mm Hg. Shortly above the heart, the 
venous pressure becomes zero and the vessels are virtually empty and 
at least partially collapsed. Under weightlessness, without this 
superimposed hydrostatic pressure, venous pressure, except for neglegi­
ble flow pressures, are the same throughout the body. Volumes are • 
now shifted only in response to the compliances, the tension if you
will, of the various areas of the venous systems. The result is that 
we have essentially central venous or right atrial pressure throughout 
the entire venous system. Veins such as head and neck which are 
normally empty, fill until their back pressure is equal to that of the 
pressure in, for example, a foot vein, which develops the same pressure 
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at a much smaller volume. When a subject stands from a lying position 
under one-g, a nominal 700 milliliters of blood goes into the legs 
and probably a comparable volume is shifted centrally. Most of this 
blood volume moves to that undefined "central volume" and produces a 
small increase in pressure with a probable effect of increasing cardiac 
output. 
A second result of the fluid shift produces results that are more 
obvious and therefore more easily to document. Certain body sensors 
detect this as an abnormally large volume and cause pla"sma to be re­
duced thus leaving high hemoglobin and hematocrits in the circulating 
blood. An as yet unknown sensor is activated to detect and reduce 
over a matter of weeks red blood cell production such that red cell 
mass becomes appropriate to the new volume. Such readjustment to 
altered volumes are also seen under one-g; for example, individuals 
with leg varicosities have increased blood volumes. I think that the 
reduced loss of red cell mass in the Skylab 4 Commander is further 
evidence of reduced leg venous volume. Table III illustrates this. 
TABLE III. FLUID SHIFTS 
Blood - Exposure to Weightlessness 
°Removal of hydrostatic forces produces essentially uniform 

pressure throughout venous system 

°Differing tensions throughout the venous system redistributes 
blood 
°Higher effective tension of leg veins force a quantity of 
blood out of the legs 
°Lower effective tension of head and neck veins accept a 
small volume of blood which increases pressure and 
distension 
°Remainder of blood increases central venous volume and 
pressure 
°Sensors reduce volume by reducing plasma volume 
°Unknown sensors detect "excessll red blood cells and reduce 

production until normal values are reached 

°Reduced blood volume is appropriate for effective reduction of 
total venous volume in weightlessness but inappropriate for one-g 
or one-g simulations 
°Increased filling pressure may increase cardiac output 
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On return to one-g, a reverse process ensues. After the first day
repeated blood tests show an anemia which is slowly replaced by an 
increasing red cell mass. These changes are delineated in table IV. 
TABLE IV. FLUID SHIFTS 
Blood - Reexposure to one-g 
°Hydrostatic pressures increase effective venous 
capacity by expansion of leg veins 
°Central volume and pressures are decreased 
°Plasma volume expands reducing hematocrit 
°Red blood cell production is resumed or increased 
until new equilibrium is reached 
Tissue fluid shifts are larger in volume than blood shifts but some­
what slower acting. For sentimental purposes, I must show my old 
campaign slide (fig. 13), poor as it is." When standing under one-g there 
is a hydrostatic column of up to 80 to 100 mm Hg pressure on arteries, 
veins, and capillaries in the foot; this is illustrated by the internal 
arrows. This pressure is opposed by tissue pressures and after a 
period of extravasation they equalize. Under weightlessness, the 
reverse occurs with resorbtion of fluid by the tissues until transmural 
pressures are again balanced. In the upper body areas and particularly
the head, we have the opposite effect from increased transmural 
pressure which produces edema. These processes are simultaneous. 
Tissue fluid shifts are delineated in table V. 
Omm He 
ONE-g ao mm He WEIGHTlESSNESS 
Figure 13. Fluid pressure/volume changes under weightlessness. 
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TABLE V. FLUID SHIFTS 
Tissue 
A. Below the heart: 
°Hydrostatic forces removed from blood column, venous and 
arterial, cause: 
increased transmural resorbtion from decreased pressure 
in legs with resultant rapid loss of fluid from legs, 
Reduction in tissue pressures in leg which may effect 
venous compliance. 
°Change in hydrostatic forces may be caused by small to moderate 
loss of fluid through diuresis or decreased intake. 
B. Above the heart: 
°Hydrostatic forces removed from blood columns and increased 
transmural pressures cause: 
edema to tissues of body above heart, 
possible effects on vestibular apparatus. 
Whether this shift of fluid produces an increase in intravascular 
volume or not depends upon how rapidly fluid is regained from some 
areas and lost to others. It is at least theoretically possible that 
fluid is lost more rapidly than it is gained, with a reduction of 
intravascular volume. I do not think this happens and expect there 
may be a very slight expansion of intravascular volume which, coupled 
with the blood from leg veins, may result in a small fluid loss via 
the Gauer-Henry scheme (increased atrial pressure and diu~esis), or 
some other mechanism. However, remember that tissue fluid shifts 
occur under one-g without undue diuresis. Legs are smaller in the 
morning and eys are puffy, and a shave lasts longer if made an hour 
or so after arising. 
Fluid shifts should be investigated as a possible participant in the 
vestibular upsets that have occurred. Time course and other aspects 
of these vestibular upsets are suggestive and I have no hard evidence 
for or against this. 
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SUMMARY 

In summary we have documented for the first time anthropometric changes 
and the correct magnitude and time course of fluid shifts under 
weightlessness that have implications for future human factors engineer­
ing and that explain some medical phenomena. More importantly these 
data provide a fundmental point of departure for future research. 
Bed rest studies for example have not properly considered such fluid 
shifts. We now have better criteria for evaluating the fidelity of 
weightless analogs such as bed rest and water immersion. .. 
Most importantly we again find the human body capable of making ·stable 
adaptation to two widely differing environments in an amazingly short 
time. In the course of these experiments, I think data has been 
offered to justify the title "Earth man - Space man". 
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Post Scriptwn 
During the Question and Answer session. Dr. Otto Gauer1s interesting 
comments and slides corroborated our findings with data from his 
independent research, hitherto unknown to us. These comments and 
reproductions of the slides have been included in the Panel Discussants 
portion. 
.. 
" 
658 

VECTORCARDIOGRAPHIC CHANGES DURING EXTENDED SPACE FLIGHT 
Raphael F. Smith~ M.D. '*; Kevin Stanton~ M.D. t; David Stoop~ M.D. t; 
Donald Brown~ M.D. t; Walter Janusz~ M.D. t and Paul King~ Ph.D. '* 
ABSTRACT 
To assess the effects of space flight on cardiac electrical properties, 
vectorcardiggrams wer~ taken on the 9 Skylab astronauts during the 
flights of 28, 59, and 84 days. The Frank lead system was used and 
observations were made at rest; during 25%, 50%, and 75% of maximum 
exercise; during a short pulse of exercise (150 watts, 2 minutes); 
and after exercise. Data from 131 in-flight tests were analyzed by 
computer and compared to preflight and postflight values. Statistic­
ally significant increase in QRS vector magnitude (six of nine crew­
men); T vector magnitude (five of nine crewmen); and resting PR 
interval duration (six of nine crewmen) occurred. During exercise the 
PR interval did not differ from preflight. Exercise heart rates in­
flight were the same as preflight, but ·increased in the immediate 
postflight period. No major changes in QRS, T, or ST vector direction 
occurred. There were sporadic (usually isolated) ectopic ventricular 
beats in-flight and one astronaut had a brief episode of ventricular 
tachycardia 21 days after the first mission. Conclusions: with the 
exception of the arrhythmias, no deleterious vectorcardiographic changes 
were observed during the Skylab missions. The increase in QRS and T 
magnitude resembles the electrocardiographic changes associated with 
athletic conditioning and may be related to increased ventricular 
volume secondary to centripetal shifts of fluid and/or the in-fljght 
isotonic exercise program. Prolongation of the PR interval at rest 
with normalization by exercise suggest that there was increased vagal 
tone in those crewmen exhibiting this response. 
INTRODUCTION 
The objectives of Skylab Experiment M093 were to measure electro­
cardiographic signals during space flight, to elucidate the electro­
physiological basis for the changes observed, and to assess the effect 
of the change on the human cardiovascular system. Vectorcardiographic 
methods were used to quantitate changes, standardize data collection, 
*Vanderbilt University, School of Medicine, Nashville, Tennessee 37232. 
tNaval Aerospace Medical Institute, Pensacola, Florida 32512. 
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and to facilitate reduction and statistical analysis of data. Since 
the Skylab missions provided a unique opportunity to study the effects 
of prolonged weightlessness on human subjects, an effort was made to 
construct a data base that contained measurements taken with precision 
and in adequate number to enable conclusions to be made with a high 
degree of confidence. Standardized exercise loads were incorporated 
"into the experiment protocol to "increase the sensitivity of the electro­
cardiogram for effects of deconditioning and to detect susceptibility 
for arrhythmias. 
Vectorcardiography provides a comprehensive, three dimensional approach 
to the analysis of electrocardiographic data which has proven to be 
useful in both clinical (1,2) and research applications (3,4).
Vectorcardiographic techniques have been utilized to quantitate electro­
cardiographic changes during bedrest experiments (4) and Keplerian 
parabola flights (5). In-flight vectorcardiograms were not obtained 
during the Mercury, Gemini, or Apollo missions, although preflight and 
postflight vectorcardiograms were obtained during Apollo 15, 16, and 
17. 
The purpose of this report is to describe the M093 experiment design, 
the data transmission system, data reduction methods, and to report 
the analysis of data from the three Skylab missions. 
METHODS 
Experiment Design 
Vectorcardiograms were taken at rest, during exercise, and after 
exercise in each crewman during preflight, in-flight, and postflight 
phases of the Skylab missions. Experiment M093 was designed primarily 
to obtain electrocardiographic data. In a second Skylab experiment, 
M171 Metabolic Activity, the Frank lead system (6) was applied for the 
purpose of obtaining electrocardiographic data during more strenuous 
exertion. In both experiments vectorcardiograms were obtained from 
the crewmen at rest for five minutes. In experiment M093 the subject 
exercised on the bicycle ergometer at a work load of 150 watts for two 
minutes; during M171 the subject exercised on the ergometer at levels 
equivalent to 25, 50, and 75% of his maximum aerobic capacity determ­
ined prior to the flight. The subject exercised for five minutes at 
each work load for a total of 15 minutes. After the single exercise 
load in experiment M093, vectorcardiograms were obtained for 10 minutes. 
In experiment M17l, postexercise vectorcardiograms were obtained for 
five minutes. The exercise profiles are depicted in figure 1 and the 
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ergometer is shown in figure 2. Mechanical problems in the orbital 
workshop during the early portion of Skylab 2 caused scheduling con­
flicts which resulted in the deletion of the M093 protocol during 
that fl i gilt. However, the r~093 protocol was performed throughout 
Skylab 3 and Skylab 4 . 
M093 
MI71 
ERGOMETER 
EXERCISE 150W 2 MIN 
RECOVERY 
, . 
" ",1 •••• 1" .1. 
o 5 10 15 20 
TI ME ( MINUTES) 
, , 
25 
Figure 1. Ergometer exercise profiles for Experiment M093 and 
Experiment M171. For the M171 protocol, the maximum 
aerobic capacity of each astronaut was determined prior
to the flight and the work levels were 25, 50, and 
75 percent of this value. 
Instrumentation 
Eight electrodes were applied to the crewmen in a modified Frank lead 
configuration. To lessen muscle noise during exercise, the lead system 
was modified by transferring the left leg electrode to the left sacral 
region since the potential difference between the left leg and the left 
sacrum is negligible. The resistor network proposed by Frank (6) was 
utilized to correct for the distortion of the cardiac dipole field that 
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Figure 2. 	 Orbital Workshop bicycle ergometer. The Experiments 
Support System and Vectorcardiographic subpanel can be 
seen in the background. The arrows show the positions 
of two electrodes of the Frank lead system. 
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results from the shape of the torso and the eccentric location of the 
heart in the chest. The output of the network is theoretically pro­
portional to the orthogonal components of the cardiac dipole. In 
the preflight period the electrode sites were marked on each crewman1s 
body by a small tattoo and immedi ate ly before the run the electrode 
site was prepared with benzalkonium chloride. The electrodes were 
well-type disks and a sponge impregnated with a conductive electrolyte 
gel served as an interface between the silver-silver chloride electrode 
and the skin. After attaching the electrodes to the body. the ground 
reference electrode was tested to determine if there was proper iso­
lation of the subject from the spacecraft ground. then each electrode 
was tested in sequence to determine the impedance of the skin-electrode 
interface. The electrode contact was considered to be satisfactory
if the impedance was less than 100 000 ohms. To prevent the electro­
cardiographic signals from exceeding the dynamic range of the recording 
system, the proper signal conditioner gain for each crewmen was 
determined prior to the flight and the appropriate switch position 
selected for the individual at the start of the experiment run. 
The signal conditioners had differential input with input impedance 
greater than 40 megohms. The frequency response of the signal con­
ditioners was flat from 0.14 Hz to 90 Hz, at 0.05 Hz and at lOa Hz 
the frequency response was less than 3 dB down from the flat portion 
of the frequency response curve. The harmonic distortion of the 
signal conditioners was less than one percent over the frequency rallge 
of the unit. The phase angle difference between vectorcardiographic 
amplifiers did not exceed one degree over the frequency rallge of the 
unit. The three vectorcardiographic channels were simultaneously 
calibrated by a 10 Hz square wave. The Experiment Support System con­
ditioned and distributed electrical power to experiment equipment, 
received experiment data in analog and digital form. displayed heart 
rate data for the crewmen, and routed analog signals to the Airlock 
Module telemetry system. 
The spacecraft recording and telemetry system consisted of two pulse
code modulation programmers, pulse code modulation interface box, a 
data storage and playback system, and remote multiplexers and signal 
conditioners. This equipment was located primarily in the Airlock 
Module. The system accepted analog signals from the vectorcardiographic 
amplifiers and arranged these data into binary coded words at a rate 
of 320 samples per second. Tape recorders were used to record data 
for delayed transmission to Lyndon B. Johnson Space Center. The units 
recorded reduced bit rate segments of the pulse code modulation out­
puts from the pulse code modulation programmer together with voice data 
from the crewmen. The recording speed was 1-7/8 inches per second 
lO.048 meters/second) and the tapes were played back 41-1/4 inches per 
second (1.05 meters/second) thus allowing four hours of data to be 
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transmi tted in 1 ess than 11 mi nutes. Data were transmi tted at I'greater­
than-real time ll rates during passes over receiving stations, a pro­
cedure referred to as data "dumps". Due to the volume of data from 
Skylab experiments it was necessary to compress the vectorcardiographic 
data and eliminate redundant samples. A zero order predictor algorithm 
was selected as the data compression technique. In essence, a digital
sample of a parameter was tested to determine if it differed from the 
value of the sample last transmitted. If there was no difference 
between the current sample and the previous sample, the value was 
considered to be redundant and not transmitted to L. B. Johnson Space 
Center. 
Computer Analysis Program 
The pattern recognition logic of the M093 program is based on a 
statistical method of identifying components of the vectorcardiogram 
rather than utilizing empirically derived fiducial values. The program
consists of a main program and 10 subprograms that scale and analyze 
the data. The main program initializes constants, enters identifying 
information, enters data pertaining to the length of calibration and 
length of experimental data, generates a digital filter, and serves 
as a control program for the subroutines. The subroutines compute 
scale factors from the calibration pulses, apply digital filtering,
define the baseline, determine onset and end of waves and segments, 
and generate a tabular and graphical output of vectorcardiographic items. 
An optional subroutine derives the 12 conventional electrocardiograms 
from the three orthogonal vector leads or derives any lead for which 
spatial coordinates are given. The following vectorcardiographic items 
are measured or calculated: 
o P, QRS, T duration; start and end time 
o P, QRS, T maximum voltage X, Y, Z leads; time of occurence 
o P, QRS, T vector loop length 
o P, QRS, T maximum vector magnitude, azimuth, elevation; 

time of occurrence 

o p, QRS, T ffi,lximum vector velocity; time of occure.nce 
o P, QRS, T, ST area X, Y, Z leads 
o P, QRS, T, ST spatial mean vector magnitude, azimuth, elevation 
o Ventricular gradient magnitude, azimuth, elevation 
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o 	 QRS instantaneous vector magnitude, azimuth, elevation at 

10 millisecond intervals 

o 	 Angle between spatial mean QRS-T vectors 
o 	 Slope and curvature ST segment 
o Heart rate 
A program for statistical analysis of intra-experiment data has been 
used in series with the M093 analysis program. The statistical program
provides tabular output and graphic displays of both standard statisti­
cal parameters and special statistical metrics for directional measure­
ments. 
Data Management 
For crew safety during the flights, the electrocardiographic signals 
from each experiment were examined within 24 hours for changes of 
clinical importance. Occasionally when the orbital workshop was in 
communications range and an experiment was in progress, electrocardio­
graphic signals were available for immediate analysis. However, due 
to the gaps in ground station coverage, in most cases the complete data 
from the experiment were not available until 12 to 24 hours following 
the run. An analog version of the lead transformation algorithm was 
available to convert the three orthogonal vectorcardiographic leads 
to a conventional 12 lead electrocardiogram. Combinations of electrical 
resistance were chosen to provide the best match between electrocardio­
graphic signals obtained from the standard clinical leads and the de­
rived electrocardiographic signals. Circuit boards were constructed 
for each astronaut and inserted into the synthesizing unit when an 
experiment was in progress. Figure 3a is an actual l2-lead electro­
cardiogram from the Commander of Skylab 2. Figure 3b shows the 12 leads 
that were derived from the vectorcardiographic signal. Microfilm copies 
of the computer analysis of experiment data were available within 
48 hours after the experiment was performed. These reduced data were 
reviewed and after inspection of an analog reconstruction, spurious 
values were deleted from the data base. 
RESULTS 
Vectorcardiographic parameters from 131 in-flight tests were analyzed 
by digital computer and compared to pre-fl"ight and postfliqht values. 
The vectorcardiographic items examined were heart rate, QRS duration, 
QRS maximum vector magnitude and direction, T maximum vector magnitude 
and direction, PR interval, QT interval, area of ST segment X lead, 
and the spatial angle between QRS and T mean vectors. 
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Figure 3a. 	 Conventional l2-lead electrocardiogram from 
Skylab 2 Commander. 
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Figure 3b. 	 Twelve lead electrocardiogram derived from 
Frank orthogonal leads. 
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A statistically significant increase in QRS maximum vector magnitude 
occurred in six of the nine crewmen. Crew trends plotted as a per­
centage change from the mean preflight value are shown for the three 
Skylab missions in figures 4, 5, and 6 respectively. Although crew 
trends were similar during the three Skylab missions, there were inter­
esting individual differences in the time course of the magnitude changes. 
Figure 4. 
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Figure 5. QRS vector magnitude during Skylab 3. 
668 
• 
.. 
SL4 CREW TRENDS: QRS VECTOR MAGNITUDE 
1.30 
1.20 
1.10 
0.90 
0.80 
T , , I I , I I I I , I I 
10 20 30 40 50 60 70 8084 
t 
MISSION DAY RECOVERY 
Fi gure 6. QRS vector magnitude dur'j ng Skyl ab 4. 
..... CDR 
.... SPT 
0--0 PLT 
For example, in some astronauts the increase in QRS maximum vector 
magnitude began in the preflight period as depicted in figures 7 and 8 
and in other crewmen the preflight increase was not evident, as shown 
in figure 9. It should be noted that the data points are spaced 
equally on the abscissa of figures 7, 8, and 9 although the actual 
time intervals between the experiments were not equal. The preflight 
data collection period for Skylab 2 was approximately six months; thus, 
the rate of QRS maximum vector magnitude increase was considerably 
greater during the flight than in the preflight period. The magnitude 
of the spatial T vector increased in five of the nine Skylab crewmen 
and although the increase was statistically significant, variation in 
the measurements was large. The angle between the spatial QRS and T 
mean vectors did not increase significantly in any crewmen during the 
flights and there were no major changes in QRS, T, or ST vector direction. 
The duration of the PR interval measured at rest increased in six of 
nine crewmen during the three flights and the crew trends for Skylab 3 
and Skylab 4 are shown in figures 10 and 11. However, the average 
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Figure 7. 	 Evolution of QRS vector magnitude change in the 
Commander of Skylab 2. Experiments are spaced 
equally on absicissa although the time intervals 
between the experiments were not equal. 
SL2 PLT 

QRS VECTOR MAGNITUOE 

1.50 
1.40 
1.30 
mV 1.20 ~ 
1.10 
1.00 ~ 
.90 
PREFLIGHT IN-FLIGHT POSTFLIGHT • 
I I I 
S 10 IS 20 
.. 
TEST NUMBER 
Figure 8. 	 Evolution of QRS vector magnitude change in 
the Pilot of Skylab 2. 
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Figure 10. PR interval duration during Skylab 3. Data plotted 
as percentage change from the mean preflight value. 
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Figure 11. PR interval duration during Skylab 4. 
PR interval in-flight did not exceed the clinical standard for the 
upper limit of normal (0.20 seconds) in any crewmen. During exercise 
the PR interval did not show a significant difference from the PR 
interval duration for comparable exercise in the preflight period. 
A significaht decrease in the resting heart rate was observed in the 
Skylab 2 crew during the flight. However. a significant change in 
resting heart rate was not a crew trend in the later missions. In 
general. the average heart rate during the third level of exercise. 
M171 protocol remained the same as preflight or tended to decrease 
slightly during the flights. In the immediate postflight period
there was a marked increase in the resting heart rate and heart rate 
response to a given exercise load. As an example. the heart rate 
responses during Skylab 4 are shown in Figures 12 and 13. 
The scalar analog reconstructions of the digital vectorcardiographic 
signals. the twelve-lead electrocardiograms obtained with the trans­
formation circuitry. and instantaneous vector loop displays were 
reviewed to check the technical quality of the data and to detect 
changes of clinical importance. During the three Skylab missions 
there were no ST segment abnormalities that suggested myocardial • 
ischemia or other changes in the configuration of the electrocardio­
graphic waveforms that were considered to be adverse. During the three 
flights cardiac arrhythmias were occasionally observed. The Commander 
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of Skylab 2 had multiple ventricular ectopic beats during the third 
level of exercise on the initial in-flight M171 test but no arrhythmias 
were evident in the exercise tests that the Pilot of Skylab 2 performed 
in the preflight period and during the mission. However, during the 
third level of exercise (M17l protocol) 21 days after recovery he had 
salvos of ectopic ventricular beats for approximately 1-1/2 minutes. 
A representative segment of the arrhythmia is shown in figure 14. The 
ectopic beats were considered to be ventricular in origin because 
because the initial beat in the salvo was often a ventricular fusion 
beat, the isolated ectopic beats did not alter the sinus rhythm, and 
the degree of QRS aberration was not clearly related to the coupling 
interval of the premature beat. Furthermore, the ectopic complexes had 
a monophasic configuration in lead Vl which suggests a ventricVlar 
origin for the arrhythmia. He was monitored for 72 hours, no arrhyth­
mias were detected and he has had no difficulty on subsequent heavy­
load exercise tests. 
The Scientist Pilot of Skylab 3 had premature ventricular beats 
sporadically during the second Sky1ab mission. On mission day 8 during 
a long extravehicular activity period he was noted to have 80 premature
ventricular beats over a 6-1/2 hour period of observation. These 
ectopic beats were isolated in occurrence and had a configuration 
suggesting a unifocal origin. This astronaut also had intermittent 
periods of atrioventricular junctional rhythm at rest throughout the 
flight. On mission day 21 the Commander of Skylab 3 had a three-beat 
run of atrioventricular dissociation presumably due to advanced 
atrioventricular block. The atrial rate was 50 and the junctional 
escape rate was approximately 39. The episode occurred during the 
recovery phase of experiment M092 and was not observed in later tests. 
The crew of Sky1ab 4 had premature ventricular beats sporadically 
throughout the mission. On mission day 43 the Commander had two 
consecutive ectopic ventricular beats during the third level of 
exercise M171 protocol and on mission day 83 he had three successive 
ventricular fusion beats during the first exercise level of an M171 
test. The Pilot of Skylab 4 had atrioventricular junctional rhythms 
at rest and after release of lower body negative pressure.· There was 
no impairment of function during the arrhythmia. 
DISCUSSION 
Elucidation of the mechanisms that underly the cardiac electrical 
changes is made difficult by the large number of uncontrolled environ­
mental and physiological variables that were operative during the 
Skylab flights. It is known that electrocardiographic changes occur 
when there are shifts in the anatomical position of the heart, with 
hypokalemia, with perturbations of the autonomic nervous system, with 
changes in the volume of intracavitary blood, and with physical 
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Figure 14. 	 ECG during arrhythmia experienced 21 days postflight by the Pilot of Skylab 2. 
The ECG was taken during exercise and six frontal plane leads are shown. The 
analysis of the arrhythmia is discussed in the text. 

conditioning and IIdeconditioning". These factors have either been 
shown to vary during space flight or alterations in these factors would 
intuitively be expected in a weightless environment. 
The increase in the magnitude of the QRS maximum vector is an 
especially interesting change because this has been a crew trend in 
each Skylab flight. In the majority of the astronauts the QRS maximum 
vector magnitude has progressively increased during the flight and in 
several the upward trend began prior to the flight. The T maximum 
vector magnitude also tended to increase but variation between 
measurments was greater. The changes observed during the Skylab 
flights differ from left ventricular hypertrophy encountered clinically 
in that the angle between the spatial QRS and T vectors was unchanged 
or decreased in the astronauts and with pathological left ventricular 
hypertrophy the angle characteristically increases. The QRS and T 
magnitude increase and the directional relationship between the QRS 
and T vectors resemble those changes seen in athletes whose electro­
cardiograms are followed during a physical conditioning program (7). 
Similarly in dogs given heavy exercise loads over a 12 week period, 
Wyatt and Mitchell observed a decrease in resting heart rate, a 
decrease in heart rate response to a standard work load, and an in­
crease in QRS spatial vector magnitude (8). 
Increased intracavitary blood due to the centripetal shift of volume 
during weightlessness may be another mechanism that contributed to 
the increase in QRS maximum vector magnitude. From a theoretical 
analysis Brody (9) predicted that an increase in intravavitary blood 
would augment potentials from radially oriented cardiac dipoles and 
attenuate those from tangentially oriented dipoles. Since the 
radially oriented dipoles have the most marked influence on the QRS 
vector, the net effect of increased diastolic volume would be to 
increase QRS vector magnitude. Millard, Hodgkin, and Nelson (10) 
using a series of physiological interventions in experimental animals 
have confirmed the validity of the Brody effect. Morganroth et aZ. 
(11) determined left ventricular volumes, wall thickness, and mass 
by echocardiograph in 26 actively competing college athletes. 
Athletes competing in events requiring strenuous isotonic exercise 
had increased left ventricular volume without increased wall thick­
ness and athletes competing in isometric events had increased wall 
thickness without increased left ventricular volume. Thus, centripetal 
shift of fluid and isotonic exercise may have had an additive effect 
in causing the increased QRS vector magnitude that has been observed 
during the Skylab flights. Measurement of cardiac diastolic dimensions 
by echocardiography during the preflight and postflight period of 
Sky1ab 4 suggested that there was a decrease in the transverse 
cardiac dimension on the first day after recovery in two of the three 
crewmen (12). However, after each mission the QRS maximum vector 
magnitude has remained increased for five to ten days. 
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An increase in the PR interval duration was a common observation during 
the three Skylab missions. The PR interval duration is a composite of 
the conduction time through intra-atrial pathways, the atrioventricular 
node, and the bundle of His. Since conduction in the atrioventricular 
node is longer than in the other components, for clinical purposes 
the PR interval duration serves as an estimate of atrioventricular 
node conduction. Although drugs such as digitalis, beta-adrenergic 
blockade, and nodal ischemia can cause prolongation of atrioventricular 
conduction time, an increase in vagal tone is a more likely explanation
of the prolongation of the PR intervals seen in the Skylab astronauts. 
Further support for this explanation comes from the observation that 
the PR duration during exercise in-flight was the same as the PR 
interval duration measured in the preflight period during comparable 
exercise. Thus the adrenergic influence of exercise tended to over­
come the increased vagal influence observed when the men were at rest. 
Ventricular ectopy occurred throughout the three Skylab missions. In 
general this was sporadic, did not alter hemodynamic function in 
a detectable manner, and electrocardiographic signs of myocardial 
ischemia were not associated. On three occasions the crewman involved 
was under extraordinary stress: the first in-flight M17l exercise test 
of Skylab 2, during a long extravehicular activity in Skylab 3, and dur­
ing the last in-flight M171 test in Skylab 4. In the case of the more 
serious ventricular ectopy observed in the Skylab 2 Pilot on the 
twenty-first postflight day, the relationship of the arrhythmia to 
the flight is conjectural. He had been in another city on the 
evening prior to the test and had returned to Houston early on the day 
of the test. No arrhythmias were observed during the 72 hours 
following the test and the exercise protocol has been repeated on 
multiple occasions and the arrhythmia has not recurred during the 
testing. 
With the exception of the arrhythmias, no adverse electrocardiographic 
changes were observed in the Skylab crews that could be attributed 
to long exposure to a weightless environment or to the other stresses 
of extended space flight. Specifically, there was no evidence of 
myocardial ischemia or changes in the electrocardiogram that would 
suggest vasoregulatory abnormalities or the emergence of patterns 
that have been observed in deconditioning experiments (4). The 
vectorcardiographic techniques utilized in the M093 experiment added 
both accuracy and precision to the data acquisition and facilitated 
both scientific investigation and monitoring for crew safety. 
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ABSTRACT 
Cardiovascular electromechanical measurements were collected on return­
ing Skylab crewmembers at rest and during both lower body negative 
pressure and exercise stress testing. These data were compared with 
averaged responses from multiple preflight tests. Systolic time 
intervals and first heart sound amplitude changes were measured. Clinical 
cardiovascular examinations and clinical phonocardiograms were evaluated. 
Postflight. in all crewmen there were significant changes in ejection 
time index, in pre-ejection period, and in the ratio, pre-ejection
period/ejection time. These changes were present at supine rest as 
well as during lower body negative pressure stress testing. All 
systolic time intervals had returned to preflight values within one 
month. There were decreases in first heart sound amplitude responses 
to lower body negative pressure by all Skylab 4 crewmen. This response 
was mar.kedly depressed in one crewman who had a presyncopal episode 
during the lower body negative pressure test on recovery day. 
Two of the three crewmen exhibited depressed first heart sound amplitude 
responses to submaximal exercise on the day after recovery. Skylab 4 
crewmen had altered systolic time intervals during upright rest and 
during exercise compared with preflight values. The systolic time 
intervals data were consistent with a reduced stroke volume and possibly
a reduction in contractility and/or Frank-Starling effect. 
Clinical cardiovascular examinations revealed a reduction in all heart 
sounds, reduction in precordial movement, and a marked reduction in 
arterial pulsations. Trace to one plus pretibial edema was noted in 
the Skylab 3 and Skylab 4 crewmen in the early postflight period. The 
causes for this transient edema are complex. 
The persistent alterations in the systolic time intervals in the face 
of a replenished blood volume and no consistent correlation with 
afterload or with change in leg volume during lower body negative pres­
sure suggest that there is a functional impairment to venous return and 
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perhaps a myocardial factor in the overall decreased tolerance to this 
stress in the postflight period. Systolic time intervals data collect­
ed during exercise support the above hypothesis and are consistent with 
decreased stroke volume. Clinical studies also support the contention. 
All changes noted returned to normal within 30 days postflight so 
that the processes appear to be transient and self limited. The 
cardiovascular system seems to adapt quite readily to zero-g, and more 
importantly it is capable of readaptation to one-g after long duration 
space flight. Repeated exposures to zero-g also appear to have no 
detrimental effects on the cardiovascular system. 
INTRODUCTI ON 
It is well known that after short duration space flights, such as the 
Apollo flights, crewmen exhibited cardiovascular instability in 
response to orthostatic and exercise stresses (l, 2). Although through 
preflight and postflight stress testing_several other physiologic 
variables associated with the decreased tolerance were documented, 
in-flight timing of the changes were impossible. The measurements were 
simple, e.g.~ electrocardiograph and blood pressure. There were wide 
unexplained interindividual variations between crewmen of the same 
flight and different flights in their responses to the tests. 
The Skylab program offered an opportunity to study man during long 
duration space flight. The medical test protocols were an established 
part of this program in the preflight, in-flight and postflight per­
iods. Because payload and flight qualified hardware were and are a 
high-cost portion of the NASA programs, there had to be a limit to the 
number of devices allowed for in-flight biomedical experiments. 
Devices and techniques which enhanced or embellished the core experiments 
in-flight were encouraged instead to be a part of the preflight and 
postflight evaluations. Therefore, most of these items were designed 
for testing "in the Skylab Mobile Laboratories and became an 'item on 
the preflight and postflight schedules. 
Devices and techniques for measuring and analyzing systolic time inter­
vals and quantitative phonocardiograms were initiated during Apollo 17, 
the last lunar mission. This first generation hardware was utilized 
as well for the Skylab 2 lTIission as part of the lower body negative
pressure experiment. The data show that the systolic time interval from 
Apollo 17 crewmen remained elevated longer postflight than the re­
sponse criteria of heart rate, blood pressure, and percent change in 
leg volume all of which had returned to preflight levels by the second 
postflight. Although the systolic time interval values were only 
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slightly outside the preflight fiducial (P<O.05) limits, this finding 
suggested that: the analysis of systolic time interval may help to 
identify the mechanisms of postflight orthostatic intolerance by 
virtue of measuring ventricular function more directly and, the non­
invasive technique may prove useful in determining the extent and 
duration of cardiovascular instability after long duration space flight. 
The systolic time intervals obtained on the Apollo 17 crewmen during
lower body negative pressure were similar to those noted in patients 
with significant heart disease.* Although similar changes in systolic 
time intervals occur with a decreased ventricular filling secondary to 
a decreased venous return in normal young subjects (3) and although a 
decreased blood volume was noted in the Apollo crewmen, a progressive 
myocardial deterioration during long exposure to zero-g could not be 
ruled out. Based on Apollo and Gemini experience, a firm stance was 
taken by the bi omedi ca1 sci enti sts that duri ng fl i ght da ily exerci se 
sessions would be provided for Skylab astronauts - the excerise was to 
be provided by an in-flight cycle ergometer. 
Postflight evaluations of systolic time intervals were accomplished 
after all Skylab missions. During Skylab 4 additional noninvasive 
techniques were allowed so that after this mission echocardiography, 
semi-bloodless (radioisotopically determined) circulation times and 
resting cardiac outputs, and peripheral venous pressure were performed.
Results from these techniques are presented in other papers of this 
symposium (4, 5). 
METHODS 
Genera 1 
Preflight examinations for the lower body negative pressure experiment 
(M092) were conducted over a four to ten month period prior to launch. 
The last three preflight tests were accomplished at F-30, F-15, and 
F-5 days, respectively. During these final baseline tests full data 
collections were performed including the systolic time intervals and 
absolute amplitude measurements. 
Postflight lower body ne9ative pressure test were performed with the 
few hou.rs of splashdown {recovery day tests). Both lower body negative 
pressure and the vectorcardiograph exercise tests were done on the day
after and on eleven days after recovery. Lower body negative pressure 
tests were done on several subsequent days after each Skylab flight up 
to two months postflight on Skylab 4. 
*(Unpublished results) 
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The lower body negative pressure protocol consisted of five minutes 
supine rest, 15 minutes of incrementally applied negative pressure 
to -50 mm Hg and a five minute recovery period. The Exercise­
Vectorcardiograph test included a five minute. rest period in the upright 
position, a two minute exercise period at 150 watts and a ten minute 
upright recovery period. The data presented in this paper will 
include only the control and end of maximal stress periods. 
Systolic time intervals were calculated from the vectorcardiograph 
X-lead, phonocardiogram, carotid pulse trace, and pneumogram during 
all three missions (fig. 1). However, data acquisition problems in 
the preflight period of Skylab 2 made the systolic time intervals data 
difficult to inerpret, and therefore these data are not presented. 
Also, for similar reasons quantitative phonocardiographic data from 
Skylab 2 and Skylab 3 are not available for this document. Amplitude
of the first heart sound (SI Amp) data during exercise and during 
lower body negative pressure stresses (preflight and postflight) are 
presented for Skylab 4 only. Systolic time intervals information is 
presented from Skylab 3 and Skylab 4 for lower body negative pressure 
and exercise stress tests. 
Equipment 
The following list of transducers, signals, and types of analyses are 
provided for a clearer understanding of the data. A more comprehensive 
description of the system used will be made available at a later date. 
Phonocardiographic System. The system used for phonocardiograms in­
cluded a 20 gram Elema EMT-25C piezo-electric crystal accelerometer 
transducer which is coupled with a high pass filter network of 25, 50, 
100, 200 and 400 Hz central frequencies (-12 dB roll off). The raw 
output from the transducer which has a high pass characteristic was 
recorded onto analog tape and sub$equently played back through a 
NASA-designed filter system for analysis. The analyzed signals were 
reproduced upon light sensitive paper at 100 mm/second using a 
Brush (Mark 2300) light beam recorder. 
Vectorcardiogram. The X-lead of a vectorcardiograph system was used 
for timing of electrical events of the heart and the characteristics 
of this system are described elsewhere (5). Tattoos on the crewmen 
insured reproducible placement of the electrodes. 
Pneumogram. A mercury-in-silastic strain gage was used to measure 
quantitative rate and qualitative depth of respiration. Used mainly 
to determine the phase of respiration the output was used in determ­
ining other measurements such as systolic time intervals. 
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Figure 1. Signals used to measure systolic time intervals. Note 
that PEP is calculated from the Q-S2 and ET measurements. 
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Carotid Pulse. A Sanborn/Hewlett-Packard APT-16 displacement trans­
ducer was used to measure carotid pulsations. This transducer had 
a flat frequency response from d.c. to approximately 60 Hz and has 
been shown to reproduce arterial pulses faithfully at high and low 
heart rates (7). 
Apexcardiogram. Apexcardiograms were collected on the Skylab 4 crew­
men only. The same displacement transducer used for the carotid pulsa­
tions was used for the apex cardiogram. 
Other Equipment. The Sky1ab blood pressure measuring system, Lower 
Body i~egative Pressure Device, leg volume measuring system, the cycle 
ergometer, vectorcardiograph, experiment support system, analog tape 
recorders, and the various other Sky1ab equipment are included in 
other documents or in other papers of this symposium. 
TECHNIQUES 
Systolic Time Intervals 
Systolic time intervals were measured in the following ~anner: signals 
from the vectorcardiograph (X-lead), carotid pulse, phonocardiogram, 
and pneumo9ram were recorded during the tests on analog tape (Ampex,
Model 1260). Replay and analysis of all signals were accomplished 
via a small computer with software developed jointly between the 
Cardiovascular Laboratory at the Johnson Space Center and the 
Massachusetts Institute of Technology. Corrections for heart rate 
were employed after Weissler, et aL. (6). Basically, the program user 
scanned the four data channels which had been digitized at 200 to 
1000 samples per second, and chose samples which met predetermined 
criteria (8). By use of movable cursors the systolic time intervals 
were determined semiautomatically. Computations were performed 
according to the program and the entire summary was stored. 
First Heart Sound Amplitude 
Absolute amplitude of the first heart sound was measured manually from 
the phonocardiographic signals. Because there is no standard refer­
ence such as voltage for phonocardiograms (as there is for electro­
cardiogram and vectorcardiogram) the stressed Sl Amp was always com­
pared with the contro) resting amplitude of the first heart sound of 
each individual for each test. Each individual served as his own 
control, both preflight and postflight. The microphone was placed
in the fourth left intercostal space just to the left of the sternum 
in all crewmen, during all tests. Amplitude of the first heart sound 
was expressed as a percent change from control state. In general, 
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20 consecutive beats were chosen in the control period of the exercise 
or Lower Body Negative Pressure test protocols, and the amplitudes 
of the first heart sound (SI) were measured in millimeters. At 
maximal steady state stress, ten consecutive beats were measured and 
compared with the control mean SI Amp. Comparison of the SI Amp at 
maximal stress was expressed as percentage change in amplitude from 
control. 
Clinical Evaluations 
In addition to systolic time intervals and SI Amp measurements clini­
cal cardiovascular examinations which included phonocardiography, 
apexcardiography, and carotid pulse analyses were performed. 'The 
results of these clinical evaluations are given in order to add more 
information about the postflight cardiovascular condition of the Sky­
lab astronauts. 
RESULTS 
Reports on the data from in-flight cardiovascular tests for the Skylab 
crewmen are contained in the papers being presented by Drs. R. L. 
Johnson, G. W. Hoffler, and R. Smith at this symposium. The following
results reflect only information from preflight and postflight 
studies which were conducted during the lower body negative pressure, 
and exercise-vectorcardiograph experiment (M093) experiments. 
Because the most extensive measurements were made on the Skylab 4 
crewmen, these data dominate the results and discussion. However, 
comparisons are made with the other Skylab missions and with Apollo. 
Lower Body Negative Pressure 
Figures 2 through 4 show the postflight systolic time intervals 
responses of the Skylab 4 (84 days) crewmen to lower body negative 
pressure over time. Heart rate was elevated postflight. 
In general, the results of the postflight tests show that there was 
no change in total electromechanical systole (Q-Sz), ejection time 
index was decreased at rest and during lower body negative pressure, 
and pre-ejection period and the ratio of pre-ejection period to 
uncorrected ejection time (PEP/ET) were both increased significantly. 
Table I shows the percent change in systolic time intervals post­
flight for Skylab 4 and Skylab 3 crewmen. It is clear from this table 
that Skylab 3 crewmen had greater increases in pre-ejection period 
and pre-ejection/ejection time than did the Skylab 4 crewmen. This 
finding was present at rest, at -50 mm Hg lower body negative pressure 
and for a longer duration postflight at rest and during maximal stress. 
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Figure 2. 	 Resting and lower body negative pressure (LBNP) stressed 
mean ejection time index (ETI) for all Skylab 4 Crewmen. 
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Figure 3. Resting and lower body negative pressure (LBNP) mean pre­
ejection period (PEP) for all Skylab 4 crewmen. 
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Skylab 4 crewmen. 
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TABLE I. 	 PERCENT CHANGE IN SYSTOLIC TIME INTERVALS DURING LOWER 
BODY NEGATIVE PRESSURE - SKYLAB 3 AND SKYLAB 4 CREWMEN 
Recovery Day, Percent Change From Preflight 
jo. 
PRE-EJECTION 
EJECTION PERIOD 
TIME PRE-EJECTION EJECTION 
SKYLAB (Q - S ) INDEX PERIOD TH1E 
r~ISSION TEST INDEX2 % % % 
,. 

REST NO CHANGE t 18 t 28
3 	 '" 7LBNP NO CHANGE 	 t 14 t 33'" 1 0 
REST NO CHANGE 7 t 15 t 204 LBNP NO CHANGE '" 7 t 10 t 28
'" 
All systolic time interval changes were back within preflight values by 
two to four weeks in all crewmen. Most resting systolic time intervals 
had returned within a week to 11 days. Most systolic time intervals 
at -50 mm Hg had returned by 9 to 16 days on Skylab 4. However, all 
three of the Skylab 3 crewmen had abnormal pre-ejection period/ejection 
time until the tests 31 days after recovery because of both abnormal 
ejection time interval and borderline high pre-ejection period during 
stress. 	 . 
Mean of the diastolic pressures (one determinant of systolic time 
intervals) for the Skylab 3 and Skylab 4 crewmen are shown in figure 5. 
Diastolic pressure tended to be elevated during the first or second day
after splashdown and then returned to preflight values; the Commander 
on Skylab 4 maintained an elevated diastolic pressure until 11 days 
after recovery. Also, the Pilot on Skylab 3 had an elevated diastolic 
pressure until 4 days after recovery. No crewman exhibited frank 
pathologic blood pressures during supine rest (control) phase of the 
lower body negative pressure tests. Stress heart rates had returned 
to preflight levels by the fourth day after recovery. 
Percent change in leg volume (fig. 6) during lower body negative pres­
sure was within preflight values on recovery day. With the exception 
of the Commander's test on the fourth day postflight. the Skylab 3 
crewmen's 	 response remained within baseline limits. The percent 
change in leg volume for two Skylab 4 crewmen (Scientist Pilot and 
Pilot) appeared to be elevated on day~ one to four after recovery, 
while the 	Commander's ~esponse was within preflight levels during this 
period. In spite of these findings the Skylab 4 crewmen regained
their preflight systolic time intervals more quickly than did the 
Skylab 3 crewmen; these findings will be addressed again in the discus­
sion. 
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The Sl Amplitude responses of all Skylab 4 crewmen were depressed 
post tlight as shown in figure 7. Figure 8 shows a typical Sl Amp 
response by the Skylab 4 Pilot preflight versus the day after recovery. 
Notice the progressive reduction in Sl Amp with increase in neqative 
pressure in the first postflight day test as compared to a preflight 
test. Heart rates are also shown in figure 8. 
During his recovery day lower body negative pressure test the Pilot's 
Sl Amp response fell to 30 percent, a value which during Apollo was 
uniformly associated with syncope (9). The Pilot exhibited presyncope 
during this recovery day test at approximately one minute into the 
maximal stress level. His Sl Amp response to lower body negative 
pressure was back to preflight limits only by 31 days postflig~t 
compared to 11 days postflight for the Commander and Scientist Pilot. 
Exercise Results 
Preflight systolic time interval responses to the two minute bout of 
exercise at 150 watts were typical of those reported by other workers 
(8, 10). Figures 9, 10, 11, and 12 reflect the Skylab 4 mean 
systolic time interval responses on the first and eleventh days post­
flight, compared with three preflight tests. Supine resting values 
were obtained from the lower body negative pressure test data which 
were collected approximately one hour before exercise. Compared to 
preflight responses the first day postflight test can be summarized 
as follows: Total electromechanical systole (Q-S2) corrected for 
heart rate (Q-S2}I increased and ejection time index decreased during 
upright rest and exercise by four percent in the Scientist Pilot and 
Pilot with the Commander showing no significant change in (Q-S2}I or 
in ejection time index. Mean pre-ejection period increased 15 percent 
at rest and increased 14 percent during excerise. The pre-ejection 
period/ejection time increased by 22 percent at rest and 26 percent 
during exercise compared with the preflight values. Table II shows 
individual crewmen results. 
TABLE II. PERCENT CHANGE IN STI - REST AND EXERCISE - POSTFLIGHT 
COMPARED WITH PREFLIGHT IN SKYLAB 4 
PEP 
CREWMAN STATE (Q-sz)I En PEP ET 
Corrmander Rest 
Exercise t t ~NC)NC) f f ~NCjNC t t 6 5 t t 19 18 
Scientist Rest t 4 f 4 t 22 t 24 
Pilot Exercise t 4 f 4 t 16 t 31 
Pilot Rest t 4 f 4 t 18 t 22 
Exercise t 4 f 4 t 22 t 30 
NC ~ No significant change 
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crewmen. 
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First heart sound amplitude responses to exercise of the individual 
Skylab 4 crewmen are shown in figure 13. The Commander had 
very litt1e if any change in the S1 Amp for given heart rate at 
150 watts postflight. The Scientist Pilot had a depressed S Amp 
response on the first day postflight, but an apparently normAl one 
on the eleventh day postflight. The Pilot's S1 Amp response was 
low compared with the other crewmen on two of the three preflight 
tests. His response appeared to be depressed further postflight with 
no differences between the first and eleventh day postflight tests. 
These data have not been analyzed statistically as of the writing of 
this paper so that full interpretation of this data is not possible 
at this time. No evidence for a training effect was apparent. 
Clinical Findings, Phonocardiography and Apexcardiography 
The crewmen of Skylab 3 and Skylab 4 were given thorough cardiovascular 
examinations which included phonocardiograms. Apexcardiograms were 
done on Skylab 4 crewmen only. Although fourth heart sounds (S4) were 
present on some crewmen preflight these sounds are not abnormal (11). 
All heart sounds were diminished postflight. Several crewmen had 
prominent S4 with exercise (12). However, even heart sounds and 
arterial pulsations obtained during exercise were attenuated in the 
immediate postflight period. By 11 day postflight these findings 
disappeared. Apexcardiography was normal preflight. Postfliqnt the 
point of maximal impulse was not palpable and no apexcardiograms could 
be obtained. This was true as late as the eleventh day postflight 
on Skylab 4 crewmen. This finding is consistent with the other data 
and probably reflects diminished ventricular action. 
One finding which was of concern at first, but which is now accepted 
as not being of clinical importance was trace to one plus pretibial 
edema in all crewmen. This finding appears to begin on day 1 or day 2 
postflight. The edema is usually iltrace" after one or two hours of 
ambulation. In Skylab 3 the edema lasted to day 16 postflight 
On Skylab 4 it was absent on day 18 postflight. Although the systolic 
time intervals data were abnormal and it is known that usually edema 
is a common sign of a compromised left ventricle, the causes for this 
postflight edema are probably more complex than those of pure cardiac 
dysfunction. 
The facies caused by cephalad fluid shifts, seen on television and in 
photographs which are so obvious during flight, are peculiarly absent 
within an hour after splashdown. It is interesting that the in-flight 
facies, described elsewhere appear quite similar to subjects who are 
studied in the head down tilt position (1). 
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Immediately postfliqht, the Skylab crewmen appeared to be relatively 
dehydrated and the skin on the face was wrinkled rather than being 
puffy and fluid filled. Clinically, it appears that the fluid is 
redistributed rapidly postflight, but the pattern of distribution is 
such that plasma volume (and blood volume) is not replaced immediately. 
This decreased blood volume is probably a major cause for abnormal 
systolic time intervals during the recovery day testing at rest and 
during lower body negative pressure stress (as is afterload). The 
Skylab 4 crewmen did not appear to be as dehydrated upon recovery 
as were the Skylab 3 crewmen. 
DISCUSSION 
Sytolic time intervals and 51 Amp data are difficult to interpret in 
man. Interpretation is even more difficult when some of the hemodynamic
variables are possibly unknown. However, a better interpretation of 
these data is possible if one knows the hemodynamic events which 
occur in response to a known stress (13, 14). The intervals of systole 
have been described and interpreted for certain stresses such as 
lower body negative pressure (3, 15, 16); and exercise (10, 8). The 
availability of additional information such as blood volume, diastolic 
or mean blood pressure, and posture are needed when one attempts to 
interpret systolic time interval information (8). The externally 
measured intervals have been shown to correlate quite well with those 
measured directly {17}. 
Actually there are two problems to the analysis of systolic time 
intervals and Sl Amp data. One problem involves accuracy of measuring 
the various parameters. Another, more difficult problem, is interpre­
tation of the obtained results. The data presented in this paper is 
subject to both of these problems. However, every attempt has been 
made to choose the proper transducers and recording equipment and to 
measure as accurately as possible the intervals and amplitudes. 
The systolic time interval data obtained from the 5kylab astronauts 
during the preflight period reflect good reproducibility of these 
measurements. During this controlled period the intervals do not vary 
a great deal as can be seen in figures 1 through 7 which present the .. 
results of the three preflight tests. Conversely, one recognizes
that the postflight, as well as in-flight, period is not nearly as 
controlled (18). However, the reproducibility of postflight from 
,
several missions allows some confidence that these data do represent
the responses of individuals after space flight. 
698 
The preflight (control) rest and lower body negative pressure data 
obtained from the Skylab astronauts are quite similar to the systolic 
time interval data obtained from younger men (3). The postflight 
systolic time interval data at rest and during lower body negative
pressure (especially on recovery day and days 1 and 2 post recovery) 
reflect changes one would expect from a decrease in total blood volume, 
but also from myocardial dysfunction (19, 20, 13, 21). In the face 
of a constant total electromechanical systole (corrected for heart rate) 
with a decreased ejection time index and an increased pre-ejection 
period one is presented with three possibilities, or combinations, 
to explain the results: 
o a decrease in preload, 
o an decrease in contractility, and/or 
o an increase in afterload (22). 
A decrease in preload was suggested by measurements of significant 
decreases in blood volume on all Skylab crewmen (5). lhere were 
deficits in both red blood cell mass and plasma volume. The blood 
volume is reportedly back to preflight levels by one week with some 
fluctuations in plasma volume although the red blood cell mass remains 
depressed for a longer duration (23). The decrease in preload 
associated with lower body negative pressure stress or with upright 
posture is well established (14, 16, 24). 
If decrease in absolute blood volume were the only factor influencing 
the systolic time interval findings after space flight one would expect 
the systolic time intervals to return to preflight values along with 
the blood volume repletion (24). However, this is not the case. The 
systolic time intervals remain abnormal for a longer period. Skylab 3 
crewmen took longer to return to baseline systolic time intervals than 
did the Skylab 4 crew although the decreased blood volume and the 
duration of 	this decrement were similar. The differences between the 
crews may be related to activities of the crewmen in-flight, e.g.~ the 
amount of exercise performed; or they may be related to postflight 
activities as well . 
• 	 The systolic time interval during lower body negative pressure stress 
remains abnormal longer than did the systolic time intervals at rest. 
This finding is not surprising since one goal of stress testing is to 
elicit cardiac malfunction when none is apparent at rest. Additionally, 
because the stressed systolic time intervals remained depressed after 
blood volume repletion, it could be argued that perhaps more blood is 
pooled at -50 mm, Hg postflight than is pooled preflight. Therefore, 
a decreased preload by virtue of increased pooling could account for 
~9 
the results of postflight lower body negative pressure induced changes 
in systolic time intervals. The percent change in leg volume does not 
support this hypothesis. The Skylab 3 crewmen exhibited abnormal 
systolic time intervals for one month after return although there was 
little deviation in percent change in leg volume during lower body 
negative pressure between preflight and postflight periods. No con~ 
sistcnt pattern of percent change in leg volume and systolic time 
interval response was noted for the Skylab 4 crewmen either (fig. 6). 
Afterload. a potent determinant of the intervals of systole, if con­
sistently elevated could cause the systolic time interval changes noted 
in the astronauts· postflight tests (22). The Commander of Skylab 4 
had significant elevation in diastolic pressure through day 11 post­
flight. The Pilot demonstrated a similar picture after Skylab 3. How­
ever. these crewmen did not differ in their systolic time interval 
responses to lower body negative pressure. or at rest. from the other 
crewmen of their respective missions. The systolic time interval 
response appears to be only partially accounted for by changes in after­
load with the exception of recovery day testing. A summary of these 
data are given in figure 5. 
Contractility. the other independent determinant of systolic time 
irtp.rvals (in particular pre-ejection period) (25. 22. 26) could be 
considered as a cause for the changes in systolic time intervals 
observed postflight. Patients with primary myocardial disease. as 
well as patients with other forms of chronic heart disease whose 
ventricles are abnormal. exhibit changes in systolic time intervals 
which are identical to those noted in Skylab crewmen postflight (22.
6. 13). However. these patients· hearts are usually enlarged. i.e.~ 
increased preload ;s a sign of the problem. Ejection fraction is quite 
low in these patients (20, 28). The total electromechanical systole 
(corrected for heart rate) of these patients are either normal or 
slightly prolonged. Althouyh preload is more than adequate. a condition 
which would be reflected by an abbreviated pre-ejection period. con­
tractility is decreased and pre-ejection period is markedly prolonged. 
The stroke volume is decreased as is the ejection fraction. the ejection 
time index is shortened. Consequently, pre-ejection period/ejection 
time is elevated in these patients. In compromised hearts. administra­
tion of a positive inotropic drug such as digitalis shortens the total 
electromechanical systole (corrected for heart rate) mainly by virtue 
of a decreased pre-ejection period. Ejection time index ;s either 
unchanged or prolonged. These systolic time intervals reflect the 
increase in contractility, stroke volume, and ejection fraction. No 
exact causal relationship can be applied to ventricular function. 
given a set of systolic time interval alone, because of the complex
variables. However. ancillary information makes their interpretation 
a valuable method for the evaluation of cardiac function. 
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The above example of how systolic time interval reflects cardiac 
function, although not directly applicable to the Skylab results does 
point out the kind of reasoning one must go through in order to 
intrepret a set of systolic time intervals. However, the astronauts 
could have had a slight decrease in contractility in addition to the 
decrease in preload. The systolic time interval responses to the 
exercise-vectorcardiograph test postflight reflect possible decreases 
in stroke volume which may be due to decreased left ventricular 
function (28, 21, 29). Significant increases in total electromechanical 
systole (corrected for heart rate) and pre-ejection period with de­
creases in ejection time index are consistent with myocardial decrements 
in the Skylab 4 crewmen in response to a 150 watt exercise challenge on 
day 1 postflight. Also, the systolic time intervals and first heart 
sound amplitude data obtaineu durlng post flight lower body negative 
pressure tests are suggestive of myocardial dysfunction, e.g., the 
recovery day test on the Pilot. This data is also suggestive of a 
bedrest response, where significant losses of blood volume exist and 
a myocardial factor could not be ruled out as a cause for cardiovascular 
decrements (30). We are confronted with the fact of a true decrement 
in performance without a clear indication that the decrement is due to 
a decrease in preload or to a mixture of decreased preload and decreased 
heart muscle function. Neurohumoral factors are also possible. 
Note 
Studies on the amplitude of the first heart sound during lower 
body negative pressure and exercise stresses provide analysis 
of ventricular function from a slightly differenct view. It 
had been shown as with systolic time intervals that during 
stress testing patients or animals with cardiac dysfuction 
show a lower increment in first heart sound amplitude than do 
normal organisms (31, 27, 29, 23, 33). First heart sound 
amplitude can be used as an index of cardiac performance, 
expecially during stress testing. 
In reviewing the data from Skylab 4 astronauts certain correlations 
are apparent between the systolic time interval and first heart sound 
amplitude data. For example, the first heart sound amplitude responses 
of the Pilot to lower body negative pressure and to exercise are quite 
similar. Of the Skylab 4 crewmen the Pilot exhibited the lowest in­
crement in first heart sound amplitude per increment in heart rate 
during the exercise tests on days 1 and 11 postflight. His first 
heart sound amplitude responses to lower body negative pressure was 
lowest and its return to preflight took longer than did the other two 
crewmen's responses. Resting value of ejection time index, an index 
of stroke volume, took longest to return of the Skylab 4 crewmen (day 11 
postflight). Lower body negative pressure stressed pre-ejection 
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period/ejection time was above preflight limits until day 18 post­
flight (the same, however, as the Commander). During postflight 
exercise on day one postfli~ht, pre-ejection period was 17 percent
and 6 percent higher than the Commander and Scientist Pilot, respec­
tively. Lengthening of total electromechanical systole (corrected for 
heart rate) and pre-ejection period/ejection time during this exercise 
stress was equal to that of the Scientist Pilot, but greater than 
these values in the Commander (4 percent and 12 percent). Also, on 
recovery day, when he exhibited a presyncopal episode during lower 
body negative pressure, the Pilot's first heart sound amplitude fell 
to 30 percent (25). His percent change in ejection time index was 
lowest and pre-ejection period highest of the crewmen during this test. 
These close correlations of systolic time interval and first heart 
sound amplitude responses to postflight stress testing add assurance 
that these techniques, each proven by direct methods to reflect 
ventricular function, point to a decrease in ventricular function as 
being a definite cause for the observed decrements in post flight 
orthostatic and exercise tolerance, whether or not peripheral mechanisms 
are responsible for the decreased ventricular performance. It is 
unfortunate that noninvasive methods are not available which can allow 
one to give an exact accounting of the specific roles played by the 
heart, the peripheral circulatory system, and neurohumoral systems in 
causing these decrements. Such techniques would certainly allow us 
to develop definite dose-response curves for cardiovascular counter­
measures during longer duration space flight. 
The postflight noninvasive measurements includinq echocardiography (4),
which were accomplished at rest and during stress testing on Skylab 4, 
present as near complete a picture of cardiovascular status as was 
possible to obtain. Furthermore, the additional accuracy which might 
have been provided by invasive methods may well have lead to less con­
clusive results on several experiments if complications of these in­
vasive procedures had occurred. To our knowledge, no measurements made 
on any of the Skylab crewmen including stress testing had any affect 
on the natural course of readaptation to one-g. 
CONCLUSIONS 
Although much of the decrement in cardiovascular functioning seen post­
flight is due to decreased blood volume, there is evidence in the 
systolic time interval, first heart sound amplitude, and clinical data 
to suggest that there was at least a functional impediment to venous 
return and possibly a myocardial factor as well. Whatever the causes, 
the impairments were not of gross pathologic porportions. If ability 
to take care of oneself is considered, the astronauts appeared to be 
quite capable of this task postflight. 
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Systolic time intervals and phonocardiographic data, at rest and during 
stress, indicate that decrements in cardiovascular function are not 
related necessarily to mission duration. However, this statement must 
be interpreted with the knowledge that each crew was handled slightly 
different. For example, on the longest mission much more time was 
alloted to various exercises than on the 28 or 59 day missions. 
Functional impairment of the cardiovascular system as a result of space 
flight appears to be self limited. Readaptation to one-g is complete 
and probably requires one to two months. Many readaptations including 
systolic time interval and first heart sound amplitude responses to 
lower body negative pressure and submaximal exercise require less time. 
The use of noninvasive techniques to study the cardiovascular responses 
after space flight is useful in determining hemodynamic changes quanti­
tatively over time. Such techniques would definitely be worthwhile 
during zero-g exposure of future missions in order to define cardio­
vascular status from first exposure to steady state adaptations.
Sensitive noninvasive techniques coupled with ground based analogs of 
weightlessness would serve to establish dose-response curves for the 
cardiovascular system so that exact countermeasures could be used 
operationally during the Space Shuttle era and beyond. 
Supplemental Comments Regarding Cardiovascular Adaptations 
It is difficult to discuss the preflight and postflight finding of 
Skylab without speculating on what happens to the body upon exposure to 
zero gravity and upon the ensuing adaptations the body makes to this 
environment. It is equally difficult to discuss the postflight
findings without speculating on the condition of the body during long 
duration space flight just prior to, during, and upon entry into the 
Earth's gravitational field. Comments in this section will be limited 
to cardiovascular responses. 
Upon entry into the zero-gravity environment the right heart is pro­
vided with an increased venous return by virtue of the lack of a gravity 
field and the relatively abundant capacity of the upper body vasculature. 
The abundance of blood available to the heart under these circumstances 
must lead to an increase in cardiac output as the healthy heart ejects 
as much blood as it is presented. The increased right ventricular 
filling may be partially compensated for by an increase in pulmonary 
blood volume, but at some filling pressure is channeled directly to the 
left ventricle, creating an increase in Starling Effect (increased 
preload). If no exercise is performed, the oxygen needs of the body 
are easily satisfied by the increased cardiac output compared with one-g 
and heart rate decreases as the adrenergic stimuli subside in the wake 
of a daily routi~e, which is established after launch. It is of interest 
that a progressive decrease in heart rate was noted during Apollo missions. 
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During exercise as on the Skylab cycle ergometer the first few trials 
are likely to be awkward secondary to lack of zero-g experience. There 
is probably a decreased mechanical efficiency until the crewman learns 
how to master the zero-g induced difficulties of holding on and pedal­
ing. Once these mechanical problems are mastered, however, the zero-g 
environment allows one to accomplish higher workloads than was possible 
during one-g cycle ergometry because the venous return is increased 
and the problems of supine exercise in one-g are absent. Oxygen 
consumption is increased also because the arms playa more active role 
during zero-g exercise on the ergometer as the crewman begins to work 
against his arms. 
An increase in ~02 Max is recognized generally as reflecting a training
effect. However, in zero-g an increased QO Max must be interpreted 
with caution. Use of the arms contributes to V0 2 . Also, the increase in cardiac output caused by the increased availaDility of blood in 
zero-g wil] cause the appearance of a training effect by causing an 
increased V0 2 and allowing greater work capacity. 
Fixed submaximal work loads (from one-g testing) present less of a 
challenge in zero-g (once learning has occurred) by the above mecha­
nisms, which mimic a training effect, so that such parameters as heart 
rate and blood pressure are decreased compared with one-g testing. The 
recovery heart rate is also decreased since blood from the working
muscles is returned more quickly in zero-g and does not stagnate as 
happens in one-g in the upright position. The rapid return of heart 
rate after exercise is a common finding after a training effect, and 
one could reach this latter conclusion if not aware of the possible 
behavior of body fluids, and especially blood, in zero-g. 
Exercise induced increases in blood pressure apparently do not signifi­
cantly effect any symptoms of increases in intercranial pressure.
Crewmen failed to recognize any di-fferences in head fullness during 
isometric as opposed to dynamic exercise although both were used 
frequently during each in-flight day. It is known, however, that 
by comparison with dynamic exercise, isometric exercise causes a much 
greater increase in both systolic and diastolic pressure with only 
small increments in heart rate. The dynamic exercise, rather than 
causing an increase in the symptom of head fullness, actually caused 
relief of this symptom. Additionally, the secondary effects of the 
cephalad fluid shifts, i.e., nasal and sinus congestion were also 
abated by strenous dynamic exercise. The mechanisms for relief of 
these symptoms are probably related to redistribution of the cardiac 
output to the exercising muscles (arms and legs) and to an outpouring 
of vasoactive catecholamines which constrict mucosal blood vessels 
and reduce mucosal tissue swelling. 
• 

In contrast to exercise responses, the lower body negative pressure test 
;s more stressful in zero-g than in one-g (1). Blood volume may be 
decreased, plus the crewman is forced deeper into the Lower Body 
Negative Pressure Device by lack of gravity. Crewmen quickly discover 
this discrepancy and learn how to make the stress more comparable to 
the one-g tests (1). Although of no clinical importance several 
crewmen noticed the recoil from the heart's contractions. This sensa­
tion is more apparent in the head and neck during complete relaxation. 
Ballistocardiography could be more useful in zero-g. 
{ Postflight, there are definite decrements in the ability of the 
cardiovascular system to withstand orthostatic and metabolic stresses. 
These decrements can be measured (24, 34, 19). There is an immediate 
decrement in exercise performance to a given workload (35. 36, 2). 
l~axima1 aerobic capacity was not evaluated postflight although the 
M17l experiment utilizes moderate to heavy workloads. Decreases in 
ability to perform heavy exercise such as jogging may be depressed for 
several weeks postflight. At least part of this lag time is due to 
postflight schedules and to weakened musculoskeletal structures. 
Orthostatic intolerance has already been discussed (1). The crewmen 
are usually surprised by the decreased stress of this test postflight
compared to in-flight sensations. 
In the postflight period readjustment to one-g probably beqins with 
the opening of the parachutes. The cardiovascular decrements noted 
shortly after this time probably are related to a decrease in absolute 
blood volume, a functional impairment to venous return (which lasts 
beyond the volume deficit) and possibly to a transient primary myocardial 
dysfunction. Fortunately, the decrements appear to be transient and 
self-limited. 
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EFFECT OF PROLONGED SPACE FLIGHT ON CARDIAC FUNCTION AND DIMENSIONS 
Walter L. Henry, M.D.; Stephen E. Epstein, M.D.; James M. Griffith, 
Robert E. Goldstein, M.D.; and David R. Redwood, M.D. 
National Institute of Health, Bethesda, Maryland 
ABSTRACT 
Echocardiographic studies were performed preflight 5 days before launch 
and on recovery day and 1, 2, 4, 11, 31 and 68 days postflight. From 
these echocardiograms the following measurements were made: 
o left ventricular transverse dimension at end-diastole, 
o left ventricular tranverse dimension at end-systole, 
o ventricular free wall thickness at end-diastole. 
From these primary measurements, left ventricular end-diastolic volume, 
end-systolic volume, stroke volume, and mass were derived using the 
accepted assumptions. Preflight measurements in the Commander revealed 
the left ventricular end-diastolic volume, stroke volume, and mass to 
be at the upper limit of normal, while those of the Scientist Pilot 
and Pilot were increased significantly above the normal range. These 
findings in the Scientist Pilot and Pilot resemble those seen in 
trained distance runners. Wall thickness measurements were normal in 
all three crewmembers preflight. Postflight basal studies were 
unchanged in the Commander on recovery day through 68 days postflight
In both the Scientist Pilot and Pilot, however, the left ventricular 
end-diastolic volume, stroke volume, and mass were decreased slightly.
These decreases were noted on recovery day through 11 days postflight 
but had returned to near normal by 31 days postflight. Wall thick­
ness measurements were unchanged. Left ventricular function curves 
were constructed for the Commander and Pilot by plotting stroke volume 
versus end-diastolic volume. In both astronauts, preflight and 
postflight data fell on the same stright line demonstratlng that no 
deterioration in cardiac function had occurred. These data indicate 
that the cardiovascular system adapts well to prolonged weightlessness 
and suggest that alterations in cardiac dimensions and function are 
unlikely to limit man's future in space. 
INTRODUCTION 
Future space programs call for the exposure of man to prolonged periods 
of weightlessness. From previous NASA studies of astronauts returning 
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from relatively brief duration space missions, it is clear that pro­
found but apparently reversible changes occur in various body functions. 
However, the effects of prolonged weightlessness on cardiac structure 
and function is largely unknown. Several observations have raised the 
suspicion that the heart might be affected adversely. These include: 
o 	 heart size - as detprmined radiographically the heart is smaller 
immediately postflight as compared to preflight, 
o 	 postural hypotension - occurs early postflight, and 
o 	 compared to control preflight studies, cardiac output during 

exercise often is reduced shortly after splashdown (1). 

One of the problems in assessing the significance of diminished heart 
size, P9stural hypotension, and reduced exercising cardiac output 
is that space flight results in a decreased blood volume and this may 
cause a diminution in cardiac filling. Since the magnitude of most 
parameters of cardiac function is dependent on left ventricular end­
diastolic volume (i.e.~ left ventricular end-diastolic fiber length),
deviations from normal, without reference to existing left ventricular 
end-diastolic volume, may merely reflect diminished cardiac filling 
rather than a primary aberration of cardiac function (2). By taking
advantage of the capabilities of echocardiography to measure non­
invasively left ventricular volume, stroke volume, and ejection
fraction, (3-8) and of the fact that the astronauts were routinely
subjected to lower body negative pressure (whereby cardiac filling is 
progressively decreased), we were able to construct classic ventricular 
function curves noninvasively, thereby obviating the difficulties 
encountered in comparing cardiac function at different end-diastolic 
volumes preflight and postflight. In this manner, the effect of an 
84-day period of weightlessness on cardiac structure and function was 
evaluated in the Skylab 4 astronauts. 
METHODS 
Equipment and Technique 
Studies were performed with a standard transducer (2.25 megahertz, 10 
centimeter focus, 1.25 centimeter diameter), and a modified commercial 
ultrasound unit. The ultrasound signal was connected via a custom-
built video amplifier to a strip-chart recorder and recorded continuously 
on light-sensitive paper. The T-scan technic was used to visualize 
the ventricular septum and posterobasal left ventricular wall (9).
The thickness of ,the ventricular septum was measured inferior to the 
distal margins of the mitral leaflets. Posterobasal left ventricular 
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free-wall thickness was measured with the transducer oriented so that 
part of the ultrasound beam was reflected from the posterior mitral 
leaflet. Both thickness measurements were made just before atrial 
systole. Left ventricular transverse dimensions at end-diastole and 
end-systole were measured using the T-scan technique to identify 
ma ximum transverse dimension just caudal to the tip of the mitral 
leaflet (fig . 1). Left ventricular volumes were estimated by cubing 
the left ventricular transverse dimensions (3-5). Stroke volume was 
calculated by subtracting the end-systolic volume from the end-diastolic 
volume while ejection fraction was determined by dividing stroke volume 
by end-diastolic volume (3, 4). Left ventricular mass was calculated 
by the method of Troy et al . (10). 
PR-PLT­
S-LBNl' 
, . . 
Control (Pre) 
Figure 1. Measurement for left ventricular dimensions at 
end-diastole and end-systole, Skylab 4. 
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Study protocol 
Echocardiographic studies were performed with each Skylab 4 astronaut 
supine and rolled slightly onto his left side. Data were collected 
preflight on day 5 and postflight on recovery. day and days 1, 2, 4 
11, 31 and 68. On each of these days a standard procedure was followed. 
First, control measurements were made prior to the standard protocol 
for application of lower body negative pressure. The same measurements 
were repeated five minutes after the end of the standard lower body
negative pressure protocol, and successively followed by an echo 
devoted lower body negative pressure study which consisted of seven 
consecutive 1-1/2 minute periods. Control values were obtained during 
the first period. The middle five periods occurred during the applica­
tion of an increasing amount of lower body negative pressure, beginning 
with -8 mm Hg, proceeding through -16 mm Hg, -30 mm Hg, -40 mm Hg,
and ending with -50 mm Hg. A post lower body negative pressure 
1-1/2 minute control period followed the release of the -50 mm Hg
negative pressure. Echocardiographic data were recorded during the 
final 30 seconds of each period. The echocardiograms from each astro­
naut were randomized and coded so that the investigator who derived 
the dimensions was unaware of the day the data were collected. In 
addition to the echocardiographic data, systemic blood pressure (ob­
tained with an automated sphygmomanometer system) and heart rate were 
recorded. 
RESULTS 
Control Values 
Figure 2 is a plot of the estimated left ventricular volume at end­
diastole in milliliters versus time in days for all three astronauts. 
Preflight, the Scientist Pilot and Pilot had volumes that were above 
the normal upper limit of 141 milliliters; immediately postflight, 
the left ventricular end-diastolic volume was reduced by 15 percent
in these same two astronauts. This reduction persisted through day 11 
postflig~t but had returned to near preflight values by the post­
flight 31-day study. Left ventricular end-diastolic volume was 
altered little in the Commander. 
Preflight left ventricular wall thicknesses were as follows: Com­
mander: septum 10 millimeters, posterior wall 11 millimeters; Pilot: 
septum 10 millimeters, posterior wall 10 millimeters; Scientist Pilot: 
septum 11 millimeters, posterior wall 11 millimters. These values were 
all within the normal range of 9 to 12 millimeters and were unchanged
postflight. 
714 

.... 
... 
200 
';; 
, 150 
[] 
A 
o 
=;;;~=t--==-=-==-;::.:="----------------------:[] 
···· ... ~·:::::: ....t::J:::Jil[]~--A<,.-----------A 
···IJIi.~-A----
...,...=-:.::-.:---Im-o-o----- -­ - - - - - - -­ - -­
······0·· -0,---------0 
R+O 5 10 
SPLASHDOWN 
Commander -0 
Scientist Pilot-a 
Pilot _6 
50 60 70 
PREFLIGHTI-- 84 DAY --1_..0--­___ 
MISSION - I POSTFLIGHT - DAYS "I 
Figure 2. Estimated left ventricular volume at end diastole in 
mililiters VB. time, Skylab 4. 
Figure 3 is a plot of estimated left ventricular mass in grams versus 
time in days for the three Skylab 4 astronauts. Preflight, all three 
were at or above the upper normal limit. Postflight, on recovery 
day the mass was slightly (8 percent) reduced in the Scientist Pilot 
and Pilot. These reductions persisted through day 11 postf11ght but 
had returned toward the preflight values by the thirty-first day
postflight. 
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in grams VB. time 
Stroke volume in milliliters per beat is plotted versus time in days 
for all three Skylab 4 crew members in figure 4. Compared to normal 
values, the preflight volume of the Scientist Pilot and Pilot were 
significantly elevated, while that of the Commander was within normal 
limits. Postflight, stroke volume diminished in the Scientist Pilot 
and Pilot and was unchanged in the Commander. The reduction in stroke 
vol ume persi sted through day 11 postfl ight but had returned to near 
preflight values by 31 days postflight. 
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Figure 4. 	 Stroke volume in milliliters/beat VB. time in days, 
Skyl ab 4. 
Lower Body Negative Pressure Data 
Satisfactory echocardiographic data were obtained during the echo­
devoted lower body negative pressure protocol for the Commander and 
Pilot but not for the Scientist Pilot (tracings from the Scientist 
Pilot were of marginal quality, probably due to chest wall configura­
ti on ). 
Figure 5 is a plot of the left ventricular end-diastolic volume (solid 
line) and the stroke volume (dotted line) at the various levels of 
lower body negative pressure for the Pilot preflight. Similar curves 
were constructed for the Commander preflight and for both the 
Commander and Pilot postflight. 
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Figure 5. 	 Left ventricular end-diastolic volume and stroke vol­
ume at the various levels of lower body negative 
pressure, Pilot of Skylab 4. 
Using these data. ventricular function curves were constructed by 
plotting left ventricular end-diastolic volume versus stroke volume 
for the Commander (fig. 6) and the Pilot (fig. 7). Preflight values 
are shown by the solid lines and the immediate postflight data by
the dotted lines. These figures illustrate that no deterioration in 
ventricular function occurred since the preflight and postflight
data fallon the same straight line. 
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DISCUSSION 
The results of the present investigation demonstrate that small but 
significant decreases in stroke volume occurred in two of the three 
Skylab 4 astronauts immediately following an 84-day period of weight­
lessness. Although this could be interpreted as an impairment of 
cardiac function, echocardiographic measurements demonstrated that 
left ventricular end-diastolic volume also was slightly diminished 
postflight in the same two astronauts. Since end-diastolic volume is 
an important determinant of stroke volume, it is obvious that compari­
sons of parameters of cardiac performance must be made at comparable 
end-diastolic volumes. vJhen this was done (by constructing ventricular 
function curves), it was clear than no significant alteration in 
cardiac function occurred in any astronaut. I~oreover, the small 
decreases in left ventricular end-diastolic volume, stroke volume and 
left ventricular mass that did occur were demonstrated to be reversible 
postflight over a 30-day period. 
It is interesting to speculate on the mechanism of the alterations in 
left ventricular volume and mass seen in the Skylab 4 astronauts. One 
mechanism that could account for the dimensional changes is the pro­
found change in plasma volume that occurs with weightlessness (1). 
The mechanism undoubtedly explains at least some of the changes ob­
served in left ventricular end-diastolic volume. However, it is 
possible that other factor(s) are involved. Of interest, the two 
astronauts (Scientist Pilot and Pilot) in whom decreases in left 
ventricular end-diastolic volumes were observed had end-diastolic 
volumes preflight that were significantly'greater than the usually 
accepted normal range. In this regard, echocardiographic data of the 
Sr.ientist Pilot and Pilot were very similar to those seen in trained 
athletes involved in endurance events ~.e'3swimmers, runners} (11) in 
that the echocardiograms of such athletes reveal a dilated, nonthick­
ened left ventricle that ejects an increased stroke volume. In 
contrast, the left ventricular end-diastolic volume and stroke volume 
of the Commander were at the upper limits of normal. Of note, the 
Scientist Pilot and Pilot ran much longer distances during their pre­
flight training than the Commander. If these differences in cardiac 
dimensions are due to the differences in the amount of preflight
distance running performed by the three astronauts. then it is possible
that at least some of the changes seen immediately following the 84-day 
space mission merely reflect the inability to continue distance 
running while in space. It should be emphasized that despite the 
decreases in left ventricular dimensions observed in the Scientist 
Pilot and Pilot immediately postflight. their echocardiograms post­
flight were still in the trained athlete range, and the Commander was 
still at the upper limit of normal. That more striking changes did 
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not occur may be at least partly a result of the bicycle exercises 
performed in space during the 84-day mission. 
While the results of the present study cannot be extrapalated to 
longer duration space missions, it is clear that 84 days of weight­
lessness did not produce any deterioration in cardiac function. More­
over, the changes in cardiac volume and mass observed were minimal 
and reversible. The data indicate that the cardiovascular system 
adapts well to prolonged weightlessness and suggest that alterations 
in cardiac dimensions and function are unlikely to limit man's future 
in space. 
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RESULTS OF SKYLAB MEDICAL EXPERIMENT M17l -- METABOLIC ACTIVITY 
E. L. Michel*~ J. A. Rummel, Ph.D.*~ C. F. Sawin, Ph.D. ~J 
M. C. Bude~e~, Ph.D.t~ and J. D. Lem* 
ABSTRACT 
The experiment was conducted to establish whether man's ability to 
perform mechanical work would be progressively altered as a result of 
exposure to the weightless environment of space flight. The Skylab 
crewmen exercised on a bicycle ergometer at workloads approximating 25, 
50, and 75 percent of their maximum aerobic capacity. The physiological 
parameters monitored were respiratory gas exchange, blood pressure, 
and vectorcardiogram/heart rate. The results of these tests indicate 
that the crewmen had no significant decrement in their responses to 
exercise during their exposure to zero gravity. Immediately after the 
flight, however. all crewmen demonstrated an inability to perform the 
programed exercise with the same physiological effectjveness as they did 
both before flight and in-flight. The most significant changes were 
elevated heart rates for the same workload and oxygen consumption 
(decreased oxygen pulse). decreased stroke volume. and decreased cardiac 
output at the same oxygen consumption level. It is apparent that some 
adaptive change~ in physiological function must have occurred in flight, 
but these did not become evident until the crewmen attempted to readapt 
to the one-g environment. 
The results of the third manned Skylab mission (Skylab 4) are presented 
and a comparison is made of the overall results obtained from the three 
successively longer Skylab manned missions. The Skylab 4 crewmemhers' 
84-day in-flight respones to exercise were no worse and were probably 
better than the responses of the crewmen on the first two Skylab 
missions. Indications that exercise was an important contributing 
factor in maintaining this response are discussed. 
As stated previously, an immediate postflight readaptation period 
was observed in all crewmen during which a decrement in response to 
exercise was evident. This period was of a short duration, was not 
intensified by the duration of the mission, and resulted in no lasting 
*National Aeronautics and Space Administration - Lyndon B. Johnson 
Space Center, Houston, Texas. 
tLife Sciences Division, Technology Incorporated, Houston, Texas. 
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effects. It appears that the observed responses are a result of a 
decreased venous return caused by an altered fluid balance/blood volume 
state as well as a possible reduction in vascular tone of the venous 
system. 
INTRODUCTION 
When the metabo1 i cacti vity experi ment was fi rs t submitted for cons i d­
eration in the proposed medical investigations associated with the 
Skylab Program, it was hypothesized that man's ability to do work would 
be compromised as a result of exposure to the weightless environment 
of space flight. At that time ground-based bed rest studies were the 
only data to support this hypothesis (1, 2, 3, 4). Exercise response 
tests conducted on some of the Gemini crewmen about this same time 
indicated trends but showed no statistically significant alterations 
postflight as compared to preflight. The Gemini Program postflight 
tests were conducted approximately 24 hours after splashdown when the 
crews returned to J. F. Kennedy Space Center. It was not until the 
Apollo Program that we were able to document a significant decrement 
in the crews' postflight response to excerise (5, 6, 7). During the 
Apollo Program, operational constraints were modified to permit post­
flight medical testing of the crew on board the recovery aircraft 
carrier within two to eight hours after splashdown. Twenty of the 27 
Apollo crewmen tested exhibited a statistically significant decrease in 
their tolerance for exercise. Although this response was reversible 
within 24 to 36 hours, it became obvious that man could not be com­
mitted to long-duration space flight until the magnitude and time 
course of these changes could be established and the underlying physio­
logical mechanisms understood. The eventual acceptance of theM-17l 
metabolic activity experiment for all three Skylab Missions provided 
us with an opportunity to attempt to do this. The primary objective 
of the experiment was to determine whether man's metabolic effective­
ness in doing mechanical work was progressively altered by exposure 
to the space environment. The secondary objective was the evaluation 
of the M-17l bicycle ergometer as an in-flight crew personal exerciser. 
The results of the first (Skylab 2) and second (Skylab 3) manned mis­
sions have been reported in detail previously (8, 9), This manuscript 
will report the results of the third (Skylab 4) manned mission and 
then attempt to summarize what has been learned from all three Skylab 
Missions about the physiological response to exercise during and after 
periods of 28 days, 59 days, and 84 days of weightlessness. 
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MATERIALS 
A detailed description of the experimental hardware has been reported 
(8). The main items of hardware associated with the performance of 
the M-17l experiment are shown in figure 1 and include the bicycle 
ergometer, the metabolic analyzer, and the experiment support system. 
The experiment support system supported common and special requirements 
of a number of medical experiments. It provided data management with 
event time and subject and test identification, and regulated power for 
these experiments. It also provided visual readouts and controls for 

~ the blood pressure measuring system and the vectorcardiograph/heart 

r rate system. 
The ergometer is a hand- or foot-driven electromechanical bicycle-type 
exercise device designed to allow a test subject to exercise in the 
zero-g environment. A restraint system consisting of a shoulder and 
waist harness and foot restraints was developed, but the upper torso 
harness was found ineffective and was discarded during Skylab 2. The 
foot restraints were most effective and upon the recommendation of the 
first crew, modified wrap-around handlebars were installed by the 
Skylab 3 crew (fig. 2). Although these were, in general, well accepted 
by the crewmen some p.referred to put thei r hands on the cei 1 i ng or to 
place padding between their head and the ceiling. 
In the manual work-load mode of control of the ergometer, which was 
utilized in the conduct of the M-17l experiment, a continuous range 
of 25 to 300 watts was available. The loading of the erogmeter was 
independent of the pedalling rate - between 50 to 80 cycles/minute.
In addition to being the M-17l experiment stressor, the ergometer was 
the principal device for personal exercise during the mission. 
A ground support calibration system consisting primarily of a torque 
motor, torque sensor, and power computer was developed to provide 
accurate calibration of the ergometer prior to installation in the work­
shop. Additionally, electronic calibration was performed prior to each 
in-flight test. 
The metabolic analyzer consists of a rolling seal dry spirometer for 
the measurement of volume, a mass spectrometer for the measurement of 
the four respiratory gases and an analog computer to calculate minute 
volume, oxygen consumption, carbon dioxide production,and respiratory 
exchange ratio. Figure 3 is a functional schematic of the metabolic 
analyzer. 
End-to-end calibrations utilizing a hand pump and known gas mixtures 
were performed prior to installation of the metabolic analyzer in the 
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Figure 1. Skylab in-flight experiments. 
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Figure 2. M-171 ergometer restraint methods. 
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workshop and during activation of the workshop at the beginning of 
each mission. No change in calibration was evidenced throughout the 
entire program. 
METHODS 
The experiment protocol, as shown in table I, consisted of measuring 
metabolic expenditures during rest and calibrated exercise. Each 
crewman's aerobic capacity was determined at approximately 12 months 
and again at six months prior to launch. Based upon these tests, a 
three-step workload protocol was established as follows: 
o 	 After obtaining a five-minute resting metabolic rate, the 

crewman exercised on the bicycle ergometer at fixed work levels 

approximating 25, 50, and 75 percent of his maximum oxygen 

uptake (002 max) for a period of five minutes at each level. 

o 	 This was followed by a five-minute recovery period. 
o 	 The experiment protocol was scheduled to be repeated every 

5 to 6 days by each crewman during all three Skylab Missions. 

The acquisition of significant baseline data for each crewman was 
implicit in our experimental approach. Each subject served as his own 
control. 
The physiological measurements (table II) which wer~ made during the 
conduct of the experiment were oxy~en consumption (V02)' carbon dioxide production (OC02)' minute volume (VE)' vectorcardiogram/heart rate, 
and blood pressure. These measurements, with the exception of the 
vectorcardiogram/heart rate, were updated every minute. Heart rate was 
updated every 5 beats but only minute averages were utilized in the 
analysis of M17l data. Environmental conditions, ergometer work load 
and vectorcardiogram were measured continuously during each experiment 
run. An oral body temperature was obtained prior to each test. During
the preflight and postflight tests single breath cardiac output (10, 11), 
vibrocardiographic and carotid pulse measurements were made. The 
derived respiratory data included respiratory exchange ratio, oxygen 
pulse, and mechanical and pulmonary efficiency. The derived cardio­
vascular data were mean arterial pressure, pulse pressure, and in the 
preflight and postflight tests, total peripheral resistance, A-V0
difference, and stroke volume. Not all of these derived data have2 
been reduced and analyzed at this time . 
In performing the M-17l experiment, each Skylab 4 crewman had eight 
preflight baseline tests, six spaced at approximate monthly intervals 
729 
TABLE I. M17l EXPERIMENT PROTOCOL 
Time Exercise Protocol 
5 minutes Rest 
5 minutes 25 Percent of Maximum V02 
5 minutes 50 Percent of Maximum V02 
.. 
5 minutes 75 Percent of Maximum V02 
5 minutes Recovery 
Legend: 
Performed by each of three Crewmen 
Five times in 28-day mission 
Eight times in 59-day mission 
Twelve times in 84-day mission 
TABLE II. M-17l PHYSIOLOGICAL MEASUREMENTS 
Raw Data Derived Data 
Ergometer Work Level (Watts) Respi ratory 
Respi rator,)' Respiratory Exchange Ratio 
Oxygen consumption Oxygen pul se 

Carbon dioxide production Pulmonary efficiency (V E/V02) 

Minute volume Mechanical efficiency (V0 2/Watt) 

Cardiovascular Cardiovascular 
ECGlVCG Mean Arterial pressure 
Systolic/Diastolic blood pressure Total Peripheral Resistence 

"Cardiac output Arterial-Venous Oxygen Difference (A-902) 

"Vlbrocardiogram Stroke VoluA1e 

"Carotid Pulse 

"Preflight and Post flight only 
ECG = Electrocardiograph

VCG = Vectorcardiograph 
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over a 6-month period prior to launch and two additional tests at 15 
and 5 days before flight. The first six baseline tests were conducted 
by the crew on themselves utilizing the one-g trainer. The last two 
baseline tests were conducted in the Skylab Mobile Laboratories by 
the principal investigators who subsequently performed the postflight 
tests in the Skylab Mobile Laboratories onboard the recovery ship. 
Each crewman ~Jas tested approximately every 6 days during the 84-day 
mission for a total of 12 tests per man. 
As a result of the experience gained from the Gemini and Apollo pro­
grams. a concerted effort was made during the planning for Skylab to 
perform the postflight tests on the crew as soon as possible after 
splashdown. To insure the best possible comparison between the pre­
flight and postflight experiment data with those obtained in-flight 
the Skylab Mobile Laboratories were outfitted with a set of M-171 
experiment instrumentation and transported intact to the recovery 
shi p. Postfl i ght. eight t4-171 tests were conducted on each crewman: 
at recovery and on days 1. 2. 3, 5. 11, 17 and 31 following recovery. 
Prior to the Skylab 4 launch and based on data obtained from the 
first two Skylab manned missions, the principal investigators decided 
to perform preflight and postflight tilt ergometry exercise tests 
(300 from horizontal) on the crew in an attempt to better understand 
the previously observed postflight decrements in response to exercise. 
Since the recovery medical testing day was already excessively long, 
we elected to substitute the supine/upright ergometry testing for the 
standard M-171 protocol. The standard protocol was conducted on the 
day after recovery and on all subsequent postflight test days. The 
protocol used for the modified test on the day of recovery, consisted 
of five minutes supine rest, five minutes upright rest. five minutes 
upright exercise. five minutes supine exercise and five minutes supine 
recovery. The exercise level used was identical to the first level of 
work (25 percent maximum) of each crev/man's standard M-l71 protocol. 
This modified protocol was accomplished 15 and 5 days preceding launch, 
on recovery day, on the first day after recovery prior to ~,1-171 standard 
protocol, and on 17 and 31 days post recovery. 
RESULTS OF SKYLAB 4 
The next three t~bles (tables III, IV, V) summarize the Skylab 4 re­
sults for the Commander, Scientist Pilot, and Pilot, respectively,
utilizing the physiologic variables which were routinely monitored during 
all performances of the M-17l experiment. Resting, level-3 exercise, 
and recovery mean values are presented for each variable dur-ing the 
three phases of the mission. Those values outside the preflight
95 percent confidence levels are marked with an asterisk. The values 
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TABLE II I. SKYLAB 4 M171 DATA SUMMARY 
Commander 
VARIABLE PREFLIGHT IN-FLIGHT POSTFLIGHT 
X X X 
Heart Rate (bpm) 
,. 
Rest 66 66 76* 

Level 3 157 152 163 

Recovery 112 87* 109 

., 
(l/mi n STPD)V02 , 
Rest .237 .283* .203* 

Level 3 2.26 2.20 2.14 

Recovery .603 .632 .717 

'C02(1/min STPD) 
Rest .234 .301* .187* 

Level 3 2.14 2.13 2.05 

Recovery .721 .776 .839 

SBP (mm Hg) 
Rest 96 97 106 

Level 3 192 195 195 

Recovery 149 131 170 

DBP (mm Hg) 
Rest 67 59* 72 

Level 3 71 56* 67 

Recovery 66 61* 78 

VE (l/min BTPS) 
Rest 8.90 11.79* 9.27 

Level 3 64.43 62.04 60.04 

Recovery 25.98 24.65 29.18 

Key: 
* :: Outside the 95% confidence limit 
STPD = Standard temperature, pressure dry 
bpm • Beats per minute 
BTPS = Body temperature, pressure saturated 
V0 :: Oxygen ~onsumption2 
= Carbon dioxide production 
"CO 2VE = Minute volume 
... 
SBP = Systolic blood pressure 
DBP :: Diastolic blood pressure ." 
X 
TABLE IV. SKYLAB 4 M171 DATA SUMMARY 

Scientist Pilot 
VARIABLE PREFLIGHT IN-FLIGHT POSTFLIGHT 
X X 
Heart Rate (bpm) 
Rest 64 62 74* 
Level 3 164 166 167 
• Recovery 104 92* 102 
• 
'02 (1 Imi n STPD) 
Rest .269 .289 .263 
Level 3 3.07 3.01 3.00 
Recovery .676 .745 .763 
(l/min STPD)
'CO 2 
Rest .255 .279 .221 
Level 3 2.88 3.03* 2.91 
Recovery .791 .982* .893 
SBP (mm Hg) 
Rest 127 119* 123 
Level 3 204 200 198 
Recovery 186 174 189 
DBP (mm Hg) 
Rest 84 74* 78* 
Level 3 55 52 51 
Recovery 66 61 63 
'E (l Imi n BTPS) 
Rest 7.51 9.98* 10.33* 
Level 3 84.18 97.24* 102.69* 
Recovery 24.6 31.44* 34.07* 
Key: 
* =Outside the preflight 95~ confidence limit 
STPD = Standard temperature, pressure,dry 
bpm =Beats per minute 
BTPS = Body temperature, pressure saturated 
'0 • Oxygen consumption
2 
'C0 =Carbon dioxide, production 
'E = 2 Minute volume 
, 
SBP =Systolic blood pressure

DBp·· Diastolic blood pressure 
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TABLE V. SKYLAB 4 M171 DATA SUMMARY 
Pilot 
VARIABLE PREFLIGHT IN-FLIGHT POSTFLIGHT 
X X X 

Heart Rate (bpm) 
Rest 54 53 65* 

Level 3 147 147 156* 

Recovery 114 91* 118 

'02(1/min STPD) 
.. 
Rest .238 .283* .253 

Level 3 2.86 2.59* 2.63* 

Recovery .849 .754 .849 

'C02{1/min STPD) 
Rest .216 .247 .222 

Level 3 2.72 2.65 2.68 

Recovery 1.22 1.08 1.08 

SBP (mm Hg) 
Rest 115 115 125* 

Level 3 204 200 213 

Recovery 188 186 204 

DBP (mm Hg) 
Rest 72 64* 74 

Level 60 51* 59 

Recovery 65 60 69 

'E (l/min BTPS) 
Rest 6.69 8.47* 10.73* 

Level 3 98.51- 90.61* 95.12 

Recovery 40.97 34.77* 45.02 

Key: 
* = Outside the preflight 95% confidence limit 

STPD =Standard temperature, pressure dry 

bpm =Beats per minute 

BTPS = Body temperature, pressure saturated 

=Oxygen consumption
'02
'C0 = Carbon Dioxide production 
2

'E =Minute volume 
SSP =Systolic blood pressure 

DSP • Diastolic blood pressure , 

for each test data point in the case of resting values were based on 
the average of the entire five minute period. The exercise values 
were based on the average of the last three minutes of the five min­
ute period and the recovery values were those obtained for the second 
minute during the five minute recovery period. 
As can be seen in the case of the Commander, significant changes 
observed in-flight were decreased recovery heart rate, decreased 
resting, exercising, and recovery diastolic blood pressure and in­
creased resting minute volume, oxygen consumption and carbon dioxide 
production. Postflight, the Commander exhibited a significant ele­
vation in rest-ing heart rate and decreases in both resting oxygen 
consumption and carbon dioxide production. 
The in-flight response of the Scientist Pilot showed a decreased re­
covery heart rate and increased ventilation not only during rest but 
during exercise and recovery. Additionally, decreases in resting 
systolic and diastolic blood pressures were observed as well as in­
creased carbon dioxide production during both exercise and recovery_ 
Postflight, the Scientist Pilot demonstrated significant elevation 
in resting heart rate and in resting, exercising, and recovery ventila­
tion accompanied by a decreased resting diastolic blood pressure. 
The in-flight response of the Pilot was similar to the other crewmembers 
in that he also exhibited a significant reduction in both recovery 
heart rate and diastolic blood pressure as well as an increase in 
resting minute volume. Unlike the others, though, he had a signifi­
cant decrease in exercising oxygen consumption and exercising minute 
volume. The significant changes observed in the Pilot's postflight 
response were elevated resting and exercising heart rates, systolic 
blood pressure, and resting minute volume. The decreased oxygen 
consumption observed in-fl.ight in the Pilot during exercise remained so 
during the imnediate postflight test period. 
Because of the immense quantity of data, we elected to report the mean 
values obtained during the various phases of the mission. However, 
this type of presentation precludes following transients and/or
trends in these data. Using only the Pilot's data, the individual 
plots representative of the most common significant alterations seen 
in the Skylab 4 crew will be presented. The rest of these pertinent
data are presented in the appendix. Figure 4 deals with alterations 
in heart rate. All three crewmen displayed a decreased in-flight re­
covery heart rate. Additionally, all crewmen exhibited a significantly
elevated resting and exercising heart rate immediately postflight . 
Figure 5 is a plot of the ventilation response. All crewmen exhibited 
a significantly elevated in-flight resting minute volume which continued 
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during the postflight testing for both Scientist Pilot and Pilot. 
Figure 6 shows the decreased in-fliqht, resting and exercising 
diastolic blood pressure pattern observed in all Skylab 4 crewmen. 
Figures 7 and 8 show the results of the preflight and postflight 
cardiac output and stroke volume measurements. As stated previously, 
the first standard M-17l protocol was done on the first day after 
recovery. On that day only the Commander exhibited a decrease in 
cardiac output (41 percent) and stroke volume (41 percent); these 
values showed a prolonged but gradual increase back toward normal and 
both parameters were within 15 percent of normal by 31 days after 
recovery. The cardiac output values for the Scientist Pilot and Pilot 
were slightly increased over preflight while their stroke volume 
values were slightly decreased. The cardiac output and stroke volume 
levels of the Scientist Pilot gradually increased from the first day
after recovery to 31 days postflight when both of these levels were 
significantly increased over preflight values. The Pilot showed a 
slight downward trend in cardiac output after the first day following
recovery but his postflight stroke volume showed no particular trend. 
As would be expected based on the cardiac output and stroke volume 
data, the Scientist Pilot and Pilot had no change in their A-V02 
differences while the Commander exhibited an increased A-V differencegof about the same percent magnitude as his observed reduce 2cardiac 
output. The interpretation of these results will be addressed later 
in conjunction with the results from the Skylab 2 and Skylab 3 
missions. 
The tilt ergometry studies demonstrated that resting heart rate in­
creased when subjects were placed upright from the supine position. 
Preflight, the average increase was from 54 to 61 beats per minute 
(12.6 percent) while in the immediate postflight period the increase 
was from 65 to 83 beats per minute (27 percent). Thus, not only was 
the resting level slightly increased in the supine position postflight 
but the change in heart rate when positioned upright was siqnificantly 
greater. The late postflight values were similar to preflight. 
Figure 9 summarizes the response of Skylab 4 crewmen during the 25, per­
cent maximum exercise in the supine and upright positions. For data 
comparison, the six tests obtained on each crewman were categorized
into preflight, immediate postflight, and late postflight periods. 
During preflight tests there was very little change in exercising 
heart rate when the subject was placed supine after five minutes in the 
upright position. Preflight mean supine and upright values were ex­
actly the same at 103 beats per minute while the immediate postflight 
change was only from 117 beats per minute to 114 beats per minute. For 
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some yet unexplained reason the Commander exhibited a very marked re­
sponse on one of his late postflight tests. All other late post­
flight tests were similar to baseline. On the other hand, stroke 
volume, as depicted by the dotted line, did show significant changes 
when the subject was positioned from the upright to the supine during 
immediate post flight exercise. Whereas the supine exercising values 
immediately postflight were within.5 milliliters of preflight, stroke 
volume decreased approximately 24 milliliters in all three crewmen 
upon assuming the upright position. 
Table VI depicts what each Skylab crewman elected to do for personal 
exercise. After mission day 23 the crew reverted to negative reporting 
and only reported deviations from their selected protocols. As can be 
seen, each crewman selected a very vigorous personal exercise program 
which involved not only quantitative bicycle ergometry for stressing 
of the cardiovascular system but also the minigym, extensor springs, 
and "treadmill II; these exercises and exercise devices are described 
elsewhere (12). The latter three exercise devices were placed aboard 
for exercise of arm and leg antigravity muscles not adequately condi­
tioned by bicycle ergometer exercise. These data will be further 
addressed when summarizing the differences in personal exercise habits 
of the various crewmen. Additionally, during Sky1ab 4 we ohtained in­
strumented personal e~ercise periods on all crewmen (table VII). There 
had been no requirement for any instrumentation during personal exercise, 
however, in preflight discussions with the Skylab 4 crew they agreed 
to periodically instrument (vectorcardiograph/heart rate, blood pressure 
and metabolic analyzer) themselves. Measured heart rates and oxygen 
consumptions revealed that the crew had no difficulty in performing 
maximum levels of exercise during their personal exercise periods. 
Heart rates in the range of 180 to 185 beats per minute were observed 
during crew work loads of 240 to 286 watts. With regard to the V0 2 
values normalized for body weight, there can be no doubt that the 
Skylab 4 crew did improve their physical condition during the course of 
the mission. 
SUMMARY OF SKYLAB EXERCISE RESPONSE TESTING 
Table VIII summarizes the performance of experiment M-171 during three 
Skylab Missions. A total of 82 tests were performed in-flight on the 
nine crewmen. All in-flight tests were completed as programed with the 
exception of the first in-flight tests on the Pilot and Scientist Pilot 
of Skylab 2. The Pilot's test was terminated two minutes and the 
Scientist Pilot's test four minutes into the third level of exercise 
due to ergometer restraint and environmental thermal problems. 
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TABLE VI. DAILY PERSONAL EXERCISE PROTOCOL 
SELECTED BY EACH SKYLAB 4 CREWMAN 
EXERCISE COllluander Scientist Pilot 
Pilot 
LEG ERGOMETRY (Watt min) 5000 8337 6000 

MINIGYM (TOTAL REPETITIONS) 100 200 200 

SPRINGS (TOTAL REPETITIONS) 75 0 120 

TORSO ISOMETRICS (TOTAL REPETITIONS) 20 0 20 

TREADMILL 

WALK (min) 10 0 0 

RUN (min) 0 0 

SPRINGS (REPETITIONS) 300 1000 100 

TOE RISES (REPETITIONS) 200 200 75 

TABLE VII. INSTRUMENTED MAXIMUM IN-FLIGHT ERGOMETRY 
HEART 
CREWMAN MISSION ~RKlOAD. Vo V02 RATE. DAY Watts (liter~/min) (cc/kg per min) (bpm) 
COlllllander (PREFLIGHT) 2.716 40 183 

21 240 3.041 45 181 

66 244 3.149 46.2 183 

79 242 2.930 42.5 184 

Sci enti s t Pi 1ot (PREFLIGHT) 3.423 48.9 183 

20 286 3.692 53.3 184 

27 286 '3.910 56.3 185 

42 286 3.855 55.3 183 

65 286 183 

82 286 3.801 54.2 185 

Pilot (PREFLIGHT) 3.182 47 183 

33 238 2.932 44.6 176 

37 230 2.932 44.2 178 

63 244 3.584 53.8 183 

83 286 3.366 50.5 185 
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TABLE VIII. EXPERIMENT M17l 
Commander 
Skylab 2 
PREFLIGHT TESTS 5 
IN-FLIGHT TESTS 6 
POSTFLIGHT TESTS 8 
'" 
-.. Skylab 3 
PREFLIGHT TESTS 7 
IN-FLIGHT TESTS 9 
POSTFLIGHT TESTS 8 
Skylab 4 
PREFLIGHT TESTS 8 
IN-FLIGHT TESTS 12 
POSTFLIGHT TESTS 8 
PERFORMANCE SUMMARY 
Sci enti st Pil ot Pilot 
5 5 
6 7 
7 9 
7 7 
9 9 
8 8 
8 8 
12 12 
8 8 
Tables IX and X summarize the resylts for pulmonary efficiency (VE at 
2LV02) or mechanical efficiency (VO~ at 150 watts). The only signifi­
cant changes in pulmonary efficiency in flight were observed in the 
Skylab 2 Pilot and the Skylab 4 Scientist Pilot. Postfli~ht, only the 
Skylab 3 Scientist Pilot and Skylab 4 Scientist Pilot demonstrated a 
significant difference in pulmonary efficiency relative to preflight 
baseline. Thus, there appears to be no trend in these data that would 
indicate that space flight changes the pulmonary efficiency of the crews 
during submaximal exercise. Conversely, six of the nine crewmen 
demonstrated a small but statistically significant increase in in­
flight mechanical efficiency and four of these six maintained this 
increased mechanical efficiency during the postflight test period.
The exact reason for this is not known, but it might be a result of a 
training effect. This was unexpected in that one would expect mechanical 
efficiency, if changed, to decrease because of the restraint problems
expected in the weightless environment . 
.. 
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TABLE IX. PULMONARY EFFICIENCY 

VE AT 2Liters Vo 
2 
SKYLAB 
HISS ION TIME PERIOD 
Conmander 
X SO 
Scientist Pilot 
X SO 
Pi lot
X SO 
2 
PREFLIGHT 51.8 3.78 59.8 3.68 59.6 2.16 .. 
IN-FLIGHT 50.9 3.32 64.9 3.49 68.4 2.30* 
POSTFLIGHT 40.9 3.65 61.2 2.89 67.5 4.06 
3 .. 
PREFLIGHT 57.6 7.73 49.4 3.46 56.8 3.69 
IN-FLIGHT 56.8 5.56 51.9 5.21 57.9 4.19 
POSTFLIGHT 55.3 3.66 54.8 1.96* 59.3 2.05 
4 
PREFLIGHT 54.7 3.15 48.8 1.80 60.4 2.53 
IN-FLIGHT 54.8 4.41 55.6 2.93* 62.9 3.71 
POSTFLIGHT 53.3 3.10 54.5 2.94* 62.4 2.67 
*SIGNIFICANT AT p<0.05 
WE • Hinute volume 
V0 2 - Oxygen consumption 
SD = Standard deviation 
TABLE X. MECHANICAL EFFICIENCY 
V0 2 AT 150 watts 
SKYLAB 
MISSION TIME PERIOD 
COIIIIIander 
X SO 
Scientist Pilot 
X so 
PilotX S 
2 
PREFLIGHT 2.07 0.09 2.07 0.22 2.10 0.069 
IN-FLIGHT 1.87 .10 1.83 .14 1.84 .05* 
POSTFLIGHT 2.05 .08 2.06 .08 2.00 .07 
3 
PREFLIGHT 2.04 0.11 2.01 0.07 2.02 0.17 
IN-FLIGHT 1.93 .08* 1.79 .27* 1.87 .07* 
POSTFLIGHT 1.93 .10 1.89 .05" 1.86 .06* 
4 
PREFLIGHT 1.96 0.09 1.94 0.05 2.11 0.11 
IN-FLIGHT 1.85 .09* 1.89 .08 1.88 .08* 
POSTFLIGHT 1.83 .05* 1.98 .10 1.90 .04* 
*SIGNIFICANT AT p<0.05 
V02 ­ Oxygen consumption 
SD • Standard deviation 
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Generally, the in-flight and postflight responses to exercise by the 
crews of Skylab 2, 3 and 4 were similar. In-flight, some subtle, 
isolated differences were seen. However, there were no trends observed 
which would indicate a degradation in the exercise response of the 
crews. The Skylab 4 crew exhibited a significant in-flight decrease in 
recovery heart rate but not in resting (sitting position) heart rate. 
The Skylab 2 crew, on the other hand, exhibited decreases in both para­
meters while the Skylab 3 crew exhibited no changes in either. 
Figure 10, shows six of the nine crewmen had elevated resting vent"ila­
tion in-flight which was maintained in five of these same individuals 
during the immediate postflight period. "Exercising " diastolic blood 
pressures were significantly decreased in flight in five of the crew­
men while "exercising" in-flight oxygen consumption was slightly de­
creased in six crewmen (fig. 11 and 12). 
Postflight, a significant decrement in response to exercise was noted 
in all crewmen. The degradation was evidenced by a decreased oxygen 
pulse (increased heart rate for a given oxygen consumption) as seen in 
figure 13. Additionally, a decreased cardiac output for the same 
oxygen consumption, and a decreased stroke volume were found. Signifi­
cantly elevated resting ventilation was evidenced immediately post­
flight in both the Scientist Pilot and Pilot on Skylab 4 and the 
Commanders of Skylab 2 and 3. 
Figures 14 and 15 summarize the cardiac output and stroke volume data 
for all three crews. Changes in blood flow during exercise subsequent 
to prolonged exposure to weightlessness were among the most consistent 
and striking findings of the Skylab medical experiments. The six 
astronauts who comprised the crews of Skylab Missions 2 and 3 exh"ibited 
large decreases in both cardiac output and stroke volume during exer­
ci se on the recovery day M-171 tests. At thi s t"ime, the Skyl ab crew­
men showed an average cardiac output deficit of 28 percent coupled with 
a 47 percent decline in stroke volume as compared to preflight values. 
For the Skylab 3 crew on the day of recovery, cardiac output was 
decreased by 35 percent and stroke volume was 45 percent lower than 
preflight. For both crews, the cardiac output values returned to with­
in 15 percent of preflight by the second day after recovery while the 
stroke volume deficit required 8 to 16 days to return to within 15 per­
cent of preflight values. However, stroke volume increased rapidly to 
within 80 percent of preflight during the first four postflight days. 
The percent changes in cardiac output and stroke volume were accompanied
by changes in A-V02 differences of approximately equal magnitude but 
opposite direction. 
745 

liters/minI! STANDARD 
24 .­ DEVIATION 
22 r 00 PREFLIGHT 
20 I­ ~ IN-FLIGHT 
18 I 0 POSTFLIGHT
. 
16 
VE • Volume expired, rate 
BTPS • Body temperature. 
~E' 14 pressure saturated 
12 
...... BTPS 10
.+::> 
0'1 
8 
6 
o t:-;·rl1 ':-;:;1', ";';YA t····I £. 1;-;·;rLl t;';';££1 vV'J ..··;yA ";';'V4 
SKYLAB 2 SKYLAB 3 SKYLAB 4 
·SIGNIFICANT DIFFERENCE FROM BASELINE (p < 0.05) 
Figure 10. Resting minute volume . 
'" 
... 
"". · 
J •'" 	 " 
II1II 	Hg 
140 
130 
120 
110 
~ 	100 
::l 
Vl 
Vl 
OJ 	 90 
S­
o.. 80 
"'0 
0 
r-
0 70 
..0 
(,) 
'r-
60 
'-I r­
~ 0 50.j...l'-I 
Vl 
ttl 
'r­
0 
I ± STANDARD DEVIATION 
mPREFLIGHT 
~ IN·FLlGHT 
o POSTFLIGHT 
CDR SPT PLT CDR SPT PLT 
SKYLAB 2 SKYLAB 3 
• SIGNIFICANT 	DIFFERENCE FROM BASELINE (p < 0.05) 
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The present data collected on the Skylab crew would tend to implicate 
altered venous return as the cause of decreased cardiac output. The 
augmented stroke volumes noted during 300 tilt exercise reduce the like­
lihood that decreased myocardial function was the limiting process. 
Also, the rapid initial rise in both cardiac output and stroke volume 
over the first four postfHght day would better parallel presumed
readjustments in blood volume and vascular competence than would be 
expected if restorative processes were occuring in the myocardium. 
In comparing the personal exercise levels of the various crews it be­
comes obvious that the amount of exercise accomplished in-flight was 
effective in maintaining a normal crew exercise response in·-flight as 
well as in shortening the length of the postflight readaptation p~riod. 
Table XI compares the quantitative bicycle ergometer exercise accomp­
lished by the crews. Reference to the far right-hand column, showing 
these data normalized to the crewman IS body weight, reveals that the 
Skyl ab 3 crew exerci sed about 107 percent more than the Skyl ab 2 crew 
and the Skylab 4 crew exercised 130 percent more than the Skylab 2 crew. 
Except for some isolated individual responses in the cardiac output 
and stroke volume data, all other parameters returned to normal in 
approximately 18 to 21 days for the Skylab 2 crew, 5 days for the Sky­
lab 3 crew, and 4 days for the Skylab 4 crew. Based on these data 
there appears to be no correlation between the length of the postflight
readaptation period and mission duration. It is interesting to note 
that the amount of exercise performed in-flight was inversely related 
to the length of time required postflight to return to preflight status. 
TABLE XI. IN-FLIGIIT QIJA"T1TATIVE PERSONAl EXERCISE SUII1ARY 
SKYLA8 (J) TOTAL (2) DAILY .'9 (3) DAILY o.g 
MISSION (Witt .In) (watt ..In) (watt ..In/kgm 
Body llleight) 
c-nder 62810 2855 47 
Scientist Pilot 45 307 1 618 21 31.3 .'9 
Pilot 55 795 1 993 26 
C..-ande.. 228 581 3 874 58 
Scientist Pilot 214 645 3638 62 65 .'9 
Pilot J8Ij 193 6 545 75 
Comander 349 210 4108 62 
Scientist Pilot 469 420 5 523 80 72.30.g
.. 
Pilot 414 760 4 879 75 
:. 
(1) Include, M171 Experiment tests and person.1 exercise. 
(2) 8ased on l8-day Skyl.b 2 "hslon, 59-day Skylab 3 ..Inion ••nd B4-day Skylob 4 ..hslon. 
(3) e.sed on _n In-flight body weight. 
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As stated previously, the Skylab 4 results were somewhat different and 
are more appropriately depicted by examining the response of the 
individual Skylab 4 crewmen shown in figures 7, 8. 
The data from the Skylab 4 Commander are similar to those seen in 
Skylab 2 and Skylab 3 crewmen although his return to normal was slower 
than the astronauts of Skylab missions 2 and 3. 
The consistent postflight elevation in cardiac output and stroke 
volume for the Scientist Pilot of Skylab 4 may be a reflection of 
in-flight physical conditioning in this individual. His in-flight 
exercise regimen was rigorous, and it is likely that his measured 
preflight cardiac output and stroke volume values were not representa­
tive of his improved physical condition at the end of the orbital 
period. Thus, his immediate postflight values might well have been 
depressed and only fortuitously appeared to be the same as his pre­
flight values. The upward trend in stroke volume during the latter 
days of postflight testing would seem to lend credance to the idea 
that his postflight IInormal" levels were somewhat higher than pre­
fl ight. 
The results from the Skylab 4 Pilot are perhaps even more difficult 
to explain. His cardiac output and stroke volume values showed little 
or no change from preflight values during any of the postflight tests. 
From the first through the 17th day postflight both parameters showed 
a small downward trend but the overall magnitude of the trend is small 
enough to be of questionable significance. It is possible that his 
cardiovascular system was inherently nonresponsive to the weightless 
environment due to factors which we cannot define at this time. 
The tilt ergometry testing accomplished preflight and postflight in 
the Skylab 4 mission demonstrated that immediate postflight supine 
heart rates were elevated both during rest and exercise. Although a 
tachycardia was observed in the upright position, the change in 
"exercising" heart rate was not nearly as pronounced as during rest. 
Both systolic and diastolic blood pressures were elevated in the 
upright position in at least two of the three Skylab 4 crewmen while 
data for the thj'rd crewman were not as clear-cut due to technical prob­
lems with the blood pressure measuring system postflight. During both 
the supine and upright postions reduced cardiac output was observed 
immediately postflight for the same stress level. However, the 
decrease was less in the supine position. These results on highly 
active crewmen cannot be directly compared with the limited studies 
accomplished after complete bed rest in which supine exercising stroke 
volumes were greatly reduced (2, 4). 
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The secondary objective of the 1\1-171 experiment was to evaluate the 
bicycle ergometer as an in-flight exerciser for long-duration missions. 
Upon exposure to the weightless environment, the crews commented on a 
"fullness in the head II feeling and sinus problems which never really 
subsided. The crews have reported that the bicycle ergometer exercise 
provided relief from these subjective feelings, which partially explains 
the strong desire for the crewmen to exercise. The heavy leg exercise 
evidently facilitated the return of the blood to the lower extremities 
thus relieving their symptoms. The bicycle ergometer proved to be a
• very effective stressor of the cardiovascular system. If it were to be 
the exerciser chosen for long-duration missions, additional provision
would have to be made for maintaining muscular strength in tho?e anti­
gravity muscles not adequately exercised by the bicycle ergometer. 
CONCLUSIONS 
Immediately postflight all crewmen showed a significant decrement in 
submaximal exercise response. The degradation was, in large part, 
evidenced by decreases in oxygen pulse, cardiac output, and stroke 
volume. Since similar in-flight effects were neither observed nor 
suspected, it is apparent that these physiological responses were 
a result of readaptation to one-g. Furthermore, it appears that the 
responses we observed resulted from decreased venous return due to re­
adjustments in fluid balance/blood volume state or vascular tone. This 
postflight readaptation p~riod was of short duration, was not intensi­
fied by the duration of the mission, and resulted in no irreversible 
effects. 
Although personal exercise was not experimentally controlled during the 
Skylab Program, qualitative comments by the crewmen indicated that they
derived some psychological benefits from these activities. In addition, 
given the known physiological effects of high levels of physical activ­
ity that occur in normal gravity, it would not be unreasonable to 
assume that in-flight exercise had a beneficial effect not only in the 
maintenance of a normal in-flight response to exercise and well being 
but also in reducing the period of time required for readaptation post 
flight. However, this hypothesis must be evaluated by proper experi­
mentation. In the meantime, we will recommend exercise as a beneficial 
adjunct to space flight. 
.. 	
The successful completion of the 28-, 59-, and 84-day Skylab Missions 
showed that man can perform submaximal and maximal aerobic exercise in 
the weightless environment without detrimental trends in any of the 
physiologic data. 
753 
ACKNOWLEDGEMENT 
Evaluation of the bicycle ergometer hardware used for the Skylab Program 
M17l Experiment and personal exercise showed that it was utilized 
approximately 248 hours in flight and the metabolic analyzer was util­
ized approximately 100 hours in-flight without malfunction in either 
device; thus, all experimental data were obtained as programed without 
failure. The outstanding performance of these pieces of hardware was 
further amplified by the successful usage of these two devices by the 
crewmen in their in-flight performance of 82 M171 experiment tests by .. 
and on themselves. The outstanding performance of the crewmen indicates 
their dedication in light of the complexity of the hardware operation 
and their extremely busy schedules. 
This retrospective review of the successful completion of the Metabolic 
Activity portion of the Skylab Program experiments prompts the authors 
to express, here, their appreciation to the Skylab astronauts and to 
Mssers. R. E. Heyer, J. M. Waligora, D. J. Horrigan, H. S. Sharma, 
P. Schlottman of NASA-JSC and Messers. P. Schachter (Ph.D) and D. G. 
Mauldin of Technology Incorporated for their respective contributions 
and invaluable assistance in the six years of effort in design, develop­
ment and performance of this experiment for Skylab. We also wish to 
acknowledge the counsel and encouragement of Dr. U. C. Luft of the 
Lovelace Fuundation for Medical Education and Research. 
REFERENCES 
1. 	 Cardus, D. 1966. Effects of 10 days recumbency on the response to 

the bicycle ergometer test. Aerospace Med.~ 37: 993-999. 

2. 	 Hyatt, K. H., L. G. Kamenetsky, and W. M. Smith. 1969. Extravascu­

lar dehydration as an etiologic factor in post-recumbency ortho­

statism. Aerospace Med.~ 40: 644-650. 

3. 	 Miller, P. B., R. L. Johnson and L. E. Lamb. 1965. Effects of 

moderate physical exercise during four weeks of bed rest on 

circulatory functions in man. Aerospace Med.~ 36: 1077-1082. 

4. 	 Saltin, B., G. Blomquist, J. H. Mitchell, R.L. Johnson, Jr., 
K. Wildenthal and C. B. Champman. 1968. Response to exercise 

after bed rest and after training. A longitudinal study of 

adaptive changes in oxygen transport and body composition. 

CircuZation~ 38: 1-78. 

5. 	 Berry, Charles A. 1969. Preliminary clinical report of the medical 

aspects of Apollos VII and VIII. Aerospace Med.~ 40: 245-254. 

754 
6. 	 Berry, Charles A. 1970. Summary of medical experience in the 

Apollo 7 through 11 manned space flights. Aerospace Med.~ 

41: 	 500-519. 
7. 	 Rummel, J. A., E. L. Michel and C. A. Berry. 1973. Physiological 

response to exercise after space flight - Apollo 7 to Apollo 11. 

Aerospace Med.~ 44: 235-238. 

8. 	 Michel, E. L., J. A. Rummel and C. F. Sawin. 1974. Skylab 

Experiment M-171 "Metabolic Activity": Results of the First 

Manned Mission, Acta Astronautica~ (in press). 

9. 	 Rummel, J. A., E. L. Michel, C. F. Sawin and M. C. Buderer. 1974. 
Metabolic Studies During Exercise: The Second Manned Mission, 
Aerospace Med.~ (in press). 
10. 	 Kim, T. S., H. Rahn and L. E. Farhi. 1966. Estimates of true 
venous and ar~eria1 PC0 2 by gas analysis of a single-breath. J. Appl. Phys~ol.~ 21: 1338-1344. 
11. 	 Buderer, M. C., J. A. Rummel, C. F. Sawin and D. G. Mauldin. 1973. 
Use of the single-breath method of estimating cardiac output 
during exercise-stress testing. Aerospace Med.~ 44: 756-760. 
12. 	 Thornton, W. and J. Rummel. 1974. Measurement and Prevention of 
Muscle Deconditioning on Skylab. Presented at Sky1ab Life Sciences 
Symposium, Johnson Space Center, Houston, Texas. 
755 


APPENDIX 
757 

HEART RATE, 
LEGEND 
x REST 
e:. LEVEL 1 EXERCISE 
o LEVel 2 EXERCISE 
o lEVel 3 EXERCISE 
• RECOVERY 
HEART RATE, 
LEGEND 
x REST 
e:. LEVel 1 EXERCISE 
o LEVEL 2 EXERCISE 
o LEVel 3 EXERCISE 
• RECOVERY 
bpm 

160 

t40 
t20 
100 .. 
80 

40L-~~~~-i~--L-~~-L~~~~--~-L--~~~~ 
-t20 -60 to 30 SO 70 5 to 15 20 25 30 

-90 -30 20 40 60 80 

DA YS BEFORE FLIGHT MISSION DA YS DA YS AFTER FLIGHT 

Figure lAo Heart rate, Skylab 4 Commander. 
160 

140 

120 

100 

80 

60 

-120 -60 10 30 SO 70 5 10 IS 20 25 30 

-90 -30 20 40 60 80 

DAYS BEFORE FLIGHT MISSION DAYS DA YS AFTER fliGHT 
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Figure 5A. 
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Commander. 

Figure 58. 
Systolic blood 
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Figure 5C. 
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pressure, Skyl ab 4 
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PULMONARY FUNCTION EVALUATION DURING AND FOLLOWING 

SKYLAB SPACE FLIGHTS 

c. F. Sawin~ ph.D.*; A. E. Nicogo88ian~ M.D.*; A. P. Schachter~ Ph.D;t 
J. A. Rummel~ ph.D.*; and E. L. Michel* 
ABSTRACT 
Previous experience during the Apollo postflight exercise testing 
indicated no major changes in pulmonary function. Although pulmonary 
function has been studied in detail following exposure to hypoxic and 
hyperoxic environments, few studies have dealt with normoxic environ­
ments at reduced total pressure as encountered during the Skylab 
missions. 
Forced vital capacity was measured during the preflight and postflight 
periods of the Skylab 2 mission. Initial in-flight measurements of 
vital capacity were obtained during the last two weeks of the second 
manned mission (Skylab 3). Comprehensive pulmonary function screening 
was accomplished during the Skylab 4 mission. The primary measurements 
made during Skylab 4 testing included residual volume determination, 
clos"ing volullle, vital capacity, and forced vital capacity and its 
derivatives. In addition, comprehensive in-flight vital capacity 
measurements were made during the Skylab 4 mission. Vital capacity 
was decreased slightly during flight in all Skylab 4 crewmen. No 
major preflight to postflight changes were observed in the other 
parameters. 
INTRODUCTION 
Previous experience during the Apollo Program showed no major changes 
in pulmonary function when evaluated by postflight exercise testing (1). 
Although pulmonary function has been studied in detail following ex­
posure to hypoxic and hyperoxic environillents, few studies (2, 3. 4, 
5, 6) have dealt with normpxic environments at reduced total pressure 
as encountered during Skylab. The absence of a gravity vector would be 
expected to facilitate ventilation/perfusion relationships and result 
in better overall gas exchange in the weightless state. Because of this 
and the absence in previous history of postflight pulmonary problems, 
vital capacity was initially proposed as the only functional screening 
test for Skylab. 
*National Aeronautics and Space Administration - Lyndon B. Johnson 
Space Center, Houston, Texas. 
tLife Sciences Division, Technology Incorporated, Houston, Texas. 
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Cardiac output measurements were made in our laboratory (7) during 
prefligh(t and postflight exercise tests using the technique of Kim 
et al. 8), Due to the magnitude of decreases in cardiac output 
following the first and second manned Skylab missions and because the 
method of Kim et al. is based upon normal pulmonary function, it was 
decided to perform more thorough pulmonary function screening in con­junction with the final and longest duration Skylab mission. This 
paper summarizes pulnlonary function data obtained during all three 
Skylab missions. 
METHODS 
The Skylab Program consisted of three manned, earth-orbital flights of 
progessively increased duration (28, 59, and 84 days). Each Skylab 
crew included a Commander, a Scientist Pilot, and a Pilot. The average 
composition of the spacecraft gas atmosphere during Skylab was: in­
spired oxygen partial pressure equal to 170 torr (226 x 102 N/m2),
inspired nitrogen partial pressure equal to 75 torr (10 x 10 3 N/m2), 
inspired water partial pressure equal to 10 torr (13 x 102 N/m2), and 
inspired carbon dioxide partial pressure equal to 5 torr (67 x 102 N/m2) , 
although the nominal composition was inspired oxygen partial pressure
equal to 181 torr (241 x 102 N/m2) and inspired nitrogen partial
pressure equal to 77 torr (103 x 102 N/m2) at a total pressure equal 
to 258 torr (344 x 102 N/m2). This atmosphere was planned to provide 
approximate sea level equivalent of alveolar oxygen partial pressure. 
The Skylab 4 pulmonary function test equipment layout is shown in figure 1. 
Skylab metabolic analyzers (9) were used for all Skylab 2 and Skylab 3 
pulmonary function studies. Briefly, these units were designed to 
measure vital capacity and respiratory gas exchange (~02' VC02, VE).Each unit had rolling seal spirometers, a mass spectrometer, and an 
analog computer. 
Forced vital capacity and its derivatives were measured during the 
preflight and postflight periods of the first manned mission (Skylab 2). 
Initial in-flight measurements of vital capacity were obtained during 
the last two weeks of the second manned mission (Skylab 3). Comprehen­
sive pulmonary function screening was accomplished during the final 
manned mission (Sky1ab 4). One metabolic analyzer was modified to 
support the Skylab 4 preflight and postflight pulmonary function 
screening. This unit was modified to compute the volume of nitrogen 
washed out as: ~ - (V' x F - V'I F )
vN2 - E EN2 X IN2 . 
Oxygen was supplied to the inspiration spirometer via a demand regulator.
These modifications permitted residual volume determination by open
circuit washout of pulmonary nitrogen during oxygen breathing (10,11,12). 
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Figure 1. Skylab 4 Pulmonary Function Test Equipment. 
A respiratory mass spectrometer monitored nitrogen partial pressure 
continuously at the subject interface. An XV plotter provided con­
tinuous nitrogen partial pressure (ordinate) as a function of time 
(abscissa) during residual volume determinations. 
Closing volume and closing capacity together with their ratios to 
vital capacity and total lung capacity, have been proposed as indicators 
of small airway mechanics (13, 14). These indices were computed from 
data obtained from the single-breath oxygen washout test and residual 
volume. Vital capacity and forced vital capacity were measured to 
obtain commonly reported flow and volume parameters (15, 16, 17, 18).
Residual volume and closing volume measurements were made with the 
subject in the sitting position. Vital capacity and forced vital capac­
ity measurements were made with the subject standing. 
An analog tape recorder and stripchart were used during all Skylab 4 
preflight and postflight testing to provide permanent, synchronous 
records of nitrogen partial pressure at the mouthpiece, tidal volume, 
flow rate, and nitrogen washout. The Skylab 4 preflight pulmonary
function examinations were· conducted five days preflight. Vital 
capacity was measured at six day intervals in-flight. Complete post­
flight examinations were conducted on recovery day and 1, 2 and 5 days
after recovery. Vital capacity measurements were continued at 11, 17, 
and 31 days postflight. 
RESULTS AND DISCUSSION 
Pulmonary function data for Skylab crewmen obtained in the Cardio­
pulmonary Laboratory at Johnson Space Center during annual astronaut 
physical examinations are summarized in table I. Vital capacity and 
flow rate data for the Skylab 3 Scientist Pilot were low relative to 
reported normal values (16, 18); however, the Scientist Pilot demon­
strated adequate pulmonary reserve during numerous bicycle ergometer 
exercise tests in our laboratory. With the exception of pulmonary 
function data for the Skylab 2 Scientist Pilot and the Skylab 4 Pilot, 
table 1 contains the means and standard deviations of data from each 
crewman's three or four annual physical examinations preceding Skylab. 
Sky1ab 2 Forced Vital Capacity Determinations 
Table II summarizes the preflight, recovery day, and first day post 
recovery forced vital capacity data. No data were obtained for the 
Scientist Pilot postflight due to orthostatic intolerance complicated 
by sea sickness. The values shown for each crewman represent the best 
effort of two trials. The Commander's forced expired volume in l-second 
on the first daY'postflight was significantly reduced. Based on his 
766 
normal forced vital capacity, it is possible that his decreased forced 
expiratory volume in l-second was due to less than maximal subject
effort. 
TABLE!. PREFLIGHT AllliUAl PHYS lCAl EXAMINATION SUItIARI ES 
Age Hei9ht Weight Vital Capacit,)' Res Idua1 Vo1ume FEY ""FR (yr) (III) (kg) (11 ters. BTPS) (1 Hers, BTPS) ( li teri, BTPS) 25-75% 
(liters/sec, STPS) 
~ Skylab 2 
~ COftIIIiInder 43 1.7 62 4.77±0.21 2.18±0.42 3.71±O.14 3.27±0.32 
Scientist Pilot 41 1.83 77 6.95" 2.66" 5.07· 4.06" 
Pilot 41 1.78 80 5.31±O.O9 2.10±O.24 3.94±0.14 3.05±O.11 
S~ylab 3 
Conwnander 41 1. 75 69 5.03±O.O6 2.12±O.25 4.16±0.05 4.34±O.33 
SCientist Pilot 42 1. 75 62 4.04±0.13 1. 54±O.22 3.27±0.04 3.07±0.34 
Pilot 37 1.83 89 6.95±0.10 2.02±0.15 5.21±0.18 4.33±0.75 
Skylab 4 
Comnander 41 1. 75 68 6.05±0.21 1.95±0.32 4.65±0.18 4.17±0.25 
Scientist Pilot 37 1.75 71 6.26±0.08 1. 77±0.01 4.78tO.06 3.93±0.25 
Pi lot 43 1.75 68 6.30* 1.99* 5. JO±O. 35 7.43±0.22 
All values are mean <SO with the exception of those with one test only (.). /lost va 1ues are 
from annua 1 exams on the preceding 4 years. 
STPS = Body temperature, pressure saturated 
FEV 1 - Forced expiratory volume In one second 
I'IIFR • MaxllllUlll lIIidexplratory flow rate 
TABLE II. SKYLAB 2 POSTFLIGHT FORCED VITAL CAPACITIES 
FVC(liters.BTPS) FEV 1 (liters, BTPS) 
Preflight Postflight Preflight Postflight 
F-5 R+O R+l F-5 R+O R+l 
Conmander 4.95 4.74 4.88 3.56 3.57 2.51 
Scientist Pilot 7.0 NA NA 5.02 NA NA 
Pilot 5.28 5.41 5.35 4.03 3.89 4.22 
FVC = forced vital capacity in one second 
FEV 1 = Forced expiratory volume in one second 
F- = Preflight days to launch 
R+ = Postflight days after recovery
NA = Not applicable
BTPS = Body temperature, pressure saturated 
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Skylab 3 Vital Capacity Determinations 
In-flight vital capacity measurements were made during the last two 
weeks of the Skylab 3 mission. Results of preflight, in-flight. and 
postflight measurments are shown in table III. The Commander showed 
no changes except a slight increase in vital capacity five days post 
recovery. Vital capacity of the Scientist Pilot was slightly higher 
in-flight but normal postflight relative to preflight values. The 
Pilot exhibited decreased vital capacity in-flight but normal vital 
capacity postflight relative to preflight. 
TABLE III. SKYLAB 3 VITAL CAPACITIES 
Vital Capacity (liters, BTPS) 
Preflight* In-flight P~tfii~t 
M045-47 t MD50-52 MOSS R+l R+2 R+4 R+5 
Commander 5.03±0.06 SD 5.07 4.96 4.87 4.95 5.16 5.30 
Scientist Pilot 4.04±0.13 SO 4.24 4.36 3.92 4.11 4.19 
Pilot 6.95±0.10 SO 6.10 6.35 6.17 6.91 6.90 6.94 7.01 
*Oata from table I 
tMD - Mission Day 
BTPS : Body temperature, pressure saturated 
SO : Standard deviation 
Skylab 4 Vital Capacity Determinations 
Vital capacity data for the Commander. Scientist Pilot, and Pilot are 
shown in figure 2. Vital capacities were generally observed to be 
lower in-flight relative to preflight. Vital capacity for the Commander 
remained below preflight for the entire in-flight period. All data 
presented in figure 2 were obtained using experiment M17l metabolic 
analyzers. 
Skylab 4 Pulmonary Function Screening Tests 
Nitrogen washout curves showed no indications of trapping. All washout 
curves appeared to reflect the anticipated two time constants represent­
ing washout of pulmonary and total body nitrogen spaces. 
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Figure 2. Skylab 4 vital capacity data. 
The Commander had a pronounced vasovagal response following maximal 
oxygen inspiration during the first closing volume determination on 
recovery day and further testing was curtailed until the next day. A 
hardware fa"ilure resulted in loss of residual volume measurement for 
the Commander on the first day following recovery. All other measure­
ments on the first day following recovery. and all measurements on 
days two and five postflight were within normal ranges. The composite 
results for Skylab pulmonary function screening tests are presented 
in table IV. 
Residual volume in the Scientist Pilot was slightly increased immed­
iately following recovery and on day two compared to preflight.
Residual volume/total lung capacity percent indicated that these 
changes were probably insignificant. Ventilatory equivalents were 
variable and reflected the Scientist Pilot's irregular respiratory
pattern during washouts. 
Although vital capacity for the Pilot was slightly decreased on the 
second day following recovery relative to preflight. forced vital capac­
ity was normal. Maximum midexpiratory flm'l rate (between 25 percent and 
75 percent of the forced vital capacity) values for the Pilot are 
the highest recorded in our laboratory for any individual. 
Skylab 4 provided the first opportunity for extensive. noninvasive 
pulmonary function screening on astronauts before and following an 
extended zero-g exposure. No physiologically significant quantitative
decrement in pulmonary function was shown by any crewman during exam­
inations following this 84-day Earth-orbital mission. 
Postflight chest films for all crewmen were compared to preflight 
films to detect changes. if any. in the pulmonary vessels. parenchyma. 
or heart size. No significant pulmonary vasculature or parenchymal 
changes were observed in any instance. 
Vital capacity. the only parameter measured preflight. in-flight, and 
postflight. showed in-flight decreases approaching 10 percent in the 
case of the Skylab 3 Pilot and for the Commander, Scientist Pilot. and 
Pilot on Skylab 4 (table III and figure 2). These decreases in vital 
capacity apparently resulted from one or a combination of the follo\'Jing 
factors: 
o cephalad shift of the diaphragm in zero-g. 
o body fluid redistribution into the thoracic cavity. or 
o a direct r~sult of decreased ambient pressure. 
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TABLE IV. PULMONARY FUNCTION SCREENING* 

COI'IWIDE! SCIENTIST PILOT 
..--.... r·::> R+u 1+. 1+2 ..., f.." I+Q 1+. 
velll....) 5.83 S.'. 5.72 5.12 S.'H 6." 6.16 6.00 
ltV (llt..., 1...0 1.53 .­ 1.31 1.43 1.$1 2.11 1.21 
TLC (li'_1 7.23 7.'7 
--
7.13 7.37 7." '.28 7.21 
.vIlLC ('!lot 20 21 
-­
1. 19 20 216 II 
TV tIi.onIbt....h) 1.07 I 1.20 1.00 1.15 0.92 2." 2.83 1.17 
V.•/IV 30 23 
--
33 '6 .. 21 .. 
FVC ilif.... ) 5.61 I -­ 5.56 5.7' I 6.OS 5.83 5.77 5.39 
fVCVC l'liol 99 -. '17 98 102 96 9. 90 
,. EV 1 ili,...vMel '.62 -. '.29 - .." '.70 '.35 '.61 '.2'
. 
MMfI2S.7S II/,.cl 4.3.2 
--
•• 30 •. 39 '.1' 3.17 I 5.15 3.69l I 
MEl It.e, 0.65 . - 0." 0.65 I 0.73 0.92 0.56 0.73 
MEFI lliter1l,.cl 12.• -. 12.0 12.4 12:3 10.5 11.0 10.5 
V {lIO'!b HC) (1/_, 4.74 
-­
3.88 •.61 5.50 3.70 4.7. 3.67 
ev (lit.... ; 0.80 I 0.88 0.83 0.56 0.76 1.02 0.99 0.99 
CC (Ii..." 2.20 2.•1 
-­
1.87 2.18 2.55 3.18 2.26 
CVIVC {'!Iol I. 15 16 10 13 17 16 17 
CClTLC ('lio) 30 I 3.2 . - 28 30 33 31 31 
. 
1+2 
.+" 
6.16­ 6.26 
2.43 1.65 
.." 7.92 
28 2. 
-­
1. .. 
27 16 
5•• 6.2' 
96 99 
'.37 •• 54 
3.43 3.65 
0.• 0.86 
10.9 10.11 
3.73 I ••87 
0.49 0.81 
2.9'2 2." 
• 13 
34 31 
P-) 
6.• 
2.20 
'.69 
26 
2.23 
23 
6.22 
96 
5.50 
6.61 
0.47 
11.6 
7.76 
o.n 
2.91 
11 
34 
l+u 
6.31 
1.67 
'.OS 
2' 
0.92 
21 
6.22 
97 
5.50 
7.06 
0." 
!l.6 
7.55 
0.89 
2.56 
I. 
32 
PILOT 
1+1 
6.31 
2.00 
'.31 
2. 
0.9. 
I 17 
5.n 
90 
5.39 
7.73 
0.37 
11.0 
7.33 
0.50 
3.43 
I 8 
32 
1+2 I·' 
6.OS 6." 
2.20 1.53 
'.2. '.17 
27 19 
0.82 0.80 
18 16 
6.27 6.32 
104 95 
5•• 5.29 
6.82 5.10 
O • .co • 0.62 
12.2 
" .4 
7 . .co s.n 
0.45 0.59 
2." 2.12 
7 I 9 
I 33 25 
."-J 
"-J 
--' 
*A sUll1l1lry of measured and derived values obtained 5 days preflight (F-5). jll'll1l!diately following 
recovery (R+O). I day (R+I). 2 days (R+2) and 5 days (R.5) fo 11 owi ng recovery. 
All vell_ .nd flow ....u ....... nU .re reportl!d .t BTPS conditions. 
VC - Vital capacity 
RV- Residual volume 
TlC - Total lung capacity 
YA/RV • Ventilatory equivalents 
FYC • Forced vital capacity 
Iil'lF'R • Maximum mldexpfratory flow rate 
MET • Midexpiratory time 
MEFR • Midexpi ratory flow rate 
CV = Closing volume 
CC • Closing capacity 
KEY; 
CDR=CoRInander 
SPT=Scientest Pilot 
PLT·Pilot 
FEY " Forced expiratory volume in I second l 
Foley and Tomashefski (2) showed a decrease in flow rate with no 
significant decrease in forced vital capacity when performed during 
the zero-g portion of Keplerian maneuvers in KC-135 aircraft. Ulvedal 
et al. (6) showed forced vital capacity to be reduced 3 to 8 percent 
by exposure to equivalent 18 to 33 500 foot altitudes without con­
comitant hypoxia. Robertson and McRae (4) similarly observed a 4 per­
cent decrease in forced vital capacity in subjects exposed to a 5 psia, 
oxygen-helium gaseous environment with inspired oxygen partial pres­
sure of 175 torr (233 x 102 N/m2) for a_period of 56 days. Vital cap­
acities returned to normal upon chamber descent to near sea level 
ambient pressure. Vital capacities were measured during Skylab Medical 
Experiments Altitude Test (SMEAT) (5), a ground-based 56-day simulated 
Skylab mission in which the environment was comparable to Skylab with 
the important exception of the presence of Earth's gravity. A standard 
vitalometer was used for both the pre-altitude and the 5 psia measure­
ments. IVlean vital capacity values for the SMEAT Commander, Sci enti st 
Pilot, and Pilot were decreased by -4.5, -2.9, and -4.9 percent, 
respectively, during this 56-day exposure to barometric pressure 
equivalent to a 27 000 foot altitude without hypoxia. Post SMEAT, 
vital capacities returned to baseline values. Our -in-flight Skylab 
data are in general agreement with all reported studies (4, 5, 6). 
CONCLUSIONS 
In summary, the vital capacity changes observed in-flight may be 
partially explained as a response to 5 psia ambient pressure. However, 
the proportion of vital capacity decreases directly attributable to 
other factors such as body fluid shifts and a cephalad shift of the 
diaphragm cannot be determined from the present data. Regardless of 
the cause(s) of decreased in-flight vital capacities, a review of post~ 
flight data shows that these changes revert to normal within two 
hours following recovery without significant impact on crew health 
status. 
Further in-flight comprehensive pulmonary function testing will be 
necessary during future manned missions in order to substantiate 
observed decreases in vital capacity and increase our knowledge con­
cerning the physiological effects of the weightless state upon the 
human body. The Space Shuttle will have a sea level equivalent 
atmosphere. Therefore, it will provide the first opportunity to 
evaluate pulmonary function where the primary environmental change 
will be the weightless state (zero-g). 
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METABOLIC COST OF EXTRAVEHICULAR ACTIVITIES 
James M. Waligora and David J. Horriagan, Jr. 
National Aeronautics and Space Administration 
Lyndon B. Johnson Space Center 
Houston, Texas 
ABSTRACT 
The data on metabolic rates during Skylab extravehicular activities are 
presented and compared with prior experience during Gemini and Apollo. 
Difficulties experienced with Gemini extravehicular activities are 
reviewed. The effect of a pressure suit on metabolic rate is discussed 
and the life support equipment capabilities of each life support system 
are reviewed. The methods used to measure metabolic rate, utilizing
bioinstrumentation and operational data on the life support system, are 
described. Metabolic rates are correlated with different activities. 
Metabolic rates in Skylab were found to be within the capacities of the 
life support systems and to be similar to the metabolic rates experi­
enced during Apollo lunar 1/6-g extravehicular activities. They were 
found to range from 100 kcal/h to 500 kcal/h, during both 1/6-g and 
zero-g extravehicular activities. The average metabolic rates meas­
ured during long extravehicular activities were remarkably consistent 
and appeared to be a function of crew pacing of activity rather than to 
the effort involved in individual tasks. 
INTRODUCTION 
The prospect of pressure suit operations outside of space vehicles and 
on the lunar surface was the source of much speculation prior to Gemini. 
Prediction varied from the prospect of almost effortless activity to the 
fear that without the stabilization provided by Earth gravity useful 
activity would be very difficult. The Skylab zero-g extravehicular 
activity data is of particular interest when it is considered in 
combination with the Apollo and Gemini data. This paper covers the 
energy cost of extravehicular activity from Gemini through Skylab. 
Gemini 
A summary of the Gemini extravehicular activities, their length, the 
difficulties experienced by the crewmen, and the average and peak heart 
rates, is presented in table I. There was no attempt to measure 
metabolic rates. It was apparent that on several occasions, the meta­
bolic rates were above the capacity of the life support systems, both 
for thermal control and carbon dioxide washout. 
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TABLE I. GEMINI EXTRAVEHICULAR ACTIVITY EXPERIENCE 
5 Gemini extravehicular activity missions - 6 hours total extravehicular activity time 
Heart Rates 
Duration (b~ats per minute) 
Flight Experience (hours) x Peak 
Gemini 4 	 Overheating during hatch closing - 0.60 155 175 
objectives completed 
Gemini 9 	 Visor fogging - hot at ingress - 2.11 155 180 
objectives incompleted 
Gemini 10 No problem with heat or work rate - 0.65 125 165 
'" objectives completed 
'" 0'1 
Gemi ni 11 	 Exhausting work - no specific 0.55 140 170 
mention of heat - objectives 
incomp1eted 
Gemini 12 	 Good restraints - no problems - 2.10 110 155* 130 
objectives completed 
Metabolic rates - not determined but in excess of life support system 
capability at times 
*Voicing a message to Houston 
~ ~ I 
The energy cost of extravehicular activities is dependent to a large 
extent on the pressure suit and life support system. The Gemini 
pressure suit had a fixed resting position and had minimum mobility 
for extravehicular activity. Considerable energy was expended working 
against the suit. The heat removal capacity of the life support system 
was limited physically to about 225 kcal/h in Gemini 4. The gas 
cooling life support system used on the later Gemini units had an 
increased physical capacity, but at acceptable body temperatures the 
system was limited to about 250 kcal/h. The emphasis in the earlier 
Gemini extravehicular activities was in the use and evaluation of 
propulsive maneuvering units. Beginning with Gemini 12 increased 
emphasis was placed on extravehicular activity technology and improved 
restraint and systems. In summary, the Gemini Program indicated that 
extravehicular activities could be much more difficult and physically 
taxing than had been anticipated and that more emphasis should be 
placed in crew training and restraint technology. 
Apollo 
The lunar portion of the Apollo Program presented entirely different 
extravehicular activity problems, i.e.~ 1/6-g and an unknown terrain. 
The effect of 1/6-g on the cost of work in a pressure suit had been 
investigated by several researchers using 1/6-g simulators (l, 2, 3). 
Indications were that the cost of walking would be reduced while the 
cost of other activities would be increased; however, the results and 
conclusions were by no means uniform. An additional factor of 
uncertainty was the terrain and surface composition of the moon and its 
effect on the metabolic cost of walking. In response to these 
uncertainties, conservative biomedical estimates of the life support 
requirements were defined based on the ava-jlable data, and methods to 
measure metabolic rate during the extravehicular activities were 
developed utilizing operational data from the life support system and 
bioinstrumentation. 
To handle high workloads during Apollo extravehicular activities and 
the resulting high heat production in the suit. a liquid cooling system 
was used. The liquid cooled garment used in this system could suppress 
sweating at work rates up to 400 kcal/h and allow sustained operations 
at rates as high as 500 kca1/h without thermal stress. 
Real-time estimates of metabolic rate were made during the lunar sur­
face extravehicular activities using three parameters: oxygen bottle 
pressure, the heat removal by the liquid cooled garment, and heart rate. 
The noise experienced in the telemetered oxygen-bottle-pressure data 
made it difficult to obtain reliable oxygen utilization rates for time 
periods of less than 30 minutes, particularly at low metabolic rates. 
The oxygen utilization rates included the suit leakage which had 
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to be estimated. The maximum leakage rate of oxygen allowed by the 
pressure suit specification was equivalent to a metabolic rate of 
approximately 50 kcal/h. 
Because of the limitations of the oxygen-bottle-pressure method, corre­
lation of liquid cooled garment data to metabolic rate was also used 
during the mission. Using a thermoregulatory mathematical model and 
empirical data on the liquid cooled garment, a relationship was defined 
between liquid cooled garment heat removal and metabolic rate for each 
liquid cooled garment inlet temperature. This method was verified with 
test data obtained during altitude chamber training. 
Correlations between heart rate and metabolic rate were obtained for 
each individual from a series of preflight exercise response tests on 
the ergometer. The heart rate method was used only as a relative 
measurement because of its known sensitivity to psychological and 
environmental factors. The heart rate method, however, when related to 
total energy expenditure as determined by oxygen and liquid cooled 
garment methods, permitted an estimate of the cost of specific activi­
ties on a minute-by-minute basis. 
The average metabolic rates experienced during these extravehicular 
activities, as shown in table II, were lower than had been predicted 
prior to Apollo, and the crewmen were able to move easily and confi­
dently on the lunar surface. Within the operational classification of 
activities the most energy consuming were those classified as overhead. 
These activities included egress, offloading and setup of equipment 
around the lunar module vehicle, and ingress and stowage of lunar 
samples. The highest metabolic rates experienced during the performance 
of discrete activities (350-450 kcal/h) were associated with steep 
uphill walking traverses, transporting of the Apollo Lunar Scientific 
Experiment Package pallet, ingressing the lunar module with lunar 
samples, drilling, and removing of drill bits. The Apollo Lunar 
Scientific Experiment Package deployment and geologic survey activities 
resulted in lower metabolic rates than the overhead activity. These 
acti vi ti es as a group were 1 ess predi ctab 1 e and requi red more t"j me for 
judgment and in some cases for precise manual manipulation. The lowest 
metabolic rates and the most clearly defined operation activity was 
observed while riding the Lunar Rover. The metabolic rates for this 
activity approached rates reported for shirtsleeve riding in an auto­
mobile. 
The highest average rate of 300 kcal/h was experienced by the Lunar 
Module Pilot on Apollo 11. This crewman had been assigned to the task 
of evaluating modes of locomotion during what was the shortest extra­
vehicular activity, and he was quite active in performing this task. 
Several crewmen experienced the minimum average metabolic rates of 
approximately 200 kcal/h on different missions. 
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TABLE II. APOLLO LUNAR SURFACE EXTRAVEHICULAR ACTIVITIES 
Flight EVA Crewman 
Sctenti ftc 
Pack.age 
Deployment 
Geological 
Station 
Activity 
Overhead 
Lunar 
Rover 
Vehicle 
Operations 
All 
Acti vi ties 
EVA 
Duration 
(hours ) 
Apollo 11 Annstrong 195 244 214 227 
Aldrin J02 351 J03 J02 2.43 
~pollo 12 Conrad 206 243 294 246 
Bean 240 245 267 252 3.90 
2 Conrad 218 215 221 
Bean 253 248 252 3.78 
Apollo 14 Sttepard 182 294 220 202 
,!1tchel1 226 174 259 234 4.80 
2 Shepard 118 238 214 229 
Mitchell 203 267 213 252 3.58 
Apollo 15 Scott 282 275 338 152 276 
rrwi.n 321 186 293 104 246 6.53 
2 Scott 243 293 287 149 253 
[nrin 265 189 266 99 204 7.22 
3 Scott 261 242 311 138 260 
Inrin 2JO 188 234 107 204 4.83 
Apollo 16 Young 207 216 273 173 220 
Duk.e 258 268 275 159 255 7.18 
2 Young 223 249 112 198 
Duk.e 244 236 105 208 7.38 
Young 231 235 124 205 
Duk.e 242 264 103 208 5.67 
Apollo 17 Cernan 285 261 J02 121 275 
Sctunitt 278 30Q 285 113 272 7.20 
2 Ceman 261 J02 121 207 
Scbmi.tt JOO 285 113 210 7.62 
3 Cernan 261 JO.2 121 234 
Scbm;:tt JOQ 285 113 237 7.25 
Average 244 244 270 123 234 
Total TUne. LlIou~t 28,18 52.47 52,82 25.28 158.74 
Particular efforts were made to relate walking speed to metabolic rate 
during Apollo 14 which included the most extensive walking traverses. 
The data are presented in figure 1. 
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Figure 1. - Metabolic cost of lunar walking. 
The data exhibited a very poor correlation between traverse rate and 
metabolic rate. During these operational traverses it appeared that 
the crewman maintained a comfortable wa"lking effort and to a large 
extent the rate of travel at this level of effort varied with the 
terrain and the requirements of each traverse. The average speed for 
the 2.9 kilometers covered was 2.4 km/h at a metabolic rate of 
300 kcal/h. The speed and efficiency of lunar walking were both 
greater than could be achieved wearing a pressure suit at one-g while 
neither speed nor efficiency was the equivalent of shirtsleeve opera­
tion at one-g. 
A time and motion study (4 and 5 ) was carried out on Apollo 15 and 16 
utilizing operation motion picture film and kinescope. This study 
compared the facility and energy cost of performing several specific
activities at one-g during suited training and at 1/6-g on the lunar 
surface. One of the observations of this study was that manipulative 
tasks were completed more rapidly at one-g than at 1/6-g, but at 
greater metabolic cost. 
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In addition to the 14 lunar surface extravehicular activities, there 
were 4 zero-g extravehicular activities. The first was a standup extra­
vehicular activity on Apollo 9 utilizing a portable life support system 
and on this extravehicular activity we have data (table III) similar to 
that obtained during the lunar surface extravehicular activities. 
During the Command Module extravehicular activities of Apollo 15, 16, 
and 17 the only data available were the heart rates. The metabolic 
rates estimated from heart rate were not used to constrain these extra­
vehicular activities and it appears that in some cases the heart rates 
were elevated due to psychogenic causes. 
TABLE III. APOLLO ZERO-G EXTRAVEHICULAR ACTIVITIES 
Metabolic Rate 

Flight Crewman (kcal/h) Duration-hours 

Apollo 9 Schewickart 151 0.98 
Apollo 15 Worden <237 0.66 
Irwi n* <117 0.66 
Apollo 16 Mattingly <504 1.41 
Duke* not measured 1. 41 
Apo 11 0 17 Evans <302 1.11 
Schmitt* <143 1.11 
Total Time (hours) 7.38 
*Standup extravehicular activities 
Skyl ab 
Despite the large quantity of 1/6-9 extravehicular activity data 
collected during Apollo; when the Skylab Program began, the experience 
with zero-g was limited to six hours of Gemini experience during which 
considerable difficulty was encountered and four hours of Apollo 
Command Module extravehicular activity consisting of a standup extra­
vehicular activity and three repetitions of a comparatively simple 
film retrieval task. The original extravehicular activities planned 
for Skylab were six 3- to 4-hour extravehicular activities primarily to 
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replace film in the ATM cameras. The umbilical life support system of 
Skylab had a heat removal capability equivalent to the Apollo portable 
life support system. The metabolic rate data were limited to the liquid 
cooled garment data and the heart rate data because of the different 
life support system. The correlation of heart rate and metabolic rate 
was based on the most recent in-flight experiment M171 bicycle ergometer .. 
test. The Skylab data are presented in table IV. 
TABLE IV. 
r~ission 
SL2 EVA-l 

(Gas cooling only) 

SL2 EVA-2 

SL2 EVA-3 

SL3 EVA-l 

SL3 EVA-2 

SL3 EVA-3 

(Gas cooling only) 

SL4 EVA-l 

SL4 EVA-2 

SL4 EVA-3 

SL4 EVA-4 

Total Time 
SKYLAB EXTRAVEHICULAR ACTIVITIES 

Metabolic Rates 
Duration 
(hours) 
0.61 
3.38 
1.56 
6.51 
4.51 
2.68 
6.56 
6.90 
3.46 
5.31 
83.6 h 
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Metabolic Rate (kcal/h) 
CDR PLT SPT 
330 260 

315 265 

280 

265 240 

310 250 

225 180 

230 250 

155 205 

145 220 

220 185 

•
-
x 230 kcal/h 

The first Skylab extravehicular activities were done to deploy the solar 
panels. After success was achieved, and a considerable capability to 
perform work in zero-g was demonstrated, the number of extravehicular 
activities was increased to 10 and the duration of these extravehicular 
activities was lengthened. These additions included the deployment of 
the solar panels, erection of a solar canopy, repair of an Earth 
resource antenna, replacement of a gyro six-pack and other vehicle and 
experiment repairs. An additional extravehicular activity was done to 
make observations on the Comet Kohoutek. Because of problems with one 
of the vehicle coolant loops all three crewmen operated from a single
coolant supply but the comfort cooling capacity at the loops remained 
at about 400 kcal/h steady-state. No problems were experienced from 
overheating. Because of the problem with the vehicle coolant system, 
the last extravehicular activity on Skylab 3 was conducted with gas 
cooling only. It was of limited scope and duration and no problems 
were experienced. 
The metabolic rates were similar to those on the Apollo 1/6-g extra­
vehicular activities. The highest metabolic rate, 500 kcal/h, was 
reached while the Commander on Sky1ab 2 was trying to cut a strap that 
was keeping the solar panels from deployment. The lowest rates were 
resting rates and these were reached several times during the extra­
vehicular activities, particularly at the times when there was not 
enough light to continue an ongoing activity during a night pass. Crew 
comments during extravehicular activities indicated that it was easier 
to maneuver themselves and their equipment in zero-g than in water tank 
simulations, but that adequate restraints were even more important. 
CONCLUSIONS 
o 	 With adequate life support equipment and adequate restraints 
the capability was demonstrated to perform varied and 
extensive extravehicular activity tasks both in zero-g and 
1/6-g with considerable real-time flexibility. 
o 	 The capability to work at relatively high levels, up to 
500 kcal/h, when required was demonstrated without 
physiologic problems provided the life support capability 
is adequate. 
o 	 The average energy cost of long extravehicular activities 
was remarkably consistent at about 200 to 250 kcal/h, 
and appears to be a function of the crew pacing its 
activity rather than to the effort involved in performing 
individual tasks. 
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DETERMINATION OF CARDIAC SIZE FROM CHEST ROENTGENOGRAMS 

FOLLOWING SKYLAB MISSIONS 

A. 	 Nicogo88ian~ M.D.*~ G. w. HoffZer~ ~.D.*~ R. L. John8on~ M.D.* 

and R. J. Gowen~ Ph.D. t 

ABSTRACT 
Decreased cardiothoracic transverse diameter ratios following Mercury, 
Gemini and Apollo space flights have been reported previously. To 
evaluate further changes in cardiac size, standard posteroanterior 
chest films in systole and diastole were obtained before flight and 
within a few hours after recovery on each of the Skylab astronauts. 
Postflight chest X-rays were visually compared to the preflight
roentgenograms for possible changes in pulmonary vasculature, lung 
parenchyma, bony or soft tissue structures. From these roentgenograms 
the following measurements were obtained: cardiac and thoracic trans­
verse diameters, cardiothoracic transverse diameter ratio, cardiac area 
from the product of both diagonal diameters, cardiac silhouette area 
by planimetry, thoracic cage area and cardiothoracic area ratio. The 
postflight frontal cardiac silhouette sizes were significantly decreased 
when compared with the respective preflight values (P<0.05 or 0.01). 
The observed changes are thought to be related to postflight decrease 
in the intracardiac chamber volume. 
INTRODUCTION 
Determination of size is a major factor in the clinical evaluation of 
the healthy or failing heart. Knowledge of heart size assists the 
interpretation of both electrocardiographic and hemodynamic information. 
The evaluation of changes in cardiac size has been important in the 
overall cardiovascular assessment of orthostatic intolerance observed 
among the majority of astronauts following space missions. 
Decreased cardiothoracic transverse diameter ratios following Mercury, 
Gemini and Apollo flights have been reported earlier from our labora­
tory (1, 2). More recently similar data following space missions of 
*National Aeronautics and Space Administration - Lyndon B. Johnson 

Space Center, Houston, TX. 

tU.S.A.F. Academy, Colorado Springs, Colorado. 
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longer duration have been presented (3). The majority of crewmembers 
who exhibited postflight decreases in the cardiac silhouette size 
also showed a decreased orthostatic tolerance to lower body negative 
pressure. Similar findings were also reported by the Soviet investi­
gators following 30-day bed rest studies (4) and in cosmonauts upon 
return from space missions. This paper presents further radiological 
data from all three Skylab manned missions and discusses the physio­
logical factors possibly involved in the cardiac silhouette changes. 
METHODS AND MATERIALS 
Standard posteroanterior chest films were obtained before and as soon 
as possible after flight on each of the Skylab astronauts following 
extended space flights of different durations: 28, 59 and 84 days. All 
X-ray exposures were 150 milliseconds in duration. Systolic and 
diastolic exposures were triggered electronically from the electro­
cardiographic R-wave peak by a special device interposed with the 
X-ray equipment control. The electronic trigger device delayed the 
roentgenographic exposures from the R-wave peak according to the 
instantaneous heart rate (the preceding RR interval). For systole the 
delays were 175 to 325 milliseconds. corresponding to heart rates 
ranging from 140 to 40 beats per minute. and for diastole 385 to 
1165 milliseconds for heart rates ranging from 140 to 44 beats per minute. 
Postflight chest X-rays were visually compared with the preflight films 
for possible changes which might have occurred in pulmonary vasculature, 
lung parenchyma, bony or soft tissue structures. One or two additional 
postflight films were taken several days following splashdown to assess 
trends. While many of the film pairs showed readily apparent postflight 
decreases in heart size (fig. 1), several measures have been adopted 
to determine this change quantitatively. Figure 2 shows the geometry 
utilized in determining thoracic and cardiac areas. The thoracic cage 
area was obtained by a modified method as described b.y Barnhard (5) 
and by loyd (6). After the inner border of the ribs was outlined, the 
thoracic center was determined by drawing the line (Cl) along the 
vertebral column. Next. perpendicular lines to (Cl) were drawn at 
2.5, 5.0 and 15.0 centimeters from the first thoracic inter-
vertebral space - point of origin (a) creating three upper polygonal 
segments. A horizontal line (k-m) drawn halfway between the level of 
the apices of the right and left hemidiaphragms delineated the lower 
border of the fourth segment. The last segment was delimited by a 
horizontal line (n-p) drawn at mid-distance between the two costophrenic 
angles; actual area of this segment was modified by circular deductions 
for infra diaphragm space. The total thoracic area was summed from 
the computed area of each of the above five segments. 
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Figure 1. Systolic Chest X-ray of the Skylab 4 Scientist 
Pilot. (Preflight and on the day of Recovery) 
788 

To obtain uniform evaluation of the cardiac area, the heart silhouette 
was outlined in the following manner. 
o 	 The lower border of the heart was defined as the line (B-D) 

between the intersections of the right and left cardiac 

borders and the respective hemidiaphragms, 

o 	 the right cardiac border (A-D) followed the right atrium and 

superior vena cava, 

o 	 the left cardiac border (B-C) was completed by drawing a 

regression line of the left heart border intersecting with 

the left margin of the descending aorta, 

o 	 the upper cardiac border was outlined by a perpendicular 

(A-C) to the center line at the level of the upper left 

heart border. 

The following parameters were measured andlor computed: 
o 	 Cardiothoracic transverse diameter ratio (CITD)' 
o 	 Cardiac silhouette area, by planimetry. 
o 	 Cardiothoracic area ratio (C/TA). 
o 	 Cardiac area from the product of long and short diagonal 

diameters. 

It is hoped that the additional information inherent in this technique 
will reflect more accurate size values and help compensate for slight
variations in body position and inspiratory level. All postfli.ght 
data were compared to the respective preflight v.alues using the 
Student's t-test and regression analysis. 
RESULTS 
No roentgenological abnormalities were observed on either preflight or 
postfliqht films. The chest X-rays of the Skylab 3 Pilot on the day
of recovery were of poor quality and not amenable to analysis; all other 
X-rays were of acceptable quality. Differences between preflight and 
postflight systolic and diastolic cardiothoracic diameter and area 
ratios are presented in tables I and II. Both CIT and C/TA showed a decrease in the individual values postflight. In Beneral tn~re was 
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more variability in the C/TO responses postflight. some cases in 
diastole showing a modest increase in the immediate postflight ratios. 
Comparison of the preflight and postflight cardiac silhouette area 
differences showed a fairly consistent decrease in the cardiac area on 
the day of recovery (tables III and IV). The Skylab 3 Commander. how­
ever. showed a postflight increase in the systolic cardiac area as 
determined from the products of minor and major diameters (19.76 cm2 ) 
and a very slight increase in the diastolic cardiac area as measured 
by the planimetric method (0.30 cm2 ). 
TABLE I. SYSTOliC CARDIOTHQRACIC RATIO DIFFERENCES 
PREFLIGHT VERSUS POST FLIGHT 
Skylab 
~ ~ 
Date 
1Qml 
FIRST 
C/TD* C!TA 
t 
POSTFLIGHT ROENTGEN EXAMINATION 
SECOND 
Date C/TO C/TA1Qml Date 1Qml 
THIRO 
CITo CITA 
2 
COIIIIIIInder 
Scientist Pilot 
Pilot 
RtO 
...0.003 
0.000 
-0.013 
-0.003 
-0.015 
...0.011 
R+B 
-0.020 
to.004 
-0.020 
...0.008 
-0.005 
to.OO4 
3 
COIIII1ander 
Scientist Pilot 
Pilot 
RtO 
...0.040 
-0.040 
NA 
-0.012 
-0.039 
NA 
R+S 
-0.014 
-0.043 
to.012 
to.003 
-0.025 
+0.004 
R+20 
-0.001 
-0.007 
0.000 
to.023 
-0.010 
-0.004 
4 
COIIII1ander 
Scientist Pllot 
Pilot 
RtO 
...0.010 
...0.059 
to.003 
-0.011 
-0.020 
-0.004 
1\+5 
...0.024 
-0.025 
...0.008 
...0.015 
to.OOl 
-0.019 
R+ll 
-0.023 
-0.036 
+0.009 
-0.007 
-0.006 
-0.017 
*C/To • D1ametral Ratio 
tC/T A • Areal Ratio 
NA • Not avai labl. 
R • lIecovery 
TABLE II. DIASTOLIC CARDIOTHORACIC RATIO DIFFERENCES 
PREFLIGHT VERSUS POSTFLIGHT 
Skylab 
Mission 
2 
Crewmembers 
COIIIIIIInder 
Scientist Pilot 
Pilot 
Date 
1Qml 
11+0 
FIRST 
to.012 
+0.003 
-0.008 
CITAt 
+0.002 
-0.012 
-0.025 
POSTFLIGHT ROENTGEN EXAMINATION 
SECOND 
Date C/To C/TA1Qm1 
-0.006 +0.003 
R+8 0.000 -0.007 
-0.003 -0.003 
Date 
1Qm1 
THIRD 
C/T
o 
3 
Comnander 
Scientist Pilot 
Pilot 
R+O 
-0.005 
-0.034 
NA 
-0.006 
-0.022 
NA 
11+5 
to.009 
-0.029 
+0.002 
+0.012 
-0.015 
+0.005 
R+20 
+0.035 
-0.011 
+0.012 
to.027 
+0.006 
-0.007 
4 
COIIIIIIInder 
Scientist Pilot 
Pilot 
litO 
+0.014 
+0.013 
+0.015 
-0.018 
-0.006 
·0.013 
R+5 
to.026 
to.034 
-0.001 
-0.010 
to.014 
-0.011 
R+11 
+0.018 
to.022 
to.003 
-0.003 
+0.012 
·0.010 
*CIT0 • Olametra 1 ratio 
tCiTA • Areal ratio 
NA • Hot avaflable 
R • Recovery 
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TABLE Ill. DIFFERENCES IN SYSTOLIC CARDIAC AREAS 
PREFLIGHT COMPARED TO POSTFLIGHT 
POSTFLIGHT ROENTGEN EXAMINATION 
FIRST SECOND THIRD 
Skylab Date D1XD2* Plan. t Date DIXD2 Plan. Date DI~D2 Plan.Missions Crewmembers (Day) (Day), (Day)
.l..9tl .l9ti. .l..9tl .l..9tl (cm2 ) .l..9tl 
Co_nder 
·16.10 • 2.40 -19.00 
- 9.50Scientist Pilot R+O -29.20 • 9.80 R+8 +10.70 - 2.10Pilot 
·15.50 • 9.80 +20.90 + 6.00 
COITIIIander +19.76 
- 1.90 +21.20 + 6.30 
-72.00 +24.803 SCient1st Pilot R+O ·55.80 ·26.70 R+5 ·30.40 -15.50 R+20 -19.64 
- 6.60Pilot NA NA + 7.35 + 6.10 
- 8.63 - 2.30 
COITIIIander 
-16.30 • 7.60 • 7.70 + 6.30 
-11.00 
- 5.604 Scientist Pilot R+O -21.00 • 9.90 R+5 ·10.50 
- 5.60 R+ll -11.30 
- 8.40Pilot 
- 1.70 - 3.30 + 1.30 
- 7.70 
- 0.30 - 6.90 
'*Cardiac area detel'lllinecl fl"Olll the product of the major and minor diameters 
tcardiac area detel'1llinecl by planlmetry 

NA • Not available 

R • Recovery 

TABLE IV. DIFFERENCES IN DIASTOLIC CARDIAC AREAS 

PREFLIGHT COMPARED TO POSTFLIGHT 

POSTFLIGHT ROENTGEN EXAMINATION 
FIRST SECOND THIRD 
Skylab Date 0 x0 * Plan. t Date °IXD, Plan. Date O)xD2 Plan. 
Missions Cre>ornan (Day) 1 2 (Day) (Day)(cm2) (cm2 ) (cm2) 
.l..9tl .l..9tl (cm" ) 
COIIIMnder -14.20 2.70 
- 4.80 5.10 

2 Scientist Pilot R+O -33.80 -12.00 R+8 
- 3.00 5.60 

Pilot -40.70 -14.70 4.00 + 1.40 

COIII114nder - 2.10 + 0.30 +18.00 +16.30 +46.90 +27.10 
3 Scientist Pilot R+O -25.40 -16.50 R+5 -10.80 - 8.SO R+20 +30.00 - 5.00 
Pilot NA NA -12.80 + 2.20 -28.20 - 7.70 
COITIIIander -107.10 -17.30 -89.10 
- 9.10 -78.30 • 6.90 
Scientist Pilot R+O -41.20 
- 1. 70 R+5 - 0.00 +11.30 R+ 11 7.50 +10.30 
Pilot ·24.60 -15.60 
- 4.60 - 7.60 + 5.00 - 2.00 
'Cardiac area determined from the product of the major and minor diameters 
+Cardiac area determined by planimetry 

NA • Not available 

R • Recovery 

Table V summarizes the determinants of cardiac sizes, their preflight 
and postflight means and standard deviation as well as the statistical 
significances. The mean differences, preflight versus postflight, of 
the cardiac areas. measured by planimetry. and of the derived measure­
ment (C/TA). were statistically significant (P<O.Ol or P<0.05). Return 
to preflight values was quite variable for all crewmen, but most showed 
this directional trend by 4 to 5 days after splashdown. There was a 
significant correlation (r : -0.91) between postflight decrement in 
systolic heart size as measured by C/TD. and the corresponding augmen­
tation in heart rate responses registered during lower body negative 
pressure stress. There was no apparent correlation between the duration 
of orbital stay and the postflight change in heart size. 
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TABLE V. DETERMINANTS OF CARDIAC SIZE FROM ROENTGENOGRAMS 
PREFLIGHT POSTFLIGHT (R+O) 
Cardiac Standard Standard Statistical 
~ Mea~urement Mean Deviation ~ Deviation Signi ficance 
CIT D* 0.416 0.029 0.390 O.OlB p <0.05 
Systole 
CITAt 
D xD * ) 2 
O.lBO 
23B.B7(cm2) 
0.019 
3B.13(cm2) 
0.166 
221. 90(cm2) 
O.OlB 
40.B2(cm2 ) 
p <0.01 
NS 
Plan. § 123.Bl (cm2) 13.31 (cm2) 114.22 (cm2) 12.74(cm2) p <0.05 
CIT D 0.403 O.OlB 0.399 0.021 NS 
Diastole CITA 0.177 0.015 0.164 0.020 p <0.01 
D)xD2 24B. 41(cm2) 2B.2B(cm2) 212. 27(cm2) 34.09(cm2) p <0.05 
Plan. 121.71 (cm2) 7.74(cm2) 111.67(cm2) 12.20(cm2) P <0.01 
N • B (R+O Film of Skylab 3 Pilot unsatisfactory) iCardiac area detennined by planimetry 
*Cardiothoracic ratio based on the respective diameters P = Probabil ity 
tCardiothoracic ratio based on the respective areas N.S .• Not significant 
*Cardiac area detennined from the product of the minor and major diameters 
DISCUSSION AND CONCLUSIONS 
Radiographic techniques for evaluating the size of the heart have the 
advantages of technical simplicity and widespread availability of 
equipment. Although the conventional cardiothoracic ratio has for many 
years provided a useful clinical standard (7) it carries a rather large 
variability due to body position, phase of respiration and other 
uncontrollable elements of thoracic configuration. In our practice 
the C/TA and the associated cardiac area were found to compare well with the CIT , were easily obtained and quite adequate for serial 
comparisons 8n the same subject (3). In addition, the areal measure­
ments provide more comprehensive information concerning the heart size 
than transverse diameters. The observed postflight decrease in 
frontal plane cardiac silhouette size could be attributed to a decrease 
in myocardial tissue mass and/or intrachamber blood content, anatomical 
reorientation or a combination of all of the above mentioned factors. 
Previous studies have shown that significant among determinants of 
cardiac size is the amount of blood returned to the heart (8). It is 
quite conceivable that caudad displacement of blood and other fluids 
together with an absolute decrease in the circulating blood volume (9) 
could account for the observed decreases in the cardiac silhouette 
size. At the present time there is certainly no indication that the 
Skylab crewmen exhibited a greater decrease in their cardiac size than 
that observed in the Apollo astronauts following shorter duration space 
missions, nor that the decrease in diastole heart size was of greater 
magnitude than that of the systolic phase of the cardiac cycle. A 
small diastolic size might more clearly delineate a deficit in blood 
return and chamber filling rather than loss of myocardial mass. 
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Further studies during the Shuttle era should be directed toward a 
better understanding of the intracardiac chamber and myocardial tissue 
components possibly involved in the reported X-ray find"ings. 
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SYMPOSIUM SUMMARY 

SKYLAB: A BEGINNING 
Lawerence F. DietZein~ M. D. 
Deputy Director of Life Sciences 
NationaZ Aeronautics and Space Administration 
, Lyndon B. Johnson Space Center 
liThe Eagle has landed; Tranqu"illity Base here." This simple and now 
historic message of July 20, 1969, marked the attainment of perhaps 
the greatest peacetime goal "in the history of man. It fulfilled 
President Kennedy's directive issued some 8 short, hectic years earlier, 
when he procla"imed on May 25,1961: "I believe we should go to the 
moon ... before this decade is out. II It marked the culmination of 
a technically complex engineering accomplishment that began with r,1ercury 
and continued uninterrupted through Gemini and prelunar Apollo. The 
ultimate goal of these efforts was a manned lunar landing. None of 
these programs had as a major objective the detailed study of man's 
biomedical responses to the space environment, except in the broadest 
sense of survival and the ability to live and work effectively in that 
environment. Nevertheless, throughout each program, information con­
cerning man and his new surroundings was obtained wherever possible 
and whenever practicable, ever mindful of the time constraints imposed
by the lunar landing goal and the weight limitations of the launch 
vehicles. 
In these few days, the preliminary biomedical results of NASA's Skylab 
effort have been presented to you. A major goal of Skylab was to 
learn more about man and his responses to the space environment for 
missions lasting up to 84 days. The results are necessarily prelimin­
ary, for in the short time which has elapsed since the end of the pro­
gram, no in-depth cross-correlation of the voluminous multidisciplinary 
data has been possible. This will be done through successive future 
meetings of specialized working groups. 
In this 1974 Skylab Life Sciences Symposium, you have been briefed on 
the results of measurements and experiments that were conceived some 
six to eight years ago, and which have added immeasurably to our under­
standing of man, his physiological responses and his capabilities in 
space. 
In one sense Skylab is the beginning of an in-depth study of man in 
this unique environment, for Skylab has resolved some problems while 
inevitably raising new questions. 
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MERCURY 1961-1963 
In order to view the Skylab data in their proper context, let us go
back for a moment some 13 years to 1961. At that time both the United 
States and Soviet Union were placing animals, such as chimpanzees 
Ham and Enos, in orbital flight. The goal of these flights was to 
refute untested but plausible theories of catastrophic failures in 
various vital functions if such animals were suddenly thrust into 
weightless flight. There were, of course, additional stresses to be 
reckoned with in space, the most important of which are listed in 
table I and which are by now quite familiar to you. .. 
TABLE I. PRINCIPAL ENVIRONMENTAL STRESSES IN MANNED SPACE FLIGHT 
o Weightlessness 
o Ionizing radiation 
o Temperature and humidity 
o Accelerations 
o Circadian rhythm disruption 
o Noise and vibration 
o Atmospheric composition 
But the factor of greatest concern to man with his many gravity­
influenced body systems was and continues to be null gravity. Many dire 
effects - some of them diametrically opposed to each other - were 
postulated as direct consequences of exposing man to zero gravity. Some 
of these predictions are listed in table II and are well known from 
previ ous publ i cations (1, 2). 
TABLE II. PREDICTED WEIGHTLESS EFFECTS 
Anorexia Demineralization of bones 
Nausea Renal calculi 
Disorientation Motion sickness 
Sleepiness Pulmonary atelectasis 
Sleeplessness Tachycardia

Fatigue Hypertens i on 

Restlessness Hypotension
Euphoria Cardiac arrhythmias 
Hallucinations Postflight syncope
Decreased g tolerance Decreased exercise capacity 
Gastrointestinal disturbance Reduced blood volume 
Urinary retention Reduced plasma volume 
Diuresis Dehydration
Muscular incoordination Weight loss 
Muscle atrophy Infectious illnesses 
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A few of these predictions were later shown to be valid; happily, most 
of them were not substantiated by subsequent flight experience. During
the Mercury Program, NASA scientists 111ade some tentative realistic 
predictions of their own regarding the time course of certain symtoms
should they develop during weightless fl ight. These are "indicated in 
figure 1 and, except for sensory deprivation and sleep changes, have 
been generally proved quite realistic. 
The first indication of cardiovascular or circulatory impairment related 
to s~ace flight was the orthostatic intolerance exhibited by Schirra 
following his 9-hour MA-8 flight and Cooper after his 34-hour MA-9 
flight. Cardiovascular data from the last and longest Mercury flight 
are indicated in table III, including orthostatic intolerance and 
dizziness on standing, weight loss (dehydration) and hemoconcentration. 
TABLE II I. FLIGHT ~1ERCURY-ATLAS-9 (MA-9) CARDIOPULMmJARY DATA SUMMARY 
RESPIfb'TION 
EVENT PULSE (bpm) PRESSURE (mm Hg) RATE reaths/min) 
Prelaunch 72 113/79 19 
Orbital 89 119/81 15 
Postflight 83 (supine) 89/64 
(1 to 7 h) 123 (erect) 90/73 
(18 h) 58 (supine) 98/61 
80 (erect) 94/68 
Flight time: 34 h 20 min. 
Weight Loss: 3.5 kg (7.75 lb) 
Postflight temperature: 310.6° K (99.4° F) (Oral) 
Hematocrit: 43 (Preflight); 49 (Postflight)
Subjective symptoms: Dizziness 
GEMINI 1965-1966 
The biomedical studies conducted during the Gemini Program were directed 
toward evaluating the magnitude of flight-related changes first noted 
following the Mercury flights, and other physiological changes that 
might occur in Earth-orbital flights of up to two weeks' duration. 
Heavy emphasis was placed upon evaluation of the cardiovascular system, 
since the principal changes observed during Mercury involved alterations 
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Figure 1. Expected time course of symptoms if they occurred in 
weightlessness. 
.. ( .. 
;n cardiovascular reflexes that regulate blood flow in the face of a 
continuous hydrostatic gradient in Earthts gravity field. 
The preflight, in-flight, and postflight studies conducted during the 
Gemini Program were intended to detect alterations in the functional 
status of the principal human body systems with increased flight
duration. The results of these studies indicated that some of the 
major human physiological systems undergo consistent and predictable 
alteration as a result of space flight. The significant biomedical 
findings in Gemini are listed in table IV. 
TABLE IV. SIGNIFICANT BIOMEDICAL FINDINGS IN GEMINI PROGRAM 
o Moderate loss of red cell mass 
o Moderatr postflight orthostatic intolerance 
o Moderate postflight loss of exercise capacity 
o ~1inimal loss of bone density 
o Minimal loss of bone calcium and muscle nitrogen 
o High metabolic cost of extravehicular activity 
It should be emphasized that the principal objectives of the 10 Gemini 
flights were to perfect the techniques of rendezvous, station keeping, 
docking and extravehicular activity--all critical to the Apollo lunar 
landing mission, then only four and one-third years away from Gemini 3. 
Three flights of the Gemini series were of medical and physiological
interest. Gemini 4, 5, and 7, lasting 4, 8, and 14 days respectively. 
Several in-flight measurements or experiments were accomplished on 
these missions, as well as preflight and postflight studies. There in­
vestigations confirmed the postflight orthostatic intolerance observed. 
in ~'lercury and extended the fi ndi ngs to i ncl ude moderately decreased 
exercise capacity and red cell mass, minimal loss of bone calcium and 
muscle nitrogen, and the high metabolic cost of extravehicular activity.
The medical findings' of the Gemini Program have been reported in detail 
elsewhere (2, 3, 4). 
APOLLO 1968-1973 
Eleven manned missions were completed in the five year span of the 
Apollo program: four prelunar flights (Missions 7 through 10); the 
first lunar landing (Mission 11), and five subsequent lunar exploratory 
flights (Missions 12 through 17). Apollo 13 did not complete its 
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lunar landing mission because of the unfortunate pressure vessel 
explosion in the service module. Instead, it returned to Earth after 
a partial lunar orbit. 
As stated previously, biomedical studies in Apollo were limited 
essentially to the preflight and postflight mission phases, along 
with in-flight monitoring and observations. Apollo witnessed the 
addition of vestibular disturbances to the list of significant bio­
medical findings incident to space flight. 
Vestibular disturbances with nausea were noted by Soviet Cosmonaut 
Titov during his one-day, Vostok 2 flight on August 6,1961, and by 
the crews of other later Soviet flights. No astronauts had experienced 
any motion sickness symptoms until the early Apollo experience. In 
retrospect, however, the anorexia and reduced caloric intake observed 
on certain Gemini and later Apollo flights, may have been, in fact, 
early symptoms of vestibular disturbance. 
Apollo 8 and 9 especially were plagued with vestibular problems: 
five of the six crewmen developed stomach awareness, three of the six, 
nausea, and two of these six proceeded on to frank vomiting. In 
Apollo 15 and 17, three of six of the crewmen also experienced stomach 
awareness. The flight plans of Apollo 8 and 9 required that the cer­
tain crewmen leave their couches soon after orbital insertion. All 
three Apollo 8 crewmen noted some motion sickness symptoms (stomach 
uneasiness or awareness, nausea, or vomiting), confined generally to 
the first day of flight. There is some confusion concerning the 
etiology of the Apollo 8 crew's symptomatology, since the Commander 
felt that a viral gastroenteritis accounted for (or aggravated) his 
symptoms. In Apollo 9, the vestibular disturbance lasted for a con­
siderably longer time, and in the case of the most severely affected 
crewman, necessitated a postponement of the flight plan. And thus an 
additional problem area was introduced into the American space experi­
ence. This disturbance, which had long plagued the Soviets and which 
had been predicted in the early 1960's as a probable effect of weight­
less flight, had made its belated American debut. Its late appearance 
was probably related to the relative immobility of the crews in their 
spacecraft during the Mercury and Gemini flights and the absence of 
any rotation of the vehicles themselves. 
Other significant biomedical findings in Apollo are indicated in 
table V. Generally, they confirmed the Gemini findings of postflight 
dehydration and weight loss, postflight orthostatic tolerance de­
crease, and postflight reduction in exercise capacity (5)., 
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TABLE V. SIGNIFICANT BIOMEDICAL FINDINGS IN APOLLO PROGRAM 
o Vestibular disturbances 
o Adequate diet; less than optimal food consumption 
o Postflight dehydration and weight loss 
o Decreased postflight orthostatic tolerances 
o Reduced postflight exercise tolerance 
o Apollo 15 cardiac arrhythmias 
o Decreased red cell mass and plasma volume 
In addition, the decreased red cell masses and plasma volumes noted 
in Gemini were confirmed, but were less pronounced in Apollo. 
One final observation deserving mention was the cardiac arrhythmia 
episode of Apollo 15. Two of the crewmembers each experienced a single 
run of bigeminy during the mission - the first significant arrhythmia
observed during any American space flight up to that time. Two short 
bursts (9 and 17 beats, respectively) of nodal tachycardia were ob­
served on the postponed MA-6 launch attempt of John Glenn in 1962. At 
the time of the arrhythmia, he was lying in his couch preparing for 
the final countdown. No arrhythmias were subsequently observed on 
Glenn either during flight or following his historic five hour orbital 
flight. In the case of the two Apollo 15 astronauts, it was first 
thought that a dietary deficiency of potassium might have been a 
contributory factor. Subsequent careful analysis of their intake and 
mission simulation studies failed to bear this out. The etiology
remains obscure. Fatigue, following vigorous lunar surface activities 
most certainly was a factor. Other contributory factors remain 
speculative and are likely to remain so. It should be noted that one 
of these two crewmen sustained a myocardial infarction in April 1973, 1 
some 21 months after his flight in July 1971. Thus coronary athero­
sclerosis was very likely a factor in one case at least. 
For further details concerning the biomedical results of Apollo, the 
reader is referred to the final summary report which will be available 
shortly (6). 
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SKYLAB 1973-1974 

The three principal objectives of the Skylab Program were the study 
of man, his Earth and his Sun. This symposium has reported on man's 
responses to long-duration space flight (7), Reports on the other two 
study objectives of the program will be forthcoming at a later date. 
Before summarizing the salient biomedical findings of Skylab, I should 
like to stress the sometimes overlooked fact that, in assessing the 
effects of weightlessness on man during prolonged space flight, we 
are not examining absolute effects or responses. Clearly, man is not 
vegetating in space, but is actually doing his utmost to maintain a 
high level of physical fitness and performance. Thus the absolute 
detrimental effects of null gravity will, in most cases, have to be 
determined in subhuman surrogates. Other points worth emphasizing 
are the relative inflexibility of the principal studies or measurements 
made on space missions, including Skylub, once conceptual design has 
been finalized; and the fact that space flight investigations are 
essentially "field studies", fraught with many attendant difficulties, 
in which the investigator is even farther removed from the experiment 
and subject than in field studies on Earth. And finally, although the 
measuring eqUipment is highly reliable in performance and the astro­
naut a superbly trained, perceptive scientist/observer in his own 
right - yet the circumstances fall short of the classical picture of the 
experimenting scientist in his exceptionally well equipped laboratory, 
constantly fine-tuning his equipment and personally conducting experi­
mental trials and collecting precious data. 
All these factors, notwithstanding, the efforts of the Skylab investi­
gative team have resulted in a major contribution toward understanding 
man in his new environment. 
Cardiovascular 
In the cardiovascular area we have learned that so-called cardio­
vascular deconditioning does occur during flight. that the change is 
adaptive in nature and stabilizes after a period of four to six 
weeks, that this change does not impair crew health or performance
aloft and that it is triggered by factors tending to reduce circulating
blood volume. These changes are summarized in table VI. 
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TABLE VI. SKYLAB CARDIOVASCULAR SUMMARY 
o 	 Cardiovascular deconditioning was observed during flight; 

changes appear adaptive in nature and tend to 

stabilize after 4 to 6 weeks. 

o 	 Cardiovascular changes do not impair crew health or ability 
to function effectively in weightless flight. 
o 	 Lower body negative pressure tests provide fairly reliable 
predictive index of postflight cardiovascular status. 
o 	 Cardiac electrical activity as measured by vectorcardiogram 
was not significantly altered and remained within 
physiological limits. 
o 	 Decreased cardiac output noted in crewmen postflight; 

thought to be related to reduced venous return. 

o 	 Single episode of significant cardiac arrhythmia in one 

Skylab 2 crewman during exercise early in mission. 

o 	 No significant in-flight decrement in work capacity or 

physiological responses to exercise. 

o 	 All crewmen have shown postfl ight decrease in exercise 

capacity and altered physiological responses. 

o 	 Skylab 3 and 4 crews returned to preflight cardiovascular 

status by the fourth and fifth day and the Skylab 2 

crew on the twenty-first day postflight. Increased. 

exercise by Skylab 3 and 4 crewmen thought to be a 

factor in improved recovery rate. 

The provocative lower body negative pressure test has proved to be a 
fairly reliable predictive index of postflight cardiovascular status. 
Cardiac arrhythmias have been rare: only one episode noted early in 
Skylab 2 during intensive personal exercise interpreted as multiple,
unifocal ventricular premature beats with no evidence of coupling. 
Other arrhythmias observed have been limited to isolated rare to 
occasional premature beats. Cardiac electrical activity has been 
within physiological limits as judged from the vectorcardiographic 
data. 
Exercise tolerance during flight was unaffected. It was only after 
return to Earth that a tolerance decrement was noted. 
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Finally, the rapid postflight recovery of orthostatic and exercise 
tolerance following two of the three Skylab missions appears to be 
directly related to total in-flight exercise as well as to a graded, 
regular program of exercise during the postflight debriefing period. 
As indicated in table VII, the postflight orthostatic intolerance 
and diminished exercise capacity are both related etiologically to 
a decreased effective circulating blood volume at one-g, with consequent 
decreased venous return and cardiac output. 
TABLE VII. CARDIOVASCULAR SYSTEM 
Findings 
o 	 Postflight orthostatic intolerance 
o 	 Postflight diminished exercise capacity 
Probable etiological factors 
o 	 Decreased effective circulating blood volume postflight 
o 	 Diminished venous return at one-g 
o 	 Muscular imbalance occasioned by functional disuse atrophy 
of antigravity muscles 
o 	 Altered internal milieu (fluid/electrolyte dynamic 
flux) during early postflight period 
o 	 ? altered venous reflexes/tone 
o 	 Fatigue 
Other factors to be considered are muscle imbalance, altered electo­
lyte flux, possible changes in venous tone or reflexes and, of course, 
fatigue. There is no convincing incidence of myocardial damage as an 
etiological factor; however, transient cellular changes during the 
period of homeostatic perturbation would not be surprising or unusual. 
In animal oxygen toxicity studies, we have observed such changes in 
lung, liver and kidney. 
The thrust of future cardiovascular investigations is indicated in 
table VIII. Continued human studies, as well as critical invasive 
experiments on animals must be conducted to define the time course of 
pertinent mechanisms. The Gauer-Henry reflex has yet to be demonstrated. 
This will not be easy to demonstrate in man, since the critical time­
period to be investigated is thought to coincide with the early 
operationally exacting first day of the mission. 
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TABLE VIII. CARDIOVASCULAR SYSTEM 
Rule out 
o Permanent myocardial damage (cellular level) - remote 
Candidate future cardiovascular studies 
o 	 In-depth, noninvasive cardiovascular dynamics 
monitoring 
o 	 Invasive pressure/volume/flow changes in early flight 
(animal) 
o 	 Demonstrate presence or absence of Gauer-Henry reflex 
o 	 Total body exercise regimen to maintain integrity of 
antigravity as well as major muscle groups 
o 	 Assess role of venous (capacitance) vessels in observed 
deconditioning process 
o 	 Assess role of fatigue 
Attention must also be given to devising an effective, practicable
exercise regimen for all major muscle groups, including the anti­
gravity muscles. 
Finally, we must assess the roles of the capacitance vessels or veins 
and the elusive fatigue factor in the deconditioning phenomenon. 
Mineral/Fluid Balance 
Findings in this area are sunmarized in table IX. They include the 
moderate losses of calcium, phosphorus and nitrogen that have been 
observed in the first two Skylab missions. Preliminary evaluation of 
data from these flights as well as from the 84-day mission tends to 
support the general observation that these losses are comparable to 
those observed at bed rest or six grams of calcium per month or five 
tenths percent of total body calcium per month. Complementary mineral 
losses in the as calcis have been relatively low. It would appear from 
these data that missions of from 8 to 9 months' duration would be 
feasible without preventive or remedial measures. 
The Skylab experience has provided evidence that the caloric require­
ments of space flight are identical with those for the individual on 
Earth - at least for high activity missions such as Skylab. From the 
Gemini and Apollo experience we were led to believe that the in-flight 
caloric requirements was some 300 calories/day less than Earth require­
ments. This judgment may have been colored by the relative low 
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activity profiles of these missions, and the fact that the food pro­
vided was often not consumed. In retrospect, as mentioned before, this 
anorexia may have been a manifestation of early motion sickness and not 
recognized as such at the time. 
TABLE IX. SKYLAB MINERAL/CALORIC, FLUID/ELECTROLYTE SUMMARY 
o 	 Moderate losses of calcium, phosphorus, and nitrogen have 
been observed comparable to those seen in bedrested sub­
jects: 6 grams/month calcium or 0.5 percent/month total 
body calcium. 
o 	 Rate of calcium loss would not preclude extended missions of 
8 to 9 months' duration. Longer missions may require re­
medial measures. 
o 	 Significant os calcis mineral loss: 
Skylab 3: Scientist Pilot: 7.4 percent 
Skylab 4: Scientist Pilot: 4.5 percent; Pilot: 7.9 percent 
o 	 Caloric requirements during flight identical with individual 
requirements at one-g. 
o 	 Renal function unimpaired; however, apparently unique adaptive 
functional changes observed require further study. 
o 	 Skylab 4 anthropometric studies consistent with predicted 
shift of body fluids during weightless flight. 
Renal function was unimpaired during flight through a complex interplay 
of humoral and possibly hemodynamic factors as we will consider shortly. 
In addition, anthropometric studies performed on Skylab 4 support a 
cephalad shift of body fluids at zero-g. 
With regard to the musculoskeletal system, the negative balances ob­
served are due primarily to the absence of gravity as shown in table X. 
However, the correct balance of weight bearing, muscular activity,
hormonal influence and circulatory factors required to prevent or arrest 
mineral and nitrogen loss during bedrest simulations has to date defied 
definition. Elevated cortisol secretion during flight helps to confound 
the picture and doubtless contributes to nitrogen and potassium loss. 
Continued studies must be pursued--and we are currently active in this 
area--to define absolute catabolic change in the musculoskeletal system 
of animals. We also continue to evaluate various countermeasures in bed­
rest studies in order to determine the most suitable for flight use. More 
attention must be given to the selection of individuals who are most 
refractory to catabolic influences of space flight. The prediction for­
mula of Vogel, et at., may be useful in this regard. 
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TABLE X. MUSCULOSKELETAL SYSTEM 
Finding 
o Moderate losses of calcium, nitrogen, and phosphorus 
Possible etiological factors 
o 	 Primary - loss of gravity gradient 
o 	 Secondary 
Absence of weight bearing 
Absence of hydrostatic venous gradient 
? hormonal imbalance (elevated cortisol secretion)
Combinations of above 
Candidate future studies 
o 	 Absolute catabolic in-flight changes (bone, muscles) 
in animals 
o 	 Countermeasure evaluation 
Dietary 

Physical

? Hormonal 

o 	 Selection criteria for prolonged missions 

(Prediction formula) 

Fluid and Electrolytes 
Following Apollo and before Skylab a working hypothesis was advanced (5) 
which provided a logical flow of events outlining the adaptive changes 
in the fluid, electrolyte and hormonal area. The essential steps in 
this adaptive process are outlined in figure 2. In brief, the 
relative hypervolemia (total circulating blood volume) experienced 
on orbital insertion resulted in decreases in antidiuretic hormone 
(Gauer-Henry reflex) and aldosterone resulting in a diuresis of water 
and solute (sddium and ?potassium). Such a diuresis may have occurred 
during mission day 1, but was not evident since fractional urine 
samples could not be obtained due to mission constraints. Thus, a 
diuresis could have occurred but was obscured by collection procedures
or modified by increased insensible loss and sweating which were not 
measured. 
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Figure 2. Adaptive responses to weightlessness pre-Skylab hypotheSiS. 
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Even assuming the occurrence of a diuresis during early mission, there 
are some consistently paradoxical findings which are difficult to recon­
cile with the working hypothesis. These findings are listed in table XI. 
Antidiuretic hormone secretion was uniformly decreased during all 
missions with the exception of Skylab 2 in which case it was elevated, 
especially in early mission following the overheating of the orbital 
workshop. Also, aldosterone secretion was consistently elevated 
throughout all missions, and particularly in the early part of 
Skylab 2 and 3. Despite this elevated aldosterone, solute (sodium and 
potassium) excretion was consistently elevated and was reflected in the 
increased urine osmolality. As stated earlier, the consistently elevated 
cortisol secretion doubtless contributed to muscle catabolism and in­
creased nitrogen and postassium loss. Its overall effect on fluid and 
electrolyte homeostasis must remain conjectural at this pOint in time. 
In general then, it is evident that internal homeostasis and satis­
factory renal function are maintained through complex humoral and/or 
hemodynamic (physical) factors that await clarification. 
Future studies currently being pursued at this Center include demon­
stration of the presence (or absence) of the Gauer-Henry reflex during 
early weightlessness, the changes in renal hemodynamics during zero-g; 
the renal response to provocative stresses such as water loading, salt 
loading and water deprivation during space flight; and the hormonal 
interplay involved in these processes. 
TABLE XI. FLUID/ELECTROLYTE AREA 
Pre-SkYlab working hypothesis 
Paradoxical Skylab urinary findings 
o + Antidiuretic hormone (t Skylab 2) 
o t Aldosterone secretion 
o t Na+ K+ excretion 
o t Osmolality 
o t Cortisol 
Interpretation 
o Internal homeostasis maintained 
o Renal function maintained 
o 	 Interaction of complex humoral (and ? hemodynamic)
factor.s required to maintain homeostasis during 
weightlessness 
Future studies 
o Demonstrate Gauer-Henry reflex 
o Renal hemodynamics in zero-g 
o Renal response to water/salt loads, dehydration in zero-g 
o Humoral interactions involved in above 
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Hematology 
Red cell mass loss was again observed following the Skylab missions. 

The mean loss in Gemini was about 17 percent; in Apollo, 10 percent; 

and ln Skylab, 8 percent. Further, the mean loss in Skylab 2, 3, and 4 

was 9.4 percent, 8,6 percent. and 5.9 percent respectively. Other 

findings in the areas of hematology, immunology and cellular biology 

were not consistently remarkable as indicated in table XII. 

TABLE XII. SKYLAB HEMATOLOGY, IMMUNOLOGY AND CYTOLOGY SUMMARY 
o 	 Loss of red cell mass observed postflight 
appears to be suppression of red cell 
production rather than increased destruction. 
o 	 Red blood cell mass loss not related to mission 
duration. 
o 	 No significant changes consistently observed 
in humoral or cellular immune responses. 
o 	 Cellular proliferation (tissue culture) normal 
during space flight. 
The red cell mass losses are apparently related to marrow suppression
(table XIII), since there is little evidence to support increased cell 
destruction. The stimulus resulting in marrow suppression is not clear 
and requires further study. Toxic suppression appears remote; physical 
factors, such as a pulse of increased hone marrow venous pressure should 
be investigated. It is apparent that there is no increased red cell 
mass loss with increased mission duration. The apparent diminition in 
red cell mass losses from Gemini through Skylab may be a reflection of 
the distance of the first postflight sampling period from the initial 
in-flight suppressive stimulu~ (fig. 3). 
TABLE XIII. HEMATOLOGIC SYSTEM 
Finding 
• Red cell mass loss 
Etiological factor(s) 
.• Increased destruction - no evidence 
• Marrow suppression 
Toxic 
Physical (increased blood volume. Bone marrow 
venous 	 pressure) 
Candidate future studies 
, • Ground-based marrow-suppression factors 
• Validate Skylab results on longer Earth-orbital flights 
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Figure 3. Red Cell Mass/Skylab. 
Clearly, ground-based studies regarding the bone marrow suppression 
mechanism must be pursued. Further validation of the Skylab results 
should be pursued on orbital flights of longer than 4 months' duration, 
since the mean life span of the red blood corpuscle is 120 days. 
Neurophysical and Performance Areas 
The salient findings in the neurophysiological and performance areas 
of Skylab are indicated in table XIV. 
TABLE XIV. SKYLAB NEUROPHYSIOLOGICAL AND PERFOMANCE Slt'MARY 
• After Inftfal fn-fllght adaptive period. all crewmen show marked 
Increased tolerance to motion sickness measured by rotation 
and head movements. Tolerance threshold gradually reverted 
to baseline post flight. Antlmotlon medications helpful In 
contro 1 of symptoms. 
• No major disturbances noted 1n quantity or quality of sleep . 
• Carefully regulated crew work/rest cycles essential for 
maintaining crew efficiency. 
o Postflight hyperreflexia confirmed and quantftated. 
o Improved In-flight performance efflcfency exhibited by all 
crews • 
• Overlearning recommended for critical tasks on short-duration 
IIlsslons. 
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Among these findings, the occurrence of motion (space) sickness symptoms 
during the first few days of space flight is of paramount operational 
importance for the forthcoming Shuttle flights. Some possible 
etiological factors are indicated in table XV, although at the present 
time true etiological factor or factors cannot be specified. It would 
appear that otolith function is profoundly influenced by null gravity 
and its modulating influence perturbed; sensory inputs are accordingly 
distorted and appropriate responses are not forthcoming, since these are 
based on a one-g environmental memory store. Presumably, a repatterning 
of this central memory network must perhaps occur, so that new and un­
familiar zero-g sensory inputs are correctly interpreted and appropriate 
motor responses elicited. This repatterning of the central memory core 
is, we believe, the end result of the process of habituation or adapta­
tion. Other contributory factors should be considered such as hyper­
volemia or increased venous pressure effects on the vestibular system. 
Future studies in this area should address the problem of space sickness 
slJsceptibility and the development of a reliable predictive test for this 
susceptibility in candidate crews and passengers. Basic studies should 
be pursued relative to etiological factors involved in the space sickness 
syndrome and the role of one-g training in its prevention or mitigation. 
Finally, improved medications should be sought for more effective pre­
vention or control of the vagal manifestations of this vestibular 
disturbance in space. 
TABLE XV. SKYLAB VESTIBULAR FINDINGS 
Possible etiological factors 
o Otolith receptor physiological deafferentation 
+ Modulating influence on canals 
Direct interaction with canals 
Rule out: 
o 	 Influence of hypervolemia
(Transient t pressure) on vestibular system 
Candidate future studies 
o 	 Role of altered cues: visual, kinestHetic other sensory 
o 	 Effect of overhydration, dehydration and increased venous 
pressure on motion sickness threshold 
o 	 Predictive test for zero-g space sickness susceptibility 
(1 parabolic flights) 
o 	 Basic studies regarding etiology 
o 	 Role of one-g training in prevention 
o 	 Improved medications for prevention/control 
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GENERAL SUMMATION 

Table XVI lists the general conclusions reached as a result of the 
Skylab biomedical experience. In substance, the findings indicate 
that man adapts well to and functions effectively in the space environ­
ment for time periods approaching three months. Appropriate dietary 
intake coupled with adequate, programed exercise, sleep, work and 
recreation periods are essential to crew health and well being. No 
untoward physiological responses have been noted that would preclude 
longer duration space flights, but more research is required in order 
to understand the mechanisms involved in the observed responses. 
Finally, remedial or preventive measures may be required for Mars-type 
missions, and further study of man in Earth orbit for an uninterrupted 
six-month period should ideally precede this Mars-type mission - truly
the gate~ay to exploration of the Universe: a step which may bring man 
closer to answering the eternal questions of whence he came, why he is 
here, and whither he goes. 
TABLE XVI. SKYLAB GENERAL SUMMATION 
o 	 Biomedical results show that man can adapt and function 
effectively in weightless environment for extended 
periods. 
o 	 Daily in-flight personal exercise regimens coupled with 
appropriate dietary intake and programed adequate 
sleep, work and recreation periods essential for· 
maintaining crew health and well-being. 
o 	 No untoward physiological changes noted that would 
preclude longer duration manned space flights; 
however, research required to understand the 
mechanisms responsible for many observed changes. 
o 	 Remedial or preventive measures may be required for 

mission durations in excess of 9 to 12 months 

(e.g.~ bone demineralization countermeasures) 

o 	 Ideally, further observations of man in Earth orbit for 
an uninterrupted period of 6 months should precede a 
Mars-type mission. 
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SYMPOSIUM PANEL DISCUSSION 
Charles A. Berry, M.D., M.P.H., Moderator 
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DR. BERRY: Could we ask the panelists to please come up and take a 
seat at the table? 
Well, colleagues, ladies and gentlemen, we've reached that point that 
we've all been waiting for, to try and decide the total meaning of all 
the material which has been presented. That's an awesome task. I 
think Dr. Dietlein did a fantastic job of pulling his materia: to­
gether. I certainly think his summary was excellent and he did a very 
good job of telling us where we are. 
There are a few remarks that I would like to make at the outset, and 
then I would like to note how we're going to work the remainder of 
this session. For this period, we have asked the panelists covering 
various areas, to be a part of this discussion and give their views 
of the data. They're not limited to their special area of discussion, 
but they should present their views concerning what they have heard of 
these results. These statements will be relatively brief so that we 
don't end up with a whole series of papers allover again. The 
objective is to have some interchange among those of us on the panel 
and with you in the audience. We particularly want those who have 
been investigators, those of you who have been carrying out some of 
these studies, to address questions you may have to the panelists. It 
would be interesting to determine if they view the data the same way 
you did. 
Now I think it's very important that we all realize one of the things 
that Dr. Dietlein said and is well stated in the title of his paper. 
This point is still a beginni~g. It's a culmination, though, of many
things, as you saw from the slides that he presented; and that there 
are many people in this room who have had a tremendous amount to do 
with reaching this pOint. There are some people whom I think have 
not been singled out --- and this is always dangerous, once you 
start doing that. I want to say at the outset that there is no way
possible that I could single out all the people in this room who have 
something to do with making today possible, and this day is possible 
only after roughly the last 15 years of activity in this field --- a 
tremendous effort to get us to the point where we had data to review 
as has been done today. 
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I would like to congratulate the entire biomedical team for the 
development of this symposium. As you know, this team is composed of 
members from both inside NASA and from the scientific community. ~lith­
in NASA we have people from the Johnson Space Center, from other 
Centers and Headquarters. ~'1y congratul ati ons are di rected to this 
entire group, and in particular, to the Johnson team who worked so 
earnestly in organizing the program in which we are participating 
this afternoon. Now some of the individuals who are in this audience 
are people who have formerly worked with this team in one form or 
another. They've had activities tied with the team -- trying to get 
data for one area or another or working with the operations teams. 
Many of you are here because of those particular interests and welre 
thankful to all of you. There are some people here, though, who have 
played a particular role in some of our activities over the years 
because they've taught many of us and led many of us down these 
productive paths. Dr. Strughold I see sitting over here. Hets 
been with us for many, many years and really led us into space 
medicine. I think we owe a particular debt to him. We also have a 
couple of people in the audience who were quite active in leading the 
team of us who were involved at the very beginning of the program back 
in the Mercury days. They have since moved to other areas, one of 
them only recently, but they are sti 11 very tied to our area of 
interest. 11m referring to Stan White and Bill Douglas, who are here 
in the audi ence. \~e have Dr. Hi tchcock down here in the very front 
of the room, and it's people such as he who have helped to teach us 
along the way and have made great imprints upon the capability to 
develop data such as youlve seen here. Dr. Bjurstedt and Dr. Gauer 
from across the oceans are here with us in the room. You~ve heard 
Dr. Gauer's name mentioned so many times during the symposium.
Drs. Luft and Sam White from Lovelace started very early in the 
program working with us, and they have continued with that activity. 
We could go on and on and on with people like these. There is another 
thing I would like to emphasize -- there are a number of panelists
here who went through some very trying times with us. 
I saw Herb Hultgren out in the audience during the last three days, 
and lid like to say something about the role he and some other fine 
people played wi.th us. Youlve heard many very fine comments about 
what great teamwork we had; what a great job everyone has done and 
how happily it's all ended. Today, everyone is bouncing and full of joy. lid like to tell you that this last year has not always been 
bouncing and full of joy for the people who have been working on 
this program. At times, I tell you very personally, I considered it 
hell. And I'm not sure that some other people on the team didn't 
consider it that way also. So while it has all turned out great, I 
don't want anyone to go away from here with the idea that it's easy
and that it all just sort of happens, because it doesn't just happen. 
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There were daily problems, and these were alluded to in some of the 
opening morning speeches vlhen some of our key peopl e in the Program 
Office mentioned that there had been some of these early problems. 
Some of the people who were talking about the program operations 
mentioned these, and there was daily some sort of difficulty in 
trying to work out the problems which were occurring on a minute-to­
minute and hour-to-hour basis. These problems and their resolutions 
were important to the outcome of these data which you've heard 
discussed here. While some of them may have sounded not important 
at the time, they had great importance; and those decisions required 
were not always easy to reach, and they always vleren' t made to 
everyone's satisfaction, of course. There \'Ias severe management 
concern, and Dr. Oietlein, I think, led up to that very well in some 
of the things that he was telling you about past history. 
I'd like to call to your attention the fact that the cardiovascular 
system, while it was the first system that was ever noted to show 
measurable changes and with which we had problems~ certainly remained 
one of concern. This concern was augmented by our problems with 
Apollo 15 - the arrhythmias \'Jhich were mentioned -- and then a great 
deal of data which we obtained from our Russian cohorts. I would 
just make one parenthetical statement here; that we have come a long 
way in our dealing with our Russian colleagues over these years. A 
great deal has changed in the last 15 years. We've exchanged a 
significant amount of data directly. They're looking at many of the 
same problems and questions as we are. They're not always looking at 
them in the same way that we are, but they're searching for an under­
standing of the physiological mechanisms. 
These concerns of top management surfaced to the point that we were 
required to get decisions we~kly, for medical purposes, as to whether 
we would continue to extend the mission or not. I can tell you that 
those weekly meetings were deadly serious; that the Administrator was 
very, very serious about what he was going to do, or not do, and he 
required that he be reassured by evidence. It was fine to try and 
give that reassurance on a personal basis, backed by our NASA team 
such as we had conducting these missions, but we needed other assist­
ance. We formed two particular consultant groups. One group was a 
cardiovascular group. And John Shepherd, who's here on the panel, 
spent a great deal of time with that. Scott Swisher, who is also a 
member of this panel, was on that group. This group met many times 
during the course of the' program. They met with others and gave of 
their time unstintingly to help us convince management; I needed that 
support and 11m deeply grateful for it. We also had a group that was 
organized to try and look at the vestibular area, and one of those 
people is here on the panel, t~elvil1 Jones. Itls hard to find many 
vestibular experts once you get past Ash Graybiel. We went to great 
817 

lengths to try and find vestibular people to come. They did meet and 
we appreciate the guidance they provided. 
I've revi ev~ed the remarks that I had a chance to present in tryi ng 
to sum up this program on two previous occasions; namely, the Fifth­
Man-in-Space Symposium last December, and then again in May at the 
Aerospace Medical Association meeting. In December, we were still 
flying the last mission and in May, we were at the point where the 
missions were completed and we were sort of able to sum up, at least 
with data as they were revealed at that point in time. I don't think 
that I would change anything that I said in any of those remarks, and 
so I'm not going to repeat them here today. I think that Dr. Dietlein 
has summarized very well the status that we all believe exists and 
that man has sholtln adaptive changes to a unique environment. In some 
cases, these changes are definitely going to require some counter­
measures. I think in the calcium balance area we're going to have to 
use countermeasures. I suspect even in the cardiovascular area we're 
going to continue to look for these procedures. 
There is one observation that I would like to leave you with, and 
that is the fact that we are defining many new norms as we look at 
these findings. There's no question about that. We're looking at 
man, normal man, placed into this very unique environment. As we 
make our observations, we know we can't look at the absoluteness of 
weightlessness because man is qoing about his mission activities. 
Still I believe that we are conducting an unparalleled experiment in 
man's adaptation. As we derive these new norms, we are able to look 
at the hypothesis that we've developed. There are some gaps in this 
hypothesis and they lead to the future research that needs to be done. 
I hope that our panelists are going to identify a good deal of that 
needed research in their discussions. 
I'm left \vith the feeling that \-<Jhile \-/e have probably come up with 
more questions than answers, still we have gained a lot of answers. 
And certainly, if you look back at the time of the beginning of 
Mercury, we've come a long way in deciding what's really happening to 
man in this very unique environment. Now I'd like to begin our panel 
discussion~ The cardiovascular system was mentioned first. To save 
time, 1'11 not introduce everybody on the panel until we come to them. 
First, although listed on your program, Neal Bricker is not with us. 
Nor is Ted Cooper. 1'm going to call on Dr. Epstein in a moment, as 
he is replacing Dr. Cooper. lid first like to call on John Shepherd, 
because of his interest in the cardiovascular system which we've 
mentioned so frequently and most recently in our elaborations of the 
last day and a half. And so, John, I'd like for you to take a few 
minutes and give us your views about how you sum this all up, as far 
as the cardiovascular system is concerned. 
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John T. Shepherd, M.D., D.Sc. 
Director for Research 
Mayo CZinic and Foundation 
200 First Avenue S.W. 
Rochester> Minnesota 55901 
For those of us from the biomedical community who have followed the 
progress of the manned space program from its inception, this symposium 
has been a great occasion, and t~r. Richard Johnston and his colleagues 
at the Space Center deserve our congratulations. Over these years you, 
our colleagues in NASA, have been receptive to suggestions and tolerant 
of our lack of understanding of the lead time which is essential for the 
proper implementation of experiments to be conducted during manned space 
flight, and the constraints that are necessary to meet the overall 
objective of each mission. By the cooperation you have achieved between 
the astronauts, the in-house NASA scientists and the scientific 
community, we now have, as Dr. Larry Dietlein said in his excellent 
summary of the symposium, objective data of man's ability to adapt to 
the space environment, and hence of his potential for extended space 
missions. As Doctors Ker~'1in and Musgrave so aptly rut it, "just feed 
us, house us and let us exercise". 
Dr. Berry has reminded us that all this has not come about easily, but 
rather as a consequence of a logical progression of knowledge and 
appropri ate adjustments as we moved through the mi ssi ons from ~lercury, 
Gemini, and Apollo to Skylab. ~1any of you will recall our long-past 
panel discussions at Woods Hole, Cape Cod, as we talked wisely of 
cardiovascular deconditioning, without much idea of what we were talking 
about in coining this term. We worried about potassium loss and cardiac 
arrythmias in the later Apollo missions. Today for those interested in 
the cardiovascular system, you have provided a clear picture of the 
physiological changes in space flight, which can fit into an accepted 
and logical pattern of normal cardiovascular adaptation. 
With the achievement of the weightless state, fluid shifts quickly 
from the lower to the upper part of the body. Evidence for this has 
been given by the astronauts. Doctors Gibson and Kerwin have described 
to us the fullness of the head which they experienced, the distension 
of the head and neck veins, the congested sinuses and the facial puffi­
ness. Leg measurements have demonstrated a rapid decrease in leg volume. 
With this transfer of blood and tissue fluid from the legs to the 
central circulation (one might estimate the amount to be around 700 mtlli­
liters) the volume of the heart and the cardiac filling pressure is 
increased. This results in a small increase in cardiac output, due 
mainly to an increase in stroke volume because of the greater end­
diastolic volume of the ventricles (Frank-Starling mechanism). At the 
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same time the activity of the mechanoreceptors in the cardiopulmonary 
region is increased; this results in a greater inhibition of the 
vasomotor centers with a resultant reduction in sympathetic adrenerqic 
outflow. Consequently the peripheral blood vessels dilate so that the 
total systemic vascular resistance is decreased. Evidence for this was 
provided by Dr. Johnson, who shovled that during weightlessness there 
was a widening of the arterial pulse pressure and by Dr. Thornton who 
indicated from measurements made on the calf of the leg by venous 
occlusion plethysmography that the blood flow to the legs may be 
increased. 
Even though the cardiopulmonary receptors are strongly activated by 
the increased volume of blood in the heart and lungs, the magnitude 
of the peripheral vasodilatation is limited by the counterbalancing 
effect of the carotid baroreceptors. In cats and dogs these latter 
receptors are more effective in opposing the increase in muscle blood 
flow and the glomerular filtration rate will be increased. Diuresis 
is facilitated by the reduced reabsorption from the renal tubules, 
since stimulation of the cardiac receptors results in a diuresis which 
is brought about by a blood-bone agent. 
At the same time the amount of renin released from the kidney is reduced 
because these cardiopulmonary receptors act continuously to inhibit its 
release and the more so when they are strongly stimulated. As a con­
sequence less angiotensin II is secreted. Thus there is a loss of fluid 
from the body as a consequence of this normal response to an increased 
central blood volume. Somehow, as I hope Dr. Scott Swisher will tell 
us, the red blood cells are reduced in proportion to the decrease in 
plasma volume. The astronauts have reported that exercise relieves the 
fullness of the head. With the severe exercise which they undertook 
the blood flow to the active muscles is increased as the arterioles 
dilate. This causes an increase in pressure in the capillary and post­
capillary vessels in these muscles so that fluid passes from the 
capillaries into the interstitial spaces and more blood is accommodated 
in the post-capillary bed; as a consequence, the distension of the 
vessels in the thorax and head is lessened. With the application of a 
given set of negative pressures to the lower part of the astronaut's 
body during the Skylab missions, there was a greater increase in heart 
rate and in diastolic blood pressure (indicative of a greater reflex 
constriction of systemic resistance veesels) than when the same 
stimulus was applied on Earth. In the weightless state, with less blood 
and tissue fluid in the legs, and more in the central circulation, more 
blood is pulled into the lm"ler body vJith application of the same 
negative pressure than in a gravity environment. The reductior. of the 
stimulation of the cardiopulmonary mechanoreceptors is greater, the in­
hibition of the vasomotor centers is less, and hence the increase in 
sympathetic adrenergic outflow is more than that with the same test 
preflight. 
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If we could amputate the legs, which have little use and indeed may he 
an inconvenience in space flight, these shifts in blood volume would 
not occur. In fact, the major question for prolonged space flight is 
\1ha t to do about the 1egs . The bones in the 1egs lose cal ci U111 as they 
no longer perform their normal function of weight bearing. Exercise 
seems the best answer and the astronauts described an ingenious plastic 
platform they used that slips backwards with each step, so that as the 
subject walks he stays in the same position. 
Immediately on return to Earth gravity these changes are reversed. There 
is more blood in the legs and less in the upper part of the body. Since 
both the plasma and the red cell volume are slightly reduced, the system 
as a whole must adjust to a smaller total blood volume. The fillinq
pressure of the heart is decreased, the heart volume is less and as­
shown by the excellent echocardiographic studies of Doctors Henry and 
Epstein, the stroke volume and diastolic volume are reduced. With 
exercise under these conditions the increased cardiac output to meet 
the increased oxygen requirements is achieved by a faster heart rate 
and a smaller stroke volume. Also, the hemodynamic response to lower 
body negative pressure will continue to be exaggerated until blood 
volume which is customary for Earth's environment is restored. Again
it is important to emphasize that these are the normal cOP.1pensatory 
physiological responses to changes in blood volume and its distribution 
within the vascular system. At this time, immediately postflight the 
astronauts report that they are thirsty and drink freely. 
As we turn from the studies of Skylab and look to the Shuttle era, the 
success of the forP.1er has provided the stimulus for gaining new under­
standing of man in the latter. There is much still to be learned from 
well-conceived animal experiments and complimentary studies on man, 
both on Earth and at zero-g. 
For example, the presence of mechanoreceptors in the heart and lungs 
has long been known, and many investigators are active in studies 
designed to elucidate their function and morphology. Complex unencap­
sulated sensory endings are present around the junctions of the 
pulmonary veins and of the caval veins with the left and riaht atrium 
respectively. It has been postulated that there are two types of 
these receptors, one type having its bursts of activity coincident 
with the a-wave of the atrial pressure pulse, and the other with 
activity related to the v..wave. Others conclude that their character­
istics are similar. They are connected to medullated vagal afferents 
and their stimulation causes an increase in heart rate, a decrease in 
activity in nerves to the kidney and a diuresis caused by a blood-bone 
agent. Discussion continues as to whether the diuresis is caused by 
a decrease in the concentration of antidiuretic hormone or an increase 
of an unknown diuretic substance. By contrast vii th these receptors 
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with medullated afferents, there exists in the left ventricle and in 
the atria a diffuse and large population of receptors connected to 
slowly-conducting non-medullated vagal afferent fibers. Activation of 
these receptors causes bradycardia, a generalized vasodilatati0n, and 
especially an augmentation of the vagal outflow to the heart receptors, 
probably located in the left ventricle and \,/ith unmyelinated afferents 
in the vagi. Thus it is possible that a similar mechanism in man 
contributes to the sickness experienced by the astronauts. The lung 
too, like the heart, is a source of reflexes which modify the cardio­
vascular system and which merit further study. The role of left 
ventricular receptors in the causation of the vasovagal reaction also 
needs elucidation; it has been suggested that the vigorous contraction 
of the ventricles when their volume is reduced miqht excite these 
receptors and induce a reflex bradycardia. Perhaps this might occur 
in susceptible subjects with the reduction in central blood volume 
that follows the application of negative pressure to the lower body. 
The Shuttle too with its increased facilities for observations in man 
will permit a more detailed analysis of the rapid adaptations in the 
body systems which occur within the first few hours of weightlessness 
and which provide the explanation for the subsequent responses to 
various stresses. 
Thus the wealth of data which has been accumulated on the adjustments 
of man to space travel, and which have been so well described in this 
symposium, truly establish his future role in the exploration of our 
un i verse. 
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Professor: Dr. Otto H. Gauer 
Director, Physiological Institute of the lTee University 
West Berlin, Germany 
[Note: Although Dr. Otto Gauer was not a Panelist per se his comments 
together with illustrations and references fit most appropriately into 
the panel discussions at this point, and are therefore included.] 
I was much impressed by Dr. Kerwin's vivid description of the severe 
engorgement of the cephalad circulation characterized by extended neck 
veins, a puffy face and nasal congestion. These findings are corro­
borated by Dr. Thornton's report of a dramatic loss of extracellular 
fluid and blood volume from the thighs and calves in the order of two (!) 
liters. This figure is based on foolproof anthropometric measurements. 
Although venous pressure was not recorded, we can safely assume, that 
the intrathoracic circulatory compartment, which has to accommodate 
the lion's share of this volume, was greatly distended. In the weight­
less condition the cephalad fluid displacement was in all likelihood 
greater than that induced by whole body immersion in a thermoneutral 
bath. It is therefore not surprising that similar effects on circula­
tion and fluid balance in the weightless condition (1-6) and in whole 
body water immersion have been observed. Upon immersion, intrathoracic 
blood volume increases by 700 milliliters (1), and the heart volume 
by 320-120 (mean 180/milliliters) (5). (Figure 1, table I.) 
This engorgement is reflected in an elevation of central venous pressure
to 12-15 mm Hg (3) (fig. 2). The distension of the heart has a primary 
effect on cardiac dynamics and secondary reflex effects on the arterial 
and capacitance systems (table I). Thus an increase in cardiac output, 
a fall in total peripheral resistance (TPR) and a reduction in the tone 
of the capacitance system were well established during immersion and 
weightlessness. Furthermore the volume control reflex is activated 
for the relief of the central engorgement. This reflex is by no means 
adequately described by the sequence: left atrial distension, reduced 
antidiuretic hormone (ADH) secretion, diuresis. Numerous factors are 
involved (2,4) (fig. 3). Although the final results, namely, plasma
volume loss, impaired orthostatic tolerance and reduced working capac­
ity are the same after exposure to immersion or weightlessness there are 
considerable differences in the behavior of the effector mechanism. 
For example; during immersion a negative fluid balance is effected by 
excess urinary excretion, in weightlessness this effect is attained by
deficit drinking. During immersion the attenuation of plasma volume 
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immersed 
Figure 1. Roentgenometric demonstration of the change of heart size 
in relation to posture and immersion in a bath. The lines 
to calculate heart volume from the postero-anterior (left)
and the lateral projection (right) have been drawn. With 
immersion of the subject standing in air heart volume rises 
by 233 ml. Considering the severe congestion of the 
cephalad circulation in the weightless condition a similar 
increase in heart volume can be expected. (Lange,L. ' et aZ.~ 
1974. ) 
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TABLE I. CIRCULATORY CHANGES INDUCED BY WHOLE BODY IMMERSION* 
Primary and secondary effects on the circulation induced by
whole body immersion. (Data from Arborelius et aZ. 1972, 
Echt, Lange and Gauer 1974 and Lange et aZ. 1974) 
Pr-jmary Effects 
A Central Blood Volume (L)t +700 m1 
A Heart Volume (G)t +180 ml 
A Central Venous Pressure (G,L) +12 to +18 mm Hg 
A Intrathoracic Pressure (G,L) + 4 to + 5 mm Hg 
A Transmural Pressure (G,L) + 8 to +13 mm Hg 
Secondary Effects 
A Stroke Volume (L) +35%'" ..t. 
A Cardiac Output (L) +32%J..L. 

A Total Peripheral Resistance (L) -30% 

A Peripheral Venous Tone (G) -30% 

A Arterial Pressure (L) +10 mm Hg§ 

*Subject standing or sitting erect in air versus 
standing or sitting in water . 
..t.
'(G) Gauer and co-workers; (L) Lungren and co-workers. 
iHeart rate was unchanged. 
§The arteriovenous pressure gradient was not changed 
since CVP was increased by the same amount. 
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Figure 2. 	 The effects of \'1hole body il1ll1ersion on various parameters. 
From above: peripheral venous tone; central venous pressure, 
oesophageal pressure, central venous transmural pressure, 
peripheral venous pressure. Recording of oesophageal 
pressure was discontinued after 1 hour il1ll1ersion. N=5. 
(Echt, .M. et al' J 1974,) 
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Figure 3. 	 Intrathoracic vascular distension induced by whole body immersion and plasma
volume control. With an increased intrathoracic volume the combined effect of 
several hormonal mechanisms leads to an increased renal excretion of water and 
sodium. a tendency towards outward filtration in the capillary bed and (pro­
bably an attenuation of the thirst mechanism. The three effects combined (or
single) lead to a reduction in plasma volume. (Gauer. O.H .•1973.) 
is supported by an increased outward filtration (6), which is probably
distributed over the whole body (2). In the weightless condition this 
outward filtration is obviously confined to the cephalad regions. Not 
easily explained is the observation presented by Dr. Leach, that sodium 
loss in the weightless condition occurs iri spite of an increased 
aldosterone activity. Of particular interest is the adaptation of 
the red cell mass to the reduced plasma volume. In summary, numerous 
problems have been presented by the Skylab results. If they can be 
solved, our knowledge of the overall regulation of circulation and 
fluid metabolism will be greatly augmented. 
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Stephen E. Epstein, M.D. 
Chief> Cardiology Branah 
National Heart and Lung Institute 
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Bethesda> Maryland 20014 
Dr. Shepherd painted quite beautifully the broad strokes of what can be 
derived from the data youlve heard over these past few days. What I'd 
like to do now is to focus on a few specific questions I believe still 
remain to be answered regarding the long-term effects on myocardial 
function of prolonged space flight. 
The results of the excellent paper presented by Dr. Bergman on systolic 
time intervals led him to the conclusion that there seemed to be at 
least some depression of myocardial function following return from 
space. However, it is quite clear from the studies of Dr. Bergman and 
his associates that systolic time intervals are exquisitely sensitive 
to preload; that is, during lower-body negative pressure (when, as our 
echocardiographic data show, left ventricular end-diastolic volume 
decreases), measurements of the systolic time intervals change. There­
fore, interpretation of the meaning of changes in systolic time inter­
vals is complicated, and distinction between alterations in intrinsic 
myocardial function from changes in the loading conditions of the heart 
may be impossible. However, on the basis of the ventricular function 
curves we were able to perform with echocardiography, we found no 
evidence of deterioration in intrinsic myocardial function. Paren­
thetically, lid like to suggest that it might be interesting to relate 
the changes in systolic time intervals to the existing left ventricular 
end-diastolic volume. We know what left ventricular end-diastolic 
volume was at the time Dr. Bergman was measuring the systolic time 
intervals. Thus, we might be able to conclusively demonstrate whether 
or not changes in these intervals are caused by changes in ventricular 
volume. 
Although I would like to state that the echo studies unequivocally 
demonstrate that there is no impairment in myocardial function, I don't 
think we can be absolutely definitive. After all, we studied only 
three. astronauts, and we studied them only under resting conditions. 
The exercise studies, presented by Mr. Ed Michel, et al.> indicate that 
there is depression in cardiac output and stroke volume during sub",," 
maximal levels of upright exercise that returns to normal in a rather 
brief period of time after splashdown. It seems reasonable to ascribe 
these transient changes to the decreased left ventricular volume we 
measured byechocardiography. Hov/ever, one of the limitations of the 
exercise studies is that post flight, only submaximal levels of 
exercise performa'nce were studied. The crucial measurement that still 
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must be made is what the maximal performance of the heart is in late 
postflight, compared to preflight. For example, if an impairment of 
myocardial function exists, measurements made at submaximal levels of 
exercise may be entirely normal and not necessarily 'reflect an impair­
ment of the maximal pumping capacity of the heart. 
One other aspect of myocardial function that has not been touched on 
at all is whether there is any alteration in myocardial compliance. 
This possibility occurred to us "/hen vie found that during the echo 
studies, although there was a decreased left ventricular end-diastolic 
volume post flight, we were unable to increase end-diastolic volume 
back to preflight levels by subjecting the astronauts to lower-body 
positive pressure, or by elevating their legs. One of the explanations 
of such a finding is that the mission led to a decrease in cardiac 
compliance. If this were the case, it could be due to a change in 
the heart muscle itself, or to a change in the dimensions of the 
pericardial sac. For example, if fluid volume is diminished during 
space flights and the heart is functioning at smaller volumes, it is 
possible that the pericardium adapts to this change by shrinking and 
decreasing the volume of the pericardial sac. The pericardium may
thereby act as a restricting membrane postflight so as to keep the 
heart from returning the preflight volume until increased intracardiac 
pressures generated by the normalization of intravascular volume 
slowly distend the pericardium. It would be relatively easy to measure 
compliance changes in the heart by combining echocardiographic studies 
with more invasive techniques. 
In summary, I think it would be important during future space missions 
to obtain more echocardiographic studies with ventricular function 
curves. Perhaps such studies could be performed in-flight, in which 
case it would be interesting to test Dr. Shepherd's hypothesis that 
left ventricular volume is increased during flight and only in 
transition to one-g does volume decrease. I also believe that maximal 
exercise testing would be essential to perform and that compliance 
studies of the heart should be considered to ensure that no other dele­
terious change in myocardial function has occurred that vie have 
neglected to look at. 
As a final comment, I would like to say that this has been a very 
fruitful collaboration for all of us at the National Institutes of 
Health. \~e already have begun to employ some of the techniques we have 
used on the astronauts to study the patients we see in our clinics and 
wards, and I'm optimistic that new data and insights will be generated 
using in patients some of the techniques we've helped develop and learn 
about here at NASA. Thank you. 
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It was worth restating that Dr. Berry said the program is the 
culmination of 15 years of effort. This is about half or a good portion 
of the lifetime of many members of this audience. This period of time 
has involved extensive work in many fields of physiology and "space 
medicine". After the very detailed and excellent review of only one 
kind of problem, namely, the cardiovascular responses to weightlessness 
we should move away from that and picture what was one of the very first 
physiological concerns and which has not even been mentioned yet during
this symposium. This is the exchange of gas with the respirable envi­
ronment that is transported from Earth for the astronauts to breathe. 
This evidently has become an entirely manageable aspect of manned space
flight. However, I would like to restate one of our earlier concerns, 
namely, that if individuals became ill with diffuse pulmonary disease 
(such as viral pneumonia), that this might generate peculiar kinds of 
circumstances such as diffuse atelectasis in a weightless state in the 
handling of pulmonary debris and secretions. It will still be wise to 
keep alert to details of the respiratory gas exchange and pulmonary 
function as one moves on into longer and longer periods of time where 
illness may develop or consequences of physical changes such as fluid 
shifts may progressively modify pulmonary function. . 
Now going from the still important considerations of respiratory 
exchange, we could next look at the whole man. Something that has been 
established is that man himself is able to proceed through the whole 
pattern of flight and come back. The whole man, including his senses, 
his vision, his hearing, his ability to react to his environment per­
formed very well. His mind worked all right, so that even if his 
cardiovascular system could not tolerate all of the specific gravita­
tional stresses on return quite the way we wanted them to, he did quite 
.well with his mentality, his fingers and thumbs and other important 
parts while he was out there. He could carry out exceptionally useful 
and intelligent work. This means that gas exchange and factors 
involved in circulation to his head, and his hands and some of the parts 
in between were functioning all right. Now if we take the whole indi­
vidual and examine him a little more closely, his heart probably also 
got along well because it was exercising all of the time as it normally
tends to do in us even when we are at rest. It is normally an 
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exerclslng organ and, therefore, probably its muscle was not likely to 
suffer quite as much from the weightless state as his legs were. 
I also saw no sign that the actual skeletal motor mass, the voluntary 
muscles of the individuals themselves, if they were treated right by
being given adequate doses of exercise or of strain, had to experience 
a decrement at all. Massive work loads and rates of oxygen consumption 
were accomplished by the whole individual in this space environment ­
probably larger degrees of oxygen consumption than most of us can even 
begin to think about performing here and now. Therefore the individuals 
were certainly not limited in terms of performing hard labor activity in 
the space environment. Their muscles, therefore, in terms of the exer­
tion of force, were certainly not handicapped. The circulation to the 
muscles may have been handicapped on return, leading to some of the 
decrement in exercise capability at one-g. However, it is necessary to 
distinguish between the intrinsic capacity of skeletal muscle itself to 
contract and the factors involved in supply of nutrients and oxygen to 
the muscles during a period of work. Therefore one has to consider the 
muscle and the circulation separately. If in the circulatory system, 
the heart itself was not severely in jeopardy, then one would have to 
look towards the circulatory regulating mechanisms as the limiting 
system on return. And I think they have been elaborated upon quite 
enough for now. 
The question I have been posing is, then: Can we divide the overall 
exposure and experience into stages and look at these stages separately? 
Surely we can. One of these parts is the stage of prolonged exposure to 
the weightless state. The composite of all the observations described 
has indicated that individuals can, in fact, go on for long periods and 
keep themselves in reasonably good shape, even with the fluid shifts 
and even with the central vascular congestion and calcium loss. In 
addition, there is clearly a reasonably prompt return to - or adaptation 
on return to sea level and one-g again, back to Earth's atmosphere. The 
stage of real problems is that of transition between that harmless 
exposure in space and the readaptation on Earth. It therefore seems to 
me that the concentration that those of you directly involved in this 
work must make is on the stage of transition from one more or less 
Ilnormal" state in weightlessness to a second normal state after return 
to one-g again, because the failures really occurred at that point.
Actually it is still true that present astronauts are active, working, 
laborers in space but passive on entry into the Earth's gravitational 
field. Some day one will require active, self-controlled entry, and it 
is at that particular point that these questions are going to be most 
important: Can the individual be fully active during the stress of 
return, including during the entry; not only can he readapt to life in 
this atmosphere and at one-g well enough. 
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It seems now that a good deal of the attention from here on is going to 
be required to take the excellent observations made in the program to 
date and modify the experiment procedures drastically in ways that are 
controllable. I would urge that from this point on more attention be 
given to long-term studies in which individuals in space are allowed to 
actually deteriorate naturally, without attempting to sustain their 
-y physiological systems so that they can function fully on return. In 
other words, we now need professional "subjects" in addition to the 
pilot-commander and other responsible individuals in the spacecraft 
system. Then, having generated natural failure and studied it, one 
should study use of low-mass materials, such as drugs as stressors, 
which may, in fact, be able to modify fluid volumes, modify cardiovas­
cular tone, supplement or replace baroreceptor mechanisms, and modify
calcium loss. I think we now have to set up the kind of long-term 
laboratory in space in which such professional subjects are, in fact, 
considered not as "astronauts ll but as "subjects", with physically com­
petent individuals serving as transport crew for other individuals who 
are being studied in detail along with other experimental animals. Out 
of such an approach can come the exact pattern of unmodified deteriora­
tions and adaptations to be dealt with in planning toward the ultimate 
in manned space flight. 
,­
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I believe the crucial problem that this symposium has heard about is 
that related to red cell mass change. The material presented on the 
change in red cell morphology may be a fascinating insight into a 
who 1 e new set of problems, but we are still along way from even 
beginning to be able to make an interpretation of these observations. 
I want to spend most of my time on the first problem. 
There's a rather interesting psythological set, if you will, that 
overlays many of the reported investigations which has had a great 
influence on the way the observations are now coming together and 
beginning to make a coherent picture. The NASA Manned Space Flight 
Program has had a very laudable, and I must say, enviable record of 
attention to crew safety issues. But one of the things this has done 
is that it has put many of us who have been either peripherally or 
directly interested in one or another of the investigative aspects of 
the program in what might be called a "pathophysiological frame of mind". 
We tended to look first at changes as possible expressions of path­
ological mechanisms and possibly rightly so; but, in so doing, I think 
we have from time to time lost sight of what we were really observing, 
i.e. evolving physiological adaptations. I am delighted to see that 
this conference had its principal focus on physiological adaptation, 
and the concerns about pathological processes have been put into second 
rank. 
It seems there is no argument that .there is a distinct downward shift 
in red cell mass. Again taking the view that this is not a pathological 
process, that it is not a process which thus has the potential of 
becoming continuously downward in its direction, but that it is the 
searching for a new adaptation, one can, of course, then take a fairly
comfortable position about it, at least insofar as the safety of the 
astronaut functioning in space. Dr. Lambertsen has raised the question 
about the flight transitional states, which really are the important 
ones. Here we have some very interesting data that I think need to be 
reexamined. The data presented suggest that the red cell mass deficits 
in the shorter flights, the earlier ones we were able to study, were 
possibly greater than those encountered in missions of longer duration. 
There may be some technical explanations for this. This may not be a 
set of entirely comparable measurements. We must try in retrospect to 
reconstruct the exact circumstances of those, and see if it's possible 
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that we were overmeasuring the red cell mass decrement in the earlier 
flights and that our more recent flights and related observations are 
those which are closer to the truth. You will notice also that the 
variability in the measurements were much greater in the earlier flights. 
But it is also possible, and this would be of great interest, that 
there is a kind of overshoot in the downward readjustment of red cell 
mass and that this overshoot is gradually recovered over a longer 
period of time to a new steady state. 
I feel that the formulations we have heard of the mechanisms of re­
adjustment are both clear and reasonable. Dr. Thornton's formulation 
is that the change in central blood volume is the crucial factor that 
all other changes proceed essentially from it, in a passive or active 
kind of readjustment. Dr. Johnson's formulation, which you heard, is 
an interesting one. I would have to raise a question with his formu­
lation which in sense says that there are metabolic changes which 
favorably shift the oxygen-carrying capacity of the red cell mass and 
that this in turn permits the downward red cell mass adjustment. That 
is one way of looking at it in contrast to the way which Dr. Thornton 
presented these changes in oxygen-carrying capacity. It would seem 
that a metabolic process which produced the shift rightward in the 
oxygen dissociation curve might be more likely the secondary event than 
the causative event in the red cell mass decrease. 
It's interesting that the "pathophysiological view" still persists! I 
notice Dr. Dietlein's slides still had the concept of "marrow inhibi­
tion". Maybe we really ought to speak of the marrow that is just 
turned down or turned off because it's not necessary that its activity
remain at the normal earthbound one-g level. With this concept, bone 
marrow is really just resting and not inhibited. 
Before we can really get a picture of what happens in a situation like 
this and in comparable experiments in animals, (for example, the 
artificially polycythemic overtransfused animal), we have one very large 
black box in the canonical diagram of the regulation of erythropoiesis 
that must be opened up. This contains the sensor system, if you will, 
the sensor-set point physiology. We know a few things. We know 
erythropoiesis is a hormonally controlled apparatus. At least there is 
one stimulatory hormone. The apparatus responded to oxygen, possibly 
not only to oxygen tension but to oxygen transport, which has something 
to do with blood flow. The time constants of the system are long, and 
the rude canonical diagram would suggest that it is a system that is 
driven upward, then relaxes and passively adjusts itself downward in 
the absence of the stimulus. Many alternative models of this system 
are yet to be explored. Is it possible that it is a multihormonal 
system, that there is some type of driver-antagonist hormonal balance, 
that there are pro-hormones, and that hormone conversion rates are 
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important? What is the process of sensing, in biochemical, physical, 
chemical, or electrochemical terms? Are second messengers involved? 
Until we can answer these questions not only in the case of man but by
fundamental experimental investigation, we will have to accept the 
rather general picture we now have of the mechanism of space flight in­
duced red cell mass decrease. The best assumption to me seems to be 
that it reflects a new balance in the circulation and in the perceived 
blood volume. This formulation certainly is an adequate one to explain
what we have so far seen. 
On the other hand, we ought to exert every effort to try to develop 
other formulations of these mechanisms of change, and not accept those 
which seem reasonable and rational on the basis of our very limited 
present knowledge. For example, is there some direct mechanism by which 
erythorpoiesis is influenced that may bypass the hormonal system even, 
or at least bypass much of the regulation in control of the hormonal 
system, which is directly dependent upon some compartment of blood 
volume? Many of you can develop notions about how these kinds of 
hypotheses could be approached investigationally. There is a possibil­
ity of control of the red cell mass change. I wanted to consider this 
because I feel Dr. Lambertsen is quite correct when he says that the 
next generation of investigators in space physiology is going to have 
to put much of their effort into problems of control, compensation and 
adaptation of systems that get beyond physiological limits in less than 
ideal subject astronauts. What about phlebotomy? People entering 
zero-g seem to have about 700 milliliters too much central blood 
volume, maybe even more. What about just taking that volume from them, 
preserving it in anyone of a number of tricky ways that are now avail­
able, and putting it right back when they have to come home? 
r1ODERATOR: Dr. Berry. 
Well, the suggestions are getting better and better. We really thought 
about that, Scott. I want you to know we have thought about the 
phlebotomy route; we discussed it, but we thought everybody gets scared 
of needles and scareder of blood, it appears. 
SPEAKER: Dr. Swisher. 
I would suggest you sell it and not put it back. 
MODERATOR: Dr. Berry. 
Yes, you'd make a lot more money these days. Anyway, lid like to ask 
Dr. Bob Heaney if held give us his view of this mineral balance area. 
I know he's been brainwashed somewhat, I'm sure, by Don Whedon by now, 
but I know him to be an individualist, and he's not going to listen to 
all that input and so he's going to give you his own strict view here. 
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Two major points stand out clearly from both the Skylab mineral studies 
and their supporting ground-based projects. These are: 
o 	 bone loss definitely occurs under zero-g conditions. It is certain 
that this loss continues for at least sixty days, and it is almost 
certain that it continues for as long as 84 days. There h-as been 
no evidence that this phenomenon shows the type of adaptation to 
zero-g which has been exhibited in the other systems which have 
been the subject of this symposium. 
o 	 bed rest, under one-g conditions is surprisingly suitable as a 
model for the bone loss of zero-g. 
I shall expand, briefly, on both of these points, before going on to a 
discussion of what lies ahead. 
Bone Loss. We now have calcium balance data on six of the nine 
astronauts, and urine calcium values for all nine. Calcium balance 
shifted negatively for five of the six (one of the Skylab 2 crewmen 
showed essentially no change). Urine calcium increased substantially 
in all nine. This latter change, while highly suggestive of negative 
balance, cannot be fully assessed without knowledge of calcium absorp­
tion, so we must wait for final balance data from Skylab 4. Never­
theless, the continued high values for urine calcium through the entire 
length of the Skylab 4 study gives us no reason to believe that any kind 
of adaptation occurred during the 84 days of that mission. Finally, 
both from bed rest and from in-flight studies, we have no evidence that 
the exercise program or the physical countermeasures which have been 
employed to date in any way alter this bone loss. This is not to say 
that more strenuous measures would not work; it is simply to stress that 
those which have been tested have not been effective. 
Vogel has observed significant os caZcis bone loss in one of the three 
Skylab 3 crewmen, and in two of the three Skylab 4 crewmen. He suggests
that it may be possible to predict susceptibility to bone loss in 
advance, but data are still too few to reach a final conclusion about 
the usefulness of this approach in a zero-g situation. 
Bed Rest Model. Despite many initial reservations, one-g bed rest 
appears to mimic zero-g weightlessness to a surprisingly good extent. 
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The two situations behave similarly for calcium balance, urine calcium, 
os aaZais mineral loss, and hemodynamic effects. Hence this appears to 
be an entirely suitable, ground-based model. 
* * * * * * 
With respect to these data and their implications, there appears to me 
to be three big questions which we must try to answer. These are: 
o how clinically significant is the bone 10ss1 
o what, if anything, can be done about it? and 
o where do we go from here? 
Seriousness of Bone Loss. Here I think the major point is to focus 
briefly on the distinction between negative balance in-flight and the 
negative balance shift which occurs between preflight and in-flight
conditions. Recall that four of the six crewmembers for whom we have 
balance data were in substantial positive balance preflight; hence the 
shift in a negative direction is substantially larger than the actual 
negative balance. Positive balance is unusual in this age group; for 
this reason we must ask ourselves why it occurred. I think immediately 
of two major possibilities: preflight conditioning, or systematic 
measurement error. If the effect is due to conditioning, then it is 
only the in-flight negative balance which reflects actual bone loss; if 
there is a measurement error, then the actual zero balance or equilib­
rium point may be closer to the preflight situation, and the shift is 
then a better indicator of actual bonp. loss. 
Skylab 2 showed no really significant negative balances; however 
Skylab 3 did, with two of the three crewmen demonstrating actual nega­
tive balances of pathological severity. We eagerly await the Sky1ab 4 
data. If the balance shift is the better indicator of actual bone loss 
then four of the six crewmembers had pathological balances. The aver­
age shift, for example, in the three Skylab 3 crewmembers, exceeded 
200 milligrams Ca/day. This is a really worrisome figure. With 
respect to bone loss, therefore, I feel we must conclude that it is at 
least, potentially serious, that it remains a problem, and that it shows 
little evidence of demonstrating that adaptability which has character­
ized so many of the other$ystems studied in the Skylab projects. 
~~~,,'~' , 
What Can Be Done About the 
., 
Bone Loss? Recall that the relation 
between bone mass and stress was articulated many years ago and is 
known as Wolff's Law. Paraphrased, this law states that the mass and 
configuration of bone change in response to changes in external stress. 
Loss of bone, particularly in the legs, is an entirely normal adaptation 
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to reduced gravitational forces. Our rationale in attempting to suspend 
the operation of this law is that zero-g is not the ultimate environment 
for our astronauts and we want them to be able to function well once 
again in a one-g environment. I do not believe we would have the same 
concern if we were contemplating interstellar voyages at sublight speeds. 
It 	is the one-to-three year trips about which we worry. 
Basically, therefore, we have - it seems to me - only four ways to go: 
o 	 We can select people who are sluggish responders to Wolff's Law, 
i.e., who have a long time constant in their response to altered 
mechanical stresses. We donlt now know how to look for such indi­
viduals, but Vogel IS prediction term may be a start. I suspect 
that the urinary hydroxyproline component of his term is its most 
important and promising feature. Clinical analogs of slow 
responders are seen in human hypothyroidism and hypoparathyroidism. 
Incidentally, both hypothyroid and hypoparathyroid individuals 
would have high prediction terms. 
o 	 We can develop pharmacological or other treatments which 
effectively lengthen the time constant of response, i.e. , which 
convert astronauts into sluggish responders. Agents of possible 
utility include the diphosphonate compounds and fluoride, both of 
which, used preflight, show considerable promise of retarding in­
flight bone loss. They may be useful in-flight as well, but 
premedication seems especially promising. We also need to look at 
a whole cluster of factors which, though not primary, may never­
theless frustrate our attempts to lengthen the time constant of 
bone remodeling response. There are a great many factors which are 
known to enhance any bone resorptive stimulus. These include such 
agencies as acidosis (even mild), high tissue oxygen tension, high 
bone blood flow, as well as the level of hormones such as thyroxin.(We heard yesterday of a tantalizing increase in free plasma 
thyroxin. We need to know what this means.) I think it is prob­
ably safe also to conclude that the diets consumed by the 
astronauts had a high acid ash content. You may have noted that 
the protein intake was at least twice the recommended adult dietary 
allowance. Whereas this is typical of the adult American male, 
there is some question about whether it is good for him under even 
one-g circumstances, and I suggest that there is both less justi­
fication for its use in zero-g, and even some reason to believe 
that it may be harmful. 
o 	 We can select individuals already adapted to something closer to 
zero-g. Here I refer to sedentary, skinny, small individuals. 
Perhaps someone more like Dr. Whedon or myself would be better 
suited than these wiry athletes. I have found myself asking, 
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repeatedly, these past three days, why there is this quite 
extraordinary emphasis on physical fitness for function in a 
weightless environment? Great muscular strength and endurance 
have obvious survival value in the jungle, are of problematic 
importance in a civilized environment (except as a means of 
burning our excess caloric intake), and are all but redundant in 
a zero-g environment, where it is the human nervous system and 
cybernetic flexibility which are of crucial importance. Pushing
this suggestion even further, I think one must seriously consider 
selecting individuals who have already developed lower extremity 
disuse osteoporosis, whose legs are already - as in space - nearly
useless appendages. I refer to individuals who have a variety of 
lower extremity paralyses. 
o 	 Finally, and I suggest this quite seriously, I think sober 
consideration should be given to selection of amputees. The legs 
are the major source of our concern about bone loss. At very
least, they deadhead with us on these missions. We have seen that 
they are nearly useless. Their tissue requires food and consumes 
oxygen, and if we exercise them, they consume even more. The ulti­
mate fuel cost of legs on long missions must be really staggering. 
There are many double amputees around, and many of them must be 
veterans of our own wars. Instead of stigmatizing them as less 
than "whole men", I think we must seriously ask ourselves whether 
they do not have an important role to play in space. 
There is one other theoretical option, namely the development and 
application of even more strenuous exercise and countermeasures than 
those employed to date. It;s not known that these would work, but 
they might. I have neglected this option because its cost for long 
missions would appear to be prohibitive. Hardware weight would be the 
least of that cost. The food, oxygen, and waste management require­
ments, and the fuel necessary to orbit it all, would be uneconomical in 
the extreme. Sooner or later considerations of economy must emerge.
When that happens, minimization of caloric intake and expenditure will 
be seen to be desirable. This may mean longer reconditioning back on 
Earth, but that is not a serious problem. Running the mile within three 
days of splashdown is nice, but it's almost certainly a luxury. 
The final question is where do we go from here? Obviously, the answer 
is, "Back to space". But we need more answers, and happi ly the bed rest 
model appears able to provide them. I thus suggest a significant 
emphasis on bed rest studies, with particular attention paid to the 
development of effective pharmacologic countermeasures. I stress once 
again that, on long flights, the food and fuel costs of drug counter­
measures are far less than the cost of maintaining physical conditioning. 
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Because of the long lag time between experimental design and results, 
very careful advance planning is vital so as to insure that we obtain 
the maximum useful information from a set of bedrest experiments. We 
badly need numbers in this game, and we will not get sufficient experi­
ence from actual space flights, particularly in view of the fact that 
the Space Shuttle Program, for at least the next several years, will be 
confined to flights of no more than 30 days duration. Ground-based 
experiments constitute our only reasonable hope. Luckily, as I have 
already said, bed rest has turned out to be better than we had any 
reason to hope. 
Thank you. 
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ADAPTIVE NEUROBIOLOGY IN SPACE FLIGHT 
Introduction 
A characteristic feature of this symposium has been a general re­
orientation of research effort away from the earlier "acute" problems
of conventional flight, towards longer-term problems of "chronic" 
adaptive change incurred by exposure of Man to long durations of main­
tained space flight. In the neurobiological sphere this trend is well 
exemplified by a change of focus from problems of acute disorientation 
due to sensory illusions in flight, to long-term adaptive changes in 
our neuromuscular systems due to prolonged exposure to the zero-gravity 
environment. 
Naturally, faced with the pressing need to meet new goals in a current 
space flight program, immediate research objectives must necessarily 
be guided by severely practical objectives. Nevertheless, before dis­
cussing more applied aspects it may be helpful to touch upon a few 
currently emerging basic mechanisms which probably contribute to the 
adaptive capability of our nervous sytem. 
Sensory-Motor Interactions 
There is good evidence that much of our normal motor control is 
organised not merely as an on-going interaction between continuously
operating automatic Sherringtonian reflexes, but rather as centrally 
released preformed packages of programed neural information (l, 2). 
One might well guess that adaptation to new requirments could be re­
latively easily met by merely reprograming relevant patterns of the 
outgoing central neural discharge. However, there is a growing body of 
research findings which indicates that even cortically released patterns 
of motor drive are not devoid of early interaction with corresponding 
sensory mechanisms. For example we now know that such a central dis­
charge of motor drive is not only destined to activate muscles through 
relatively direct connections with spinal motoneurones, but also, 
through collateral branches of central fibers, to act directly upon
SENSORY neural relay stations in spinal cord pathways. Thus the corti­
cospinal (Pyramidal) motor tract, not only descends to spinal cord 
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networks generating motoneurone activity to drive skeletal muscles, 
but also sends many collateral branches to synapse directly on second 
order afferent neurones in the sensory gracile and cuneate nuclei of 
the dorsal columns of the cord. (1,3). 
A clue to the functional implication of this rather surprising fact is 
perhaps to be found in somewhat analogous mechanisms operating in the 
periphery. For example it is now well established that in many cir­
cumstances both alpha and gamma motoneurones, innervating the main 
(extrafusil) and muscle spindle (intrafusil) fibers of a skeletal 
muscle, can be coactivated at the same time. It has been proposed that 
when the combined alpha-gamma program operates "according to plan", the 
muscle spindles contract (or relax) in just such a way as to null out 
any change in their sensory discharge caused by mechanical shortening 
of the main muscle (4). This rather neat arrangement would ensure that 
it all went well (i.e. ,according to plan), then the central nervous 
system (CNS) would not be bothered with unnecessary sensory information. 
By contrast, if the lIintended" response was not achieved, then needed 
sensory information would indeed reach the CNS which, in turn, would 
presumably modify the next motor command. 
What do we know of the ways in \'Jhich such modification could be brought
about? One such mechanism might well be associated with the recently 
postulated concept of "Cortical Servo-Assistance" in skeletal muscle 
control (4). Briefly, there is growing evidence pointing to the prob­
ability that many muscular and other related afferent neural discharge 
from peripheral sensors bypass the sensory cortex of the cerebrum and 
project more or less directly to associated areas in the cerebral MOTOR 
cortex. These in turn relay suitably time (5) motor signals to relevant 
muscle groups (6) in a highly localized quasi-reflex manner. However, 
passing through cortical levels in the CNS, presumably responses of 
this nature could be subject to conscious, or even subconscious, mod­
ification (7) in such a way as to reestablished an acceptable match 
between corresponding motor and sensory signals associated with a given 
action. 
Similar properties may apply to other sensory-motor systems. For 
example it has been proposed on the basis of neurophysiological experi­
mentation that the vestibular primary afferent neural response to an 
INTENDED head movement may tend to be nulled out by a suitable outgoing • 
efferent discharge to the end organ (8). In this case involuntary
vestibular stabilizing reflexes in the neck and/or body muscles would 
only arise when unintended or pertubing head movements occurred. Again,
the normal exercise of voluntary control would include the generation of .. 
an appropriate combination of neural signals to both the relevant 
motoneurones and the associated sensory systems. Mismatch between these 
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two informational neuronal systems due to changes in the environ~ent 
would then bring about appropriate changes in their relationship so as 
to reestablish acceptable conformity in the new environment. 
At a lower, more automative, level in the CNS, other mechanisms have 
recently come to light in a series of experiments specifically designed 
to investigate habituative adaptation in the adult human brain (9). 
During normal head movements, autostabilization of the eyes relative to 
space is brought about by two complementary physiological processes
namely, visual tracking and the vestibulo-ocular reflex. By the simple 
process of optically reversing the "seen" visual field, these two pro­
cesses are forced into direct opposition: during head rotation to the 
right visual tracking then supplies a right.-going oculomotor drive, 
whilst the vestibulo-ocular reflex continues to supply what is now an 
opposing left-going drive. Obviously, the residual vestibular drive 
then disturbs, rather than aids, visual fixation during head movement. 
The question now arises whether or not central habituative adaptation 
can reorganize the available sensory-motor mechanisms to restore 
complementary interactions serving the common goal of image stabilization 
on the retina during head movement. 
Remarkably. through a rather complex sequence of detailed changes, 
radical reorganization of the vestibulo-ocular reflex occurs such that 
after about 10 to 14 days of continued vision-reversal. the adult human 
vestibulo-ocular reflex becomes effectively reversed. thus once again 
serving a complementary function with visual tracking (10). Recent and 
current findings in this field from several different laboratories point 
strongly to cerebellar involvement in these autoadaptive changes (11,12.13). 
Although in this case cerebellar involvement may be hard to equate with 
the cortical servo-assistance mechanisms outlined above, yet a common 
factor remains in the outcome of these latter experiments. Peripheral 
sensory retinal signals generated specifically by undesirable (i.e., 
blurring) movement of the image on the retina tend eventually to be 
nulled out by consequent readjustment (i.e., reversal in this case) of 
the automative vestibular drive to the extraocular muscles which control 
eye movement. 
Astronaut Adaptation 
Turning to the astronaut's problem of sensory-motor adaptation to the 
space environment. one may guess that on setting out to make a movement 
in his normal earthbound environment he formulates a motor program, as 
a result of which the EXPECTATION is: 
o 	 a particular magnitude, direction and speed of limb and/or 

body movement, and 

o 	 an anticipated set of afferent sensory signals which would be 
generated had that movement been successfully achieved as planned. 
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In zero-gravity space environment, not only is the actual movement for a 
given neuromuscular program going to be changed, but so also is the 
compatibility of the evoked sensory response, since the pattern of the 
sensory message itself will also be modified by absence of the gravita­
tional acceleration vector, even had the movement occurred as intended. 
Presumably the CNS is then forced to work through a series of sucessive 
organization readjustments which might in their simplest form be con­
ceived somewhat along the following lines: first there would be a 
mandatory call for changed associations between patterns of intended 
motor command and the actual patterns of efferent, or outgoing, neural 
discharge generated by that command. Then there would be a logical 
need for compatible readjustment in the meaningful interpretation of 
informational content in the resulting patterns of evoked sensory dis­
charge. In turn there would presumably have to be habituative, or 
goal-directed, modification of requisite automotive "ref1ex ll responses 
(e.g., ocular stabilization) to those changed patterns of sensory dis­
charge. 
Seen from this viewpoint it is little wonder that on entering the 
space environment an astronaut is faced with a more or less traumatic 
experience of habituative adaptation. Indeed in this symposium such 
adaptation has been shown to carry a significant practical penalty
sometimes manifest as a temporary reduction in acceptable work load, 
and even on several occasions overt "habituation" sickness, together 
with potentially serious accessory penalties of endogenous malaise with 
its subtle changes in motivation and the loss of appetite familiarly 
associated with ordinary Il motion sickness ll • 
Fortunately, after 7 to 10 days all Skylab personnel appear to have 
adapted well to the new environment, even to the point of becoming re­
markably agile in the organization and management of their daily move­
ments through the Sky1ab interior. Nevertheless, this very fact 
necessarily implies that some form of readaptation must occur on return 
to Earth. 
Important questions then arise concerning the rate and nature of re­
adaptation to the normal Earth environment. Certainly, immediately 
after return both postural equilibrium and locomotion are seriously 
impaired. At first it was felt that return to near normal was only a 
matter of a day or so. But quantitative tests of postural balance 
control showed that readaptation probably occurs along a similar time 
course to the initial adaptation after entering orbit, namely 7 to 
10 days. It could be argued that the measured difficulty of balance 
was merely a manifestation of diminished strength in the leg muscles. 
However, although disuse atrophy of leg muscles was shown to occur, 
this could hardly have been the only source of disequilibrium, since 
with eyes open normal balance tended to be restored very quickly; it 
was only with eyes shut that prolonged postural inadequacy was revealed. 
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Numerous other observations, such as dizziness on shaking the head, 
occas i ona 1 mi sjudgements of footi ng, diffi culty in wa"1 ki ng round corners 
et cetera~ collectively seem to indicate that the CNS does not simply 
"click back" to its remembered regimen before takeoff. Rather the 
evidence, both objective and subjective, points to a progressive re­
organization in the nervous system which has to "unravel" the adaptive 
changes incurred in space, probably by means of habituation mechanisms 
akin to those responsible for the original space adaptation. In the 
present author's view this conclusion is strongly supported by the very 
striking findings of Dr. Ashton Graybiel and his colleagues from the 
Human Vestibular Function tests of experiment M131. Controlled head
• 	 movements performed on the earthbound rotating chair produces a 
characteristic onset of motion sickness even with eyes shut. This could 
be attributable to sensory conflict between the thoroughly misleading 
semicircular canal signals which then arise and other more normal non­
visual sensory inputs such as activation of the vestibular otolith 
organs by the gravity vector and/or proprioception from the neck. 
Of very great interest is the finding that on performing similar head 
movements with eyes shut during rotation on the orbiting Skylab turn­
table, subjects were essentially free of the expected signs and symptoms 
of motion sickness. Since the essential difference between the two 
conditions 	is absence of a fixed gravity vector in space, it could be 
argued from the above finding that the earthbound phenomenon with eyes 
shut is due specifically to internal conflict between canal and otolith 
components 	 in the vestibular system, rather than other sensory sources 
such as neck proprioception. 
From the data presented in this symposium an even more striking obser­
vation seems to have been temporary retention of immunity to head 
movements with eyes shut, performed on the turntable after return to 
Earth. Dr. Graybiel has cautiously reserved judgement on this apparent 
finding on 	 account of changes in his planned schedules of tests imposed 
by such imperative factors as changed preflight schedules of the astro­
nauts. Nonetheless, the evidence is sufficiently strong to persuade 
the present 	writer that the postflight immunity mentioned above will 
eventually prove to be real. In that case there would appear to be 
two alternative conclusions: 
o 	 the space environment generally reduced susceptibility to 
motion sickness, or 
o 	 central adaptive changes of the kind discussed above left the 
CNS temporarily unresponsive to otolith stimulation by the 
steady "g II vector . 
• 
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The fact that some astronauts were made seasick shortly after splash­
down into moderately rough sea would seem to contravene the first con­
clusion, leaving one with the view that the time course of return of 
normal motion sickness on the turntable represents some index of genuine 
habituative readaptation; in this case perhaps reacquisition of a 
meaningful sensory perception of the gravity vector through the otolith­
mediated afferent neural signals. 
The reader could reasonably detect an inconsistency in this argument, 
on the grounds that seasickness after splashdown would probably be 
•attributable to periodic stimulation of the otolith organ (14). How­
ever, in this context, it is important to appreciate that changing 
linear accelerative stimulation of the otolith organ must continue to 
be experienced during head and body movements in the orbit-ing Skylab: 
but the constant gravitational field is nevertheless consistently absent 
in space. Perhaps in the context of these combined observations 
we may be seeing additional evidence in favour of an earlier suggestion
of ~ayne (15) that otolith neural responses to changing accelera­
tions and the steady acceleration of gravity may be information-
ally separated by "high-pass and "lo\'l/-pass" filtering respectively in 
the CNS; as indeed is the case in some forms of man-made inertial 
guidance. In this case it would be easy to reinforce the earlier con­
clusion (i.e.~ CNS temporarily unresponsive to otolith stimulation by
the steady "gil-vector) that one form of adaptive change in space would 
amount to a "learned" ability to disregard the presence of those neural 
signals carrying information about a constant IIg" vector. Such a con­
clusion would not be out of line with the observed difficulties of 
postural control after return to Earth, recovery from which would appear 
to run an almost parallel time course with the return of normal motion 
sickness induction during eyes-closed head movements on the turntable. 
Of course these views on basic mechanisms must be treated as highly 
speculative. Still, without speculation there would be little chance 
of progress in subsequent experimental designs having more applied
objectives. 
Applied Considerations 
Bearing in mind the relative imminence of Space Shuttle we should per­
haps consider first any relevant implications to that program from 
this symposium. In the context of the present article a prime question 
must surely be: Could adaptive phenomena of the kind discussed above 
prejudice "fly-home" of a Space-adapted Shuttle pilot? Of course it may 
well turn out that continued maintenance of a high standard of training 
..in the use of instrument aids will suffice to offset any unexpected
disorienting factors; as indeed has proved to be true in most circum­
stances encountered in conventional instrument flight. However, 
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although one may hope for this we have to face the fact that for reasons 
discussed above it seems that Skylab adaptation was uniformly associated 
with a new form of more or less profound reorganization of the body's 
orienting mechanisms. It would therefore seem negligent to disregard 
the problem. Unfortunately the paucity of intervening space flights 
leaves little opportunity for full interrogation of this question . • Nevertheless the very serious consequences of an adverse outcome en­
courages the urgent design and development of a suitable battery of 
experimental tests for inclusion in the forthcoming Apollo-Soyuz mission, 
despite the potentially limited space-adaptation offered by its short
• 	 duration and relatively small internal volume of the combined vehicle. 
Indeed perhaps the practical urgency of the matter warrants the 
additional inclusion of a "try and see" approach in which the returning 
Apollo astronaut is immediately exposed to dual-control real instrument 
flight in a familiar high-performance aircraft. 
A second feature bearing directly on the Shuttle program is the pro­
tracted period of space sickness malaise and loss of appetite encounter­
ed by a sizeable proportion of Skylab astronauts. Bearing in mind the 
short~uration of the average Shuttle mission, it seems inevitable that 
effectively 	novice personnel engaged in research or other activities 
will be penalised by reduced work potential unless some form of suc­
cessful preconditioning regimen is discovered. The difficulty of doing 
so has been 	 highlighted in this Skylab symposium by the notable lack of 
correlation 	between space sickness and both personal motion sickness 
histories and immediately preflight habituation measures. Even phar­
macological therapeutic measures did not always suffice. Consequently 
there would 	 seem to be an urgent need to search for effective means both 
of of selecting suitable personnel and for their preconditioning and/or 
therapeutic treatment. 
Preconditioning 
Presumably the major source of space sickness must be directly related 
to the sudden absence of gravity, with the somewhat uncertain implica­
tion that changed patterns of vestibular otolith stimulation may offer 
the most likely source of disturbing afferent signals concerned with 
generating space sickness. It is true that other afferent sources 
such as kinaesthesia and muscle proprioception will also be affected 
by zero-"g". But such evidence as has been discussed above in con­
nection with experiment M-131 does not encourage the view that these 
alone can provoke space sickness. Furthermore the habituation associated 
with readjustment of motor-eye coordination due to simple angular dis­
placement of the visual scene is not apparently associated with 
vegetative symptoms of "motion sickness" (16). 
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Perhaps a fruitful approach might be to explore the possibility of 
employing strictly linear oscillatory stimuli in a low frequency range 
known to be highly provocative of motion sickness (14, 17). Probably
motion should be constrained in the vertical direction to avoid 
directional changes in the resultant acceleration due to vectorial 
summation with gravity. 
• 
A further point to bear in mind is the potential need for prehabituation 
to a high gravity environment after long periods in space, as for 
example when landing on Mars. It would seem advisable in any case to 
search for means by which an astronaut in space might not only maintain • 
his leg muscle mass, but also exercise his postural equilibrium systems. 
One might for example envisage bodily control, perhaps even through
the legs and feet, of a suitably unstable mechanical device simulating 
the normally standing man. 
Otolith Dynamics 
On a long-term basis, it would seem important to learn more about the 
basic dynamic response characteristics of the vestibular otolith organs.
After many years of research, corresponding response characteristics of 
the semicircular canals have become well understood and this knowledge 
permits accurate prediction of boundries encompassing movement profiles
beyond v/hich they feed misleading information to the brain (18). How­
ever, much less is known about the mechanical and neural dynamic
response of the otolith organs (19,20,21) and there is an obvious need 
to make good this deficiency by insightful combinations of human and 
neurophysiological animal experimentation. 
Habituation 
Although some of the adaptive phenomena referred to as habituation have 
been extensively studied (22,23,24) the nature of the processes involved 
are yet far from understood. For example it has been customary in the 
past to consider the habituation process as essentially an attenuating 
one. whereby repetitive stimul i progressively cause 1 ess effect 'j n the 
eNS. However, it is now clear that this is too simple a concept. For 
example in animal experiments it has been shown that after unilateral 
labyrinthectomy the spontaneous activity of ipsilateral second order 
vestibular neurones falls drastically, probably causing the resulting 
persistent ocular nystagmus. But as the animal adapts (habituates) to 
the point of relatively normal behaviour (no spontaneous nystagmus), 
so the spontaneous activity of those neurones rises again to normal. 
The functional advantage of this is that they can then be adequately
driven by inhibitory commisural connections from the normal, contra­
lateral, vestibular system (25). Again, we have already seen that 
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optical reversal of V1Slon in the adult human subject leads progressively 
to active reversal of the involuntary vestibulo-ocular reflex, rather 
than its mere passive attenuation to zero gain (9, 10). It now appears 
from a number of difficult sources that not only can visual afferent 
signals from the retina influence vestibular afferent activity in both 
excitatory and inhibitory ways (11,12,26,27) but furthermore vestibular
• afferents can similarly modify the activity of visually evoked responses
in the tectum of the mid-brain. Evidently there are multitudinous ways 
in which intersensory, and sensory-motor interactions can bring about 
change in the adult central nervous system. One must presume that 
• 	 eventually the rational use of these powerful adaptive facilities for 
our own ends must depend upon basic knowledge of their mechanisms and 
functional capabilities. In particular, it would seem important to 
learn how to define the physiological goals towards which one may wish 
the habituative change to be driven, since as already emphasized it 
appears that the habituation mechanism characteristically acts in the 
manner of a goal-seeking process (9). 
Postural Equilibrium 
A clear-cut feature of return to Earth is the transient postural dis­
equilibrium already discussed in other contexts above. Thus the 
combined outcome of experiment M-13l and the Ilrail li tests of postural 
equilibrium suggest to this author that more profound adaptive changes 
are at play than mere deconditioning of postural muscles. However, 
the detailed 	nature of such change is by no means clear and since the 
matter has both basic and applied implications further experimental 
investigation would seem to be called for. 
First, with the background supplied by M-131, advisably carried out 
in Skylab without vision, it would be of great interest to employ the 
same methodology to further explore the role of vision. Even in space, 
the cross-coupling canal "errors ll introduced by head movement in the 
rotating chair would presumably drive the oculomotor system according 
to those lIerroneousli canal signal. Consequently with eyes open the 
retinal image of the workshop interior would then be destabilized, very 
much as on Earth. Would the added sensory conflict from vision restore 
the otherwise absence of motion sickness? 
Next, one could envisage development of the postural equilibrium test, 
using a servo controlled "posturalll platform to make quantitative 
assessment of both normal static control of equilibrium and the postural 
response to unexpected perturbations. Furthermore, following the 
example developed in Dr. L. R. Youngls IVian-Vehicle Laboratory, M.LT., 
it should be possible to extend the use of such a system to interrogate• 
the component part played by changes of proprioceptive muscle feedback 
in the post-return postural disequilibrium (28). 
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Indeed the versatility of this general approach has been further de­
veloped, using galvanic stimuli to generate artificial vestibular 
stimulation. Thus a particular galvanic stimulus causes a sensation of 
head yawing, say, to the left, due presumably to preferential stimula­
tion of the horizontal semicircular canals. Moving the head onto the 
left shoulder carries this sensation with it, so that the subject now 
feels he is "tilting" forwards. A quickly acting backward tilting
reflex response can then be demonstrated in postural muscles acting on 
the ankle joint. If the head is then moved onto the right shoulder, 
the same electrical stimulus to the vestibular system generates a 
sensation of tilting backwards, because the planes of the relevant 
canals have then been turned through 180 degrees. The corresponding 
reflex response in the limb muscles is then appropriately reversed~ 
despite the unchanged nature of the peripheral vestibular stimulus (29). 
Evidently in the Earth-adapted subject, vestibulospinal responses are 
automatically adjusted for maintenance of postural equilibrium according 
to the instantaneous attitude of the head (i.e.~ the vestibular system) 
relative to the body. Would this versatile flexibility of basic 
vestibulospinal postural reflexes disappear in the space-adapted subject? 
And if so what time course would be taken by their reappearance during 
readaptation on Earth? 
Concluding Remarks 
(The extensive Life Sciences program in Skylab has revealed that the 
zero-gravity environment of space induces a wide range of adaptive 
changes extending throughout the biological systems of the body. The 
detailed physiology behind some of these changes has been clearly de­
fined for the first time by experiments described in this symposium. 
Other ingenious experiments have demonstrated adaptive changes which 
raise more questions than they answer, leading to a continuing challenge 
for further research. 
However, taking an overview of the program as a whole, two outstanding 
features have emerged. First, Man can adapt to, and live in, the zero­
gravity space environment for extended periods of time. But second, 
and therefore above all, none of the measured changes so far seen in 
missions extending up to 84 days have proved irreversible after return 
to Earth. 
Nevertheless, these two salient and rewarding conclusions leave no room 
for complacency since this symposium has raised a wide range of new and 
varied problems needing urgent solutions. If the high quality of 
research reported during these past three days has anything to say for 
the future, we may indeed hope that these new problems will be tackled 
with equal energy and imagination. 
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